0001517681 2025-07-01 2025-12-31 0001517681 dei:BusinessContactMember 2025-07-01 2025-12-31 0001517681 2025-12-31 0001517681 2025-06-30 0001517681 us-gaap:NonrelatedPartyMember 2025-12-31 0001517681 us-gaap:NonrelatedPartyMember 2025-06-30 0001517681 us-gaap:RelatedPartyMember 2025-12-31 0001517681 us-gaap:RelatedPartyMember 2025-06-30 0001517681 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001517681 us-gaap:SeriesAPreferredStockMember 2025-06-30 0001517681 us-gaap:SeriesBPreferredStockMember 2025-12-31 0001517681 us-gaap:SeriesBPreferredStockMember 2025-06-30 0001517681 2024-06-30 0001517681 us-gaap:NonrelatedPartyMember 2024-06-30 0001517681 us-gaap:RelatedPartyMember 2024-06-30 0001517681 PPCB:FormerDirectorMember 2025-06-30 0001517681 PPCB:FormerDirectorMember 2024-06-30 0001517681 us-gaap:SeriesBPreferredStockMember 2024-06-30 0001517681 PPCB:SeriesCConvertiblePreferredStockMember 2025-06-30 0001517681 PPCB:SeriesCConvertiblePreferredStockMember 2025-12-31 0001517681 2025-10-01 2025-12-31 0001517681 2024-10-01 2024-12-31 0001517681 2024-07-01 2024-12-31 0001517681 2024-07-01 2025-06-30 0001517681 2023-07-01 2024-06-30 0001517681 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-06-30 0001517681 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2024-06-30 0001517681 us-gaap:CommonStockMember 2024-06-30 0001517681 PPCB:CommonStockIssuableMember 2024-06-30 0001517681 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001517681 us-gaap:RetainedEarningsMember 2024-06-30 0001517681 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001517681 us-gaap:TreasuryStockCommonMember 2024-06-30 0001517681 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-09-30 0001517681 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2024-09-30 0001517681 us-gaap:CommonStockMember 2024-09-30 0001517681 PPCB:CommonStockIssuableMember 2024-09-30 0001517681 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001517681 us-gaap:RetainedEarningsMember 2024-09-30 0001517681 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001517681 us-gaap:TreasuryStockCommonMember 2024-09-30 0001517681 2024-09-30 0001517681 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-06-30 0001517681 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2025-06-30 0001517681 us-gaap:CommonStockMember 2025-06-30 0001517681 PPCB:CommonStockIssuableMember 2025-06-30 0001517681 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001517681 us-gaap:RetainedEarningsMember 2025-06-30 0001517681 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001517681 us-gaap:TreasuryStockCommonMember 2025-06-30 0001517681 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-09-30 0001517681 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2025-09-30 0001517681 us-gaap:CommonStockMember 2025-09-30 0001517681 PPCB:CommonStockIssuableMember 2025-09-30 0001517681 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001517681 us-gaap:RetainedEarningsMember 2025-09-30 0001517681 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001517681 us-gaap:TreasuryStockCommonMember 2025-09-30 0001517681 2025-09-30 0001517681 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001517681 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001517681 us-gaap:CommonStockMember 2023-06-30 0001517681 PPCB:CommonStockIssuableMember 2023-06-30 0001517681 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001517681 us-gaap:RetainedEarningsMember 2023-06-30 0001517681 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001517681 us-gaap:TreasuryStockCommonMember 2023-06-30 0001517681 2023-06-30 0001517681 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0001517681 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0001517681 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001517681 PPCB:CommonStockIssuableMember 2024-07-01 2024-09-30 0001517681 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001517681 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001517681 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001517681 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-30 0001517681 2024-07-01 2024-09-30 0001517681 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-10-01 2024-12-31 0001517681 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2024-10-01 2024-12-31 0001517681 us-gaap:CommonStockMember 2024-10-01 2024-12-31 0001517681 PPCB:CommonStockIssuableMember 2024-10-01 2024-12-31 0001517681 us-gaap:AdditionalPaidInCapitalMember 2024-10-01 2024-12-31 0001517681 us-gaap:RetainedEarningsMember 2024-10-01 2024-12-31 0001517681 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-10-01 2024-12-31 0001517681 us-gaap:TreasuryStockCommonMember 2024-10-01 2024-12-31 0001517681 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-07-01 2025-09-30 0001517681 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2025-07-01 2025-09-30 0001517681 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001517681 PPCB:CommonStockIssuableMember 2025-07-01 2025-09-30 0001517681 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001517681 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001517681 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0001517681 us-gaap:TreasuryStockCommonMember 2025-07-01 2025-09-30 0001517681 2025-07-01 2025-09-30 0001517681 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-10-01 2025-12-31 0001517681 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2025-10-01 2025-12-31 0001517681 us-gaap:CommonStockMember 2025-10-01 2025-12-31 0001517681 PPCB:CommonStockIssuableMember 2025-10-01 2025-12-31 0001517681 us-gaap:AdditionalPaidInCapitalMember 2025-10-01 2025-12-31 0001517681 us-gaap:RetainedEarningsMember 2025-10-01 2025-12-31 0001517681 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-10-01 2025-12-31 0001517681 us-gaap:TreasuryStockCommonMember 2025-10-01 2025-12-31 0001517681 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-07-01 2024-06-30 0001517681 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-07-01 2024-06-30 0001517681 us-gaap:CommonStockMember 2023-07-01 2024-06-30 0001517681 PPCB:CommonStockIssuableMember 2023-07-01 2024-06-30 0001517681 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2024-06-30 0001517681 us-gaap:RetainedEarningsMember 2023-07-01 2024-06-30 0001517681 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2024-06-30 0001517681 us-gaap:TreasuryStockCommonMember 2023-07-01 2024-06-30 0001517681 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-07-01 2025-06-30 0001517681 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2024-07-01 2025-06-30 0001517681 us-gaap:CommonStockMember 2024-07-01 2025-06-30 0001517681 PPCB:CommonStockIssuableMember 2024-07-01 2025-06-30 0001517681 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2025-06-30 0001517681 us-gaap:RetainedEarningsMember 2024-07-01 2025-06-30 0001517681 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2025-06-30 0001517681 us-gaap:TreasuryStockCommonMember 2024-07-01 2025-06-30 0001517681 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001517681 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001517681 us-gaap:CommonStockMember 2024-12-31 0001517681 PPCB:CommonStockIssuableMember 2024-12-31 0001517681 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001517681 us-gaap:RetainedEarningsMember 2024-12-31 0001517681 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001517681 us-gaap:TreasuryStockCommonMember 2024-12-31 0001517681 2024-12-31 0001517681 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001517681 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001517681 us-gaap:CommonStockMember 2025-12-31 0001517681 PPCB:CommonStockIssuableMember 2025-12-31 0001517681 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001517681 us-gaap:RetainedEarningsMember 2025-12-31 0001517681 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001517681 us-gaap:TreasuryStockCommonMember 2025-12-31 0001517681 PPCB:SeriesCWarrantMember 2025-11-01 2025-11-30 0001517681 2024-08-07 2024-08-07 0001517681 2023-08-31 0001517681 srt:WeightedAverageMember 2025-12-31 0001517681 srt:WeightedAverageMember 2025-06-30 0001517681 srt:WeightedAverageMember 2024-06-30 0001517681 us-gaap:MachineryAndEquipmentMember 2025-12-31 0001517681 us-gaap:FurnitureAndFixturesMember 2025-12-31 0001517681 us-gaap:MachineryAndEquipmentMember 2025-06-30 0001517681 us-gaap:FurnitureAndFixturesMember 2025-06-30 0001517681 us-gaap:WarrantMember 2025-07-01 2025-12-31 0001517681 us-gaap:WarrantMember 2024-07-01 2024-12-31 0001517681 PPCB:SeriesAWarrantsMember 2025-07-01 2025-12-31 0001517681 PPCB:SeriesAWarrantsMember 2024-07-01 2024-12-31 0001517681 PPCB:SeriesCWarrantsMember 2025-07-01 2025-12-31 0001517681 PPCB:SeriesCWarrantsMember 2024-07-01 2024-12-31 0001517681 PPCB:SeriesCConvertiblePreferredStockMember 2025-07-01 2025-12-31 0001517681 PPCB:SeriesCConvertiblePreferredStockMember 2024-07-01 2024-12-31 0001517681 us-gaap:ConvertibleDebtSecuritiesMember 2025-07-01 2025-12-31 0001517681 us-gaap:ConvertibleDebtSecuritiesMember 2024-07-01 2024-12-31 0001517681 us-gaap:WarrantMember 2024-07-01 2025-06-30 0001517681 us-gaap:WarrantMember 2023-07-01 2024-06-30 0001517681 PPCB:SeriesAWarrantsMember 2024-07-01 2025-06-30 0001517681 PPCB:SeriesAWarrantsMember 2023-07-01 2024-06-30 0001517681 PPCB:SeriesCWarrantsMember 2024-07-01 2025-06-30 0001517681 PPCB:SeriesCWarrantsMember 2023-07-01 2024-06-30 0001517681 us-gaap:ConvertibleDebtSecuritiesMember 2024-07-01 2025-06-30 0001517681 us-gaap:ConvertibleDebtSecuritiesMember 2023-07-01 2024-06-30 0001517681 us-gaap:CommonStockMember 2025-08-18 2025-08-18 0001517681 us-gaap:SeriesCPreferredStockMember 2025-11-04 2025-11-04 0001517681 us-gaap:SeriesCPreferredStockMember 2025-11-04 0001517681 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2025-08-18 2025-08-18 0001517681 PPCB:FormerDirectorMember 2025-12-31 0001517681 PPCB:FormerDirectorMember PPCB:DebtExchangeMember 2025-01-23 2025-01-23 0001517681 PPCB:FormerDirectorMember PPCB:DebtExchangeMember 2025-01-23 0001517681 PPCB:DebtExchangeMember 2025-06-30 0001517681 PPCB:FormerDirectorsMember 2025-06-30 0001517681 PPCB:FormerDirectorsMember 2024-06-30 0001517681 us-gaap:RelatedPartyMember 2024-05-31 0001517681 us-gaap:RelatedPartyMember 2024-11-30 0001517681 us-gaap:RelatedPartyMember 2024-08-31 0001517681 us-gaap:RelatedPartyMember 2025-09-30 0001517681 PPCB:LoanAgreementMember 2024-08-01 0001517681 PPCB:LoanAgreementMember 2024-08-01 2024-08-01 0001517681 us-gaap:InvestorMember 2024-11-01 2024-12-31 0001517681 us-gaap:InvestorMember 2025-08-19 2025-08-19 0001517681 us-gaap:InvestorMember 2025-09-30 0001517681 PPCB:LoanAgreementMember 2024-12-03 0001517681 PPCB:LoanAgreementMember 2025-02-28 0001517681 PPCB:LoanAgreementMember 2024-12-03 2024-12-03 0001517681 PPCB:LoanAgreementMember 2025-04-02 0001517681 srt:DirectorMember 2025-01-01 2025-01-31 0001517681 srt:DirectorMember 2025-08-19 2025-08-19 0001517681 PPCB:LoanAgreementMember 2025-04-12 0001517681 PPCB:LoanAgreementMember 2025-04-12 2025-04-12 0001517681 PPCB:LoanAgreementMember 2025-08-19 2025-08-19 0001517681 PPCB:LoanAgreementMember 2025-06-13 0001517681 PPCB:LoanAgreementMember 2025-06-13 2025-06-13 0001517681 us-gaap:RelatedPartyMember 2025-08-19 2025-08-19 0001517681 srt:DirectorMember 2025-08-14 0001517681 PPCB:LetterAgreementMember 2023-07-05 0001517681 PPCB:LetterAgreementMember 2023-07-05 2023-07-05 0001517681 us-gaap:WarrantMember PPCB:LetterAgreementMember 2023-07-05 0001517681 us-gaap:WarrantMember PPCB:LetterAgreementMember 2023-07-05 2023-07-05 0001517681 us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember PPCB:LetterAgreementMember 2023-07-05 2023-07-05 0001517681 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember PPCB:LetterAgreementMember 2023-07-05 0001517681 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember PPCB:LetterAgreementMember 2023-07-05 0001517681 PPCB:LetterAgreementMember PPCB:CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember 2024-07-01 2025-06-30 0001517681 us-gaap:RelatedPartyMember 2024-07-01 2025-06-30 0001517681 us-gaap:RelatedPartyMember 2025-10-01 2025-12-31 0001517681 us-gaap:RelatedPartyMember 2025-07-01 2025-12-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:CrownBridgePartnersLLCMember 2025-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:CrownBridgePartnersLLCMember 2025-12-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:CrownBridgePartnersLLCMember 2019-10-03 0001517681 PPCB:ExchangeAgreementMember PPCB:CrownBridgePartnersLLCMember 2026-01-07 2026-01-07 0001517681 PPCB:ExchangeAgreementMember PPCB:CrownBridgePartnersLLCMember 2026-01-07 0001517681 PPCB:LoanAgreementMember 2024-06-30 0001517681 PPCB:TwoInvestorsMember PPCB:DebtExchangeAgreementMember 2025-02-05 2025-02-05 0001517681 PPCB:TwoInvestorsMember PPCB:DebtExchangeAgreementMember 2025-02-05 0001517681 PPCB:TwoInvestorsMember PPCB:DebtExchangeAgreementMember 2025-06-30 0001517681 PPCB:LoanAgreementMember 2025-12-31 0001517681 PPCB:LoanAgreementMember 2025-06-30 0001517681 PPCB:LoanAgreementMember 2025-08-27 0001517681 us-gaap:RelatedPartyMember PPCB:CrownBridgePartnersLLCMember 2025-12-31 0001517681 us-gaap:RelatedPartyMember 2023-11-30 0001517681 us-gaap:RelatedPartyMember 2024-11-01 2024-12-31 0001517681 us-gaap:SubsequentEventMember 2025-08-19 2025-08-19 0001517681 us-gaap:RelatedPartyMember 2025-01-01 2025-01-31 0001517681 us-gaap:RelatedPartyMember 2023-07-01 2024-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:CrownBridgePartnersLLCMember 2024-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:CrownBridgePartnersLLCMember 2022-07-01 2023-06-30 0001517681 us-gaap:SubsequentEventMember PPCB:LoanAgreementMember 2025-08-27 0001517681 PPCB:CrownBridgePartnersLLCMember 2025-06-30 0001517681 us-gaap:RelatedPartyMember PPCB:CrownBridgePartnersLLCMember 2025-06-30 0001517681 PPCB:PromissoryNoteMember 2025-12-31 0001517681 PPCB:PromissoryNoteMember 2025-06-30 0001517681 PPCB:PromissoryNoteMember 2024-06-30 0001517681 us-gaap:LoansPayableMember 2023-08-15 0001517681 us-gaap:LoansPayableMember 2023-08-15 2023-08-15 0001517681 us-gaap:LoansPayableMember 2024-05-07 2024-05-07 0001517681 PPCB:MaturityExtensionAgreementMember 2025-05-07 2025-05-07 0001517681 PPCB:MaturityExtensionAgreementMember 2025-05-07 0001517681 us-gaap:InvestorMember 2025-05-07 0001517681 us-gaap:InvestorMember 2025-05-07 2025-05-07 0001517681 us-gaap:InvestorMember 2025-06-02 0001517681 us-gaap:InvestorMember 2025-06-02 2025-06-02 0001517681 us-gaap:InvestorMember 2025-07-18 0001517681 us-gaap:InvestorMember 2025-07-18 2025-07-18 0001517681 us-gaap:LoansPayableMember 2025-08-19 2025-08-19 0001517681 us-gaap:LoansPayableMember 2025-08-19 0001517681 us-gaap:LoansPayableMember 2025-12-31 0001517681 us-gaap:LoansPayableMember 2025-06-30 0001517681 us-gaap:LoansPayableMember 2025-07-01 2025-12-31 0001517681 us-gaap:LoansPayableMember 2024-07-01 2024-12-31 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2024-05-24 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2024-05-24 2024-05-24 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2024-11-30 2024-11-30 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2024-12-30 2024-12-30 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2024-11-30 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2024-06-10 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2024-06-10 2024-06-10 0001517681 us-gaap:LoansPayableMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2024-12-15 2024-12-15 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-01-15 2025-01-15 0001517681 us-gaap:LoansPayableMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2024-11-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-01-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-01-31 2025-01-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-07-30 2025-07-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-11-30 2025-11-30 0001517681 us-gaap:LoansPayableMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-11-30 2025-11-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-08-31 0001517681 PPCB:SecuritiesPurchaseAgreementOneMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-03-25 0001517681 PPCB:SecuritiesPurchaseAgreementOneMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-03-25 2025-03-25 0001517681 PPCB:SecuritiesPurchaseAgreementOneMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-09-30 2025-09-30 0001517681 srt:ScenarioForecastMember PPCB:SecuritiesPurchaseAgreementOneMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2026-01-30 2026-01-30 0001517681 srt:ScenarioForecastMember us-gaap:LoansPayableMember PPCB:SecuritiesPurchaseAgreementOneMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2026-01-30 2026-01-30 0001517681 PPCB:SecuritiesPurchaseAgreementOneMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-08-30 0001517681 PPCB:SecuritiesPurchaseAgreementOneMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-08-31 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-06-13 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-06-13 2025-06-13 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-12-15 2025-12-15 0001517681 srt:ScenarioForecastMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2026-04-15 2026-04-15 0001517681 srt:ScenarioForecastMember us-gaap:LoansPayableMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2026-04-15 2026-04-15 0001517681 us-gaap:LoansPayableMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-08-31 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-07-01 2025-12-31 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-12-31 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-08-31 2025-08-31 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-06-30 0001517681 PPCB:RedRoadHoldingsPromissoryNoteMember 2024-12-04 0001517681 PPCB:RedRoadHoldingsPromissoryNoteMember 2024-12-04 2024-12-04 0001517681 PPCB:RedRoadHoldingsPromissoryNoteMember 2025-06-15 2025-06-15 0001517681 PPCB:RedRoadHoldingsPromissoryNoteMember 2025-07-15 2025-07-15 0001517681 PPCB:RedRoadHoldingsPromissoryNoteMember 2025-12-31 0001517681 PPCB:RedRoadHoldingsPromissoryNoteMember 2025-06-30 0001517681 PPCB:RedRoadHoldingsPromissoryNoteMember 2024-07-01 2025-06-30 0001517681 PPCB:RedRoadHoldingsPromissoryNoteMember 2025-08-31 2025-08-31 0001517681 PPCB:RedRoadHoldingsPromissoryNoteMember 2025-08-31 0001517681 PPCB:PromissoryNoteMember us-gaap:LoansPayableMember 2025-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-07-22 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-07-22 2025-07-22 0001517681 srt:MaximumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-07-22 0001517681 srt:MinimumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-07-22 0001517681 srt:MinimumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-07-22 2025-07-22 0001517681 srt:MaximumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-07-22 2025-07-22 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-07-01 2025-12-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2023-11-29 2023-11-29 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-12-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2023-12-08 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2023-12-08 2023-12-08 0001517681 srt:MinimumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2023-12-08 2023-12-08 0001517681 srt:MaximumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2023-12-08 2023-12-08 0001517681 PPCB:OneFortyFourCapitalMember 2024-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2025-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2024-07-01 2025-06-30 0001517681 PPCB:OneFortyFourCapitalMember 2025-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2025-12-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2025-07-01 2025-12-31 0001517681 PPCB:OneFortyFourCapitalMember 2025-12-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2023-08-23 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2023-08-23 2023-08-23 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2023-10-12 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2023-10-12 2023-10-12 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2024-04-12 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2024-04-12 2024-04-12 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2024-08-02 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2024-08-02 2024-08-02 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2024-09-20 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2024-09-20 2024-09-20 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2025-02-07 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2025-02-07 2025-02-07 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2025-03-11 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2025-03-11 2025-03-11 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2025-04-15 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2025-04-15 2025-04-15 0001517681 PPCB:GSCapitalPartnersLLCMember 2025-07-01 2025-12-31 0001517681 srt:MinimumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2024-04-12 2024-04-12 0001517681 srt:MaximumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2024-04-12 2024-04-12 0001517681 2024-04-12 2024-04-12 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2025-06-30 0001517681 PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember PPCB:GSCapitalPartnersLLCMember 2024-07-01 2025-06-30 0001517681 PPCB:GSCapitalPartnersLLCMember 2025-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2025-12-31 0001517681 PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember PPCB:GSCapitalPartnersLLCMember 2025-07-01 2025-12-31 0001517681 PPCB:GSCapitalPartnersLLCMember 2025-12-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2025-08-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:HundredAndFourLLCMember 2024-03-05 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:HundredAndFourLLCMember 2024-03-05 2024-03-05 0001517681 srt:MinimumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:HundredAndFourLLCMember 2024-03-05 0001517681 srt:MaximumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:HundredAndFourLLCMember 2024-03-05 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:HundredAndFourLLCMember 2024-06-20 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:HundredAndFourLLCMember 2024-06-20 2024-06-20 0001517681 srt:MinimumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:HundredAndFourLLCMember 2024-06-20 0001517681 srt:MaximumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:HundredAndFourLLCMember 2024-06-20 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:HundredAndFourLLCMember 2024-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:HundredAndFourLLCMember 2024-07-01 2025-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:HundredAndFourLLCMember 2025-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:HundredAndFourLLCMember 2025-12-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:HundredAndFourLLCMember 2025-07-01 2025-12-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:HundredAndFourLLCMember 2025-08-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2024-12-13 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2025-06-15 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2025-06-15 2025-06-15 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2025-06-12 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2025-06-12 2025-06-12 0001517681 srt:MinimumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2025-06-12 2025-06-12 0001517681 srt:MaximumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2025-06-12 2025-06-12 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2025-02-01 2025-02-28 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2025-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2024-07-01 2025-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2025-08-31 2025-08-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2025-08-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2025-12-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember 2025-07-01 2025-12-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember 2024-07-01 2024-12-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember 2025-12-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember 2024-12-31 0001517681 PPCB:ConvertibleNotesOneMember 2025-10-01 2025-12-31 0001517681 PPCB:ConvertibleNotesOneMember 2024-10-01 2024-12-31 0001517681 PPCB:ConvertibleNotesOneMember 2025-07-01 2025-12-31 0001517681 PPCB:ConvertibleNotesOneMember 2024-07-01 2024-12-31 0001517681 2025-05-07 2025-05-07 0001517681 2025-06-02 2025-06-02 0001517681 us-gaap:LoansPayableMember 2024-06-30 0001517681 us-gaap:LoansPayableMember 2024-07-01 2025-06-30 0001517681 us-gaap:LoansPayableMember 2023-07-01 2024-06-30 0001517681 us-gaap:LoansPayableMember us-gaap:SubsequentEventMember 2025-08-19 2025-08-19 0001517681 us-gaap:LoansPayableMember us-gaap:SubsequentEventMember 2025-08-19 0001517681 srt:ScenarioForecastMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-08-30 2025-08-30 0001517681 srt:ScenarioForecastMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-09-30 2025-09-30 0001517681 srt:ScenarioForecastMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-10-30 2025-10-30 0001517681 srt:ScenarioForecastMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-11-30 2025-11-30 0001517681 srt:ScenarioForecastMember us-gaap:LoansPayableMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-11-30 2025-11-30 0001517681 PPCB:SecuritiesPurchaseAgreementOneMember 2025-03-25 2025-03-25 0001517681 srt:ScenarioForecastMember PPCB:SecuritiesPurchaseAgreementOneMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-09-30 2025-09-30 0001517681 srt:ScenarioForecastMember PPCB:SecuritiesPurchaseAgreementOneMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-10-30 2025-10-30 0001517681 srt:ScenarioForecastMember PPCB:SecuritiesPurchaseAgreementOneMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-11-30 2025-11-30 0001517681 srt:ScenarioForecastMember PPCB:SecuritiesPurchaseAgreementOneMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-12-30 2025-12-30 0001517681 srt:ScenarioForecastMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-12-15 2025-12-15 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2024-07-01 2025-06-30 0001517681 PPCB:ThousandEightHundredDiagonalLendingLLCMember 2024-06-30 0001517681 us-gaap:SubsequentEventMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-07-31 2025-07-31 0001517681 us-gaap:SubsequentEventMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-08-31 2025-08-31 0001517681 2025-08-31 2025-08-31 0001517681 PPCB:PromissoryNoteMember us-gaap:LoansPayableMember 2024-06-30 0001517681 PPCB:JulyElevenTwentyTwentyTwoThousandEighthundredDiagonalNoteMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2022-07-11 0001517681 PPCB:JulyElevenTwentyTwentyTwoThousandEighthundredDiagonalNoteMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2022-07-11 2022-07-11 0001517681 PPCB:JulySixTwentyTwentyThreeThousandEighthundredDiagonalNoteMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2023-07-06 0001517681 PPCB:JulySixTwentyTwentyThreeThousandEighthundredDiagonalNoteMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2023-07-06 2023-07-06 0001517681 PPCB:JulyNineteenTwentyTwentyThreeThousandEighthundredDiagonalNoteMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2023-07-19 0001517681 PPCB:JulyNineteenTwentyTwentyThreeThousandEighthundredDiagonalNoteMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2023-07-19 2023-07-19 0001517681 PPCB:AugustSixteenTwentyTwentyThreeThousandEighthundredDiagonalNoteMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2023-08-16 0001517681 PPCB:AugustSixteenTwentyTwentyThreeThousandEighthundredDiagonalNoteMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2023-08-16 2023-08-16 0001517681 PPCB:OctoberTwentyTwentyTwentyThreeThousandEighthundredDiagonalNoteMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2023-10-20 0001517681 PPCB:OctoberTwentyTwentyTwentyThreeThousandEighthundredDiagonalNoteMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2023-10-20 2023-10-20 0001517681 PPCB:NovemberTwentyNineTwentyTwentyThreeThousandEighthundredDiagonalNoteMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2023-11-29 0001517681 PPCB:NovemberTwentyNineTwentyTwentyThreeThousandEighthundredDiagonalNoteMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2023-11-29 2023-11-29 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2023-11-29 0001517681 srt:MinimumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2023-11-29 2023-11-29 0001517681 srt:MaximumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2023-11-29 2023-11-29 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2024-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2023-07-01 2024-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2022-08-15 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2022-08-15 2022-08-15 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2023-02-14 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2023-02-14 2023-02-14 0001517681 PPCB:OneFortyFourCapitalMember 2023-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2024-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2023-07-01 2024-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2025-08-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:OneFortyFourCapitalMember 2025-08-31 2025-08-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2022-08-12 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2022-08-11 2022-08-12 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2022-09-21 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2022-09-21 2022-09-21 0001517681 PPCB:GSCapitalPartnersLLCMember 2025-02-07 2025-02-07 0001517681 PPCB:GSCapitalPartnersLLCMember 2025-03-11 2025-03-11 0001517681 PPCB:GSCapitalPartnersLLCMember 2024-07-01 2025-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2024-07-01 2025-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2024-06-30 0001517681 PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember PPCB:GSCapitalPartnersLLCMember 2023-07-01 2024-06-30 0001517681 PPCB:GSCapitalPartnersLLCMember 2024-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GSCapitalPartnersLLCMember 2025-08-31 2025-08-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember 2022-11-03 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember 2022-11-03 2022-11-03 0001517681 PPCB:CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember 2022-11-03 2022-11-03 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:CrownBridgePartnersLLCMember 2023-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember 2023-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember 2022-07-01 2023-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember 2023-07-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember 2023-07-01 2023-07-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember 2023-07-01 2024-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember 2024-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:HundredAndFourLLCMember 2025-08-31 2025-08-31 0001517681 PPCB:SecuritiesPurchaseAgreementMember 2025-06-15 2025-06-15 0001517681 PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2024-12-13 2024-12-13 0001517681 srt:MinimumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2024-12-13 2024-12-13 0001517681 srt:MaximumMember PPCB:SecuritiesPurchaseAgreementMember PPCB:GeebisConsultingLLCMember 2024-12-13 2024-12-13 0001517681 PPCB:SecuritiesPurchaseAgreementMember 2025-06-30 0001517681 PPCB:GeebisConsultingLLCMember 2025-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember 2024-07-01 2025-06-30 0001517681 PPCB:ThreeOutstandingConvertibleNotesMember 2025-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember 2023-07-01 2024-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember 2024-06-30 0001517681 PPCB:ConvertibleNotesOneMember 2024-07-01 2025-06-30 0001517681 PPCB:ConvertibleNotesOneMember 2023-07-01 2024-06-30 0001517681 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember PPCB:HexstoneCapitalLLCMember 2025-11-04 2025-11-04 0001517681 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember PPCB:HexstoneCapitalLLCMember 2025-11-04 0001517681 PPCB:HexstoneCapitalLLCMember 2025-11-04 2025-11-04 0001517681 PPCB:HexstoneCapitalLLCMember us-gaap:SeriesCPreferredStockMember PPCB:SecuritiesPurchaseAgreementMember 2025-11-04 0001517681 PPCB:HexstoneCapitalLLCMember us-gaap:SeriesCPreferredStockMember PPCB:SecuritiesPurchaseAgreementMember 2025-11-04 2025-11-04 0001517681 PPCB:HexstoneCapitalLLCMember us-gaap:SeriesCPreferredStockMember PPCB:SecuritiesPurchaseAgreementMember 2025-12-31 0001517681 PPCB:HexstoneCapitalLLCMember us-gaap:SeriesCPreferredStockMember PPCB:SecuritiesPurchaseAgreementMember 2025-07-01 2025-12-31 0001517681 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember PPCB:HexstoneCapitalLLCMember 2025-12-31 0001517681 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-01-01 2026-01-31 0001517681 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember us-gaap:SubsequentEventMember 2026-01-01 2026-01-31 0001517681 us-gaap:MeasurementInputExpectedTermMember 2025-11-04 0001517681 us-gaap:MeasurementInputPriceVolatilityMember 2025-11-04 0001517681 us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-11-04 0001517681 us-gaap:MeasurementInputSharePriceMember 2025-11-04 0001517681 us-gaap:MeasurementInputExpectedDividendRateMember 2025-11-04 0001517681 us-gaap:MeasurementInputExercisePriceMember 2025-11-04 0001517681 us-gaap:MeasurementInputExpectedTermMember 2025-12-31 0001517681 us-gaap:MeasurementInputPriceVolatilityMember 2025-12-31 0001517681 us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-12-31 0001517681 us-gaap:MeasurementInputSharePriceMember 2025-12-31 0001517681 us-gaap:MeasurementInputExpectedDividendRateMember 2025-12-31 0001517681 us-gaap:MeasurementInputExercisePriceMember 2025-12-31 0001517681 us-gaap:FairValueInputsLevel3Member 2025-06-30 0001517681 us-gaap:FairValueInputsLevel3Member 2025-07-01 2025-12-31 0001517681 us-gaap:FairValueInputsLevel3Member 2025-12-31 0001517681 us-gaap:CommonStockMember PPCB:UnderwritingAgreementMember 2025-08-14 2025-08-14 0001517681 us-gaap:CommonStockMember PPCB:UnderwritingAgreementMember 2025-08-14 0001517681 PPCB:RepresentativesWarrantsMember PPCB:UnderwritingAgreementMember 2025-08-14 2025-08-14 0001517681 PPCB:RepresentativesWarrantsMember PPCB:UnderwritingAgreementMember 2025-08-14 0001517681 PPCB:UnderwritingAgreementMember 2025-08-14 2025-08-14 0001517681 us-gaap:IPOMember 2025-08-18 2025-08-18 0001517681 us-gaap:IPOMember 2025-12-31 0001517681 us-gaap:ConvertibleDebtMember 2025-07-01 2025-09-30 0001517681 us-gaap:ConvertibleDebtMember 2025-09-30 0001517681 us-gaap:ConvertibleDebtMember 2025-10-01 2025-12-31 0001517681 us-gaap:ConvertibleDebtMember 2025-12-31 0001517681 PPCB:UnderlyingFinancingAgreementsMember 2025-12-31 0001517681 PPCB:ThreeMonthConsultingAgreementMember 2025-08-15 2025-08-15 0001517681 PPCB:ThreeMonthConsultingAgreementMember 2025-08-15 0001517681 PPCB:ThreeMonthConsultingAgreementMember 2025-07-01 2025-12-31 0001517681 us-gaap:CommonStockMember PPCB:SixMonthsConsultingAgreementMember 2025-08-24 2025-08-24 0001517681 PPCB:SixMonthsConsultingAgreementMember 2025-08-24 0001517681 PPCB:SixMonthsConsultingAgreementMember 2025-08-24 2025-08-24 0001517681 PPCB:SixMonthsConsultingAgreementMember 2025-07-01 2025-12-31 0001517681 us-gaap:CommonStockMember PPCB:ConsultingAgreementMember 2025-10-01 2025-10-31 0001517681 PPCB:ConsultingAgreementMember 2025-10-31 0001517681 PPCB:ConsultingAgreementMember 2025-10-01 2025-10-31 0001517681 PPCB:ConsultingAgreementMember 2025-07-01 2025-12-31 0001517681 PPCB:ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember us-gaap:CommonStockMember 2024-07-01 2025-06-30 0001517681 srt:MinimumMember PPCB:ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember us-gaap:CommonStockMember 2024-07-01 2025-06-30 0001517681 srt:MaximumMember PPCB:ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember us-gaap:CommonStockMember 2024-07-01 2025-06-30 0001517681 PPCB:ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember us-gaap:CommonStockMember 2025-06-30 0001517681 srt:MinimumMember PPCB:ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember us-gaap:CommonStockMember 2025-06-30 0001517681 srt:MaximumMember PPCB:ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember us-gaap:CommonStockMember 2025-06-30 0001517681 us-gaap:RestrictedStockUnitsRSUMember 2019-05-01 2019-05-31 0001517681 us-gaap:RestrictedStockUnitsRSUMember 2024-07-01 2025-06-30 0001517681 us-gaap:RestrictedStockUnitsRSUMember 2025-12-31 0001517681 PPCB:TwoThousandNinteenEquityIncentivePlanMember 2025-12-31 0001517681 us-gaap:SeriesAPreferredStockMember 2024-06-30 0001517681 us-gaap:CommonStockMember 2022-07-12 2022-07-13 0001517681 us-gaap:CommonStockMember 2022-07-13 0001517681 2022-07-12 2022-07-13 0001517681 2022-07-01 2023-06-30 0001517681 srt:MaximumMember us-gaap:InvestorMember PPCB:CommonStockPurchaseAgreementMember 2023-07-19 2023-07-20 0001517681 srt:MaximumMember us-gaap:InvestorMember PPCB:CommonStockPurchaseAgreementMember 2023-07-20 0001517681 us-gaap:InvestorMember PPCB:CommonStockPurchaseAgreementMember 2023-07-19 2023-07-20 0001517681 2023-12-13 0001517681 2024-01-31 0001517681 2024-02-20 0001517681 2024-06-11 0001517681 srt:MaximumMember PPCB:CommonStockPurchaseAgreementMember PPCB:DutchessMember 2022-11-02 2022-11-03 0001517681 PPCB:CommonStockPurchaseAgreementMember PPCB:DutchessMember 2022-11-02 2022-11-03 0001517681 PPCB:CommonStockPurchaseAgreementMember PPCB:DutchessMember 2022-11-03 2022-11-03 0001517681 PPCB:CommonStockPurchaseAgreementMember PPCB:DutchessMember 2022-11-03 0001517681 PPCB:SeriesAWarrantsMember 2023-07-01 2024-06-30 0001517681 PPCB:SeriesAWarrantsMember 2024-06-30 0001517681 PPCB:SeriesAWarrantMember 2024-06-30 0001517681 us-gaap:ConvertibleDebtMember 2023-07-01 2024-06-30 0001517681 us-gaap:ConvertibleDebtMember 2024-06-30 0001517681 us-gaap:ConvertibleDebtMember 2024-07-01 2025-03-31 0001517681 us-gaap:ConvertibleDebtMember 2025-03-31 0001517681 2025-03-31 0001517681 2025-06-30 2025-06-30 0001517681 PPCB:UnderlyingFinancingAgreementsMember 2025-06-30 0001517681 PPCB:ConsultingAgreementMember 2024-08-12 2024-10-12 0001517681 PPCB:ConsultingAgreementMember 2024-10-12 0001517681 PPCB:ConsultingAgreementMember 2024-07-01 2025-06-30 0001517681 PPCB:OfficersEmployeesDirectorsAndConsultantsMember PPCB:ConsultingAgreementMember 2025-03-03 2025-03-03 0001517681 PPCB:OfficersEmployeesDirectorsAndConsultantsMember PPCB:ConsultingAgreementMember 2025-03-03 0001517681 PPCB:ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember us-gaap:CommonStockMember 2025-01-09 2025-03-23 0001517681 srt:MinimumMember PPCB:ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember us-gaap:CommonStockMember 2025-01-09 2025-03-23 0001517681 PPCB:ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember us-gaap:CommonStockMember 2025-03-23 0001517681 srt:MinimumMember PPCB:ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember us-gaap:CommonStockMember 2025-03-23 0001517681 srt:MaximumMember PPCB:ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember us-gaap:CommonStockMember 2025-03-23 0001517681 2025-01-05 2025-01-05 0001517681 2025-03-05 2025-03-05 0001517681 2025-01-05 0001517681 2025-03-05 0001517681 srt:MinimumMember 2025-01-05 0001517681 srt:MinimumMember 2025-03-05 0001517681 srt:MaximumMember 2025-01-05 0001517681 srt:MaximumMember 2025-03-05 0001517681 PPCB:DebtExchangeMember 2024-07-01 2025-06-30 0001517681 2025-03-03 2025-03-03 0001517681 2025-03-03 0001517681 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2024-06-30 0001517681 us-gaap:RestrictedStockUnitsRSUMember 2025-06-30 0001517681 PPCB:TwoThousandNinteenEquityIncentivePlanMember 2025-06-30 0001517681 PPCB:SecuritiesPurchaseAgreementMember 2020-04-02 2020-04-03 0001517681 PPCB:SeriesBWarrantsMember PPCB:SecuritiesPurchaseAgreementMember 2020-04-03 0001517681 PPCB:SeriesCWarrantsMember PPCB:SecuritiesPurchaseAgreementMember 2020-04-03 0001517681 PPCB:PrefundedWarrantsMember PPCB:SecuritiesPurchaseAgreementMember 2020-04-03 0001517681 PPCB:SeriesAWarrantsMember PPCB:SecuritiesPurchaseAgreementMember 2020-03-20 0001517681 us-gaap:InvestorMember PPCB:SeriesAWarrantsMember PPCB:SecuritiesPurchaseAgreementMember 2020-03-20 0001517681 us-gaap:InvestorMember PPCB:SeriesAWarrantsMember PPCB:SecuritiesPurchaseAgreementMember 2020-03-19 2020-03-20 0001517681 us-gaap:InvestorMember PPCB:SeriesBWarrantsMember PPCB:SecuritiesPurchaseAgreementMember 2020-03-20 0001517681 us-gaap:InvestorMember PPCB:SeriesBWarrantsMember PPCB:SecuritiesPurchaseAgreementMember 2020-03-19 2020-03-20 0001517681 PPCB:HolderMember PPCB:SeriesBWarrantsMember PPCB:SecuritiesPurchaseAgreementMember 2020-03-19 2020-03-20 0001517681 PPCB:SeriesBWarrantsMember PPCB:SecuritiesPurchaseAgreementMember 2020-03-20 0001517681 us-gaap:InvestorMember PPCB:SeriesCWarrantsMember PPCB:SecuritiesPurchaseAgreementMember 2020-03-20 0001517681 PPCB:SeriesBWarrantsMember 2023-03-08 2023-03-08 0001517681 2023-03-08 2023-03-08 0001517681 us-gaap:WarrantMember 2023-03-08 2023-03-08 0001517681 us-gaap:CommonStockMember 2023-03-08 2023-03-08 0001517681 PPCB:SeriesBWarrantsMember 2023-03-08 2023-03-08 0001517681 PPCB:SeriesBWarrantsMember 2023-03-08 0001517681 srt:AffiliatedEntityMember us-gaap:WarrantMember 2025-06-30 0001517681 PPCB:AugustTwoThousandNineteenAuctusNoteMember PPCB:SecuritiesPurchaseAgreementMember PPCB:AuctusFundLLCMember 2024-07-01 2025-06-30 0001517681 us-gaap:WarrantMember 2025-06-30 0001517681 us-gaap:WarrantMember 2024-07-01 2025-06-30 0001517681 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:WarrantMember 2025-06-30 0001517681 us-gaap:MeasurementInputExpectedTermMember srt:AffiliatedEntityMember us-gaap:WarrantMember 2024-07-01 2025-06-30 0001517681 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember 2025-06-30 0001517681 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember 2025-06-30 0001517681 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2025-07-01 2025-12-31 0001517681 us-gaap:IndemnificationGuaranteeMember 2025-12-09 2025-12-09 0001517681 PPCB:From2012ThroughThe2014Member 2025-07-01 2025-12-31 0001517681 us-gaap:RoyaltyAgreementTermsMember 2012-06-01 2012-06-30 0001517681 us-gaap:LicenseAgreementTermsMember 2012-06-01 2012-06-30 0001517681 PPCB:OneYearCollaborationAgreementMember 2018-09-13 2018-09-13 0001517681 PPCB:TwoYearCollaborationAgreementMember 2018-09-13 2018-09-13 0001517681 PPCB:TwoYearCollaborationAgreementMember 2020-10-01 2020-10-01 0001517681 PPCB:InstallmentOneMember PPCB:TwoYearCollaborationAgreementMember 2020-11-01 2020-11-30 0001517681 PPCB:InstallmentTwoMember PPCB:TwoYearCollaborationAgreementMember 2021-03-01 2021-03-31 0001517681 PPCB:InstallmentThreeMember PPCB:TwoYearCollaborationAgreementMember 2021-12-01 2021-12-31 0001517681 PPCB:InstallmentFourMember PPCB:TwoYearCollaborationAgreementMember 2022-09-01 2022-09-30 0001517681 PPCB:UniversityOfJaenMember 2020-10-01 2020-10-01 0001517681 2020-10-01 2020-10-01 0001517681 PPCB:ResearchAgreementMember PPCB:UniversityOfJaenMember 2022-07-27 2022-07-27 0001517681 PPCB:InstallmentOneMember PPCB:ResearchAgreementMember 2022-08-01 2022-08-31 0001517681 PPCB:InstallmentTwoMember PPCB:ResearchAgreementMember 2022-09-01 2022-09-30 0001517681 PPCB:InstallmentThreeMember PPCB:ResearchAgreementMember 2022-12-01 2022-12-31 0001517681 PPCB:InstallmentFourMember PPCB:ResearchAgreementMember 2023-03-01 2023-03-31 0001517681 PPCB:InstallmentFiveMember PPCB:ResearchAgreementMember 2023-07-01 2023-07-31 0001517681 PPCB:UnderwritingAgreementMember PPCB:DBoralCapitalLLCMember 2025-08-14 0001517681 PPCB:UnderwritingAgreementMember PPCB:DBoralCapitalLLCMember 2025-08-14 2025-08-14 0001517681 us-gaap:WarrantMember PPCB:UnderwritingAgreementMember PPCB:DBoralCapitalLLCMember 2025-08-14 2025-08-14 0001517681 us-gaap:WarrantMember PPCB:UnderwritingAgreementMember PPCB:DBoralCapitalLLCMember 2025-08-14 0001517681 srt:MinimumMember us-gaap:WarrantMember PPCB:UnderwritingAgreementMember PPCB:DBoralCapitalLLCMember 2025-08-14 2025-08-14 0001517681 srt:MaximumMember us-gaap:WarrantMember PPCB:UnderwritingAgreementMember PPCB:DBoralCapitalLLCMember 2025-08-14 2025-08-14 0001517681 us-gaap:OverAllotmentOptionMember PPCB:UnderwritingAgreementMember PPCB:DBoralCapitalLLCMember 2025-08-14 2025-08-14 0001517681 PPCB:ConsultingAgreementMember 2025-09-25 2025-09-25 0001517681 us-gaap:CommonStockMember PPCB:ConsultingAgreementMember 2025-09-25 2025-09-25 0001517681 us-gaap:CommonStockMember PPCB:AdvisoryAgreementMember 2025-10-01 2025-10-31 0001517681 PPCB:NewThreeYearOperatingLeaseAgreementMember 2022-05-04 0001517681 PPCB:NewThreeYearOperatingLeaseAgreementMember 2022-05-04 2022-05-04 0001517681 PPCB:AccountingStandardUpdate201602Member 2022-05-04 0001517681 2022-05-04 2022-05-04 0001517681 PPCB:NewOneYearOperatingLeaseAgreementMember 2025-05-04 0001517681 PPCB:NewOneYearOperatingLeaseAgreementMember 2025-05-04 2025-05-04 0001517681 2025-05-04 0001517681 2025-05-04 2025-05-04 0001517681 PPCB:From2012ThroughThe2014Member 2024-07-01 2025-06-30 0001517681 PPCB:UnderwritingAgreementMember PPCB:EFHuttonLLCMember 2024-05-04 2024-05-04 0001517681 PPCB:EquityAndEquityLinkedPlacementsMember 2024-05-04 0001517681 PPCB:DebtPlacementsMember 2024-05-04 0001517681 us-gaap:CommonStockMember 2024-05-04 2024-05-04 0001517681 2024-05-04 0001517681 srt:MaximumMember 2024-05-04 0001517681 PPCB:ConsultantMember 2024-05-04 2024-05-04 0001517681 PPCB:ConsultantMember 2024-05-04 0001517681 PPCB:ConsultantMember PPCB:MergerAcquisitionAgreementMember 2024-05-04 0001517681 PPCB:ConsultantMember PPCB:InitialPayableMember 2024-05-04 0001517681 us-gaap:SubsequentEventMember PPCB:UnderwritingAgreementMember 2025-08-14 0001517681 us-gaap:CommonStockMember us-gaap:SubsequentEventMember PPCB:UnderwritingAgreementMember 2025-08-14 2025-08-14 0001517681 us-gaap:CommonStockMember us-gaap:SubsequentEventMember PPCB:UnderwritingAgreementMember 2025-08-14 0001517681 PPCB:RepresentativesWarrantsMember us-gaap:SubsequentEventMember PPCB:UnderwritingAgreementMember 2025-08-14 2025-08-14 0001517681 PPCB:RepresentativesWarrantsMember us-gaap:SubsequentEventMember PPCB:UnderwritingAgreementMember 2025-08-14 0001517681 PPCB:NorthHorizonPtyLtdMember 2016-05-05 0001517681 PPCB:NorthHorizonPtyLtdMember 2016-05-05 2016-05-05 0001517681 PPCB:NathanielszMember PPCB:NorthHorizonPtyLtdMember 2016-05-05 0001517681 PPCB:ThreeYearOperatingLeaseAgreementMember PPCB:NorthHorizonPtyLtdMember 2022-05-04 2022-05-04 0001517681 PPCB:OneYearOperatingLeaseAgreementMember PPCB:NorthHorizonPtyLtdMember 2025-05-04 2025-05-04 0001517681 us-gaap:InvestorMember 2025-08-14 0001517681 us-gaap:RelatedPartyMember 2025-08-21 2025-08-21 0001517681 PPCB:NathanielszEmploymentAgreementMember 2015-02-25 2015-02-25 0001517681 srt:MaximumMember PPCB:NathanielszEmploymentAgreementMember 2015-02-25 2015-02-25 0001517681 srt:MinimumMember PPCB:NathanielszEmploymentAgreementMember 2018-03-16 2018-03-16 0001517681 srt:MaximumMember PPCB:NathanielszEmploymentAgreementMember 2018-03-16 2018-03-16 0001517681 srt:MinimumMember PPCB:NathanielszEmploymentAgreementMember 2022-08-01 2022-08-01 0001517681 srt:MaximumMember PPCB:NathanielszEmploymentAgreementMember 2022-08-01 2022-08-01 0001517681 PPCB:MrsNathanielszMember 2018-02-01 2018-02-01 0001517681 PPCB:MrNathanielszMember 2021-08-12 2021-08-12 0001517681 PPCB:MrNathanielszMember 2020-07-01 2021-06-30 0001517681 PPCB:MrNathanielszMember 2021-06-30 0001517681 PPCB:MrNathanielszMember 2022-08-01 2022-08-01 0001517681 PPCB:MrNathanielszMember 2023-07-01 2024-06-30 0001517681 PPCB:MrNathanielszMember 2024-01-01 2024-01-31 0001517681 PPCB:MrNathanielszMember 2024-06-30 0001517681 PPCB:MrNathanielszMember 2025-06-01 2025-06-30 0001517681 PPCB:MrNathanielszMember 2025-06-30 0001517681 PPCB:MrNathanielszMember 2025-12-31 0001517681 PPCB:MrNathanielszMember PPCB:AmendedAndRestatedEmploymentAgreementMember 2019-05-14 2019-05-14 0001517681 PPCB:MrNathanielszMember PPCB:EmploymentAgreementMember 2019-05-14 2019-05-14 0001517681 PPCB:NathanielszEmploymentAgreementMember 2022-10-26 2022-10-26 0001517681 srt:MinimumMember PPCB:NathanielszEmploymentAgreementMember 2022-10-26 2022-10-26 0001517681 srt:MaximumMember PPCB:NathanielszEmploymentAgreementMember 2022-10-26 2022-10-26 0001517681 PPCB:DrKenyonMember PPCB:ServicesAgreementMember 2019-05-14 2019-05-14 0001517681 PPCB:DrKenyonMember PPCB:ServicesAgreementMember 2025-10-01 0001517681 PPCB:AccountingStandardUpdate201602Member 2016-05-05 2016-05-05 0001517681 PPCB:NorthHorizonPtyLtdMember 2024-07-01 2025-06-30 0001517681 PPCB:NorthHorizonPtyLtdMember 2023-07-01 2024-06-30 0001517681 2023-11-30 0001517681 2024-05-31 0001517681 2024-08-31 0001517681 PPCB:LoanAgreementMember 2024-11-30 0001517681 PPCB:LoanAgreementMember 2024-12-31 0001517681 PPCB:LoanAgreementMember 2024-02-28 0001517681 PPCB:LoanAgreementMember 2024-04-02 0001517681 PPCB:LetterAgreementMember 2025-01-31 0001517681 PPCB:NathanielszEmploymentAgreementMember 2022-07-01 2023-06-30 0001517681 PPCB:JamesNathanielszMember 2016-02-25 2016-02-25 0001517681 PPCB:MrsNathanielszMember 2024-07-01 2025-06-30 0001517681 PPCB:MrsNathanielszMember 2023-07-01 2024-06-30 0001517681 PPCB:BoardOfDirectorsMember PPCB:MrNathanielszMember 2021-08-12 2021-08-12 0001517681 srt:ChiefExecutiveOfficerMember 2021-06-30 0001517681 srt:ChiefExecutiveOfficerMember PPCB:MrsNathanielszMember 2021-06-30 0001517681 PPCB:BoardOfDirectorsMember PPCB:MrNathanielszMember 2022-08-01 2022-08-01 0001517681 srt:ChiefExecutiveOfficerMember 2022-07-01 2023-06-30 0001517681 srt:ChiefExecutiveOfficerMember 2023-07-01 2024-06-30 0001517681 srt:ChiefExecutiveOfficerMember 2024-07-01 2025-06-30 0001517681 srt:MaximumMember PPCB:NathanielszEmploymentAgreementMember 2024-07-01 2025-06-30 0001517681 PPCB:NathanielszEmploymentAgreementMember 2024-07-01 2025-06-30 0001517681 PPCB:LenderOneMember 2025-07-01 2025-12-31 0001517681 PPCB:LenderTwoMember 2025-07-01 2025-12-31 0001517681 PPCB:LenderThreeMember 2025-07-01 2025-12-31 0001517681 PPCB:LenderOneMember PPCB:ConvertibleAndNonconvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2025-07-01 2025-12-31 0001517681 PPCB:LenderTwoMember PPCB:ConvertibleAndNonconvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2025-07-01 2025-12-31 0001517681 PPCB:LenderThreeMember PPCB:ConvertibleAndNonconvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2025-07-01 2025-12-31 0001517681 PPCB:LenderOneMember 2024-07-01 2024-12-31 0001517681 PPCB:LenderTwoMember 2024-07-01 2024-12-31 0001517681 PPCB:LenderThreeMember 2024-07-01 2024-12-31 0001517681 PPCB:LenderFourMember 2024-07-01 2024-12-31 0001517681 PPCB:LenderOneMember PPCB:ConvertibleAndNonconvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2024-07-01 2024-12-31 0001517681 PPCB:LenderTwoMember PPCB:ConvertibleAndNonconvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2024-07-01 2024-12-31 0001517681 PPCB:LenderThreeMember PPCB:ConvertibleAndNonconvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2024-07-01 2024-12-31 0001517681 PPCB:LenderFourMember PPCB:ConvertibleAndNonconvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2024-07-01 2024-12-31 0001517681 PPCB:ReceivableMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2024-07-01 2025-06-30 0001517681 PPCB:LenderOneMember 2023-07-01 2024-06-30 0001517681 PPCB:LenderTwoMember 2023-07-01 2024-06-30 0001517681 PPCB:LenderThreeMember 2023-07-01 2024-06-30 0001517681 PPCB:LenderFourMember 2023-07-01 2024-06-30 0001517681 PPCB:LenderFiveMember 2023-07-01 2024-06-30 0001517681 PPCB:LenderOneMember PPCB:ConvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2023-07-01 2024-06-30 0001517681 PPCB:LenderTwoMember PPCB:ConvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2023-07-01 2024-06-30 0001517681 PPCB:LenderThreeMember PPCB:ConvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2023-07-01 2024-06-30 0001517681 PPCB:LenderFourMember PPCB:ConvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2023-07-01 2024-06-30 0001517681 PPCB:LenderFiveMember PPCB:ConvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2023-07-01 2024-06-30 0001517681 PPCB:LenderOneMember 2024-07-01 2025-06-30 0001517681 PPCB:LenderTwoMember 2024-07-01 2025-06-30 0001517681 PPCB:LenderThreeMember 2024-07-01 2025-06-30 0001517681 PPCB:LenderFourMember 2024-07-01 2025-06-30 0001517681 PPCB:LenderFiveMember 2024-07-01 2025-06-30 0001517681 PPCB:LenderOneMember PPCB:ConvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2024-07-01 2025-06-30 0001517681 PPCB:LenderTwoMember PPCB:ConvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2024-07-01 2025-06-30 0001517681 PPCB:LenderThreeMember PPCB:ConvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2024-07-01 2025-06-30 0001517681 PPCB:LenderFourMember PPCB:ConvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2024-07-01 2025-06-30 0001517681 PPCB:LenderFiveMember PPCB:ConvertibleDebtBenchmarkMember us-gaap:LenderConcentrationRiskMember 2024-07-01 2025-06-30 0001517681 PPCB:ReceivableMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2023-07-01 2024-06-30 0001517681 us-gaap:ConvertibleDebtMember 2025-12-31 0001517681 us-gaap:ConvertibleDebtMember 2025-06-30 0001517681 us-gaap:ConvertibleDebtMember 2024-06-30 0001517681 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ConvertibleDebtMember 2025-12-31 0001517681 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ConvertibleDebtMember 2024-12-31 0001517681 us-gaap:MeasurementInputExpectedTermMember us-gaap:ConvertibleDebtMember 2024-07-01 2024-12-31 0001517681 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ConvertibleDebtMember 2025-12-31 0001517681 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ConvertibleDebtMember 2024-12-31 0001517681 us-gaap:FairValueInputsLevel1Member 2025-12-31 0001517681 us-gaap:FairValueInputsLevel2Member 2025-12-31 0001517681 us-gaap:FairValueInputsLevel1Member 2025-06-30 0001517681 us-gaap:FairValueInputsLevel2Member 2025-06-30 0001517681 us-gaap:DerivativeMember 2025-06-30 0001517681 us-gaap:DerivativeMember 2025-07-01 2025-12-31 0001517681 us-gaap:DerivativeMember 2025-12-31 0001517681 PPCB:SeriesCWarrantsMember us-gaap:SubsequentEventMember PPCB:SecuritiesPurchaseAgreementMember 2026-02-01 2026-02-28 0001517681 us-gaap:InvestorMember PPCB:SeriesCWarrantsMember us-gaap:SubsequentEventMember PPCB:SecuritiesPurchaseAgreementMember 2026-02-28 0001517681 PPCB:SeriesCWarrantsMember us-gaap:SubsequentEventMember PPCB:SecuritiesPurchaseAgreementMember 2026-02-28 0001517681 us-gaap:SeriesCPreferredStockMember us-gaap:SubsequentEventMember 2026-02-28 0001517681 us-gaap:SubsequentEventMember 2026-01-01 2026-01-31 0001517681 us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2026-01-07 2026-01-07 0001517681 us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2026-01-07 0001517681 us-gaap:InvestorMember us-gaap:SubsequentEventMember 2025-07-18 0001517681 us-gaap:InvestorMember us-gaap:SubsequentEventMember 2025-07-18 2025-07-18 0001517681 us-gaap:SubsequentEventMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-07-22 0001517681 us-gaap:SubsequentEventMember PPCB:SecuritiesPurchaseAgreementMember PPCB:ThousandEightHundredDiagonalLendingLLCMember 2025-07-22 2025-07-22 0001517681 srt:DirectorMember us-gaap:SubsequentEventMember 2025-07-03 0001517681 srt:DirectorMember us-gaap:SubsequentEventMember 2025-08-14 0001517681 us-gaap:SubsequentEventMember PPCB:UnderwritingAgreementMember PPCB:DBoralCapitalLLCMember 2025-08-14 2025-08-14 0001517681 us-gaap:SubsequentEventMember PPCB:UnderwritingAgreementMember PPCB:DBoralCapitalLLCMember 2025-08-14 0001517681 us-gaap:WarrantMember us-gaap:SubsequentEventMember PPCB:UnderwritingAgreementMember PPCB:DBoralCapitalLLCMember 2025-08-14 2025-08-14 0001517681 us-gaap:WarrantMember us-gaap:SubsequentEventMember PPCB:UnderwritingAgreementMember PPCB:DBoralCapitalLLCMember 2025-08-14 0001517681 srt:MinimumMember us-gaap:WarrantMember us-gaap:SubsequentEventMember PPCB:UnderwritingAgreementMember PPCB:DBoralCapitalLLCMember 2025-08-14 2025-08-14 0001517681 srt:MaximumMember us-gaap:WarrantMember us-gaap:SubsequentEventMember PPCB:UnderwritingAgreementMember PPCB:DBoralCapitalLLCMember 2025-08-14 2025-08-14 0001517681 us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember PPCB:UnderwritingAgreementMember PPCB:DBoralCapitalLLCMember 2025-08-14 2025-08-14 0001517681 us-gaap:SubsequentEventMember us-gaap:IPOMember 2025-08-18 2025-08-18 0001517681 us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2025-08-01 2025-09-30 0001517681 us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2025-09-30 0001517681 PPCB:PromissoryNotesOneMember us-gaap:SubsequentEventMember 2025-07-01 2025-07-31 0001517681 PPCB:PromissoryNotesOneMember us-gaap:SubsequentEventMember 2025-08-01 2025-08-31 0001517681 PPCB:PromissoryNotesOneMember us-gaap:SubsequentEventMember 2025-07-31 0001517681 PPCB:PromissoryNotesOneMember us-gaap:SubsequentEventMember 2025-08-31 0001517681 PPCB:PromissoryNotesOneMember us-gaap:SubsequentEventMember 2025-08-12 2025-08-15 0001517681 us-gaap:RelatedPartyMember us-gaap:SubsequentEventMember 2025-08-21 2025-08-21 0001517681 us-gaap:RelatedPartyMember us-gaap:SubsequentEventMember 2025-08-21 0001517681 us-gaap:SubsequentEventMember PPCB:ConsultingAgreementMember 2025-08-12 2025-08-15 0001517681 us-gaap:SubsequentEventMember PPCB:ConsultingAgreementMember 2025-08-31 2025-08-31 0001517681 country:US 2024-07-01 2025-06-30 0001517681 country:US 2023-07-01 2024-06-30 0001517681 PPCB:CaresActMember 2020-03-24 2020-03-27 0001517681 country:US 2025-06-30 0001517681 country:AU 2025-06-30 0001517681 country:AU 2024-07-01 2025-06-30 0001517681 country:AU 2023-07-01 2024-06-30 0001517681 PPCB:SeriesAWarrantsMember 2025-03-03 2025-03-03 0001517681 PPCB:SeriesBWarrantsMember 2025-03-03 2025-03-03 0001517681 PPCB:SeriesCWarrantsMember 2025-03-03 2025-03-03 0001517681 srt:MinimumMember PPCB:NewDerivativeInstrumentsMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ConvertibleDebtMember 2025-06-30 0001517681 srt:MaximumMember PPCB:NewDerivativeInstrumentsMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ConvertibleDebtMember 2025-06-30 0001517681 srt:MinimumMember PPCB:NewDerivativeInstrumentsMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ConvertibleDebtMember 2024-06-30 0001517681 srt:MaximumMember PPCB:NewDerivativeInstrumentsMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ConvertibleDebtMember 2024-06-30 0001517681 srt:MinimumMember PPCB:NewDerivativeInstrumentsMember us-gaap:MeasurementInputExpectedTermMember us-gaap:ConvertibleDebtMember 2024-07-01 2025-06-30 0001517681 srt:MaximumMember PPCB:NewDerivativeInstrumentsMember us-gaap:MeasurementInputExpectedTermMember us-gaap:ConvertibleDebtMember 2024-07-01 2025-06-30 0001517681 PPCB:NewDerivativeInstrumentsMember us-gaap:MeasurementInputExpectedTermMember us-gaap:ConvertibleDebtMember 2023-07-01 2024-06-30 0001517681 srt:MinimumMember PPCB:NewDerivativeInstrumentsMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ConvertibleDebtMember 2025-06-30 0001517681 srt:MaximumMember PPCB:NewDerivativeInstrumentsMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ConvertibleDebtMember 2025-06-30 0001517681 srt:MinimumMember PPCB:NewDerivativeInstrumentsMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ConvertibleDebtMember 2024-06-30 0001517681 srt:MaximumMember PPCB:NewDerivativeInstrumentsMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ConvertibleDebtMember 2024-06-30 0001517681 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ConvertibleDebtMember 2025-06-30 0001517681 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ConvertibleDebtMember 2024-06-30 0001517681 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:ConvertibleDebtMember 2024-07-01 2025-06-30 0001517681 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:ConvertibleDebtMember 2024-07-01 2025-06-30 0001517681 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:ConvertibleDebtMember 2023-07-01 2024-06-30 0001517681 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:ConvertibleDebtMember 2023-07-01 2024-06-30 0001517681 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ConvertibleDebtMember 2025-06-30 0001517681 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ConvertibleDebtMember 2025-06-30 0001517681 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ConvertibleDebtMember 2024-06-30 0001517681 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ConvertibleDebtMember 2024-06-30 0001517681 us-gaap:FairValueInputsLevel1Member 2024-06-30 0001517681 us-gaap:FairValueInputsLevel2Member 2024-06-30 0001517681 us-gaap:FairValueInputsLevel3Member 2024-06-30 0001517681 us-gaap:DerivativeMember 2023-06-30 0001517681 us-gaap:DerivativeMember 2023-07-01 2024-06-30 0001517681 us-gaap:DerivativeMember 2024-06-30 0001517681 us-gaap:DerivativeMember 2024-07-01 2025-06-30 iso4217:USD shares iso4217:USD shares iso4217:AUD iso4217:EUR pure PPCB:Segment PPCB:Integer false 0001517681 S-1 PROPANC BIOPHARMA, INC. DE 33-0662986 302 6 Butler Street Camberwell, VIC 3124 +61 03 9882 0780 James Nathanielsz 302 6 Butler Street Camberwell, VIC 3124 +61 03 9882 0780 Non-accelerated Filer true false 561237 12088 16994 5302 7127293 8334046 1400 1380 7706924 8352816 291773 7347310 10925835 2000 1971 50901 59413 4397 15111532 19631808 957483 1249596 860463 1486550 168152 190795 65280 65280 472083 415329 472083 415329 543312 55000 537921 21604 17664 288635 32128 403892 703190 667901 3624018 5578240 105627 35249 41749 35249 147376 3659267 5725616 0.01 0.01 10000 10000 9900 100 1000000 1000000 0 0 0 0 1000000 1500005 1500005 0.01 0.01 0.01 0.01 500000 500000 0 0 0 0 0.01 0.01 5 5 1 1 1 1 0.001 0.001 10000000000 10000000000 13449688 13449688 11611782 11611782 13450 11612 7750 7750 8 8 143640067 138243652 1328115 1318917 -134482898 -125621520 0.001 0.001 46477 46477 10452265 13906192 15111532 19631808 3628173 153593 8226747 374352 6600 5401 21389 13718 19961 54388 80162 116102 3654734 213382 8328298 504172 -3654734 -213382 -8328298 -504172 58955 118943 364604 205173 37 56 1 8559 35741 87728 13581 68022 66368 -593710 -593710 54000 54000 14317 -18759 210178 -30078 -19497 -84121 -54196 -75698 563340 -216801 399166 -280321 -3091394 -430183 -7929132 -784493 -3091394 -430183 -7929132 -784493 932246 932246 -4023640 -430183 -8861378 -784493 -0.30 -0.30 -32.23 -32.23 -0.69 -0.69 -67.65 -67.65 13360358 13360358 13347 13347 12848520 12848520 11597 11597 -4023640 -430183 -8861378 -784493 -7846 321230 9198 222287 -7846 321230 9198 222287 -4031486 -108953 -8852180 -562206 1 7980 8 61696049 -66698220 1269581 -46477 -3779059 3237 3 99888 99891 250 15000 15000 9336 9336 -98943 -98943 -354310 -354310 1 11467 11 61820273 -67052530 1170638 -46477 -4108085 3041 3 58276 58279 321230 321230 -430183 -430183 1 14508 14 61878549 -67482713 1491868 -46477 -4158759 1 11611782 11612 7750 8 138243652 -125621520 1318917 -46477 13906192 194966 195 437869 438064 1000000 1000 3313458 3314458 510937 511 1408237 1408748 114399 114399 17044 17044 -4837738 -4837738 1 12806748 12807 518687 519 143517615 -130459258 1335961 -46477 14361167 1 12806748 12807 518687 519 143517615 -130459258 1335961 -46477 14361167 127667 128 114956 115084 510937 511 -510937 -511 4336 4 7496 7500 -932246 -932246 -7846 -7846 -3091394 -3091394 -3091394 -3091394 1 13449688 13450 7750 8 143640067 -134482898 1328115 -46477 10452265 1 13449688 13450 7750 8 143640067 -134482898 1328115 -46477 10452265 -7929132 -784493 733748 15000 5496367 -54196 -75698 354 186777 133644 9380 9866 68022 66368 -593710 35741 210178 -30078 5843 4582 -37450 11615 -752 28590 80 -310368 102374 25531 20666 -351663 166993 18853 49350 -3428 -10589 -2938207 -216786 4758 -4758 100000 80000 950099 203350 671777 98400 150808 3314458 75000 35000 78249 278915 25000 3491871 270515 243 -60181 549149 -6452 12088 21085 561237 14633 115684 17599 114399 9336 416291 71836 281773 80000 932246 <p id="xdx_806_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zElFDn3JQ7w8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_82E_z1vSCL01OtBa">NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--NatureOfOperationsPolicyTextBlock_zemf8Q5h2Mhb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Nature of Operations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Propanc Biopharma, Inc. (the “Company,” “we,” “us” or “our”) is based in Camberwell, Victoria Australia. Since its inception, substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. It is currently in the preclinical phase of development.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company was originally formed in Melbourne, Victoria, Australia on October 15, 2007 as Propanc PTY LTD. On November 23, 2010, Propanc Health Group Corporation was incorporated in the State of Delaware, and in January 2011, to reorganize the Company, all of the outstanding shares of Propanc PTY LTD were acquired on a one-for-one basis by Propanc Health Group Corporation, with Propanc PTY LTD becoming a wholly-owned subsidiary of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 22, 2016, the Company formed another wholly-owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose of submitting an orphan drug application to the European Medicines Agency as a small and medium-sized enterprise. As of December 31, 2025, there has been no activity within this entity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective April 20, 2017, the Company changed its name to “Propanc Biopharma, Inc.” to reflect the Company’s stage of operations and development better.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2020, a world-first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 85 granted, allowed, or accepted patents and 7 patents filed, or under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering the lead product candidate PRP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company hopes to capture and protect additional patentable subject matter based on the Company’s field of technology relating to pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product candidate, PRP, through various stages of development.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zXI9clUXMpci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis of Presentation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s interim unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q (this “Quarterly Report”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring adjustments) necessary to present fairly our consolidated results of operations for the three and six months ended December 31, 2025 and 2024 and cash flows for the six months ended December 31, 2025 and 2024 and our consolidated financial position at December 31, 2025 have been made. The Company’s results of operations for the three and six months ended December 31, 2025 are not necessarily indicative of the operating results to be expected for the full fiscal year ending June 30, 2026.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain information and disclosures normally included in the notes to the Company’s annual audited consolidated financial statements have been condensed or omitted from the Company’s interim unaudited condensed consolidated financial statements included in this Quarterly Report. Accordingly, these interim unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2025. The June 30, 2025 balance sheet is derived from those statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zMl0yJW6Nbxf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Principles of Consolidation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited condensed consolidated financial statements include the accounts of Propanc Biopharma, Inc., the parent entity, and its wholly-owned subsidiary, Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. Propanc (UK) Limited was an inactive wholly-owned subsidiary through December 31, 2025 and still remains inactive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--UseOfEstimates_ztsFOYAHG0X3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated financial statements include the estimates of useful lives of long-lived assets, valuation of the collectability of a refundable advance deposit, present value of the operating lease liability and related right-of-use asset, valuation of derivatives, valuation of convertible preferred stock, valuation of warrant liability, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zj13Ia4t69tk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign Currency Translation and Other Comprehensive Income (Loss)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholly-owned subsidiary’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into the Company’s reporting currency, which is the United States dollar ($) and/or (USD). Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “Accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency translations are included in the statements of operations and comprehensive income (loss) as a component of other comprehensive income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at the consolidated balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency included in the consolidated results of operations as incurred. Effective fiscal year 2021, the parent company determined that the intercompany loans will not be repaid in the foreseeable future and thus, per Accounting Standards Codification (“ASC”) 830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment, a component of accumulated other comprehensive income (loss). As of December 31, 2025 and 2024, the Company recognized a cumulative exchange gain (loss) of approximately $<span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20250701__20251231_z4lPXolb7Qag" title="Foreign currency transaction gain loss">355,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_906_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20240701__20241231_zij07wBYUJY2" title="Foreign currency transaction gain loss">(1,573,000)</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, on intercompany loans made by the parent to the subsidiary that have not been repaid as of December 31, 2025, which is included as a component of accumulated other comprehensive income on the accompanying condensed consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_z7NYqQTZmMr6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2025 and June 30, 2025, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing the consolidated financial statements were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span id="xdx_8B6_zE5S9vb8CC2i" style="display: none">SCHEDULE OF TRANSACTION EXCHANGE RATES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2025</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exchange rate on balance sheet dates</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231_ze5cr4F3kyZ6" style="width: 16%; text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6667</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20250630_z5qKzavJXsk5" style="width: 16%; text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6571</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Average exchange rate for the period</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231__srt--RangeAxis__srt--WeightedAverageMember_z4IVB3dWhFWl" style="text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6521</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20250630__srt--RangeAxis__srt--WeightedAverageMember_zTRMGhCDqaRl" style="text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6468</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AB_z0VzP6rnDC5g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zqbbh1t0wwb5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The change in Accumulated Other Comprehensive Income by component during the six months ended December 31, 2025 was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span id="xdx_8B7_zdBpICzVJ8Q7" style="display: none">SCHEDULE OF ACCUMULATED OTHER COMPREHENSIVE INCOME</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Foreign<br/> Currency Items:</span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif">Balance, June 30, 2025</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20250701__20251231_zUxFzewpRH41" style="width: 16%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,318,917</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unrealized foreign currency translation gain</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_pp0p0_c20250701__20251231_zupzfHms0Av" style="border-bottom: Black 1pt solid; text-align: right" title="Unrealized foreign currency translation gain (loss)"><span style="font-family: Times New Roman, Times, Serif">9,198</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance, December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20250701__20251231_zRHI84ZS7gYj" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif">1,328,115</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A6_zNNVtufDiclk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zr0kQrd144F2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fair Value of Financial Instruments and Fair Value Measurements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company measures its financial assets and liabilities in accordance with US GAAP. For certain financial instruments, including cash and cash equivalents, receivables, accounts payable and accrued liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for notes payable, net of discount, and loans payable also approximate fair value because current interest rates available for debt with similar terms and maturities are substantially the same.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows accounting guidance for financial assets and liabilities. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Inputs, other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also see Note 12 - Derivative Financial Instruments and Fair Value Measurements.</span></p> <p id="xdx_856_zF2NTNFxLIW2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zPixgz2eGp48" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cash and Cash Equivalents</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were <span id="xdx_908_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20250630_z8cw9VftJjb3" title="Cash and cash equivalents"><span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20251231_z1BX44MQleV4" title="Cash and cash equivalents">no</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cash equivalents as of December 31, 2025 or June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_ecustom--PrepaidExpensesPolicyTextBlock_z3k6AMWIFre9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Prepaid expenses</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses – current portion and long-term portion of $<span id="xdx_908_eus-gaap--PrepaidExpenseCurrent_iI_c20251231_zZS56sF0N2S7" title="Prepaid expenses">7,127,293</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_905_eus-gaap--PrepaidExpenseNoncurrent_iI_c20251231_znMqLPCs9pY" title="Prepaid expenses">7,347,310</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, at December 31, 2025, consist primarily of costs paid for future services which will occur between 1 month to three years. Prepaid expenses – current portion and long-term portion of $<span id="xdx_90E_eus-gaap--PrepaidExpenseCurrent_iI_c20250630_z1pOu3WKT7pl" title="Prepaid expenses current">8,334,046</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_904_eus-gaap--PrepaidExpenseNoncurrent_iI_c20250630_zXNrEBMz8Cx5" title="Prepaid expenses current">10,925,835</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, at June 30, 2025, consist primarily of costs paid for future services which will occur between 6 months to three years. Prepaid expenses principally include prepayments in fully vested, non-forfeitable equity instruments for general consulting, investor relations, and business advisory services, which are being amortized over the terms of their respective agreements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_ecustom--DeferredOfferingCostsPolicyTextBlock_z4WbUTCgMBK1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Deferred Offering Costs</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company complies with the requirements of ASC 340, Other Assets and Deferred Costs, with regards to offering costs. Prior to the completion of an offering, offering costs are capitalized and consist principally of professional, underwriting and other expenses incurred through the balance sheet date that are directly related to the Company’s proposed public offering. The deferred offering costs are charged to additional paid-in capital or as a discount to debt, as applicable, upon the completion of an offering or to expense if the offering is not completed. As of December 31, 2025 and June 30, 2025, the Company had recorded $<span id="xdx_90A_eus-gaap--DeferredCosts_iI_dxL_c20251231_zJLCfX6qd5a5" title="Deferred costs::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1042">0</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90D_eus-gaap--DeferredCosts_iI_c20250630_zPpXFfDeUWee" title="Deferred costs">291,773</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, in deferred offering costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zpNtbk1ILYHg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Property and Equipment</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred; additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_zysEBYSzpns8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated useful lives are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span id="xdx_8BA_z3oYw0iZAhBj" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zeHCEtMNZrW3" title="Property plant and equipment, useful life">5</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zfrQXLI4fyAe" title="Property plant and equipment, useful life">7</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years</span></td></tr> </table> <p id="xdx_8A6_zZQVN2kD0et2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zt1crGZBBMpc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Patents</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents are stated at cost and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency. However, the Company will expense any patent costs as long as we are in the startup stage. Accordingly, as the Company’s products are not currently approved for market, all patent costs incurred from 2013 through December 31, 2025 were expensed immediately. This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zoQkyPQ9hNtb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impairment of Long-Lived Assets</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 360-10, “Long-lived assets,” which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--EmployeeStockOwnershipPlanESOPPolicy_ztazDLSSW7vd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Employee Benefit/Liability</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities arising in respect of wages and salaries, accumulated annual leave, accumulated long service leave and any other employee benefits expected to be settled within twelve months of the reporting date are measured based on the employee’s remuneration rates applicable at the reporting date. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--GoodsAndServicesTaxPolicyTextBlock_zn2vYpzLBj1k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Australian Goods and Services Tax (“GST”)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues, expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2025 and June 30, 2025, the Company was owed $<span id="xdx_909_ecustom--GoodsAndServicesTaxReceivableCurrent_iI_c20251231_zFNRbMS367bi" title="GST tax receivable">16,994</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_900_ecustom--GoodsAndServicesTaxReceivableCurrent_iI_c20250630_zszR9Ncc8SPi" title="GST tax receivable">5,302</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, from the Australian Taxation Office. These amounts were fully collected subsequent to the balance sheet reporting dates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--DerivativesPolicyTextBlock_z6w2nWvdDxTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Derivative Instruments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 815, <i>Derivatives and Hedging</i> (“ASC Topic 815”), establishes accounting and reporting standards for derivative instruments and for hedging activities by requiring that all derivatives be recognized in the balance sheet and measured at fair value. Gains or losses resulting from changes in the fair value of derivatives are recognized in earnings. On the date of conversion or payoff of debt, the Company records the fair value of the conversion shares, removes the fair value of the related derivative liability, removes any discounts and records a net gain or loss on debt extinguishment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--ConvertibleNotesPolicyTextBlock_zrEPVL7DWCS8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Convertible Notes With Variable Conversion Options</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into shares of the Company’s common stock, par value $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20251231_z2YbOSXEJ5w7" title="Common stock, par value">0.001</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (“common stock”) at a fixed discount to the price of the common stock at or around the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, “<i>Distinguishing Liabilities from Equity</i>” and measures the fair value of the notes at the time of issuance, which is the result of the share price discount at the time of conversion and records the put premium as interest expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--WarrantLiabilityPolicyTextBlock_z2clElDREiw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_z8BbTZhz56Fe">Warrant Liability</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for the <span id="xdx_907_ecustom--WarrantsIssued_pid_c20251101__20251130__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantMember_zfTS1vRkFdp4" title="Warrants issued">9,900</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series C warrants issued in November 2025, in accordance with the guidance contained in ASC 815 “Derivatives and Hedging” whereby under that provision these warrants do not meet the criteria for equity treatment and must be recorded as a liability. Accordingly, the Company classifies these warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. This liability is re-measured at each balance sheet date until the warrants are exercised or expire, and any change in fair value will be recognized in the Company’s statement of operations. The fair value of these warrants is estimated using a Monte Carlo simulation model. Such warrant classification is also subject to re-evaluation at each reporting period (see Note 7).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zLWF0MbRtPI4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Income Taxes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows ASC 740 “<i>Accounting for Income Taxes</i>,” when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 740, Sections 25 through 60, “<i>Accounting for Uncertainty in Income Taxes</i>.” These sections provide detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized upon the adoption of ASC 740 and in subsequent periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_zD8g2kchiBb1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Research and Development Costs and Tax Credits</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 730-10, <i>“Research and Development-Overall,”</i> research and development costs are expensed when incurred. Total research and development costs for the three months ended December 31, 2025 and 2024 were $<span id="xdx_90C_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20251001__20251231_zgrmTB2LoZ2k" title="Research and development costs">19,961</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_909_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20241001__20241231_zqha7nKghkUa" title="Research and development costs">54,388</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively. Total research and development costs for the six months ended December 31, 2025 and 2024 were $<span id="xdx_909_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20250701__20251231_zuspT4TvYTo" title="Research and development costs">80,162</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_909_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20240701__20241231_z95DZWQK3s1j" title="Research and development costs">116,102</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company’s net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as a tax benefit, in operations, upon receipt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zu7FcjX0PUi8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Stock Based Compensation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records stock-based compensation in accordance with ASC 718, “<i>Stock Compensation</i>”. ASC 718 requires the fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the shorter of the service period or the vesting period. The Company values employee and non-employee stock-based compensation at fair value using the Black-Scholes Option Pricing Model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zl5aA6gV7uyk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue Recognition</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applies ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). ASC 606 establishes a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most of the existing revenue recognition guidance. This standard requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services and also requires certain additional disclosures. Subject to these criteria, the Company intends to recognize revenue relating to royalties on product sales in the period in which the sale occurs and the royalty term has begun.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--LegalCostsPolicyTextBlock_zFrIeDuLuLf8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Legal Expenses</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All legal costs for litigation are charged to expense as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zRRofnlUaedg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leases</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC Topic 842, Leases (Topic 842) and applies the package of practical expedients, which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less. Operating lease right of use assets (“ROU”) represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the adoption date in determining the present value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included in general and administrative expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_zphBEFrAx4S3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basic and Diluted Net Loss Per Common Share</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. <span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20250701__20251231_zE6GbRZKrcx9">Each holder of the convertible notes has agreed to a 4.99% beneficial ownership conversion limitation (subject to certain noteholders’ ability to increase such limitation to 9.99% upon 60 days’ notice to the Company), and each note may not be converted during the first six-month period from the date of issuance.</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s CEO holds Series B Preferred Stock that, when combined, confers upon him a majority vote, including regarding authorization of additional common shares and/or the authorization of a reverse split the stock as considered necessary. Such securities are considered dilutive securities which were excluded from the computation since the effect is anti-dilutive.</span></p> <p id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zutuxgUTsIPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BA_zAA15id6kNWc" style="display: none">SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2025</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2024</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock Warrants with no designations</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250701__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zqG0432mtFp9" style="width: 16%; text-align: right" title="Stock Warrants with no designations"><span style="font-family: Times New Roman, Times, Serif">40,150</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zcga62z9zPb7" style="width: 16%; text-align: right" title="Stock Warrants with no designations"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Series A Warrants as if converted at alternate cashless exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250701__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zvRsLRaHJB5i" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zVWkhq4zf9hd" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif">33,173</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Series C Warrants as if converted at alternate cashless exercise price *</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250701__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCWarrantsMember_fKg_____zY3wG77XI8r9" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1109">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCWarrantsMember_fKg_____zuoTqxBIc9Td" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif">152,933</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Convertible Series C Preferred stock</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250701__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCConvertiblePreferredStockMember_zjU0UCesE7k6" style="text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif">2,178,649</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCConvertiblePreferredStockMember_zbDZGhUiDYkj" style="text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1115">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Convertible Debt</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250701__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zKTSAAW1gb7j" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif">169,753</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_z4bZ0s3Uumh5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif">44,971</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250701__20251231_zKjCVS7PiiDg" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif">2,388,552</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20241231_zv1kCWe6e3X2" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif">231,327</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F01_ztpAJZEBRcjd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1A_zun3aSMUl0Yg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only convertible ratably upon exercise of Series B Warrants</span></td> </tr></table> <p id="xdx_8A6_z07o0WJgTaEc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_844_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zC8CL3HAmxbf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Segment Reporting</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses “the management approach” in determining reportable operating segments. Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker (“CODM”). The management approach considers the internal organization and reporting used by the Company’s CODM for making operating decisions and assessing performance as the source for determining the Company’s reportable segments. All activities are related to the development of cancer treatment and the Company has not commenced commercial operations or generated revenues to date. All activities are related to the development of the cancer treatment and the Company has not commenced commercial operations or generated revenues to date. The CODM is the chief executive officer of the Company, who reviews operating results and utilizes consolidated financial information, including operating expenses, operating loss, and net loss as reported on the consolidated statements of operations, to make decisions about operating decisions, allocate resources and assess performance for the entire Company. Consolidated net loss is our segment’s primary measure of loss. The measure of segment assets is reported on the consolidated balance sheets as total consolidated assets. The single segment constitutes all the consolidated entity, and the accompanying consolidated financial statements and the notes to the accompanying consolidated financial statements are representative of such amounts. For the three and six months ended December 31, 2025 and 2024, the Company operates in <span id="xdx_90F_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20251001__20251231_zK0zUKcE00Bi" title="Number of operating segments"><span id="xdx_907_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20240701__20241231_z8J9J5pvQCV2" title="Number of operating segments">one</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">operating segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zzZCtQuuhkRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Recent Accounting Pronouncements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have reviewed the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting principles and do not believe that any new or modified principles will have a material impact on the Company’s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of the Company’s financial management.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 4, 2024 the FASB issued ASU 2024-03, <i>Disaggregation of Income Statement Expenses</i> (DISE) requiring additional disclosure of the nature of expenses included in the income statement in response to longstanding requests from investors for more information about an entity’s expenses. This standard requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. ASU 2024-03 applies to all public business entities (PBEs) and is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods within annual reporting periods beginning after December 15, 2027. The requirements will be applied prospectively with the option for retrospective application. Early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2024-03 may have on the Company’s condensed consolidated financial statements.</span></p> <p id="xdx_852_zP3JPVUN0Ex4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--NatureOfOperationsPolicyTextBlock_zemf8Q5h2Mhb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Nature of Operations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Propanc Biopharma, Inc. (the “Company,” “we,” “us” or “our”) is based in Camberwell, Victoria Australia. Since its inception, substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. It is currently in the preclinical phase of development.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company was originally formed in Melbourne, Victoria, Australia on October 15, 2007 as Propanc PTY LTD. On November 23, 2010, Propanc Health Group Corporation was incorporated in the State of Delaware, and in January 2011, to reorganize the Company, all of the outstanding shares of Propanc PTY LTD were acquired on a one-for-one basis by Propanc Health Group Corporation, with Propanc PTY LTD becoming a wholly-owned subsidiary of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 22, 2016, the Company formed another wholly-owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose of submitting an orphan drug application to the European Medicines Agency as a small and medium-sized enterprise. As of December 31, 2025, there has been no activity within this entity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective April 20, 2017, the Company changed its name to “Propanc Biopharma, Inc.” to reflect the Company’s stage of operations and development better.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2020, a world-first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 85 granted, allowed, or accepted patents and 7 patents filed, or under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering the lead product candidate PRP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company hopes to capture and protect additional patentable subject matter based on the Company’s field of technology relating to pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product candidate, PRP, through various stages of development.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zXI9clUXMpci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis of Presentation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s interim unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q (this “Quarterly Report”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring adjustments) necessary to present fairly our consolidated results of operations for the three and six months ended December 31, 2025 and 2024 and cash flows for the six months ended December 31, 2025 and 2024 and our consolidated financial position at December 31, 2025 have been made. The Company’s results of operations for the three and six months ended December 31, 2025 are not necessarily indicative of the operating results to be expected for the full fiscal year ending June 30, 2026.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain information and disclosures normally included in the notes to the Company’s annual audited consolidated financial statements have been condensed or omitted from the Company’s interim unaudited condensed consolidated financial statements included in this Quarterly Report. Accordingly, these interim unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2025. The June 30, 2025 balance sheet is derived from those statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zMl0yJW6Nbxf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Principles of Consolidation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited condensed consolidated financial statements include the accounts of Propanc Biopharma, Inc., the parent entity, and its wholly-owned subsidiary, Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. Propanc (UK) Limited was an inactive wholly-owned subsidiary through December 31, 2025 and still remains inactive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--UseOfEstimates_ztsFOYAHG0X3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated financial statements include the estimates of useful lives of long-lived assets, valuation of the collectability of a refundable advance deposit, present value of the operating lease liability and related right-of-use asset, valuation of derivatives, valuation of convertible preferred stock, valuation of warrant liability, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zj13Ia4t69tk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign Currency Translation and Other Comprehensive Income (Loss)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholly-owned subsidiary’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into the Company’s reporting currency, which is the United States dollar ($) and/or (USD). Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “Accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency translations are included in the statements of operations and comprehensive income (loss) as a component of other comprehensive income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at the consolidated balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency included in the consolidated results of operations as incurred. Effective fiscal year 2021, the parent company determined that the intercompany loans will not be repaid in the foreseeable future and thus, per Accounting Standards Codification (“ASC”) 830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment, a component of accumulated other comprehensive income (loss). As of December 31, 2025 and 2024, the Company recognized a cumulative exchange gain (loss) of approximately $<span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20250701__20251231_z4lPXolb7Qag" title="Foreign currency transaction gain loss">355,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_906_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20240701__20241231_zij07wBYUJY2" title="Foreign currency transaction gain loss">(1,573,000)</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, on intercompany loans made by the parent to the subsidiary that have not been repaid as of December 31, 2025, which is included as a component of accumulated other comprehensive income on the accompanying condensed consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_z7NYqQTZmMr6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2025 and June 30, 2025, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing the consolidated financial statements were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span id="xdx_8B6_zE5S9vb8CC2i" style="display: none">SCHEDULE OF TRANSACTION EXCHANGE RATES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2025</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exchange rate on balance sheet dates</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231_ze5cr4F3kyZ6" style="width: 16%; text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6667</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20250630_z5qKzavJXsk5" style="width: 16%; text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6571</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Average exchange rate for the period</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231__srt--RangeAxis__srt--WeightedAverageMember_z4IVB3dWhFWl" style="text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6521</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20250630__srt--RangeAxis__srt--WeightedAverageMember_zTRMGhCDqaRl" style="text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6468</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AB_z0VzP6rnDC5g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zqbbh1t0wwb5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The change in Accumulated Other Comprehensive Income by component during the six months ended December 31, 2025 was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span id="xdx_8B7_zdBpICzVJ8Q7" style="display: none">SCHEDULE OF ACCUMULATED OTHER COMPREHENSIVE INCOME</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Foreign<br/> Currency Items:</span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif">Balance, June 30, 2025</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20250701__20251231_zUxFzewpRH41" style="width: 16%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,318,917</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unrealized foreign currency translation gain</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_pp0p0_c20250701__20251231_zupzfHms0Av" style="border-bottom: Black 1pt solid; text-align: right" title="Unrealized foreign currency translation gain (loss)"><span style="font-family: Times New Roman, Times, Serif">9,198</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance, December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20250701__20251231_zRHI84ZS7gYj" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif">1,328,115</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A6_zNNVtufDiclk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 355000 -1573000 <p id="xdx_894_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_z7NYqQTZmMr6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2025 and June 30, 2025, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing the consolidated financial statements were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span id="xdx_8B6_zE5S9vb8CC2i" style="display: none">SCHEDULE OF TRANSACTION EXCHANGE RATES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2025</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exchange rate on balance sheet dates</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231_ze5cr4F3kyZ6" style="width: 16%; text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6667</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20250630_z5qKzavJXsk5" style="width: 16%; text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6571</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Average exchange rate for the period</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231__srt--RangeAxis__srt--WeightedAverageMember_z4IVB3dWhFWl" style="text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6521</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20250630__srt--RangeAxis__srt--WeightedAverageMember_zTRMGhCDqaRl" style="text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6468</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 0.6667 0.6571 0.6521 0.6468 <p id="xdx_891_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zqbbh1t0wwb5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The change in Accumulated Other Comprehensive Income by component during the six months ended December 31, 2025 was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span id="xdx_8B7_zdBpICzVJ8Q7" style="display: none">SCHEDULE OF ACCUMULATED OTHER COMPREHENSIVE INCOME</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Foreign<br/> Currency Items:</span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif">Balance, June 30, 2025</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20250701__20251231_zUxFzewpRH41" style="width: 16%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,318,917</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unrealized foreign currency translation gain</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_pp0p0_c20250701__20251231_zupzfHms0Av" style="border-bottom: Black 1pt solid; text-align: right" title="Unrealized foreign currency translation gain (loss)"><span style="font-family: Times New Roman, Times, Serif">9,198</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance, December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20250701__20251231_zRHI84ZS7gYj" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif">1,328,115</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 1318917 9198 1328115 <p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zr0kQrd144F2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fair Value of Financial Instruments and Fair Value Measurements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company measures its financial assets and liabilities in accordance with US GAAP. For certain financial instruments, including cash and cash equivalents, receivables, accounts payable and accrued liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for notes payable, net of discount, and loans payable also approximate fair value because current interest rates available for debt with similar terms and maturities are substantially the same.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows accounting guidance for financial assets and liabilities. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Inputs, other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also see Note 12 - Derivative Financial Instruments and Fair Value Measurements.</span></p> <p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zPixgz2eGp48" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cash and Cash Equivalents</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were <span id="xdx_908_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20250630_z8cw9VftJjb3" title="Cash and cash equivalents"><span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20251231_z1BX44MQleV4" title="Cash and cash equivalents">no</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cash equivalents as of December 31, 2025 or June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_843_ecustom--PrepaidExpensesPolicyTextBlock_z3k6AMWIFre9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Prepaid expenses</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses – current portion and long-term portion of $<span id="xdx_908_eus-gaap--PrepaidExpenseCurrent_iI_c20251231_zZS56sF0N2S7" title="Prepaid expenses">7,127,293</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_905_eus-gaap--PrepaidExpenseNoncurrent_iI_c20251231_znMqLPCs9pY" title="Prepaid expenses">7,347,310</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, at December 31, 2025, consist primarily of costs paid for future services which will occur between 1 month to three years. Prepaid expenses – current portion and long-term portion of $<span id="xdx_90E_eus-gaap--PrepaidExpenseCurrent_iI_c20250630_z1pOu3WKT7pl" title="Prepaid expenses current">8,334,046</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_904_eus-gaap--PrepaidExpenseNoncurrent_iI_c20250630_zXNrEBMz8Cx5" title="Prepaid expenses current">10,925,835</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, at June 30, 2025, consist primarily of costs paid for future services which will occur between 6 months to three years. Prepaid expenses principally include prepayments in fully vested, non-forfeitable equity instruments for general consulting, investor relations, and business advisory services, which are being amortized over the terms of their respective agreements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 7127293 7347310 8334046 10925835 <p id="xdx_84A_ecustom--DeferredOfferingCostsPolicyTextBlock_z4WbUTCgMBK1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Deferred Offering Costs</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company complies with the requirements of ASC 340, Other Assets and Deferred Costs, with regards to offering costs. Prior to the completion of an offering, offering costs are capitalized and consist principally of professional, underwriting and other expenses incurred through the balance sheet date that are directly related to the Company’s proposed public offering. The deferred offering costs are charged to additional paid-in capital or as a discount to debt, as applicable, upon the completion of an offering or to expense if the offering is not completed. As of December 31, 2025 and June 30, 2025, the Company had recorded $<span id="xdx_90A_eus-gaap--DeferredCosts_iI_dxL_c20251231_zJLCfX6qd5a5" title="Deferred costs::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1042">0</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90D_eus-gaap--DeferredCosts_iI_c20250630_zPpXFfDeUWee" title="Deferred costs">291,773</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, in deferred offering costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 291773 <p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zpNtbk1ILYHg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Property and Equipment</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred; additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_zysEBYSzpns8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated useful lives are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span id="xdx_8BA_z3oYw0iZAhBj" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zeHCEtMNZrW3" title="Property plant and equipment, useful life">5</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zfrQXLI4fyAe" title="Property plant and equipment, useful life">7</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years</span></td></tr> </table> <p id="xdx_8A6_zZQVN2kD0et2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_zysEBYSzpns8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated useful lives are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span id="xdx_8BA_z3oYw0iZAhBj" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zeHCEtMNZrW3" title="Property plant and equipment, useful life">5</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zfrQXLI4fyAe" title="Property plant and equipment, useful life">7</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years</span></td></tr> </table> P5Y P7Y <p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zt1crGZBBMpc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Patents</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents are stated at cost and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency. However, the Company will expense any patent costs as long as we are in the startup stage. Accordingly, as the Company’s products are not currently approved for market, all patent costs incurred from 2013 through December 31, 2025 were expensed immediately. This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zoQkyPQ9hNtb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impairment of Long-Lived Assets</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 360-10, “Long-lived assets,” which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--EmployeeStockOwnershipPlanESOPPolicy_ztazDLSSW7vd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Employee Benefit/Liability</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities arising in respect of wages and salaries, accumulated annual leave, accumulated long service leave and any other employee benefits expected to be settled within twelve months of the reporting date are measured based on the employee’s remuneration rates applicable at the reporting date. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--GoodsAndServicesTaxPolicyTextBlock_zn2vYpzLBj1k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Australian Goods and Services Tax (“GST”)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues, expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2025 and June 30, 2025, the Company was owed $<span id="xdx_909_ecustom--GoodsAndServicesTaxReceivableCurrent_iI_c20251231_zFNRbMS367bi" title="GST tax receivable">16,994</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_900_ecustom--GoodsAndServicesTaxReceivableCurrent_iI_c20250630_zszR9Ncc8SPi" title="GST tax receivable">5,302</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, from the Australian Taxation Office. These amounts were fully collected subsequent to the balance sheet reporting dates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 16994 5302 <p id="xdx_841_eus-gaap--DerivativesPolicyTextBlock_z6w2nWvdDxTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Derivative Instruments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 815, <i>Derivatives and Hedging</i> (“ASC Topic 815”), establishes accounting and reporting standards for derivative instruments and for hedging activities by requiring that all derivatives be recognized in the balance sheet and measured at fair value. Gains or losses resulting from changes in the fair value of derivatives are recognized in earnings. On the date of conversion or payoff of debt, the Company records the fair value of the conversion shares, removes the fair value of the related derivative liability, removes any discounts and records a net gain or loss on debt extinguishment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--ConvertibleNotesPolicyTextBlock_zrEPVL7DWCS8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Convertible Notes With Variable Conversion Options</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into shares of the Company’s common stock, par value $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20251231_z2YbOSXEJ5w7" title="Common stock, par value">0.001</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (“common stock”) at a fixed discount to the price of the common stock at or around the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, “<i>Distinguishing Liabilities from Equity</i>” and measures the fair value of the notes at the time of issuance, which is the result of the share price discount at the time of conversion and records the put premium as interest expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.001 <p id="xdx_844_ecustom--WarrantLiabilityPolicyTextBlock_z2clElDREiw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_z8BbTZhz56Fe">Warrant Liability</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for the <span id="xdx_907_ecustom--WarrantsIssued_pid_c20251101__20251130__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantMember_zfTS1vRkFdp4" title="Warrants issued">9,900</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series C warrants issued in November 2025, in accordance with the guidance contained in ASC 815 “Derivatives and Hedging” whereby under that provision these warrants do not meet the criteria for equity treatment and must be recorded as a liability. Accordingly, the Company classifies these warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. This liability is re-measured at each balance sheet date until the warrants are exercised or expire, and any change in fair value will be recognized in the Company’s statement of operations. The fair value of these warrants is estimated using a Monte Carlo simulation model. Such warrant classification is also subject to re-evaluation at each reporting period (see Note 7).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 9900 <p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zLWF0MbRtPI4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Income Taxes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 26.2pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows ASC 740 “<i>Accounting for Income Taxes</i>,” when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 740, Sections 25 through 60, “<i>Accounting for Uncertainty in Income Taxes</i>.” These sections provide detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized upon the adoption of ASC 740 and in subsequent periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_zD8g2kchiBb1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Research and Development Costs and Tax Credits</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 730-10, <i>“Research and Development-Overall,”</i> research and development costs are expensed when incurred. Total research and development costs for the three months ended December 31, 2025 and 2024 were $<span id="xdx_90C_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20251001__20251231_zgrmTB2LoZ2k" title="Research and development costs">19,961</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_909_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20241001__20241231_zqha7nKghkUa" title="Research and development costs">54,388</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively. Total research and development costs for the six months ended December 31, 2025 and 2024 were $<span id="xdx_909_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20250701__20251231_zuspT4TvYTo" title="Research and development costs">80,162</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_909_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20240701__20241231_z95DZWQK3s1j" title="Research and development costs">116,102</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company’s net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as a tax benefit, in operations, upon receipt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 19961 54388 80162 116102 <p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zu7FcjX0PUi8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Stock Based Compensation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records stock-based compensation in accordance with ASC 718, “<i>Stock Compensation</i>”. ASC 718 requires the fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the shorter of the service period or the vesting period. The Company values employee and non-employee stock-based compensation at fair value using the Black-Scholes Option Pricing Model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zl5aA6gV7uyk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue Recognition</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applies ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). ASC 606 establishes a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most of the existing revenue recognition guidance. This standard requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services and also requires certain additional disclosures. Subject to these criteria, the Company intends to recognize revenue relating to royalties on product sales in the period in which the sale occurs and the royalty term has begun.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--LegalCostsPolicyTextBlock_zFrIeDuLuLf8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Legal Expenses</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All legal costs for litigation are charged to expense as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zRRofnlUaedg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leases</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC Topic 842, Leases (Topic 842) and applies the package of practical expedients, which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less. Operating lease right of use assets (“ROU”) represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the adoption date in determining the present value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included in general and administrative expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_zphBEFrAx4S3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basic and Diluted Net Loss Per Common Share</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. <span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20250701__20251231_zE6GbRZKrcx9">Each holder of the convertible notes has agreed to a 4.99% beneficial ownership conversion limitation (subject to certain noteholders’ ability to increase such limitation to 9.99% upon 60 days’ notice to the Company), and each note may not be converted during the first six-month period from the date of issuance.</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s CEO holds Series B Preferred Stock that, when combined, confers upon him a majority vote, including regarding authorization of additional common shares and/or the authorization of a reverse split the stock as considered necessary. Such securities are considered dilutive securities which were excluded from the computation since the effect is anti-dilutive.</span></p> <p id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zutuxgUTsIPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BA_zAA15id6kNWc" style="display: none">SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2025</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2024</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock Warrants with no designations</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250701__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zqG0432mtFp9" style="width: 16%; text-align: right" title="Stock Warrants with no designations"><span style="font-family: Times New Roman, Times, Serif">40,150</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zcga62z9zPb7" style="width: 16%; text-align: right" title="Stock Warrants with no designations"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Series A Warrants as if converted at alternate cashless exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250701__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zvRsLRaHJB5i" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zVWkhq4zf9hd" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif">33,173</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Series C Warrants as if converted at alternate cashless exercise price *</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250701__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCWarrantsMember_fKg_____zY3wG77XI8r9" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1109">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCWarrantsMember_fKg_____zuoTqxBIc9Td" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif">152,933</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Convertible Series C Preferred stock</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250701__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCConvertiblePreferredStockMember_zjU0UCesE7k6" style="text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif">2,178,649</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCConvertiblePreferredStockMember_zbDZGhUiDYkj" style="text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1115">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Convertible Debt</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250701__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zKTSAAW1gb7j" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif">169,753</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_z4bZ0s3Uumh5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif">44,971</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250701__20251231_zKjCVS7PiiDg" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif">2,388,552</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20241231_zv1kCWe6e3X2" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif">231,327</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F01_ztpAJZEBRcjd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1A_zun3aSMUl0Yg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only convertible ratably upon exercise of Series B Warrants</span></td> </tr></table> <p id="xdx_8A6_z07o0WJgTaEc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> Each holder of the convertible notes has agreed to a 4.99% beneficial ownership conversion limitation (subject to certain noteholders’ ability to increase such limitation to 9.99% upon 60 days’ notice to the Company), and each note may not be converted during the first six-month period from the date of issuance. <p id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zutuxgUTsIPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BA_zAA15id6kNWc" style="display: none">SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2025</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2024</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock Warrants with no designations</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250701__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zqG0432mtFp9" style="width: 16%; text-align: right" title="Stock Warrants with no designations"><span style="font-family: Times New Roman, Times, Serif">40,150</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zcga62z9zPb7" style="width: 16%; text-align: right" title="Stock Warrants with no designations"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Series A Warrants as if converted at alternate cashless exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250701__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zvRsLRaHJB5i" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zVWkhq4zf9hd" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif">33,173</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Series C Warrants as if converted at alternate cashless exercise price *</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250701__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCWarrantsMember_fKg_____zY3wG77XI8r9" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1109">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCWarrantsMember_fKg_____zuoTqxBIc9Td" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif">152,933</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Convertible Series C Preferred stock</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250701__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCConvertiblePreferredStockMember_zjU0UCesE7k6" style="text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif">2,178,649</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCConvertiblePreferredStockMember_zbDZGhUiDYkj" style="text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1115">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Convertible Debt</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250701__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zKTSAAW1gb7j" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif">169,753</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_z4bZ0s3Uumh5" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif">44,971</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20250701__20251231_zKjCVS7PiiDg" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif">2,388,552</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20241231_zv1kCWe6e3X2" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif">231,327</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F01_ztpAJZEBRcjd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1A_zun3aSMUl0Yg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only convertible ratably upon exercise of Series B Warrants</span></td> </tr></table> 40150 250 33173 152933 2178649 169753 44971 2388552 231327 <p id="xdx_844_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zC8CL3HAmxbf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Segment Reporting</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses “the management approach” in determining reportable operating segments. Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker (“CODM”). The management approach considers the internal organization and reporting used by the Company’s CODM for making operating decisions and assessing performance as the source for determining the Company’s reportable segments. All activities are related to the development of cancer treatment and the Company has not commenced commercial operations or generated revenues to date. All activities are related to the development of the cancer treatment and the Company has not commenced commercial operations or generated revenues to date. The CODM is the chief executive officer of the Company, who reviews operating results and utilizes consolidated financial information, including operating expenses, operating loss, and net loss as reported on the consolidated statements of operations, to make decisions about operating decisions, allocate resources and assess performance for the entire Company. Consolidated net loss is our segment’s primary measure of loss. The measure of segment assets is reported on the consolidated balance sheets as total consolidated assets. The single segment constitutes all the consolidated entity, and the accompanying consolidated financial statements and the notes to the accompanying consolidated financial statements are representative of such amounts. For the three and six months ended December 31, 2025 and 2024, the Company operates in <span id="xdx_90F_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20251001__20251231_zK0zUKcE00Bi" title="Number of operating segments"><span id="xdx_907_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20240701__20241231_z8J9J5pvQCV2" title="Number of operating segments">one</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">operating segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 1 <p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zzZCtQuuhkRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Recent Accounting Pronouncements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have reviewed the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting principles and do not believe that any new or modified principles will have a material impact on the Company’s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of the Company’s financial management.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 4, 2024 the FASB issued ASU 2024-03, <i>Disaggregation of Income Statement Expenses</i> (DISE) requiring additional disclosure of the nature of expenses included in the income statement in response to longstanding requests from investors for more information about an entity’s expenses. This standard requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. ASU 2024-03 applies to all public business entities (PBEs) and is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods within annual reporting periods beginning after December 15, 2027. The requirements will be applied prospectively with the option for retrospective application. Early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2024-03 may have on the Company’s condensed consolidated financial statements.</span></p> <p id="xdx_805_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z5qTcUztZbFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – <span id="xdx_82A_zmo1KbJaOAn6">GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with US GAAP, which contemplate continuation of the Company as a going concern. For the six months ended December 31, 2025, the Company had no revenues, had a net loss of $<span id="xdx_903_eus-gaap--NetIncomeLoss_iN_di_c20250701__20251231_z4PtVthlvJMh" title="Net loss">7,929,132</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and had net cash used in operations of $<span id="xdx_90B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20250701__20251231_zYmLfU0YZB9k" title="Net cash used in operations">2,938,207</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Additionally, As of December 31, 2025, the Company had accumulated deficit of $<span id="xdx_901_ecustom--WorkingCapitalDeficit_iI_c20251231_zw6ac07LGw58" title="Working capital deficit">134,482,898</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. It is management’s opinion that these conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of at least twelve months from the issue date of this Quarterly Report.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of this uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 18, 2025, the Company sold <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250818__20250818__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNfuWzSIgoXd" title="Shares of common stock">1,000,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock for total gross proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20250818__20250818__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zveZM98lkZpl" title="Gross proceeds">4,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. After deducting the underwriting commissions and offering expenses, the Company received net proceeds of approximately $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20250818__20250818__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVSCHV5YJfab" title="Net proceeds">3.3</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (see Note 8). Additionally, on November 4, 2025, the Company sold <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20251104__20251104__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z8S69bVkEk0a" title="Number of share issued">100</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series C Preferred Stock of the Company and Warrants to purchase up to an additional <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20251104__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z2rdpkniF9kj" title="Warrants purchase">9,900</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series C Preferred Stock, at an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20251104__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z0xRwHJTZbP6" title="Warrant exercise price">10,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Warrant share in exchange for cash payment of $<span id="xdx_904_eus-gaap--PaymentsForRepurchaseOfWarrants_c20251104__20251104__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z9APqTpikF18">1,000,099</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to the Company (see Note 7).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company’s patent applications, obtaining additional sources of suitable and adequate financing and ultimately achieving a level of sales adequate to support the Company’s cost structure and business plan. The Company’s ability to continue as a going concern is also dependent on its ability to further develop and execute on its business plan. However, there can be no assurances that any or all of these endeavors will be successful.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -7929132 -2938207 134482898 1000000 4000000 3300000 100 9900 10000 1000099 <p id="xdx_80D_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zUJTF3xPhrVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_825_zo7jkPQxCymj">PROPERTY AND EQUIPMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--PropertyPlantAndEquipmentTextBlock_zW1xVCkD7Ta5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of the following as of December 31, 2025 and June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span id="xdx_8B2_z4Y5POnwLQu8" style="display: none">SCHEDULE OF PROPERTY PLANT AND EQUIPMENT</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20251231_zJf5XRnwicv7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December 31, 2025</b> (Unaudited)</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20250630_zMmTJPgDr4Q3" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzBVB_zLUe5DszGlH8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office equipment at cost</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30,203</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,078</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzBVB_zL0V86ufRHfd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: Accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25,806</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25,078</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzBVB_z7C3uRKDgWU2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total property, plant, and equipment</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,397</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1166">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A3_zd5H9YgXltal" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the three months ended December 31, 2025 and 2024 was $<span id="xdx_90A_eus-gaap--Depreciation_c20251001__20251231_zceBevUIVBy3" title="Depreciation">229</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_906_eus-gaap--Depreciation_dxL_c20241001__20241231_zK313lCCyPl6" title="Depreciation::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1170">0</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively. Depreciation expense for the six months ended December 31, 2025 and 2024 was $<span id="xdx_906_eus-gaap--Depreciation_c20250701__20251231_zNmB2tcMf1Y6" title="Depreciation">354</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_908_eus-gaap--Depreciation_dxL_c20240701__20241231_z9BbOizTQLu1" title="Depreciation::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1174">0</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p id="xdx_896_eus-gaap--PropertyPlantAndEquipmentTextBlock_zW1xVCkD7Ta5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of the following as of December 31, 2025 and June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span id="xdx_8B2_z4Y5POnwLQu8" style="display: none">SCHEDULE OF PROPERTY PLANT AND EQUIPMENT</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20251231_zJf5XRnwicv7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December 31, 2025</b> (Unaudited)</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20250630_zMmTJPgDr4Q3" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzBVB_zLUe5DszGlH8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office equipment at cost</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30,203</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,078</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzBVB_zL0V86ufRHfd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: Accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25,806</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25,078</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzBVB_z7C3uRKDgWU2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total property, plant, and equipment</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,397</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1166">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 30203 25078 25806 25078 4397 229 354 <p id="xdx_80C_eus-gaap--OtherLiabilitiesDisclosureTextBlock_zjhb2NYFOV5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_822_zEzs01PjNF28">DUE TO AND LOANS FROM FORMER DIRECTOR - RELATED PARTY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Due to former director – related party</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to former director – related party represented unsecured advances made primarily by a former director for operating expenses on behalf of the Company, such as intellectual property and formation expenses. The expenses were paid for on behalf of the Company and were due upon demand. The Company was not charged interest under these advances. The total amount owed to the former director at December 31, 2025 and June 30, 2025 were $<span id="xdx_906_eus-gaap--OtherLiabilitiesCurrent_iI_dxL_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_zyQfemPBH8bl" title="Other liabilities::XDX::-"><span id="xdx_90B_eus-gaap--OtherLiabilitiesCurrent_iI_dxL_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_zZjckB2J1Gn3" title="Other liabilities::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1178"><span style="-sec-ix-hidden: xdx2ixbrl1180">0</span></span></span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for both periods. On January 23, 2025, the Company entered into a Debt Exchange Agreement (“the Debt Exchange”) with the former director (see below) to settle such debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Loan from Former Director - Related Party</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan from the Company’s former director at December 31, 2025 and June 30, 2025 were $<span id="xdx_907_eus-gaap--OtherReceivablesNetCurrent_iI_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_z0bwjZkbwOui" title="Loan payable"><span id="xdx_907_eus-gaap--OtherReceivablesNetCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_zXiNrcrcljye" title="Loan payable">0</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for both periods. The loan bore no interest and was payable on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 23, 2025, the Company entered into a Debt Exchange with the former director and issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pp0p0_c20250123__20250123__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zFOV784ubc61" title="Number of shares of common stock issued in exchange on loan">30,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock in exchange for the total outstanding loans of $<span id="xdx_905_ecustom--SettlementOfLoansForSharesOfCommonStock_pp0p0_c20250123__20250123__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zwq3LeqAd56j" title="Settlement of loans for shares of common stock">74,395</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(which also includes the $<span id="xdx_90C_eus-gaap--OtherLiabilitiesCurrent_iI_pp0p0_c20250123__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zEuampUjUzbb">29,759</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amount as noted above under due to former director). Those shares were valued at approximately $<span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20250123__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zbKp7s361Rsh" title="Conversion price per share">13</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share or $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pp0p0_c20250123__20250123__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_z80G8qVB8L5g" title="Value of shares of common stock issued in exchange on loan">375,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, being the closing price of the stock on the date of grant to the former director. Accordingly, the fair market value of the shares issued was $<span id="xdx_901_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20250630__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zjdjm3kcV5Al" title="Debt instrument fair value">375,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, resulting in a loss on extinguishment of debt at the time of exchange of $<span id="xdx_907_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zC5PTzo1jWt8" title="Loss on extinguishment debt conversion">300,605</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">during fiscal year 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 0 0 30000 74395 29759 13 375000 375000 300605 <p id="xdx_80A_eus-gaap--DebtDisclosureTextBlock_zhcp7u2KlTlb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_82B_zD5Er2ZfugJ6">LOANS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Loans payable - Related Party</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between November 2023 and May 2024, an institutional investor affiliated with one of our directors, Josef Zelinger, loaned the Company an aggregate of $<span id="xdx_907_eus-gaap--LoansPayableCurrent_iI_c20240531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zR9YFqt1hJN3" title="Loan payable"><span id="xdx_90A_eus-gaap--LoansPayableCurrent_iI_c20241130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zunPpK00QtZ1" title="Loan payable">71,629</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Additionally, in August 2024, the same affiliated institutional investor loaned the Company an amount of $<span id="xdx_901_eus-gaap--LoansPayableCurrent_iI_pp0p0_uAUD_c20240831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zLttAha20W6j" title="Loan payable">85,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_903_eus-gaap--LoansPayableCurrent_iI_pp0p0_uUSD_c20240831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zmzlvu0Y20Ik" title="Loan payable">57,639</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD). These loans are payable on demand and were non-interest bearing. In September 2025, the Company agreed to pay interest of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z8lH9DKUhP9b" title="Debt interest rate">12</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum beginning from the funding date of these loans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective August 1, 2024, the Company entered into and closed a loan agreement with an institutional investor affiliated with one of our directors, Josef Zelinger, pursuant to which the investor loaned the Company an aggregate principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zEEnkRAckZ9g" title="Aggregate principal amount">150,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zLvJIY0ZcMBd" title="Aggregate principal amount">98,060</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD). The Company used the net proceeds for general working capital purposes. The maturity date of the loan is <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20240801__20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zr09MEZ5jDM3">November 1, 2024</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, or sooner at the discretion of the Company, and the loan bears an interest rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20240801__20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zTeRbpMwc6rf" title="Debt interest rate">12</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum and default interest rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zCLPHsAUaxlc" title="Debt instrument interest rate">18</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum. The Company has the right to prepay in full at any time with no prepayment penalty. By mutual consent the amount can be repaid via the issuance of common stock of the Company (upon uplisting on NASDAQ) and the strike price shall be at a <span id="xdx_901_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20240801__20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z7I0M59Uk5di" title="Debt instrument strike price">35</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% discount to lowest daily balance of the five preceding trading days. Such loan is past due and currently in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between November 2024 and December 2024, an institutional investor affiliated with one of our directors, Josef Zelinger, loaned the Company an aggregate of $<span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_uAUD_c20241101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zMTMwy6RwxJk" title="Loan payable">15,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_901_eus-gaap--RepaymentsOfRelatedPartyDebt_uUSD_c20241101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zoImCytLkM92" title="Loan payable">9,731</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD). These loans are payable on demand and were non-interest bearing. The Company repaid $<span id="xdx_908_eus-gaap--RepaymentsOfBankDebt_uAUD_c20250819__20250819__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zVkK5K5R7JK3" title="Repaid loan amount">12,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_90B_eus-gaap--RepaymentsOfBankDebt_uUSD_c20250819__20250819__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_z1PA7gv3ZPr4" title="Repaid loan amount">7,774</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) including additional interest expense of $<span id="xdx_90E_eus-gaap--InterestExpense_uAUD_c20250819__20250819__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zQB13qSOapi8" title="Interest expense">653</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on August 19, 2025. In September 2025, the Company agreed to pay interest of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zuWJkX7c9mW5">12</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum beginning from the funding date of these loans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective December 3, 2024, the Company entered into and closed a loan agreement with an institutional investor affiliated with one of our directors, Josef Zelinger, pursuant to which the investor loaned the Company an aggregate principal amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20241203__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zSKozCLaBuMb">175,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20241203__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zHuASJDsqnW4">113,485</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD). The Company used the net proceeds for general working capital purposes. The term of the loan is four months or less (to be determined at the discretion of the Company), with $<span id="xdx_90B_eus-gaap--LoansPayable_iI_uAUD_c20250228__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z1ozoOxG55ba">70,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD was due on <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20241203__20241203__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z02uMoGEYb1f">February 28, 2025</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90D_eus-gaap--LoansPayable_iI_uAUD_c20250402__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zwbaivf7QzC5" title="Loans payable">105,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD was due on April 2, 2025. The loan bears an interest rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20241203__20241203__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zMzjhhMQGEa7" title="Debt instrument loan bears interest rate">12</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum and default interest rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20241203__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zhOQdOQmlvwe" title="Debt instrument interest rate">18</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum. Such loan is past due and currently in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2025, an institutional investor affiliated with one of our directors, Josef Zelinger, loaned the Company an aggregate of $<span id="xdx_902_eus-gaap--RepaymentsOfRelatedPartyDebt_uAUD_c20250101__20250131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zdgYTGoyiZuk" title="Loan payable">25,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_906_eus-gaap--RepaymentsOfRelatedPartyDebt_uUSD_c20250101__20250131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zduxT22Hybik" title="Loan payable">15,485</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD). This loan bore no interest and was payable on demand. The Company fully repaid $<span id="xdx_903_eus-gaap--RepaymentsOfBankDebt_uUSD_c20250819__20250819__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zvbUlBaYeAV2" title="Repayments of bank debt">15,485</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD including additional interest expense of $<span id="xdx_906_eus-gaap--InterestExpense_uAUD_c20250819__20250819__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--DirectorMember_zrIU0T6PHpoc" title="Interest expense">1,169</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on August 19, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 12, 2025, the Company entered into and closed a loan agreement with an institutional investor affiliated with one of our directors, Josef Zelinger, pursuant to which the investor loaned the Company an aggregate principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20250412__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zju6zc0ep5B3" title="Aggregate principal amount">63,188</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20250412__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zawNsTCcA3Rc" title="Aggregate principal amount">39,625</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD). The Company used the net proceeds for general working capital purposes. The maturity date was on June 30, 2025. The loan bore an interest rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20250412__20250412__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zCuW3iOthfM2" title="Debt instrument loan bears interest rate">12</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum and default interest rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250412__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z15qsszxMBj">18</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum. The Company fully repaid $<span id="xdx_90E_eus-gaap--RepaymentsOfBankDebt_uUSD_c20250819__20250819__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zWED6Tg6K2s6" title="Repayments of bank debt">39,625</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD including additional interest expense of $<span id="xdx_905_eus-gaap--InterestExpense_uAUD_c20250819__20250819__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_ziRjvn6Ph3yk" title="Interest expense">1,818</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on August 19, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 13, 2025, the Company entered into and closed a loan agreement with an institutional investor affiliated with one of our directors, Josef Zelinger, pursuant to which the investor loaned the Company an aggregate principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20250613__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zdrJwr2OblR5" title="Aggregate principal amount">15,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20250613__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z9CLBFoKLEAc" title="Aggregate principal amount">9,675</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD). The Company used the net proceeds for general working capital purposes. The maturity date was on June 30, 2025. The loan bore an interest rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20250613__20250613__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z4ZbrkmYcX3a" title="Debt instrument loan bears interest rate">12</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum and default interest rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250613__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zoFrhp59NMW3" title="Debt instrument interest rate">18</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum. The Company fully repaid $<span id="xdx_909_eus-gaap--RepaymentsOfBankDebt_uUSD_c20250819__20250819__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zqSa8cE7yMqc" title="Repayments of bank debt">9,675</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD including additional interest expense of $<span id="xdx_906_eus-gaap--InterestExpense_uAUD_c20250819__20250819__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zNVye8WOOKZc" title="Interest expense">257</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on August 19, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between July 3, 2025 and August 14, 2025, an institutional investor affiliated with one of our directors, Josef Zelinger, loaned the Company an aggregate of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20250814__srt--TitleOfIndividualAxis__srt--DirectorMember_zmBmZ3ST6thl" title="Debt instrument face amount">120,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20250814__srt--TitleOfIndividualAxis__srt--DirectorMember_zdoAW5y1VTp1" title="Debt instrument face amount">78,249</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD). These loans bore no interest and were payable on demand. The Company fully repaid these loans on August 19, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 5, 2023, the Company and an institutional investor affiliated with one of our directors, Josef Zelinger, entered into a letter agreement, pursuant to which such investor loaned the Company an aggregate of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zluAN9HwQjW2" title="Investor loan, value">230,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zr9EtKeYucB7" title="Investor loan, value">153,256</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD). Pursuant to such agreement, the term of such loan is three (<span id="xdx_90F_eus-gaap--DebtInstrumentTerm_dtY_c20230705__20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zV6dbT2mgZB5" title="Term of agreement">3</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) years, ending on <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20230705__20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zb6HyAUECkb9" title="Debt instrument maturity date">July 5, 2026</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, with an interest rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_z1muxzOg8jG2" title="Debt instrument interest rate">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% to be paid monthly in arrears. In connection with such loan, the Company issued 250 warrants to purchase common stock to such investor immediately exercisable at an initial exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zM4LlFRiizD4" title="Share price">600</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (subject to certain adjustments such as stock dividend, stock splits, subsequent right offering and pro-rata distribution) with an expiry date of July 5, 2026. The Company accounted for the <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20230705__20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zc8x2ctfCqfa" title="Issue of warrants">250</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants issued with this loan payable as debt discount by using the relative fair value method. The total debt discount which is equivalent to the relative fair value of the warrants of $<span id="xdx_907_eus-gaap--FairValueAdjustmentOfWarrants_c20230705__20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zwHwVulAmnmi" title="Fair value adjustment of warrants">141,084</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was based on a fair value determination using a Black-Scholes model with the following assumptions: stock price at valuation date of $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20230705__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zUnYMtqP8922" title="Stock valuation price per share">7,140</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">based on the closing price of common stock at date of grant, exercise price of $<span id="xdx_909_eus-gaap--WarrantExercisePriceIncrease_c20230705__20230705__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_z7BguSUzNwUj" title="Warrant exercise price">600</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, dividend yield of zero, expected term of <span id="xdx_903_eus-gaap--DebtInstrumentTerm_dtY_c20230705__20230705__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zvfm6IEkRxK5" title="Maturity term">3.00</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, a risk-free rate of <span id="xdx_908_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20230705__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zUEspx8azJna" title="Measurement input">4.59</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, and expected volatility of <span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20230705__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zB2H9GDh2rE5" title="Measurement input">268</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%. The debt discount shall be amortized over the term of this loan. A portion of the proceeds of such loan were used to repay an outstanding balance of approximately $<span id="xdx_907_eus-gaap--RepaymentsOfConvertibleDebt_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zuJ0nyGZZd1f">143,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">due on a convertible note held by a third-party investor which had been in default. Amortization of debt discount for fiscal year 2025 was $<span id="xdx_90F_eus-gaap--AmortizationOfDebtDiscountPremium_c20240701__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z8t1HK5mrzZa">46,985</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Amortization of debt discount from this loan for the three and six months ended December 31, 2025 was $<span id="xdx_90A_eus-gaap--AmortizationOfDebtDiscountPremium_c20251001__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z1G9KzRSSMhi">11,843</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_908_eus-gaap--AmortizationOfDebtDiscountPremium_c20250701__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHn0T5hJaPs">23,686</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively. The total principal outstanding under this loan was $<span id="xdx_90E_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z2ltVfVUtjof">153,256</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and remaining debt discount of $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zS8WaTxG3L7" title="Remaining debt discount">47,629</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of June 30, 2025 as reflected in the accompanying condensed consolidated balance sheet as loan payable – long-term – related party, net of discount of $<span id="xdx_90B_eus-gaap--LongTermLoansPayable_iI_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zLL8ZVPifCQg" title="Loan payable - long-term - related party, net of discount">105,627</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The total principal outstanding under this loan, net of discount was $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumNet_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zjT7NsLzg8Yk">129,313</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($<span id="xdx_907_eus-gaap--DebtInstrumentCarryingAmount_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_znxSdcuNfaJi">153,256</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">principal and remaining unamortized debt discount of $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zZp0iX95YLJf" title="Remaining debt discount">23,943</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) as of December 31, 2025 and has been reclassified as a short-term loan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total remaining balance of all the above loans payable – related parties, net of discount amounted to $<span id="xdx_902_eus-gaap--LoansPayableCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zxdCi7covoM6" title="Loan payable">472,083</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_909_eus-gaap--LoansPayableCurrent_iI_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zcjjmXzUZjh3" title="Loan payable">415,329</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2025 and June 30, 2025, respectively. Accrued interest for all of the above loans payable – related parties as of December 31, 2025 and June 30, 2025 were $<span id="xdx_901_ecustom--InterestPayable_iI_c20251231_zGESA2fIg07e" title="Interest payable">104,337</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_903_ecustom--InterestPayable_iI_c20250630_zVN0D2ItsX58" title="Interest payable">56,935</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Loans Payable</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective October 3, 2019, the Company entered into a securities purchase agreement with Crown Bridge Partners, LLC (“Crown Bridge”), pursuant to which Crown Bridge purchased a convertible promissory note from the Company (the “Crown Bridge Note”), which had a remaining principal balance of $<span id="xdx_908_eus-gaap--ConvertibleDebt_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zAyteYs6MUU5" title="Convertible debt"><span id="xdx_900_eus-gaap--ConvertibleDebt_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zWHud9g4dQl3" title="Convertible debt">65,280</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2025 and June 30, 2025. The maturity date of the Crown Bridge Note was October 3, 2020 and was past due. The Crown Bridge Note bore interest at a default interest rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zanJ6lZAsucc" title="Debt instrument interest rate stated percentage">15</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum. In August 2022, the SEC filed a complaint against Crown Bridge due to its violation of Section 15(a)(1) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Crown Bridge agreed to surrender all conversion rights in its currently held convertible notes, including the Crown Bridge Note. Consequently, during fiscal year 2023, the Company reclassified the remaining principal balance of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_z2a8rg8UVzl8" title="Debt instrument face amount"><span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zAJ9I6VqL7g2" title="Debt instrument face amount">65,280</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">from a convertible note into a loan payable which is the principal balance at December 31, 2025 and June 30, 2025. The total accrued interest from this loan amounted to $<span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zG2CQ1aWMh5b">60,296</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_z5arjifSNbxf">55,360</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as December 31, 2025 and June 30, 2025, respectively. On January 7, 2026, the Company entered into an Exchange Agreement with Crown Bridge and issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260107__20260107__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zgPUndJgB1sb">394,788</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock in exchange for the total outstanding balance of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20260107__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zsJPUxhZEZse">65,280</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accrued interest of $<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20260107__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zsEvVlZZXuG8" title="Accrued interest">60,484</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Those shares were valued at approximately $<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20260107__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zZnrnl6TAr38" title="Debt per share">0.51</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share or $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20260107__20260107__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zMhrPJT0W9A1" title="Convertible securities">200,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, being the closing price of the stock on the date of grant, resulting in a loss on extinguishment of debt at the time of exchange of $<span id="xdx_900_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20260107__20260107__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zJLVkwiUY2b4" title="Loss on extinguishment of debt">74,236</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(see Note 13).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Loans Payable - others</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2024, the Company entered into loan agreements with two investors who loaned the Company an aggregate of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20240630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z89EIeESSnu3" title="Debt instrument face amount">120,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20240630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z6rqBBjC7kaf" title="Debt instrument face amount">79,811</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD). The maturity dates of these loans were both in June 2025. These loans bore interest at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zzROM8RmM8A4">12</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum. On February 5, 2025, the Company entered into a Debt Exchange Agreements with the two investors and issued an aggregate of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250205__20250205__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_z6nYbxXpondl" title="Number of shares of common stock in exchange of loans">30,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock in exchange for the total outstanding loan including accrued interest of $<span id="xdx_90B_eus-gaap--LoansPayable_iI_c20250205__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_z40PegLQgVk2" title="Outstanding loan including accrued interest">86,248</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Those shares were valued at $<span id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250205__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_zSRe6IQ01KKf" title="Conversion price per share">10</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share or $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20250205__20250205__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_zM7F5mkSTaik" title="Value of shares of common stock in exchange of loans">300,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, being the closing price of the stock on the date of grant to the two investors. Accordingly, the fair market value of the shares issued was $<span id="xdx_90F_eus-gaap--DebtInstrumentFairValue_iI_c20250205__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_z58wWCFF8Sg5" title="Debt instrument fair value">300,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, resulting in a loss on extinguishment of debt at the time of exchange of $<span id="xdx_901_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_zh9D3srmMT95">213,752</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">during fiscal year 2025. As of December 31, 2025 and June 30, 2025, the total balance of these loans including accrued interest amounted to $<span id="xdx_90C_eus-gaap--NotesPayable_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z0xq2rlUyacb" title="Loans including accrued interest amount">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_908_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zxwVzsLGutNh" title="Loans including accrued interest amount">6,286</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively. The Company fully paid the accrued interest of $<span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250827__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zRf1D3xIehp" title="Interest payable">6,286</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on August 27, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate principal outstanding on the above loans was $<span id="xdx_90D_eus-gaap--LoansPayable_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_znIHofo0ICA">65,280</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2025 and June 30, 2025 for both periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Loans in default</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loans payable – related party for total principal amount of $<span id="xdx_90C_eus-gaap--LoansPayableCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zdJsoEwrorWc" title="Debt instrument face amount">211,545</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accrued interest of $<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zNQcFqugghn4" title="Interest payable current and non current">40,824</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">which includes interest accruing at the default interest rate at <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z5vwBqLkreg8" title="Debt interest rate percentage">18</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% with <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDateDescription_c20250701__20251231_zFnKGoEgCiRd" title="Debt maturity date description">maturity dates between November 2024 and April 2025 were in default as of December 31, 2025.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 71629 71629 85000 57639 0.12 150000 98060 2024-11-01 0.12 0.18 0.35 15000 9731 12000 7774 653 0.12 175000 113485 70000 2025-02-28 105000 0.12 0.18 25000 15485 15485 1169 63188 39625 0.12 0.18 39625 1818 15000 9675 0.12 0.18 9675 257 120000 78249 230000 153256 P3Y 2026-07-05 0.10 600 250 141084 7140 600 P3Y 4.59 268 143000 46985 11843 23686 153256 47629 105627 129313 153256 23943 472083 415329 104337 56935 65280 65280 0.15 65280 65280 60296 55360 394788 65280 60484 0.51 200000 74236 120000 79811 0.12 30000 86248 10 300000 300000 213752 0 6286 6286 65280 211545 40824 0.18 maturity dates between November 2024 and April 2025 were in default as of December 31, 2025. <p id="xdx_805_ecustom--NotesPayableAndConvertibleNotesTextBlock_zFFJUkmpnBK9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – <span id="xdx_828_zRI2bIKSqrrl">NOTES PAYABLE AND CONVERTIBLE NOTES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89D_eus-gaap--ScheduleOfDebtTableTextBlock_zYMR9uGdwvmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s promissory notes outstanding at December 31, 2025 and June 30, 2025 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BD_z63iD4ALv8Xf" style="display: none">SCHEDULE OF PROMISSORY NOTES OUTSTANDING</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zM7vvysYCZCk" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December 31, 2025</b> (Unaudited)</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zr39nLfAtOJe" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--NotesPayable_iI_maDICAzqJo_zQEUjBVhiom7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Principal amounts of notes payable</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right">          <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1382">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">589,277</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_msDICAzqJo_zAL6Z1gRJ3A8" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Unamortized discounts</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1385">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(45,965</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40A_eus-gaap--DebtInstrumentCarryingAmount_iTI_mtDICAzqJo_zv2qp3ZVNgne" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Notes payable, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1388">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">543,312</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A4_zLkUcr0exgz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Promissory Notes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 15, 2023, the Company issued to an institutional investor (the “August 2023 Lender”) a <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20230815__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zlDvdfscul7h" title="Debt instrument original issue discount rate">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% original issue discount promissory note (the “Promissory Note”) in consideration for $<span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20230815__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zSoS0dmIaz8f" title="Debt instrument, discount amount">120,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, which has a principal face amount of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20230815__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zRwXYqxvBaVh">132,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, matured on <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20230815__20230815__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zZUl0egYOKya" title="Debt instrument maturity date">November 15, 2023</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accrued interest at a rate of <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230815__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_znLXgtJDQqj9">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, and was increased to <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateIncreaseDecrease_pid_dp_uPure_c20230815__20230815__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zAXUbP9g9uDl" title="Debt instrument increase interest rate">18</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% due to the event of a default. The Company had the right to prepay the principal and accrued but unpaid interest due under the Promissory Note, together with any other amounts that the Company may owe the August 2023 Lender under the terms of the Promissory Note, on or before September 14, 2023 at a 110% premium of the face amount plus accrued and unpaid interest and any other amounts owed to the August 2023 Lender, which increases to (i) 120% if prepaid after such date, but on or before October 14, 2023, and (ii) 130% if prepaid after October 14, 2023 (including on the maturity date), unless the Company and the Lender agree to otherwise effect repayment.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Promissory Note contains certain customary events of default set forth in the Promissory Note, including, among others, breach of covenants, representations or warranties, insolvency, bankruptcy, liquidation and failure by the Company to pay the principal and interest due under the Promissory Note. On May 7, 2024, the August 2023 Lender notified the Company that the <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20240507__20240507__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zrxal0hBVXg6" title="Debt interest rate">130</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% default repayment plus interest will be waived and shall extend the maturity of the Promissory Note to December 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective May 7, 2025, the Company entered into a Maturity Extension Agreement with the August 2023 Lender whereby the August 2023 Lender agreed to extend the maturity date of the promissory note dated August 15, 2023, which was amended on May 7, 2024 (the “Old Note”) to June 15, 2025 and increasing the principal amount by a default penalty of $<span id="xdx_904_eus-gaap--LongTermDebtAverageAmountOutstanding_c20250507__20250507__us-gaap--TypeOfArrangementAxis__custom--MaturityExtensionAgreementMember_zP7S8beNLvB5" title="Debt default penalty">39,600</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and adding accrued interest of $<span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250507__us-gaap--TypeOfArrangementAxis__custom--MaturityExtensionAgreementMember_zmBzxQ2YfvE7" title="Accrued interest">30,805</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">into the principal amount thereby increasing the current principal amount to $<span id="xdx_901_eus-gaap--DebtInstrumentAnnualPrincipalPayment_iI_c20250507__us-gaap--TypeOfArrangementAxis__custom--MaturityExtensionAgreementMember_zWRsdcvm9KYd" title="Amount repaid for covertible debt">202,405</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. All other terms of the Old Note shall remain unchanged and in full force and effect. As of June 30, 2025, the Promissory Note was in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 7, 2025, the Company entered into a promissory note agreement with an institutional investor, pursuant to which the investor agreed to purchase a promissory note from the Company in the aggregate principal amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20250507__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zdlWoz6bshBc" title="Principal amount">90,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, for a purchase price of $<span id="xdx_901_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20250507__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zwLJrkPlsk8i" title="Purchase amount">75,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Such note is a non-convertible note. The maturity date of the note was on <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20250507__20250507__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zGoJJCeh5R4d">June 15, 2025</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and bears interest at a rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20250507__20250507__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zMH2hf7XE497" title="Debt instrument loan bears interest rate">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum and default interest rate of <span id="xdx_90A_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20250507__20250507__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z9FxdxOQuXAf" title="Debt instrument default interest rate">18</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum. <span id="xdx_907_eus-gaap--DebtInstrumentPaymentTerms_c20250507__20250507__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zJiRF0UMMea1" title="Debt instrument repayment term">Repayment of the note may occur as follows: (a) if the Company repaid this note on or before June 7, 2025, then Company shall pay investor in cash the sum of one hundred percent (100%) of the sum of the outstanding principal amount of the note (the “Principal Amount”) at such time, all accrued interest unpaid at such time, and any other payment due; and (b) if the Company repaid the note after June 7, 2025 and on or before July 7, 2025, then Company shall pay investor in cash the sum of one hundred twenty percent (120%) of the sum of the outstanding Principal Amount at such time, all accrued interest unpaid at such time, and any other payment due (the “Maximum Repayment Amount”) or (b) at such time as the Company and the investor may agree to effect repayment. As of June 30, 2025, the promissory note was in default.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 2, 2025, the Company entered into a promissory note agreement with an institutional investor, pursuant to which the investor agreed to purchase a promissory note from the Company in the aggregate principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20250602__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zApy57ljMyz7" title="Debt instrument face amount">60,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, for a purchase price of $<span id="xdx_901_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20250602__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zmZpXceu9Lg5" title="Purchase amount">50,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Such note is a non-convertible note. The maturity date of the note is on <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20250602__20250602__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zQnDQEYUVvc6" title="Debt instrument maturity date">July 15, 2025</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and bears interest at a rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20250602__20250602__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zyMb3hRrpRF6" title="Debt instrument loan bears interest rate">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum and default interest rate of <span id="xdx_908_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20250602__20250602__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zBUTBp9NA1k7" title="Debt instrument default interest rate">18</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum. <span id="xdx_907_eus-gaap--DebtInstrumentPaymentTerms_c20250602__20250602__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z2ne7oGMqaj2" title="Debt instrument repayment term">Repayment of the note may occur as follows: (a) if the Company repaid this note on or before July 7, 2025, then Company shall pay investor in cash the sum of one hundred percent (100%) of the sum of the outstanding principal amount of the note (the “Principal Amount”) at such time, all accrued interest unpaid at such time, and any other payment due; and (b) if the Company repaid the note after July 7, 2025 and on or before August 7, 2025, then Company shall pay investor in cash the sum of one hundred twenty percent (120%) of the sum of the outstanding Principal Amount at such time, all accrued interest unpaid at such time, and any other payment due (the “Maximum Repayment Amount”) or (b) at such time as the Company and the investor may agree to effect repayment.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 18, 2025, the Company entered into a promissory note agreement with an investor, pursuant to which the investor agreed to purchase a promissory note from the Company in the aggregate principal amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20250718__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zZz4t3HRHoG1" title="Debt instrument face amount">82,500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, for a purchase price of $<span id="xdx_908_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20250718__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zD31lbE01Gwa" title="Purchase amount">75,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Such note was a non-convertible note. The Company used the net proceeds therefrom for general working capital purposes. The maturity date of the note was <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_dd_c20250718__20250718__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zGSirgGnvru9" title="Debt instrument maturity date">September 15, 2025</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and bore interest at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20250718__20250718__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zS290sT7Bsih" title="Debt instrument loan bears interest rate">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum and default interest rate of <span id="xdx_900_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20250718__20250718__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zdt1QyvKHtX" title="Debt instrument default interest rate">18</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum. <span id="xdx_908_eus-gaap--DebtInstrumentPaymentTerms_c20250718__20250718__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zjPKISUAJv8c" title="Debt instrument repayment term">Repayment of the note may occur as follows: (a) if the Company repaaid this note on or before August 18, 2025, then Company shall pay investor in cash the sum of one hundred percent (100%) of the sum of the outstanding principal amount of the note (the “Principal Amount”) at such time, all accrued interest unpaid at such time, and any other payment due; and (b) if the Company repaid the note after August 18, 2025 and on or before September 18, 2025, then Company shall pay investor in cash the sum of one hundred twenty percent (120%) of the sum of the outstanding Principal Amount at such time, all accrued interest unpaid at such time, and any other payment due (the “Maximum Repayment Amount”) or (b) at such time as the Company and the investor may agree to effect repayment.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 19, 2025, the Company fully repaid the total principal for all the above mentioned promissory notes amounting $<span id="xdx_904_eus-gaap--DebtInstrumentRepaidPrincipal_c20250819__20250819__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_z9FDc1Fg73U2">434,905</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">including total accrued interest, default and prepayment penalty of $<span id="xdx_90A_eus-gaap--DebtDefaultLongtermDebtAmount_iI_c20250819__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zCIiXdM3pFn4" title="Debt default long term debt amount">35,076</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2025 and June 30, 2025, the total principal outstanding under these notes was $<span id="xdx_907_eus-gaap--DebtInstrumentCarryingAmount_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_z0uoNq1Amrv5" title="Debt remaining">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_906_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zKOEWWVnhhHc" title="Debt remaining">352,405</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, and remaining debt discount of $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zlxLj3JI5Wn1" title="Remaining debt discount">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_z0k1uvDCrDvk" title="Remaining debt discount">3,488</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2025 and June 30, 2025, respectively, as reflected in the accompanying condensed consolidated balance sheet as notes payable, net of discount. Accrued interest from these notes amounted to $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zRM7bSZ6Teo8" title="Interest payable">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zvytPNFsUdS8" title="Interest payable">5,718</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2025 and June 30, 2025, respectively. Amortization of debt discount from these notes for the three and six months ended December 31, 2025 was $<span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_c20250701__20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zwvEY9TnyPbg" title="Amortization of debt discounts">10,988</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_903_eus-gaap--AmortizationOfDebtDiscountPremium_c20240701__20241231__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zUfvmBkK4Ly5" title="Amortization of debt discounts">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">1800 Diagonal Lending Promissory Notes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 24, 2024, the Company entered into a <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20240524__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zGmlOq444h6j" title="Debt instrument original issue discount rate">15</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% promissory note in the amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20240524__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z9EkHJjKxkLc" title="Principal amount">49,200</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">less original issue discount of $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20240524__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zSvQtVw3nJJg">8,200</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and legal and financing costs of $<span id="xdx_90E_eus-gaap--PaymentsOfFinancingCosts_c20240524__20240524__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zpwvwf6Suyr6" title="legal and financing costs">6,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for net proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_c20240524__20240524__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z4xDMTWhM9S4" title="Net proceeds">35,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with 1800 Diagonal Lending, LLC. The principal and accrued interest is payable on or before March 30, 2025. Any amount of principal or interest on this note which is not paid when due shall bear interest at the rate of twenty two percent (<span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240524__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z509M1w8bp1d" title="Debt instrument interest rate">22</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%) per annum from the due date thereof until the same is paid. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid on November 30, 2024 in the amount of $<span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPayment_c20241130__20241130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zdogppsFooMh" title="Debt periodic payment">28,290</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and 4 payments each in the amount of $<span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20241130__20241130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zRikYPdIHlef" title="Debt repayment">7,072.50</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a total payback to the Holder of $<span id="xdx_909_eus-gaap--RepaymentsOfShortTermDebt_c20241130__20241130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zzfw2sw53Kf5" title="Payment of debt">56,580</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">). The first payment of $<span id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20241230__20241230__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zqKH2KMwccM9">7,072.50</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shall be due on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20241230__20241230__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zgztDw5qXcGf">December 30, 2024</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with 3 subsequent payments each month thereafter. The Company shall have a five (5) day grace period with respect to each payment. In November 2024, the Company fully paid the principal of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20241130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zb5KiNTC5CH3" title="Principal amount">49,200</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accrued interest of $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20241130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zI6WhLLkc5Mj" title="Accrued interest">5,683</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 10, 2024, the Company entered into a <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20240610__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zAcEtKK5DsEj" title="Debt instrument original issue discount rate">15</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% promissory note in the amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20240610__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zuTGJqP2duda" title="Principal amount">49,200</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">less original issue discount of $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20240610__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z83vGrkAKbmg">8,200</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and legal and financing costs of $<span id="xdx_904_eus-gaap--PaymentsOfFinancingCosts_c20240610__20240610__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z5yQTLESs9b4" title="legal and financing costs">6,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for net proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfDebt_c20240610__20240610__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zxKS7Fvgnm44" title="Net proceeds">35,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with 1800 Diagonal Lending, LLC. The principal and accrued interest is payable on or before April 15, 2025. Any amount of principal or interest on this note which is not paid when due shall bear interest at the rate of twenty two percent (<span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240610__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zAEWW77jZRnc">22</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%) per annum from the due date thereof until the same is paid. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid on December 15, 2024 in the amount of $<span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPayment_c20241215__20241215__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zxvvOQOBuKk" title="Debt periodic payment">28,290</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and 4 payments each in the amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPaymentInterest_c20241215__20241215__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zE0F9V8S1kB4">7,073</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a total payback to the Holder of $<span id="xdx_90E_eus-gaap--RepaymentsOfShortTermDebt_c20241215__20241215__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zSNUSXRASM45">56,580</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">). The first payment of $<span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPaymentInterest_c20250115__20250115__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zOgJ7xArp0bb" title="Debt repayment">7,073</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shall be due on January 15, 2025 with 3 subsequent payments each month thereafter. The Company shall have a five (5) day grace period with respect to each payment. In November 2024, the Company fully paid the principal of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20241130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zbpJ52ftg24g" title="Payment of debt">49,200</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accrued interest of $<span id="xdx_907_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20241130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zjzvGJvoCWE6" title="Accrued interest">5,683</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 31, 2025, the Company entered into and closed a securities purchase agreement 1800 Diagonal (the “Investor”), pursuant to which the Investor agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20250131__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zv4DdsbkDwce" title="Principal amount">65,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, for a purchase price of $<span id="xdx_908_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20250131__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zXobNGFycUe6">56,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company used the net proceeds therefrom for general working capital purposes. The maturity date of the note was <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20250131__20250131__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zYXU8ULFqxcl">November 30, 2025</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and the note bore a one-time interest charge of fifteen percent that shall be applied on the issuance date. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in five (5) payments, with the first on July 30, 2025 for $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_c20250730__20250730__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zL7paxlRHiA9">37,375</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and the other four payments of $<span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20251130__20251130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z34QUpSSmM5b">9,344</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on August 30, 2025, September 30, 2025, October 30, 2025 and November 30, 2025 (a total payback to the Holder of $<span id="xdx_900_eus-gaap--RepaymentsOfShortTermDebt_c20251130__20251130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zQ3XNlgSIN3b">74,750</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">). The Company shall have a five (5) day grace period with respect to each payment. In July 2025 and August 2025, the Company fully paid the principal of $ <span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20250831__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zd5ZOKqX7fJf">65,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">including interest of $<span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250831__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z7JXJ10Zw1y6">9,750</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 25, 2025, the Company entered into and closed a securities purchase agreement 1800 Diagonal (the “Investor”), pursuant to which the Investor agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20250325__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zTrN8ZYyRgCd">79,200</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, for a purchase price of $<span id="xdx_907_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20250325__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zX2t9tlsnnmd">67,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. <span id="xdx_906_eus-gaap--DebtInstrumentDescription_c20250325__20250325__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zSfS3GmZAAWj">The Company used the net proceeds therefrom for general working capital purposes. The maturity date of the note was </span></span><span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20250325__20250325__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zuTSQJeJstFe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Deb maturity date">January 30, 2026</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and the note bore a one-time interest charge of fifteen percent that shall be applied on the issuance date. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in five (5) payments</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, with the first on September 30, 2025 for $<span id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20250930__20250930__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember_zqeMnnbdZ1Sj">45,540</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and the other four payments of $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20260130__20260130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zOA1b4XEu4Lk">11,385</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on October 30, 2025, November 30, 2025, December 30, 2025 and January 30, 2026 (a total payback to the Holder of $<span id="xdx_901_eus-gaap--RepaymentsOfShortTermDebt_c20260130__20260130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z4vIk4Ko2O4h">91,080</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">). The Company shall have a five (5) day grace period with respect to each payment. In August 2025, the Company fully paid the principal of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20250830__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember_z8jKXZZ01MNa">79,200</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">including interest of $<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250831__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember_zsqeiAAgSqIg">11,880</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 13, 2025, the Company entered into a <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20250613__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zpYI3KtLty09" title="Debt effective percentage">15</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% promissory note in the aggregate principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20250613__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zAtcNs1suhtc">67,860</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, for a purchase price of $<span id="xdx_90E_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20250613__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zhvdoFXjaB88">58,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. This note contained original issue discount of $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20250613__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z07A2r6OIIaa">8,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and legal and financing costs of $<span id="xdx_90C_eus-gaap--PaymentsOfFinancingCosts_c20250613__20250613__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_znm5Q2uGC3ha">9,860</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for net proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfDebt_c20250613__20250613__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zqkZ5wrQny2c">50,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with 1800 Diagonal Lending, LLC. The maturity date of the note was <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20250613__20250613__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zAMRqq8TFtY5">April 15, 2026</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and the note bore a one-time interest charge of fifteen percent that shall be applied on the issuance date. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in five (5) payments, with the first on December 15, 2025 for $<span id="xdx_908_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20251215__20251215__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zw5SDSJnz2Mf">39,020</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and the other four payments on January 15, 2026, February 15, 2026, March 15, 2026 and April 15, 2026, each for $ <span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20260415__20260415__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z0aEEyJXCZ91">9,755</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a total payback to the Holder of $<span id="xdx_903_eus-gaap--RepaymentsOfShortTermDebt_c20260415__20260415__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zUQZT2YVoNE6">78,039</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">). The Company shall have a five (5) day grace period with respect to each payment. In August 2025, the Company fully paid the principal of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20250831__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zLPHQTQnbQ2a" title="Face value">67,860</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">including interest of $<span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250831__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zsFYPT5xAmTk">10,179</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had the right to accelerate payments or prepay in full at any time with no prepayment penalty. At any time following an event of default, the noteholder had the right, to convert all or any part of the outstanding and unpaid amount of these notes into shares of common stock. The conversion price of the above notes was <span id="xdx_901_ecustom--DebtInstrumentDebtConversionRate_pid_dp_uPure_c20250701__20251231__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z4QrIpKYWx9g">65</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% multiplied by the lowest trading price for the common stock during the 10 trading days prior to the conversion date (representing a discount rate of <span id="xdx_908_ecustom--DebtInstrumentDiscountRate_dp_uPure_c20250701__20251231__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zfR1GLy7L7j6">35</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%) subject to a <span id="xdx_902_ecustom--BeneficialOwnershipLimitationPercentage_dp_uPure_c20250701__20251231__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zCDg9gnsg157">4.99</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% beneficial ownership limitations. Upon the occurrence of any event of defaults, these notes shall be immediately due and payable in an amount equal to <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20251231__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zmkvunXfZpZ4">150</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% default percentage multiplied by the sum of the outstanding principal balances plus accrued interest and default interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between July 2025 and August 2025, the Company fully repaid the total principal amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentRepaidPrincipal_c20250831__20250831__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zhguBeJJdEof">212,060</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">including accrued interest for the above 1800 Diagonal Lending promissory notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2025 and June 30, 2025 the total balance of these 1800 Diagonal Lending promissory notes amounted to $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20251231__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zEk1f4wWMTTg">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_900_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zaGg3o5Nxuhj">212,060</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively and accrued interest of $<span id="xdx_908_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20251231__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zMpNNhhGnLM9">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zRkQZ3gFVazk">7,638</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Red Road Holdings Promissory Note</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 4, 2024, the Company entered into a <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_z1FxVCep0FHk">15</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% promissory note in the amount of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_z2eUvoARSUo6">49,200</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">less original issue discount of $<span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zAhm46QtzLy1">8,200</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and legal and financing costs of $<span id="xdx_906_eus-gaap--PaymentsOfFinancingCosts_c20241204__20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zdOOtlmuIyRk">6,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for net proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfDebt_c20241204__20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zNHLCvz8wmda">35,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with Red Road Holdings. The principal and accrued interest was payable on or before October 15, 2025. Any amount of principal or interest on this note which was not paid when due shall bear interest at the rate of twenty two percent (<span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zR6oIZZ5WxMb">22</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%) per annum from the due date thereof until the same was paid. Accrued interest and outstanding principal, subject to adjustment, shall be paid on June 15, 2025 in the amount of $<span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPayment_c20241204__20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zlIwahegukxk">28,290</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and 4 payments each in the amount of $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentInterest_c20241204__20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zuKEnVLh5rg4">7,072</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a total payback to the Holder of $<span id="xdx_900_eus-gaap--RepaymentsOfShortTermDebt_c20250615__20250615__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zKYkJEDtM7h">56,580</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">). The first payment of $<span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPaymentInterest_c20250715__20250715__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zmeNZJgWkXGl">7,072</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is due on July 15, 2025 with 3 subsequent payments each month thereafter. The Company had a five (5) day grace period with respect to each payment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had the right to accelerate payments or prepay in full at any time with no prepayment penalty. At any time following an event of default, the noteholder has the right, to convert all or any part of the outstanding and unpaid amount of the note into shares of common stock. The conversion price of the note is equal to <span id="xdx_90C_ecustom--DebtInstrumentDebtConversionRate_pid_dp_uPure_c20241204__20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zR3CSWtfFeY3">65</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% multiplied by the lowest trading price for the common stock during the 10 trading days prior to the conversion date (representing a discount rate of <span id="xdx_900_ecustom--DebtInstrumentDiscountRate_pid_dp_uPure_c20241204__20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zdFzvP4nxIu2">35</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%) subject to a <span id="xdx_901_ecustom--BeneficialOwnershipLimitationPercentage_pid_dp_uPure_c20241204__20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_z67x0YvheP82">4.99</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% beneficial ownership limitations. Upon the occurrence of any event of defaults, the note shall be immediately due and payable in an amount equal to <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20251231__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zYv68TNhXPc2">150</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% default percentage multiplied by the sum of the outstanding principal balances plus accrued interest and default interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2025, the total balance of principal and accrued interest of the Red Road Holdings promissory note amounted to $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zSXIc9KXx0G8">24,812</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zlJ3qaf5CzUf">303</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, after the payment of the first installment of $<span id="xdx_90E_eus-gaap--DebtInstrumentPeriodicPayment_c20240701__20250630__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zGx6ifAk7PJk">28,290</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in June 2025. As of December 31, 2025, the total balance of principal and accrued interest of the Red Road Holdings promissory note amounted to $<span id="xdx_908_eus-gaap--DebtInstrumentCarryingAmount_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zzuZPGpPsbW5">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">after the full payment of the principal of $<span id="xdx_90E_eus-gaap--DebtInstrumentPeriodicPaymentInterest_c20250831__20250831__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_z5VLNJMcRhD6">24,812</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">including interest of $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250831__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zdTLBBj0Z6r7">3,478</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in July 2025 and August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total balance of the above promissory notes, net of unamortized discount of $<span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zsygw3J08Cg">45,965</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was $<span id="xdx_90F_eus-gaap--NotesPayable_iI_c20250630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zz2dKDwIaixh">543,312</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at June 30, 2025. As of December 31, 2025 the total balance of the above promissory notes amounted to $<span id="xdx_90F_eus-gaap--DebtInstrumentCarryingAmount_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zNd4cEBTSgg6">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accrued interest of $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zUAWEUxq22Ha">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Convertible Notes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ConvertibleDebtTableTextBlock_zQI8dSDEj5cb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s convertible notes outstanding at December 31, 2025 and June 30, 2025 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BC_zADJIYHBTjS6" style="display: none">SCHEDULE OF CONVERTIBLE NOTES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20251231_zlSo6o5zNT23" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December 31, 2025</b> (Unaudited)</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20250630_zkKeBVOXAJ0d" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleNotesPayableCurrent_iI_maLTDzcuB_zwxsiOp2BKz7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Convertible notes and debenture</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">520,797</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_msLTDzcuB_zMFGM3F2IYZ2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Unamortized discounts</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1577">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(97,276</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40A_eus-gaap--DebtInstrumentUnamortizedPremium_iI_maLTDzcuB_zXsyOqJLFKle" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Premium, net</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1580">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">114,400</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebt_iTI_mtLTDzcuB_z3ekceMwwgH9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Convertible notes, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">537,921</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AE_zpxq6kiqeQN5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>1800 Diagonal Lending (formerly known as Sixth Street Lending) Securities Purchase Agreements </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>July 22, 2025 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 22, 2025, the Company entered into and closed a securities purchase agreement with 1800 Diagonal, pursuant to which the 1800 Diagonal agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20250722__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zrHyeyQaXMzg">112,350</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, for a purchase price of $<span id="xdx_909_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20250722__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zDpFuoUQjoL1">107,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company used the net proceeds therefrom for general working capital purposes. The maturity date of the note was <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20250722__20250722__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zIYBS7t5AUL3">April 30, 2026</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and bore interest at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250722__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__srt--RangeAxis__srt--MaximumMember_zup9Q5A6N0I4">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum. Such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of 1800 Diagonal any time after 180 days from the date of issuance. This note contained debt issue costs of $<span id="xdx_907_eus-gaap--DeferredFinanceCostsNet_iI_c20250722__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zqkHakc9pPhc">7,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company fully repaid this note in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following terms shall apply to the above 1800 Diagonal notes:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 1800 Diagonal Note bore interest at a rate of <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20250722__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__srt--RangeAxis__srt--MinimumMember_zUdRVqbOfnI3">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, which interest may be paid by the Company to 1800 Diagonal in shares of the Company’s common stock; but shall not be payable until the 1800 Diagonal Note becomes payable, whether at the maturity date or upon acceleration or by prepayment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first 60 to 180 days following the date of the note, the Company had the right to prepay the principal and accrued but unpaid interest due under all of the above notes, together with any other amounts that the Company may owe the holder under the terms of the note, at a premium ranging from <span id="xdx_907_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20250722__20250722__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__srt--RangeAxis__srt--MinimumMember_z5emgAUrOhR">120</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% to <span id="xdx_90C_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20250722__20250722__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__srt--RangeAxis__srt--MaximumMember_zHp7hQiXTzxa">125</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% as defined in the note agreement. After this initial 180-day period, the Company does not have a right to prepay such note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The conversion prices for the above 1800 Diagonal note was <span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionRatio1_pid_dp_uPure_c20250722__20250722__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zywkghBMyIIb">75</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% (representing a <span id="xdx_90E_ecustom--DebtInstrumentDiscountRate_pid_dp_uPure_c20250722__20250722__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zhTLv9PyJWo2">25</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% discount) of the market price which means the average of the lowest ten trading prices of the common stock for the ten trading days immediately prior to the delivery of a notice of conversion. Notwithstanding the foregoing, 1800 Diagonal shall be restricted from effecting a conversion if such conversion, along with other shares of the Company’s common stock beneficially owned by 1800 Diagonal and its affiliates, exceeds <span id="xdx_906_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20250722__20250722__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__srt--RangeAxis__srt--MaximumMember_zsuc3fCrtbj9">9.99</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the outstanding shares of the Company’s common stock. The Company treated the convertible note as stock settled debt under ASC 480 and accordingly the Company recorded a total debt premium of $<span id="xdx_906_ecustom--DebtInstrumentSettlementDebtAmount_c20250701__20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zlRmuyEmdNQd">37,450</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">which was recorded during the six months ended December 31, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The above note contained certain events of default, upon which principal and accrued interest will become immediately due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate of <span id="xdx_909_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20250722__20250722__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z0WDoFFBoTMd">22</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further, certain events of default may trigger penalty and liquidated damage provisions. Failure to deliver shares of common stock upon conversion of the above 1800 Diagonal notes within three business days of notice of conversion will result in the Company paying a penalty of $<span id="xdx_905_ecustom--PenaltyAmount_c20250722__20250722__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zoQh6ECQOfdg">1,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per day, subject to certain exceptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon certain events of default, the above 1800 Diagonal notes will become immediately due and payable and the Company must pay 1800 Diagonal <span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20231129__20231129__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zS1Iq2ztesR9">150</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the then-outstanding principal amount of the above 1800 Diagonal note, plus any interest accrued upon such event of default or prior events of default (the “Default Amount”). Further, upon any event of default relating to the failure to issue shares of common stock upon the conversion of such notes, such note become immediately due and payable in an amount equal to twice the Default Amount.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total principal amount outstanding under the above 1800 Diagonal financing agreements was $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zCfoLDByDtP5">0 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2025 following the repayment in full of principal balance of $<span id="xdx_90E_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20250701__20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z1iM3O0f3Yg">112,350</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">including accrued interest and prepayment penalty of $<span id="xdx_901_eus-gaap--DebtDefaultLongtermDebtAmount_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zMoo1eimnK57">23,283</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Accordingly, $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zxqYaWa17ux8">37,450</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the put premium was recorded into gain on extinguishment of debt in respect to the 1800 Diagonal financing agreements during the six months ended December 31, 2025 following repayment of the principal balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>ONE44 Capital Securities Purchase Agreements</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>December 8, 2023 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 8, 2023, the Company entered into a securities purchase agreement with ONE44, pursuant to which ONE44 purchased a convertible redeemable note (the “December 8, 2023 ONE44 Note”) from the Company in the aggregate principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zWrYtulYY9eh">150,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, such principal and the interest thereon were convertible into shares of the common stock at the option of ONE44 any time after the six-month anniversary of the December 8, 2023 ONE44 Note. The transaction contemplated by such purchase agreement closed on December 8, 2023. The December 8, 2023 One44 Note contained an original issue discount amount of $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zo2ntsrWbnPe">15,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Pursuant to the terms of such purchase agreement, the Company paid $<span id="xdx_904_eus-gaap--LegalFees_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zm7MdiVEpShk">7,500</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for ONE44’s legal fees. The Company used the net proceeds from the December 8, 2023 ONE44 Note for general working capital purposes. The maturity date of the December 8, 2023 One44 Note was December 8, 2024. The December 8, 2023 ONE44 Note bore interest at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zKuYxPkepBNd">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, which interest was payable in shares of common stock, but was not payable until the maturity date or upon acceleration or by prepayment of such note. The December 8, 2023 One44 Note was fully converted in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following terms shall apply to the above ONE44 note:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid interest due under the above note issued to ONE44, together with any other amounts that the Company may owe ONE44 under the terms of the note, at a premium ranging from <span id="xdx_909_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember__srt--RangeAxis__srt--MinimumMember_z8J84nih0HC4">120</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% to <span id="xdx_904_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember__srt--RangeAxis__srt--MaximumMember_zXOZy4mORTL1">135</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% as defined in the relevant note. After this initial 180-day period, the Company does not have a right to prepay such note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The conversion price for the above ONE44 note was <span id="xdx_906_ecustom--DebtInstrumentDebtConversionRate_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zg7LU9aU1Hac">60</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% (representing a <span id="xdx_904_ecustom--DebtInstrumentDiscountRate_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_z3oSBqnVzSfe">40</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% discount) of the market price of the common stock, which was based on the lowest closing bid prices of the common stock between ten and fifteen trading days immediately prior to the delivery of a notice of conversion. Notwithstanding the foregoing, such note was subject to <span id="xdx_908_ecustom--BeneficialOwnershipLimitationPercentage_pid_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zBqciPuvNcCb">4.99</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% beneficial ownership limitations. The above ONE44 note was treated as stock settled debt under ASC 480 and accordingly the Company recorded a total debt premium of $<span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20240630__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zNyXAJLkagQe">100,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">which was recorded during fiscal year 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The above ONE44 notes contain certain events of default, upon which principal and accrued interest will become immediately due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate of <span id="xdx_904_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zWBzIFFmgoff">24</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further, certain events of default may trigger penalty and liquidated damage provisions. In the event that the Company fails to deliver to ONE44 shares of common stock issuable upon conversion of principal or interest under a ONE44 note, it will incur a penalty of $<span id="xdx_90F_ecustom--PenaltyAmount_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember__srt--RangeAxis__srt--MinimumMember_zIQz04sT1Ifa">250</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per day the shares are not issued beginning on the 4^th day after the conversion notice was delivered to the Company. This penalty increases to $<span id="xdx_90F_ecustom--PenaltyAmount_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember__srt--RangeAxis__srt--MaximumMember_zw2YZ4t30Ik5">500</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per day beginning on the 10^th day. In the event that the Company loses the bid price of its common stock on OTC markets, such ONE44 note does not incur penalty and instead the outstanding principal amount increases by <span id="xdx_906_ecustom--DebtInstrumentIncreasePrincipalPercentage_pid_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zis90L3HnoYe">20</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total principal amount outstanding under the above ONE44 financing agreements was $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_z2Ol53QVsvB3">104,460</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accrued interest was $<span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zru6dcMss7b8">24,962</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of June 30, 2025 following conversion of $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_z8tDEAatnuo6">14,840</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the principal balance and $<span id="xdx_908_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zmeDfgPRaCm9">1,006</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accrued interest during the year ended June 30, 2025. Accordingly, $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zBAv6Ttmv0ll">9,893</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the put premium was released to additional paid in capital in respect to the ONE44 financing agreements during the year ended June 30, 2025 following conversion of the principal balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total principal amount and accrued interest outstanding under the above ONE44 financing agreement was $<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zGlMTRPB5Wuc">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2025 following conversion of $<span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250701__20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zfRHCUe433f7">104,460</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the principal balance and $<span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20251231__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_z52ypmhA8Ull">17,715</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accrued interest during the six months ended December 31, 2025. Accordingly, $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zVAyZ02tBeMj">69,640</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the put premium was released to additional paid in capital in respect to the ONE44 financing following the conversion of the principal balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>GS Capital Partners Securities Purchase Agreements</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>August 23, 2023 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 23, 2023, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20230823__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zquk2p2sh3l5">77,500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, such principal and the interest thereon are convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contained a $<span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20230823__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zJBwdK2q62L">5,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">original issue discount. Pursuant to the terms of the GS Purchase Agreement, the Company paid GS Capital’s legal fees of $<span id="xdx_90B_eus-gaap--LegalFees_c20230823__20230823__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zlDtSdfnyIn4">2,500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note was <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20230823__20230823__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zXgaAo5Nqzni">February 23, 2024</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The GS Capital Note bore an interest at a rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230823__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_z9i1VGuohlj4">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum and was increased to 24% due to the event of a default, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note became payable, whether at the Maturity Date or upon acceleration or by prepayment. The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note was equal to $2,400 per share, provided that the fixed price will be reduced to $1,200 per share in the event that the market price of the Common Stock trades below $1,800 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price was lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price was subject to re-adjustment every thirty calendar days during the period in which the Company remained in default. The August 23, 2023 GS Capital Note was fully converted in July 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>October 12, 2023 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 12, 2023, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20231012__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zVSuZJFx4NUe">61,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contained a $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20231012__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zkQNpZUhg4T1">3,500</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">original issue discount. Pursuant to the terms of the GS Purchase Agreement, the Company paid GS Capital’s legal fees of $<span id="xdx_905_eus-gaap--LegalFees_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zFrxe6jvaTF9">2,500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note was <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20231012__20231012__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z1CZyBODfdo1">April 12, 2024</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and was in default. The GS Capital Note bore interest at a rate of 8% per annum and was increased to 24% due to the event of a default, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note became payable, whether at the Maturity Date or upon acceleration or by prepayment. The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note was equal to $900 per share (the “Fixed Price”), provided that the Fixed Price will be reduced to $600 per share in the event that the market price of the Common Stock trades below $450 per share for ten consecutive trading days. In the event of a default under the Note and unless the Fixed Price was lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price was subject to re-adjustment every thirty calendar days during the period in which the Company remained in default. The October 12, 2023 GS Capital Note was fully converted in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>April 12, 2024 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 12, 2024, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20240412__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zFhkpIb1Ecri">27,500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contained a $<span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240412__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zJFxz0byRRle">2,500</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">original issue discount. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note was <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_dd_c20240412__20240412__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zmgpdxkmF3y9">October 12, 2024</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and was in default. The GS Capital Note bore interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240412__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zL4weSjp4ls1">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note became payable, whether at the Maturity Date or upon acceleration or by prepayment. The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note was equal to $102 per share, provided that the fixed price will be reduced to $60 per share in the event that the market price of the Common Stock trades below $84 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price was lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price was subject to re-adjustment every thirty calendar days during the period in which the Company remained in default. The April 12, 2024 GS Capital Note was fully converted in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>August 2, 2024 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 2, 2024, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20240802__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_z4yyWa9ChDyd">33,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contained a $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240802__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zBkMhZACZ4t5">3,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">original issue discount. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note was <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20240802__20240802__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zgH6o7lUq5ak">February 2, 2025</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and was in default. The GS Capital Note bore interest at a rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240802__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zuIkia8K7KSd">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note became payable, whether at the Maturity Date or upon acceleration or by prepayment. The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note was equal to $102 per share, provided that the fixed price will be reduced to $60 per share in the event that the market price of the Common Stock trades below $84 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price was lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price was subject to re-adjustment every thirty calendar days during the period in which the Company remained in default. The August 2, 2024 GS Capital Note was fully repaid in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>September 20, 2024 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 20, 2024, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zegiZkfkUsF6">33,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contained a $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zRESR8I22izj">3,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">original issue discount. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note was <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zhsd4IrGj9X">March 20, 2025</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and was in default. The GS Capital Note shall bore interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zhKNj6QcP4N">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note became payable, whether at the Maturity Date or upon acceleration or by prepayment. The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note was equal to $18 per share, provided that the fixed price will be reduced to $6 per share in the event that the market price of the Common Stock trades below $18 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price was lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price was subject to re-adjustment every thirty calendar days during the period in which the Company remained in default. The September 20, 2024 GS Capital Note was fully repaid in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>February 7, 2025 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 7, 2025, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20250207__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_ziLMqpbiVrSf">43,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contained a $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250207__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zwdUEdN12j5g">3,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">original issue discount. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note was <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20250207__20250207__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zii1YD9XLrIc">October 7, 2025</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The GS Capital Note bore interest at a rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250207__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zd7KAnypoTyh">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note became payable, whether at the Maturity Date or upon acceleration or by prepayment. <span id="xdx_902_eus-gaap--DebtConversionDescription_c20250207__20250207__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zFwirV6Yeoi9">The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note was equal to $9 per share, provided that the fixed price will be reduced to $6 per share in the event that the market price of the Common Stock traded below $8 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price was lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price was subject to re-adjustment every thirty calendar days during the period in which the Company remained in default. The February 7, 2025 GS Capital Note was fully converted in October 2025.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>March 11, 2025 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 11, 2025, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20250311__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zT8wp7Iakrpc">33,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contained a $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250311__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zUjSCGq0Jkfi">3,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">original issue discount. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note was <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20250311__20250311__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zES5Y9yCU8mj">November 11, 2025</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The GS Capital Note bore interest at a rate of <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250311__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_z0evqhc8e6h4">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note became payable, whether at the Maturity Date or upon acceleration or by prepayment. <span id="xdx_908_eus-gaap--DebtConversionDescription_c20250311__20250311__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zyFckvvDXWhc">The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note was equal to $6 per share, provided that the fixed price will be reduced to $3 per share in the event that the market price of the Common Stock trades below $5 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price was lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price was subject to re-adjustment every thirty calendar days during the period in which the Company remained in default. The March 11, 2025 GS Capital Note was fully converted in December 2025.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>April 15, 2025 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 15, 2025, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20250415__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_ztb2BGOblagk">55,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, such principal and the interest thereon are convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contains a $<span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250415__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zOvvh4EJfAKl">5,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">original issue discount. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note was <span id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_dd_c20250415__20250415__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zikuNtRuaVrj">December 15, 2025</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and is currently in default. The GS Capital Note shall bear interest at a rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250415__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zKZBYvyb0Yjb">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note becomes payable, whether at the Maturity Date or upon acceleration or by prepayment. The GS Capital Note is exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note is equal to $5 per share, provided that the fixed price will be reduced to $2.50 per share in the event that the market price of the Common Stock trades below $4 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price is lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price is subject to re-adjustment every thirty calendar days during the period in which the Company remains in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following terms shall apply to all of the above GS Capital notes:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the above <span id="xdx_90C_eus-gaap--DebtConversionDescription_c20250701__20251231__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zBe50eUbYbvh">GS Capital notes, in the event that such conversion price is below the par value of the Common Stock, the Company has agreed to take all steps to reduce such par value or conduct a reverse split of its Common Stock, as applicable. Notwithstanding the foregoing, such conversion price and lookback periods are subject to adjustment in favor of the Investor in the event the Company issues securities to another party with more favorable conversion terms, and such conversions are subject to a 4.99% beneficial ownership limitation (which may be increased to 9.9% upon 60 days’ prior written notice from the holder of the Note) and adjustments for mergers, consolidations, reorganizations and similar events set forth in the Note, other than a transfer or sale of all or substantially all Company assets. Pursuant to the Note, the Company is required to maintain an initial reserve of at least 400% of the number of Conversion Shares, subject to any increase of such reserved amount to reflect the Company’s obligations under the Note.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, the conversion prices of the above GS Capital notes will be adjusted in favor of the note holder if the Company issues securities with more favorable conversion terms. The effective conversion price of the outstanding GS Capital notes are <span id="xdx_90D_ecustom--DebtInstrumentDebtConversionRate_dp_uPure_c20250415__20250415__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zOt7VhvAHula">60</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% (representing a <span id="xdx_90E_ecustom--DebtInstrumentDiscountRate_dp_uPure_c20250415__20250415__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zsv9MYqbSEAa">40</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% discount) of the market price, which means the lowest closing bid prices of the Common Stock for the ten trading days immediately prior to the delivery of a notice of conversion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The above GS Capital notes were bifurcated from the embedded conversion option which was recorded as derivative liabilities at fair value (see Note 12).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first 60 to 180 days following the date of the above GS Capital notes, the Company has the right to prepay the principal and accrued but unpaid interest due under all of the above notes issued to GS Capital, together with any other amounts that the Company may owe GS Capital under the terms of the notes, at a premium ranging from <span id="xdx_909_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20240412__20240412__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__srt--RangeAxis__srt--MinimumMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zryHO7ML56ah">110</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% to <span id="xdx_90A_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20240412__20240412__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z4QikzXCNLVh">125</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the principal amount and interest of such note. After this initial 180-day period, the Company does not have a right to prepay such notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon the occurrence and during the continuation of certain events of default, interest accrues at a default interest rate of <span id="xdx_90F_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20240412__20240412_z8IOHdd25y47">24</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum or, if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. In the event that the Company fails to deliver to GS Capital shares of common stock issuable upon conversion of principal or interest under all of the above GS Capital notes, the penalty becomes $<span id="xdx_904_ecustom--PenaltyAmount_c20240412__20240412__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zqlL9K1l0Uv3">250</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per day for each day that the shares are not issued beginning on the 4^th day after the conversion notice was delivered to the Company. This penalty increases to $<span id="xdx_905_ecustom--PenaltyAmount_c20240412__20240412__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zp8tVvxyJsRe">500</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per day beginning on the 10^th day. In the event that the Company loses the bid price of its common stock on OTC markets, such GS Capital note does not incur penalty and instead the outstanding principal amount increases by <span id="xdx_90D_ecustom--DebtInstrumentIncreasePrincipalPercentage_pid_dp_uPure_c20240412__20240412__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z8xbPo4gPLHa">20</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total principal outstanding and accrued interest under all of the above GS Capital notes were $<span id="xdx_90C_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zuZdB5FW5Vq5">252,650</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_908_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zW0a9IGEOw3l">23,676</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, as of June 30, 2025, following conversion of $<span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zdB5rQKZwaV6">54,850</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the principal balance and $<span id="xdx_901_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zAS6NW35A5w8">4,365</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accrued interest during the year ended June 30, 2025. During the year ended June 30, 2025, an aggregate total of $<span id="xdx_902_eus-gaap--DerivativeLiabilities_iI_c20250630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zmFtTpqvZcAc">252,650</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the above GS Capital notes were bifurcated with the embedded conversion option which were recorded as derivative liabilities at fair value (see Note 12).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total principal outstanding and accrued interest under all of the above GS Capital notes were $<span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20251231__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zi9gyNThqF3i">55,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20251231__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zGh9d64cwys1">3,520</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, as of December 31, 2025, following conversion of $<span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250701__20251231__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_ziyXfyVEqA03">131,650</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the principal balance, $<span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20251231__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_z7KC6n4r4irg">13,537</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accrued interest and $<span id="xdx_90A_eus-gaap--DebtInstrumentFeeAmount_iI_c20251231__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_znvcsBbPoZG3">1,875</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">conversion fees during the six months ended December 31, 2025. Additionally, the Company repaid total principal balance of $<span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250831__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zb7L7YnbR2Q5">66,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accrued interest of $<span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250831__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zHVtxHjWT5l6">5,164</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in August 2025. During the six months ended December 31, 2025, $<span id="xdx_90C_eus-gaap--DerivativeLiabilities_iI_c20251231__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zUl7HTjqArJa">55,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the above GS Capital notes were bifurcated with the embedded conversion option which were recorded as derivative liabilities at fair value as of December 31, 2025 (see Note 12).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>104 LLC Securities Purchase Agreement</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>March 5, 2024 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective March 5, 2024, the Company entered into and closed a securities purchase agreement with 104 LLC (“104”), pursuant to which 104 agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20240305__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zby9uGmo3Of4">50,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, for a purchase price of $<span id="xdx_907_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20240305__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zsodQFSjI4Th">46,875</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, after an original issue discount of $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240305__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zzFuoELBY4o2">3,125</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company paid legal and financing costs of $<span id="xdx_909_eus-gaap--PaymentsOfFinancingCosts_c20240305__20240305__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zuDwX5FdBPYj">7,500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company used the net proceeds therefrom for general working capital purposes. The maturity date of the note was March 1, 2025 and was in default. The note bore interest at a rate of eight percent (<span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20240305__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__srt--RangeAxis__srt--MinimumMember_z8We4fu9j76c">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%) per annum, which may be increased to sixteen percent (<span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20240305__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__srt--RangeAxis__srt--MaximumMember_zCdBqCJLnCm9">16</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%) in the event of a default. The March 5, 2024 104 note was fully converted in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>June 20, 2024 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective June 20, 2024, Company entered into and closed a securities purchase agreement with 104 LLC, pursuant to which 104 agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zVvLAj8KyC05">33,750</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, for a purchase price of $<span id="xdx_900_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_z7jB7yUUBRO8">30,375</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, after an original issue discount of $3,375. The Company paid legal and financing costs of $<span id="xdx_90B_eus-gaap--PaymentsOfFinancingCosts_c20240620__20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_z2WwsPsheym1">5,200</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company used the net proceeds therefrom for general working capital purposes. The maturity date of the note was <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20240620__20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zHBtCQLdBDEi">June 20, 2025</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and was in default. The note bore interest at a rate of eight percent (<span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__srt--RangeAxis__srt--MinimumMember_zToEjREiLOV5">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%) per annum, which may be increased to sixteen percent (<span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__srt--RangeAxis__srt--MaximumMember_zxdlfAwZqT83">16</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%) in the event of a default. The June 20, 2024 104 note was fully converted in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The principal and interest on the notes were convertible into shares of common stock of the Company at the option of 104 at any time following the issuance date of the notes (the “Conversion Shares”) at a price per share equal to <span id="xdx_900_ecustom--DebtInstrumentDebtConversionRate_dp_uPure_c20240620__20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_z3QQVicJFnX5">65</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the lowest closing trade price of the common stock during the ten (10) trading days prior to conversion (representing a discount of <span id="xdx_90D_ecustom--DebtInstrumentDiscountRate_dp_uPure_c20240620__20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zcqn2N3dzGo2">35</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%). Notwithstanding the foregoing, such conversions were subject to a <span id="xdx_907_ecustom--BeneficialOwnershipLimitationPercentage_dp_uPure_c20240620__20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zUKxOScOfgcb">4.99</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% beneficial ownership limitation and adjustments for mergers, consolidations, reorganizations and similar events set forth in the notes, other than a transfer or sale of all or substantially all Company assets. Pursuant to the notes, the Company was required to maintain an initial reserve of at least 500% of the number of conversion shares, subject to any increase of such reserved amount to reflect the Company’s obligations under the notes. The above 104 notes were treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zqJ8DrmIcTx7">45,096</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was recorded as a put premium during fiscal year 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first 60 days following the date of the notes, the Company had the right to prepay the principal and accrued but unpaid interest due under the notes, at a one hundred ten percent (110%) premium of the face amount plus accrued and unpaid interest, which increases to (i) one hundred fifteen percent (115%) if prepaid after 60 days, but less than 91 days from the issuance date, (ii) one hundred twenty percent (120%) if prepaid after 90 days, but less than 121 days from the issuance date, (iii) one hundred twenty five percent (125%) if prepaid after 120 days, but less than 181 days from the issuance date. After this initial 180-day period, the Company does not have a right to prepay the notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 104 notes contained certain events of default, including failure to pay principal and interest when due, failure to timely issue the conversion shares, failure to maintain the listing of the common stock on at least one of the OTC markets (which specifically includes the quotation platforms maintained by the OTC Markets Group) or an equivalent replacement exchange, failure to comply with its reporting requirements with the U.S. Securities and Exchange Commission, a breach of certain covenants in the purchase agreement, default by the Company under any other note issued to the investor, as well as certain customary events of default set forth in the notes, including, among others, breach of covenants, representations or warranties, insolvency, bankruptcy, and liquidation. Upon an event of default, the notes became immediately due and payable by the Company. Upon the occurrence of any event of defaults, these notes shall be immediately due and payable in an amount equal to 150% default percentage multiplied by the sum of the outstanding principal balances plus accrued interest and default interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded a total default penalty of $<span id="xdx_90E_eus-gaap--LongTermDebtAverageAmountOutstanding_c20240701__20250630__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zF4Cma8xjfth">41,563</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as additional principal as of June 30, 2025. The total principal amount outstanding and accrued interest under all of the above 104 notes was $<span id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zcI0mcYwAe5a">124,688</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">including the default penalty and accrued interest of $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zx3TUtWgUaCi">9,093</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of June 30, 2025, following conversion of $<span id="xdx_907_eus-gaap--DebtInstrumentAnnualPrincipalPayment_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_z5ylfPBpR2cf">625</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the principal balance and $<span id="xdx_90E_ecustom--InterestPayable_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zWYRdPKFj6u3">4,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accrued interest during fiscal year 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total principal amount outstanding and accrued interest under all of the above 104 notes was $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20251231__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zKOqzzAONgN4">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2025, following conversion of $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250701__20251231__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zF6MskbqZ6Yl">124,688</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the principal balance and $<span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250831__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zZRgpCma57k">8,819</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accrued interest in August 2025. Accordingly, $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20251231__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zAg2Vcze0Dt5">44,760</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the put premium was released to additional paid in capital in respect to the 104 notes following the conversion of the principal balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Geebis Consulting Purchase Agreement</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>December 13, 2024 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 13, 2024, the Company entered into a securities purchase agreement with Geebis Consulting, LLC (“Geebis”), pursuant to which Geebis purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20241213__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_zLR94azeJBkf">22,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of Geebis. The Geebis note contained a $<span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241213__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_z9mn0mayWNL8">2,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">original issue discount. The Company used the net proceeds from the Geebis note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the Geebis note was June 15, 2025 and was in default. The Geebis note shall bore interest at a rate of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250615__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_zzvV8xj78iUc">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, which interest may be paid by the Company to Geebis in shares of common stock but shall not be payable until the Geebis note became payable, whether at the Maturity Date or upon acceleration or by prepayment. <span id="xdx_90F_eus-gaap--DebtConversionDescription_c20250615__20250615__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_zuYANXDspbC7">The Geebis note was exchangeable for an equal aggregate principal amount of note of different authorized denominations, as requested by Geebis surrendering the same. The initial conversion price for the Geebis note was equal to $18 per share, provided that the fixed price will be reduced to $6 per share in the event that the market price of the common stock trades below $18 per share for five consecutive trading days. In the event of default, the conversion price shall be equal to the lowest trading price of the common stock on which the Company’s shares were then traded or any exchange upon which the common stock may be traded in the future.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>June 12, 2025 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 12, 2025, the Company entered into a securities purchase agreement with Geebis, pursuant to which Geebis purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20250612__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_z7G87Z0bwOy5">25,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of Geebis. <span id="xdx_90C_eus-gaap--DebtConversionDescription_c20250612__20250612__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_zPaOdW99YH5h">The Geebis note contained a $2,500 original issue discount. The Company used the net proceeds from the Geebis note for general working capital purposes. The initial conversion price for this note was equal to $5 per share, provided that the fixed price will be reduced to $4 per share in the event that the market price of the common stock trades below $3 per share for five consecutive trading days. In the event of default, the conversion price shall be equal to 65% of the lowest ten trading price of the common stock on which the Company’s shares are then traded or any exchange upon which the common stock may be traded in the future.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following terms shall apply to all of the above Geebis notes:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding the foregoing, such conversions were subject to a <span id="xdx_905_ecustom--BeneficialOwnershipLimitationPercentage_dp_uPure_c20250612__20250612__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_znN017Wd4Hug">4.99</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% beneficial ownership limitation and adjustments for mergers, consolidations, reorganizations and similar events set forth in the note, other than a transfer or sale of all or substantially all Company assets. Pursuant to the note, the Company was required to maintain an initial reserve of at least 500% of the number of conversion shares, subject to any increase of such reserved amount to reflect the Company’s obligations under the note.Additionally, the conversion price of the Geebis note will be adjusted in favor of the note holder if the Company issues securities with more favorable conversion terms. The effective conversion price of the outstanding Geebis note was 60% (representing a 40% discount) of the market price, which was the lowest closing bid prices of the common stock for the ten trading days immediately prior to the delivery of a notice of conversion. The above Geebis notes were bifurcated from the embedded conversion option which were recorded as derivative liabilities at fair value (see Note 12).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first 60 to 180 days following the date of the above Geebis notes, the Company had the right to prepay the principal and accrued but unpaid interest due under all of the above notes issued to Geebis, together with any other amounts that the Company may owe Geebis under the terms of the note, at a premium ranging from <span id="xdx_906_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20250612__20250612__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__srt--RangeAxis__srt--MinimumMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zc7B0msp8vJ8">110</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% to <span id="xdx_900_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20250612__20250612__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5EEfuFXfyK4">125</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the principal amount and interest of such note. After this initial 180-day period, the Company does not have a right to prepay such notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon the occurrence and during the continuation of certain events of default, interest accrued at a default interest rate of <span id="xdx_904_ecustom--DebtDefaultAmountPercentage_pid_dp_uPure_c20250612__20250612__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_z09mufGlIfB2">24</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum or, if such rate was usurious or not permitted by current law, then at the highest rate of interest permitted by law. In the event that the Company failed to deliver to Geebis shares of common stock issuable upon conversion of principal or interest under all of the above Geebis note, the penalty became $<span id="xdx_904_ecustom--PenaltyAmount_c20250612__20250612__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MinimumMember_z8loybIwhMtc">250</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per day for each day that the shares were not issued beginning on the 4^th day after the conversion notice was delivered to the Company. This penalty increased to $<span id="xdx_909_ecustom--PenaltyAmount_c20250612__20250612__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zTrEMiCWOumf">500</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per day beginning on the 10^th day. In the event that the Company loss the bid price of its common stock on OTC markets, such Geebis notes do not incur penalty and instead the outstanding principal amount increases by <span id="xdx_907_ecustom--DebtInstrumentIncreasePrincipalPercentage_pid_dp_uPure_c20250612__20250612__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zQSiOfsD1iwg">20</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2025, the Company repaid $<span id="xdx_907_eus-gaap--DebtInstrumentRepaidPrincipal_c20250201__20250228__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z06u2S1juLo3">8,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the principal amount. The total principal outstanding and accrued interest under all of the above Geebis notes were $<span id="xdx_908_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zRpE3LMt0cs5">39,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zWCS0ylBsVC7">821</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, as of June 30, 2025. As of June 30, 2025, an aggregate total of $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240701__20250630__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zgbcHIcMG9Dh">39,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the above Geebis note was bifurcated with the embedded conversion option which was recorded as derivative liabilities at fair value as of June 30, 2025 (see Note 12).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2025, the Company repaid $<span id="xdx_904_eus-gaap--DebtInstrumentRepaidPrincipal_c20250831__20250831__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zSvbteMsbjqg">25,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the principal amount and accrued interest of $<span id="xdx_90C_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250831__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zSIHwJfRMe13">2,916</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Additionally, the Company fully converted $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250831__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zKMDpbAwUY76">14,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the principal balance and $<span id="xdx_905_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20250831__20250831__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zwCboYVtCWPl">1,423</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accrued interest in August 2025. Consequently, the total principal outstanding and accrued interest under all of the above Geebis notes were $<span id="xdx_900_eus-gaap--DebtInstrumentCarryingAmount_iI_c20251231__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zqIn7NnWGskk">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Amortization of debt discounts</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded $<span id="xdx_901_eus-gaap--AmortizationOfDebtDiscountPremium_c20250701__20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zePl5DveXB37">12,350</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_c20240701__20241231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zzAzSVvZFC2i">88,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, of debt discounts related to the above note issuances during the six months ended December 31, 2025 and 2024, respectively. The Company recorded $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zEx8Av2r8m6b">37,450</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20241231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zCQ6tdBH7Gqf">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of put premiums related to the above note issuances during the six months ended December 31, 2025 and 2024, respectively. The debt discounts are being amortized over the term of the debt and the put premiums are expensed on issuance of the debt with the liability released to additional paid in capital on conversion of the principal.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization of all debt discounts for the three months ended December 31, 2025 and 2024 was $<span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_c20251001__20251231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesOneMember_zGPR7MFhiMce">35,875</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_c20241001__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesOneMember_zPWtIRUs1oP">76,661</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively. Amortization of all debt discounts for the six months ended December 31, 2025 and 2024 was $<span id="xdx_90F_eus-gaap--AmortizationOfDebtDiscountPremium_c20250701__20251231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesOneMember_zmysn86qmi6j">186,777</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_904_eus-gaap--AmortizationOfDebtDiscountPremium_c20240701__20241231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesOneMember_zodIzTjUmSH8">133,644</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reclassified $<span id="xdx_90D_eus-gaap--ConversionOfStockAmountConverted1_c20250701__20251231_zYGIuSZ8Lb63">114,399</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90C_eus-gaap--ConversionOfStockAmountConverted1_c20240701__20241231_zR5xrBSBgJzf">9,336</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in put premiums to additional paid in capital following conversions during the six months ended December 31, 2025 and 2024, respectively. Additionally, $<span id="xdx_904_eus-gaap--AccretionAmortizationOfDiscountsAndPremiumsInvestments_iN_di_c20250701__20251231_zvIHhdnPXnQ7">37,450</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the put premium was recorded into gain on extinguishment of debt during the six months ended December 31, 2025 following repayment of the principal balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89D_eus-gaap--ScheduleOfDebtTableTextBlock_zYMR9uGdwvmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s promissory notes outstanding at December 31, 2025 and June 30, 2025 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BD_z63iD4ALv8Xf" style="display: none">SCHEDULE OF PROMISSORY NOTES OUTSTANDING</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zM7vvysYCZCk" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December 31, 2025</b> (Unaudited)</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zr39nLfAtOJe" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--NotesPayable_iI_maDICAzqJo_zQEUjBVhiom7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Principal amounts of notes payable</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right">          <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1382">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">589,277</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_msDICAzqJo_zAL6Z1gRJ3A8" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Unamortized discounts</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1385">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(45,965</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40A_eus-gaap--DebtInstrumentCarryingAmount_iTI_mtDICAzqJo_zv2qp3ZVNgne" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Notes payable, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1388">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">543,312</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 589277 45965 543312 0.10 120000 132000 2023-11-15 0.10 0.18 1.30 39600 30805 202405 90000 75000 2025-06-15 0.10 0.18 Repayment of the note may occur as follows: (a) if the Company repaid this note on or before June 7, 2025, then Company shall pay investor in cash the sum of one hundred percent (100%) of the sum of the outstanding principal amount of the note (the “Principal Amount”) at such time, all accrued interest unpaid at such time, and any other payment due; and (b) if the Company repaid the note after June 7, 2025 and on or before July 7, 2025, then Company shall pay investor in cash the sum of one hundred twenty percent (120%) of the sum of the outstanding Principal Amount at such time, all accrued interest unpaid at such time, and any other payment due (the “Maximum Repayment Amount”) or (b) at such time as the Company and the investor may agree to effect repayment. As of June 30, 2025, the promissory note was in default. 60000 50000 2025-07-15 0.10 0.18 Repayment of the note may occur as follows: (a) if the Company repaid this note on or before July 7, 2025, then Company shall pay investor in cash the sum of one hundred percent (100%) of the sum of the outstanding principal amount of the note (the “Principal Amount”) at such time, all accrued interest unpaid at such time, and any other payment due; and (b) if the Company repaid the note after July 7, 2025 and on or before August 7, 2025, then Company shall pay investor in cash the sum of one hundred twenty percent (120%) of the sum of the outstanding Principal Amount at such time, all accrued interest unpaid at such time, and any other payment due (the “Maximum Repayment Amount”) or (b) at such time as the Company and the investor may agree to effect repayment. 82500 75000 2025-09-15 0.10 0.18 Repayment of the note may occur as follows: (a) if the Company repaaid this note on or before August 18, 2025, then Company shall pay investor in cash the sum of one hundred percent (100%) of the sum of the outstanding principal amount of the note (the “Principal Amount”) at such time, all accrued interest unpaid at such time, and any other payment due; and (b) if the Company repaid the note after August 18, 2025 and on or before September 18, 2025, then Company shall pay investor in cash the sum of one hundred twenty percent (120%) of the sum of the outstanding Principal Amount at such time, all accrued interest unpaid at such time, and any other payment due (the “Maximum Repayment Amount”) or (b) at such time as the Company and the investor may agree to effect repayment. 434905 35076 0 352405 0 3488 0 5718 10988 0 0.15 49200 8200 6000 35000 0.22 28290 7072.50 56580 7072.50 2024-12-30 49200 5683 0.15 49200 8200 6000 35000 0.22 28290 7073 56580 7073 49200 5683 65000 56000 2025-11-30 37375 9344 74750 65000 9750 79200 67000 The Company used the net proceeds therefrom for general working capital purposes. The maturity date of the note was 2026-01-30 45540 11385 91080 79200 11880 0.15 67860 58000 8000 9860 50000 2026-04-15 39020 9755 78039 67860 10179 0.65 0.35 0.0499 1.50 212060 0 212060 0 7638 0.15 49200 8200 6000 35000 0.22 28290 7072 56580 7072 0.65 0.35 0.0499 1.50 24812 303 28290 0 24812 3478 45965 543312 0 0 <p id="xdx_89D_eus-gaap--ConvertibleDebtTableTextBlock_zQI8dSDEj5cb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s convertible notes outstanding at December 31, 2025 and June 30, 2025 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BC_zADJIYHBTjS6" style="display: none">SCHEDULE OF CONVERTIBLE NOTES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20251231_zlSo6o5zNT23" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December 31, 2025</b> (Unaudited)</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20250630_zkKeBVOXAJ0d" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleNotesPayableCurrent_iI_maLTDzcuB_zwxsiOp2BKz7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Convertible notes and debenture</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">520,797</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_msLTDzcuB_zMFGM3F2IYZ2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Unamortized discounts</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1577">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(97,276</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40A_eus-gaap--DebtInstrumentUnamortizedPremium_iI_maLTDzcuB_zXsyOqJLFKle" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Premium, net</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1580">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">114,400</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebt_iTI_mtLTDzcuB_z3ekceMwwgH9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Convertible notes, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">537,921</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 55000 520797 97276 114400 55000 537921 112350 107000 2026-04-30 0.10 7000 0.10 1.20 1.25 0.75 0.25 0.0999 37450 0.22 1000 1.50 0 112350 23283 37450 150000 15000 7500 0.10 1.20 1.35 0.60 0.40 0.0499 100000 0.24 250 500 0.20 104460 24962 14840 1006 9893 0 104460 17715 69640 77500 5000 2500 2024-02-23 0.08 61000 3500 2500 2024-04-12 27500 2500 2024-10-12 0.08 33000 3000 2025-02-02 0.08 33000 3000 2025-03-20 0.08 43000 3000 2025-10-07 0.08 The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note was equal to $9 per share, provided that the fixed price will be reduced to $6 per share in the event that the market price of the Common Stock traded below $8 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price was lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price was subject to re-adjustment every thirty calendar days during the period in which the Company remained in default. The February 7, 2025 GS Capital Note was fully converted in October 2025. 33000 3000 2025-11-11 0.08 The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note was equal to $6 per share, provided that the fixed price will be reduced to $3 per share in the event that the market price of the Common Stock trades below $5 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price was lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price was subject to re-adjustment every thirty calendar days during the period in which the Company remained in default. The March 11, 2025 GS Capital Note was fully converted in December 2025. 55000 5000 2025-12-15 0.08 GS Capital notes, in the event that such conversion price is below the par value of the Common Stock, the Company has agreed to take all steps to reduce such par value or conduct a reverse split of its Common Stock, as applicable. Notwithstanding the foregoing, such conversion price and lookback periods are subject to adjustment in favor of the Investor in the event the Company issues securities to another party with more favorable conversion terms, and such conversions are subject to a 4.99% beneficial ownership limitation (which may be increased to 9.9% upon 60 days’ prior written notice from the holder of the Note) and adjustments for mergers, consolidations, reorganizations and similar events set forth in the Note, other than a transfer or sale of all or substantially all Company assets. Pursuant to the Note, the Company is required to maintain an initial reserve of at least 400% of the number of Conversion Shares, subject to any increase of such reserved amount to reflect the Company’s obligations under the Note. 0.60 0.40 1.10 1.25 0.24 250 500 0.20 252650 23676 54850 4365 252650 55000 3520 131650 13537 1875 66000 5164 55000 50000 46875 3125 7500 0.08 0.16 33750 30375 5200 2025-06-20 0.08 0.16 0.65 0.35 0.0499 45096 41563 124688 9093 625 4000 0 124688 8819 44760 22000 2000 0.08 The Geebis note was exchangeable for an equal aggregate principal amount of note of different authorized denominations, as requested by Geebis surrendering the same. The initial conversion price for the Geebis note was equal to $18 per share, provided that the fixed price will be reduced to $6 per share in the event that the market price of the common stock trades below $18 per share for five consecutive trading days. In the event of default, the conversion price shall be equal to the lowest trading price of the common stock on which the Company’s shares were then traded or any exchange upon which the common stock may be traded in the future. 25000 The Geebis note contained a $2,500 original issue discount. The Company used the net proceeds from the Geebis note for general working capital purposes. The initial conversion price for this note was equal to $5 per share, provided that the fixed price will be reduced to $4 per share in the event that the market price of the common stock trades below $3 per share for five consecutive trading days. In the event of default, the conversion price shall be equal to 65% of the lowest ten trading price of the common stock on which the Company’s shares are then traded or any exchange upon which the common stock may be traded in the future. 0.0499 1.10 1.25 0.24 250 500 0.20 8000 39000 821 39000 25000 2916 14000 1423 0 12350 88000 37450 0 35875 76661 186777 133644 114399 9336 -37450 <p id="xdx_809_eus-gaap--PreferredStockTextBlock_zkERBmRFgTXa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 - <span id="xdx_823_zvd6X22JqH1d"><span style="text-decoration: underline">SERIES C PREFERRED STOCK AND SERIES C WARRANTS</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Temporary Equity – Convertible Series C Preferred Stock</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 4, 2025 (the “Closing Date”), the Company completed a private placement pursuant to a Securities Purchase Agreement with Hexstone Capital LLC (“Hexstone”). At closing, Hexstone purchased <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesOther_c20251104__20251104__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--HexstoneCapitalLLCMember_zYyDmmrvub42">100</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series C Preferred Stock, par value $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20251104__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--HexstoneCapitalLLCMember_zgzC6L4Sfgui">0.01</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, with a stated value of $<span id="xdx_908_ecustom--PreferredStockStatedValuePerShare_iI_pid_c20251104__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--HexstoneCapitalLLCMember_zdTN3TnrCtz9" title="Preferred stock value per share">10,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, for total gross proceeds of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueOther_c20251104__20251104__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--HexstoneCapitalLLCMember_zY4LFApRiKg9">1,000,099</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company paid legal fees of $<span id="xdx_905_eus-gaap--LegalFees_c20251104__20251104__us-gaap--TypeOfArrangementAxis__custom--HexstoneCapitalLLCMember_z3v7kklhyCGe">50,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">related to this private placement and was recorded as deemed dividend during the six months ended December 31, 2025. In connection with the transaction, the Company also issued warrants to purchase up to <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251104__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--HexstoneCapitalLLCMember_zT3EgnNvymQe">9,900</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">additional shares of Series C Preferred Stock. Each warrant is exercisable for one share of Series C Preferred Stock at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20251104__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--HexstoneCapitalLLCMember_zWWlFwFc4UL4">10,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (subject to equitable adjustments by the Company relating to stock-splits, reclassifications, combination, extraordinary distributions and similar events) and expires two years from issuance. The Series C Preferred Stock and warrants were issued in a private placement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series C Preferred Stock shall have a stated value of $<span id="xdx_90A_eus-gaap--PreferredStockLiquidationPreference_iI_pid_c20251104__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HexstoneCapitalLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z6rtYZA45fdj">10,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and liquidation value equal to the greater of (A) <span id="xdx_904_ecustom--PreferredStockStatedValuePercentage_pid_dp_c20251104__20251104__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HexstoneCapitalLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zf9MP12Irbuh">100</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of stated value of such Series C Preferred Stock and (B) the amount per share such holder would receive if such holder converted into Common Stock immediately prior to the date of such payment. The holder of Series C Preferred Stock shall have a dividend rate of <span id="xdx_901_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_c20251104__20251104__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HexstoneCapitalLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zMXdGuzThL65">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%. However, the dividend rate shall automatically be increased to ten percent (<span id="xdx_903_ecustom--DividendRateAnnualIncreasePercentage_pid_dp_c20251104__20251104__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HexstoneCapitalLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zTu2gMloLuL7">10.0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%) per annum upon any bankruptcy triggering event as defined in the Certificate of Designation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At any time after the initial issuance date, each share of Series C Preferred Stock shall be convertible into shares of common stock of the Company by the holder thereof by dividing the stated amount of each share of Series C Preferred Stock of $<span id="xdx_903_ecustom--PreferredStockConversionPrice_iI_pid_c20251104__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HexstoneCapitalLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zpBJJ7MTQLf5" title="Preferred stock conversion price">10,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by the conversion price. The conversion price shall be the lesser of the fixed conversion price of $<span id="xdx_904_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_c20251104__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HexstoneCapitalLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zk4TzCuDLq3f">5.00</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share or 85% of the of the lowest trading price of the Common Stock during the period beginning on the day the holder sends a conversion notice to the Company and ending on the trading day on which the aggregate dollar volume of the Company’s common stock exceeds the product of the conversion amount set forth on the applicable conversion notice multiplied by seven (7) after the applicable holder receives the shares of common stock issuable upon conversion of the Series C Preferred Stock, subject to a five (5) trading day minimum (such period, the “Conversion Measuring Period”); provided, however, that each day on which <span id="xdx_905_eus-gaap--PreferredStockConversionBasis_pid_c20251104__20251104__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HexstoneCapitalLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z7yYHVkurWN3">(i) the Common Stock has been suspended for trading on all Eligible Markets, (ii) Conversion Shares cannot be sold by the Holder because of violation of Section 32 by the Company, or (iii) Conversion Shares are not delivered after the Share Delivery Deadline, that day’s dollar volume shall be excluded from the calculation of the total aggregate dollar volume of the Conversion Measuring Period. All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the Common Stock during such Conversion Measuring Period; provided further that in no event shall the Conversion Price be lower than the Floor Price of $0.50 subject to adjustment per the Board’s discretion.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_90E_ecustom--PreferredStockConversionBasisForBankruptcy_pid_c20251104__20251104__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HexstoneCapitalLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zqyl0jjwo98b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Preferred stock conversion basis bankruptcy">Upon any bankruptcy triggering event, the Company shall immediately redeem, in cash, each of the Series C Preferred Stock then outstanding at a redemption price equal to the applicable triggering event redemption price. Each of the Series C Preferred Stock subject to redemption by the Company shall be redeemed by the Company at a price equal to the greater of (i) the product of (A) the conversion amount to be redeemed multiplied by (B) the redemption premium of 110% and (ii) the product of (X) the conversion rate with respect to the conversion amount in effect multiplied by (Y) the product of (1) the redemption premium of 110% multiplied by (2) the VWAP of the Common Stock on any trading day during the period commencing on the date immediately preceding such triggering event and ending on the trading date prior to the date the Company makes the entire payment required to be made. Subject to the limitations specified in the Certificate of Designation, holders of Series C Preferred Stock shall have the right to vote on all matters presented to the stockholders for approval together with the shares of Common Stock, voting together as a single class, on an “as converted” basis using the conversion price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Series C Preferred Stock does not have a fixed maturity date and is not mandatorily redeemable on a specified date, the contingent redemption feature upon a bankruptcy triggering event represents a conditional obligation to transfer assets outside the Company’s control. Accordingly, the Company determined that under ASC 480, the Series C Preferred Stock should be treated as temporary equity. Upon issuance of the Series C Preferred Stock, the Company allocated the fair value of $<span id="xdx_905_ecustom--PreferredStockFairValueAmount_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HexstoneCapitalLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z7a5ib4LzIOh" title="Preferred stock fair value amount">117,754</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to the Series C Preferred and subsequent accretion to redemption value. Accordingly, during the six months ended December 31, 2025, the Company accreted $<span id="xdx_900_ecustom--PreferredStockDeemedDividendAmount_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HexstoneCapitalLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zhLfQK8kppHh">882,246</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to redemption value along with the $<span id="xdx_909_eus-gaap--DeferredOfferingCosts_iI_pid_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HexstoneCapitalLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z2UBEe32iXzj">50,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in offering costs and was recorded as deemed dividend. At December 31, 2025, the Series C Preferred Stock redemption value amounted to $<span id="xdx_906_eus-gaap--PreferredStockRedemptionAmount_iI_pid_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HexstoneCapitalLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zoZWomu0xGc">1,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, due to delayed filing and declaration of effectiveness relative to the deadlines defined in the Registration Rights Agreement in connection with this Securities Purchase Agreement, the Company accrued a registration rights penalty amounting to $<span id="xdx_907_ecustom--RegistrationRightsPenaltyAmount_c20250701__20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HexstoneCapitalLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zxc9ECpZ1joc" title="Registration rights penalty amount">54,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, which is payable in <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250701__20251231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HexstoneCapitalLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z6ovobT1vzz5">100,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company’s common stock to Hexstone and was included in accrued expenses and other payables on the accompanying condensed consolidated balance sheets as of December 31, 2025 and a corresponding other expense during the three and six months ended December 31, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were <span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_c20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--HexstoneCapitalLLCMember_zIio1Vc7pLR3">100</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series C Preferred Stock issued and outstanding as of December 31, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrant Liability – Series C Warrants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounted for the <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251104__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--HexstoneCapitalLLCMember_zVnJToHze9i9">9,900</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants issued on November 4, 2025, in accordance with the guidance contained in ASC 815 “Derivatives and Hedging” whereby under that provision these warrants did not meet the criteria for equity treatment and were recorded as a liability since the host instrument itself (Series C Preferred Stock) is classified as temporary equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The initial valuation of the <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251104__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--HexstoneCapitalLLCMember_zMG4WPYw4oQh">9,900</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants was valued at $<span id="xdx_906_ecustom--InitialFairValueOfWarrantLiabilityUponIssuance_c20251104__20251104__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--HexstoneCapitalLLCMember_zhwdeiMqHUEf">882,345</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on November 4, 2025 and shall be recorded at fair value as of each reporting date with the change in fair value reported within other income in the accompanying consolidated statements of operations as “Change in fair value of warrant liability” until the warrants are exercised, expired or other facts and circumstances lead the warrant liability to be reclassified to stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company utilized a Monte Carlo Simulation model to estimate the fair values of the <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251104__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--HexstoneCapitalLLCMember_zc9KsY4BGEUk">9,900</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants, which incorporated significant inputs that were not observable in the market, and thus represents a Level 3 measurement as defined in ASC 820. The unobservable inputs utilized for measuring the fair value of the contingent consideration reflect management’s own assumptions about the assumptions that market participants would use in valuing the contingent consideration. The Company determined the fair value by using the below key inputs to the Monte Carlo Simulation Model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_898_ecustom--FairValueWarrantLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z8EWkh6NV6yk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The key inputs for the warrant liability were as follows as of initial valuation on November 4, 2025:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zhpN86RyYgIh" style="display: none">SCHEDULE OF KEY INPUTS WARRANT LIABILITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Key Valuation Inputs</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected term (years)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20251104__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zNAkctAusEL6" style="width: 16%; text-align: right" title="Expected term"><span style="font-family: Times New Roman, Times, Serif">2.00</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Annualized volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_uPure_c20251104__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zYx3Em6fEN3" style="text-align: right" title="Annualized volatility"><span style="font-family: Times New Roman, Times, Serif">92.27</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_uPure_c20251104__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zEmHQCUVA8Z8" style="text-align: right" title="Risk-free interest rate"><span style="font-family: Times New Roman, Times, Serif">3.58</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Series C Convertible Preferred Stock per Share Value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20251104__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zPopD1efTuZc" style="text-align: right" title="Series C Convertible Preferred Stock per Share Value"><span style="font-family: Times New Roman, Times, Serif">1,177.54</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_uPure_c20251104__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z30k3shiq0nl" style="text-align: right" title="Dividend yield"><span style="font-family: Times New Roman, Times, Serif">0.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20251104__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zTd47c4h9Sh6" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif">10,000.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The key inputs for the warrant liability were as follows as of December 31, 2025:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Key Valuation Inputs</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected term (years)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z2krfISvR3Y6" style="width: 16%; text-align: right" title="Expected term"><span style="font-family: Times New Roman, Times, Serif">1.84</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Annualized volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z0L1SfttyjZb" style="text-align: right" title="Annualized volatility"><span style="font-family: Times New Roman, Times, Serif">86.25</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zgtrmmbloLE4" style="text-align: right" title="Risk-free interest rate"><span style="font-family: Times New Roman, Times, Serif">3.47</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Series C Convertible Preferred Stock per Share Value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zVPnpycOEzrc" style="text-align: right" title="Series C Convertible Preferred Stock per Share Value"><span style="font-family: Times New Roman, Times, Serif">950.25</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zlOT8tKlKTvd" style="text-align: right" title="Dividend yield"><span style="font-family: Times New Roman, Times, Serif">0.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_z38zPMcFNjZ6" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif">10,000.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth a summary of the changes in the fair value of the Level 3 warrant liability for the six months ended December 31, 2025:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrant<br/> Liability</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Fair value as of June 30, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iS_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zINYVWkt6Yn6" style="text-align: right" title="Initial valuation of warrant liability"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1802">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Initial fair value of warrant liability upon issuance</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--InitialFairValueOfWarrantLiabilityUponIssuance_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zjbQ8WKKfhd5" style="width: 16%; text-align: right" title="Initial fair valuation of warrant liability"><span style="font-family: Times New Roman, Times, Serif">882,345</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of warrant liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--FairValueAdjustmentOfWarrants_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYpmVchoHoJ5" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value of warrant liability"><span style="font-family: Times New Roman, Times, Serif">(593,710</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair value as of December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstanding_iE_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUbmtWfiDXd8" style="border-bottom: Black 2.5pt double; text-align: right" title="Initial valuation of warrant liability"><span style="font-family: Times New Roman, Times, Serif">288,635</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AF_zyKOyh0KeKsk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2026, the Company issued an aggregate of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_za4nN7ueiCV4">2,000,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock as a result of the conversion of <span id="xdx_907_eus-gaap--ConversionOfStockSharesConverted1_c20260101__20260131__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zlCZDVOMQKXg">50</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series C Preferred stock (see Note 13).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 100 0.01 10000 1000099 50000 9900 10000 10000 1 0 0.100 10000 5.00 (i) the Common Stock has been suspended for trading on all Eligible Markets, (ii) Conversion Shares cannot be sold by the Holder because of violation of Section 32 by the Company, or (iii) Conversion Shares are not delivered after the Share Delivery Deadline, that day’s dollar volume shall be excluded from the calculation of the total aggregate dollar volume of the Conversion Measuring Period. All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the Common Stock during such Conversion Measuring Period; provided further that in no event shall the Conversion Price be lower than the Floor Price of $0.50 subject to adjustment per the Board’s discretion. Upon any bankruptcy triggering event, the Company shall immediately redeem, in cash, each of the Series C Preferred Stock then outstanding at a redemption price equal to the applicable triggering event redemption price. Each of the Series C Preferred Stock subject to redemption by the Company shall be redeemed by the Company at a price equal to the greater of (i) the product of (A) the conversion amount to be redeemed multiplied by (B) the redemption premium of 110% and (ii) the product of (X) the conversion rate with respect to the conversion amount in effect multiplied by (Y) the product of (1) the redemption premium of 110% multiplied by (2) the VWAP of the Common Stock on any trading day during the period commencing on the date immediately preceding such triggering event and ending on the trading date prior to the date the Company makes the entire payment required to be made. Subject to the limitations specified in the Certificate of Designation, holders of Series C Preferred Stock shall have the right to vote on all matters presented to the stockholders for approval together with the shares of Common Stock, voting together as a single class, on an “as converted” basis using the conversion price. 117754 882246 50000 1000000 54000 100000 100 9900 9900 882345 9900 <p id="xdx_898_ecustom--FairValueWarrantLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z8EWkh6NV6yk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The key inputs for the warrant liability were as follows as of initial valuation on November 4, 2025:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zhpN86RyYgIh" style="display: none">SCHEDULE OF KEY INPUTS WARRANT LIABILITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Key Valuation Inputs</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected term (years)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20251104__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zNAkctAusEL6" style="width: 16%; text-align: right" title="Expected term"><span style="font-family: Times New Roman, Times, Serif">2.00</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Annualized volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_uPure_c20251104__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zYx3Em6fEN3" style="text-align: right" title="Annualized volatility"><span style="font-family: Times New Roman, Times, Serif">92.27</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_uPure_c20251104__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zEmHQCUVA8Z8" style="text-align: right" title="Risk-free interest rate"><span style="font-family: Times New Roman, Times, Serif">3.58</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Series C Convertible Preferred Stock per Share Value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20251104__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zPopD1efTuZc" style="text-align: right" title="Series C Convertible Preferred Stock per Share Value"><span style="font-family: Times New Roman, Times, Serif">1,177.54</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_uPure_c20251104__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z30k3shiq0nl" style="text-align: right" title="Dividend yield"><span style="font-family: Times New Roman, Times, Serif">0.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20251104__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zTd47c4h9Sh6" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif">10,000.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The key inputs for the warrant liability were as follows as of December 31, 2025:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Key Valuation Inputs</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expected term (years)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z2krfISvR3Y6" style="width: 16%; text-align: right" title="Expected term"><span style="font-family: Times New Roman, Times, Serif">1.84</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Annualized volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z0L1SfttyjZb" style="text-align: right" title="Annualized volatility"><span style="font-family: Times New Roman, Times, Serif">86.25</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zgtrmmbloLE4" style="text-align: right" title="Risk-free interest rate"><span style="font-family: Times New Roman, Times, Serif">3.47</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Series C Convertible Preferred Stock per Share Value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zVPnpycOEzrc" style="text-align: right" title="Series C Convertible Preferred Stock per Share Value"><span style="font-family: Times New Roman, Times, Serif">950.25</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_dp_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zlOT8tKlKTvd" style="text-align: right" title="Dividend yield"><span style="font-family: Times New Roman, Times, Serif">0.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_z38zPMcFNjZ6" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif">10,000.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth a summary of the changes in the fair value of the Level 3 warrant liability for the six months ended December 31, 2025:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrant<br/> Liability</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Fair value as of June 30, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iS_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zINYVWkt6Yn6" style="text-align: right" title="Initial valuation of warrant liability"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1802">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Initial fair value of warrant liability upon issuance</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--InitialFairValueOfWarrantLiabilityUponIssuance_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zjbQ8WKKfhd5" style="width: 16%; text-align: right" title="Initial fair valuation of warrant liability"><span style="font-family: Times New Roman, Times, Serif">882,345</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of warrant liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--FairValueAdjustmentOfWarrants_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYpmVchoHoJ5" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value of warrant liability"><span style="font-family: Times New Roman, Times, Serif">(593,710</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair value as of December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstanding_iE_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUbmtWfiDXd8" style="border-bottom: Black 2.5pt double; text-align: right" title="Initial valuation of warrant liability"><span style="font-family: Times New Roman, Times, Serif">288,635</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 2.00 0.9227 0.0358 1177.54 0.0000 10000.00 1.84 0.8625 0.0347 950.25 0.0000 10000.00 882345 -593710 288635 2000000 50 <p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zNy1e3Lyixb7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span id="xdx_828_zVEH1elJjBO5">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Preferred Stock</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total number of shares of preferred stock that the Company is authorized to issue is <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_c20251231_zP6QWCpmOxti">1,500,005</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, $<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20251231_zJPMvP9wMMn6">0.01</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">par value per share. These preferred shares have no rights to dividends, profit sharing or liquidation preferences, subject to any such rights provided for such shares in any certificate of designation filed by the Company with the State of Delaware.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of the total preferred shares authorized, <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_ze4QME9XAVXl">500,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">had been designated as Series A Preferred Stock (“Series A Preferred Stock”), pursuant to the Certificate of Designation for the Series A Preferred Stock filed with the Secretary of State of the State of Delaware on December 9, 2014. There were <span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zTZrJVMpMQhj">no</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series A Preferred Stock issued and outstanding as of December 31, 2025 and June 30, 2025 for both periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to a certificate of designation filed with the Secretary of State of the State of Delaware on June 16, 2015, five shares of preferred stock have been designated as Series B Preferred Stock, par value $<span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zOOGrrF8IOLa">0.01</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, of the Company (“Series B Preferred Stock”). Each holder of shares of Series B Preferred Stock is entitled to voting power equivalent to the number of votes equal to the total number of shares of common stock outstanding as of the record date for the determination of stockholders entitled to vote at each meeting of stockholders of the Company and entitled to vote on all matters submitted or required to be submitted to a vote of the stockholders of the Company. <span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_pid_dc_uShares_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zMcgnqgx1yT">One</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">share of Series B Preferred Stock is issued and outstanding as of December 31, 2025 and June 30, 2025. Mr. Nathanielsz, the Company’s Chief Executive Officer, directly beneficially owns such one share of Series B Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span id="xdx_90F_eus-gaap--SharesIssued_iI_pid_do_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zZ4VR5PIiQNg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">additional shares of Series A Preferred Stock or Series B Preferred Stock were issued during six months ended December 31, 2025 and fiscal year 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Common Stock:</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares issued for cash</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 14, 2025, the Company entered into an underwriting agreement with D. Boral Capital, LLC, as representative of the underwriters in connection with a public offering of the Company’s common stock. The Underwriting Agreement provided for the offer and sale of <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250814__20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zb1OEOUQjWa1">1,000,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at a price to the public of $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdx1FEIUOvq2">4.00</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the “Offering”). In connection therewith, the Company agreed to issue to the representative, warrants to purchase <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250814__20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativesWarrantsMember_zRCXa62B0JXe">30,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of shares of common stock at a price equal $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativesWarrantsMember_z5Mum3araBxk">4.00</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the “Representative’s Warrants”). The Representative’s Warrants are exercisable at any time and from time to time, in whole or in part, from February 15, 2026 through August 15, 2030 and contains cashless exercise provision. The Company also granted the Underwriters an overallotment option for a period of 45 days to purchase up to an additional <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20250814__20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGY5acAZnYib">150,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock which was not consummated. The Company paid underwriting commissions and offering expenses of $<span id="xdx_908_eus-gaap--PaymentsForRepurchaseOfInitialPublicOffering_c20250814__20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zgwl4Dqieuyg">535,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in August 2025 upon closing of the Offering (see below).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 18, 2025, the Offering was completed. At the closing, the Company (i) sold <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250818__20250818__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zHlViIzSLZ39">1,000,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Common Stock for total gross proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20250818__20250818__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zKih8whobmK4">4,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and (ii) issued the Representative’s Warrants. After deducting the underwriting commissions and offering expenses, the Company received net proceeds of approximately $<span id="xdx_90E_ecustom--NetProceedsFromIssuanceOfCommonStock_pn5n6_c20250818__20250818__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPFUqRA6nhR8">3.3</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million after deducting commissions and related offering expenses of approximately $<span id="xdx_90C_eus-gaap--PaymentsForRepurchaseOfInitialPublicOffering_c20250818__20250818__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zyCPfLOvFn6">686,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(“Total Offering Fees”). During the six months ended December 31, 2025, deferred offering costs of $<span id="xdx_90A_eus-gaap--DeferredOfferingCosts_iI_c20251231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zzJHf3byeMA">281,773</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(included in the Total Offering Fees) were charged to additional paid-in capital upon the completion of the Offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares issued for conversion of convertible debt</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From July 1, 2025 through September 30, 2025, the Company issued an aggregate of <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250701__20250930__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zvmZAVpNeNxi">194,966</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock at an average contractual conversion price of $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250930__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z6qe3E1bVcA9">1.75</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as a result of the conversion of principal of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20250930__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z7ji5WzX5Uve">298,797</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, interest of $<span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250930__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zsbLXzl4GUL8">37,053</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and conversion fees $<span id="xdx_90F_eus-gaap--DebtInstrumentFeeAmount_iI_c20250930__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zRPR6AcZIkNd">4,906</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">underlying certain outstanding convertible notes converted during such period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From October 1, 2025 through December 31, 2025, the Company issued an aggregate of <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251001__20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zwogkwMo7pB2">127,667</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock at an average contractual conversion price of $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z3ntKWqIvzHj">1.75</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as a result of the conversion of principal of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zJ4dBJLIq7C9">76,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest of $<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zWBKkr8I353d">4,441</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and conversion fees $<span id="xdx_906_eus-gaap--DebtInstrumentFeeAmount_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zqzgDhKRHkc8">937</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">underlying certain outstanding convertible notes converted during such period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in the above conversion during the six months ended December 31, 2025, were principal aggregate amount of convertible notes of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20251231_z2STM5D6TKue">145,650</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, accrued interest of $<span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20251231_zTxSdzhogaec">14,960</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and conversion fees of $<span id="xdx_90B_eus-gaap--DebtInstrumentFeeAmount_iI_pp0p0_c20251231_zHMjpyGrIhSj">2,343</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">containing bifurcated embedded conversion option derivatives were converted into common stock. Accordingly, the fair market value of the shares issued upon conversion was $<span id="xdx_901_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20251231_zqY9alUvGZV8">293,968</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, resulting in a loss on extinguishment at the time of conversion of $<span id="xdx_906_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20251231_zXVUCUjcmAB3">131,015</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_904_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20251231_z3Ak8kRHM1Ch">303,743</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of derivative liability fair value was recorded as a gain on extinguishment at the time of conversion, resulting in a net gain of $<span id="xdx_909_eus-gaap--ExtinguishmentOfDebtGainLossNetOfTax_c20250701__20251231_zVNAdgnuB7d5">172,728</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">which is included in gain (loss) on extinguishment of debt in the accompanying condensed consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reclassified $<span id="xdx_902_ecustom--ReclassifiedFromPremiumLiabilitiesToAdditionalPaidInCapital_c20250701__20251231_zpIZWVa3C296">114,399</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">from put premium liabilities to additional paid in capital following conversions during the six months ended December 31, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has <span id="xdx_90A_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20251231__us-gaap--TypeOfArrangementAxis__custom--UnderlyingFinancingAgreementsMember_zqPE0F5dqyIi">117,882</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock reserved for future issuances based on lender reserve requirements pursuant to underlying financing agreements at December 31, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares issued for services </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 15, 2025, the Company and a consultant agreed to enter into a three-month consulting agreement to provide digital marketing related services for a monthly fee of $<span id="xdx_900_ecustom--MonthlyFeeForServices_c20250815__20250815__us-gaap--TypeOfArrangementAxis__custom--ThreeMonthConsultingAgreementMember_z9IRf0LmjAna" title="Monthly fee for services">100,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and a one-time payment of $<span id="xdx_906_eus-gaap--PaymentsForFees_c20250815__20250815__us-gaap--TypeOfArrangementAxis__custom--ThreeMonthConsultingAgreementMember_znrcF1hgLywb">300,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon signing this agreement. On August 30, 2025, the Company amended this agreement whereby the Company agreed to provide additional compensation by issuing <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250815__20250815__us-gaap--TypeOfArrangementAxis__custom--ThreeMonthConsultingAgreementMember_zcIFsWBh3Qk">500,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock every three months. The first issuance of shares occurred on September 1, 2025 and subsequent issuances shall occur on the first day of every three-month period thereafter. Except for the changes made in the amendment, all other terms and provisions of the original agreement shall remain unchanged and in full force and effect. These shares were valued at $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250815__us-gaap--TypeOfArrangementAxis__custom--ThreeMonthConsultingAgreementMember_zlciLy0FRTWf">2.73</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20250815__20250815__us-gaap--TypeOfArrangementAxis__custom--ThreeMonthConsultingAgreementMember_zJ1jhGEkwp79">1,365,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, being the closing price of the stock on the date of grant. During the six months ended December 31, 2025, the Company recorded stock-based compensation of $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_c20250701__20251231__us-gaap--TypeOfArrangementAxis__custom--ThreeMonthConsultingAgreementMember_zfO8Dtx0KxT7">1,365,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 24, 2025, the Company incurred consulting fees of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20250824__20250824__us-gaap--TypeOfArrangementAxis__custom--SixMonthsConsultingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQWQH6Pa4e2j">43,748</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for management advisory services rendered to a consultant. The Company agreed to issue <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250824__20250824__us-gaap--TypeOfArrangementAxis__custom--SixMonthsConsultingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbt3XbOTVRce">10,937</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of shares of common stock to consultant. These shares were valued at approximately $<span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250824__us-gaap--TypeOfArrangementAxis__custom--SixMonthsConsultingAgreementMember_zHwM4tBU6SF1">4.00</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20250824__20250824__us-gaap--TypeOfArrangementAxis__custom--SixMonthsConsultingAgreementMember_zYUlKe414Uzc">43,748</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, being the closing price of the stock on the date of grant. During the six months ended December 31, 2025, the Company recorded stock-based compensation of $<span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_c20250701__20251231__us-gaap--TypeOfArrangementAxis__custom--SixMonthsConsultingAgreementMember_zH71FIp2PX07">43,748</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2025, the Company issued an aggregate of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20251001__20251031__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLxMMTRdA4Q7">4,336</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">share of common stock for services rendered and to be rendered from September 25, 2025 to December 25, 2025 in connection with the Advisory agreement dated on September 25, 2025. These shares were valued at approximately $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20251031__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zh4sS8w9ti0f">1.73</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20251001__20251031__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zdYqCvh5oYD">7,500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, being the closing price of the stock on the date of grant. During the six months ended December 31, 2025, the Company recorded stock-based compensation of $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20250701__20251231__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zh4uqqLkwM0f">7,500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During fiscal year 2025, the Company issued an aggregate of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember_zNPKjZrepOIh">2,025,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of fully vested, non-forfeitable common stock to various consultants for prepaid consulting, investor relations and business advisory services with service terms ranging from <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_dtM_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember__srt--RangeAxis__srt--MinimumMember_zXYBfl10aBs7">6</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">months to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_dc_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember__srt--RangeAxis__srt--MaximumMember_zmnFGiCA14ed">three years</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Those shares were valued at a weighted average price of approximately $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember_zdqPbOXFLdwj">12</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ranging from $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MinimumMember__srt--TitleOfIndividualAxis__custom--ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember_zTAbRAHpxIA1">7</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MaximumMember__srt--TitleOfIndividualAxis__custom--ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember_zTXZwBZEwfzf">15</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) or $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember_zOpYE3KmclPi">23,881,110</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, being the closing prices of the stock on each respective date of grants. During the fiscal year 2025, the Company recorded stock-based compensation of $<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20240701__20250630_zi1uX24qC6e2">4,621,230</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. During the three months ended December 31, 2025, the Company recorded stock-based compensation expense of $<span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_c20251001__20251231_z1UFx4JoR1o9">1,789,262</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. During the six months ended December 31, 2025, the Company recorded stock-based compensation expense of $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20250701__20251231_z0US3WTIyntd">4,813,867</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. At June 30, 2025, the Company recorded prepaid expense – current portion of $<span id="xdx_904_eus-gaap--OtherPrepaidExpenseCurrent_iI_c20250630_zBOPXCNS2Tg">8,334,046</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and prepaid expense – long-term portion of $<span id="xdx_906_eus-gaap--PrepaidExpenseNoncurrent_iI_c20250630_zuGbrq6b0Tnh">10,925,835</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to be amortized over the terms of the respective agreements. At December 31, 2025, the Company recorded prepaid expense – current portion of $<span id="xdx_901_eus-gaap--OtherPrepaidExpenseCurrent_iI_c20251231_zWGHFuIJhY15">7,127,203</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and prepaid expense – long-term portion of $<span id="xdx_901_eus-gaap--PrepaidExpenseNoncurrent_iI_c20251231_zRoWNGhSsNl9">7,347,310</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">related to fiscal year 2025 issuances to be amortized over the terms of the respective agreements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Restricted Stock Units</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to employment agreements dated in May 2019, the Company granted de minimis restricted stock unit (after the Reverse Stock Split) to the Company’s Chief Executive Officer and Chief Scientific Officer. Such restricted stock units are subject to vesting terms as defined in the employment agreements. Such restricted stock units were valued at the fair value of approximately $<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190501__20190531__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zPrIVAowTpJ3">497,240</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">based on the quoted trading price on the date of grant. There were $<span id="xdx_900_ecustom--UnrecognizedRestrictedStockUnitsExpense_pp0p0_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOE9NNlogRZ6">248,620</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unrecognized restricted stock units expense as of December 31, 2025 and June 30, 2025. A de minimis amount of unvested restricted stock units which are subject to various performance conditions have not yet been met and have not yet vested as of December 31, 2025 to which the above amount of $<span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_iI_c20251231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOpfNiS2Cbbl">248,620</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">relates to.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Stock Warrants:</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zpP9SXGQmCh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes warrant activity for the six months ended December 31, 2025:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zTDd94AZ3hmh" style="display: none">SUMMARY OF WARRANT ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price Per Share</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2025</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250701__20251231_zPXf3YrUJTp8" style="width: 16%; text-align: right" title="Number of Warrants, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_pid_c20250701__20251231_zEelqHQfIn6l" style="width: 16%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">600.00</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted – Common stock warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20250701__20251231_zVJxWWXH4M25" style="text-align: right" title="Number of Warrants, Granted"><span style="font-family: Times New Roman, Times, Serif">30,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_pid_c20250701__20251231_zjsBj95g8cm" style="text-align: right" title="Weighted Average Price Per Share, Granted"><span style="font-family: Times New Roman, Times, Serif">4.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted – Series C preferred stock warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20250701__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zp9LNuhMBzJc" style="text-align: right" title="Number of Warrants, Granted"><span style="font-family: Times New Roman, Times, Serif">9,900</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_pid_c20250701__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zGPnE3wKsRqk" style="text-align: right" title="Weighted Average Price Per Share, Granted"><span style="font-family: Times New Roman, Times, Serif">10,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20250701__20251231_z6OMmq875QS7" style="text-align: right" title="Number of Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1898">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_pid_c20250701__20251231_zDFqhZENDq0l" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1900">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20250701__20251231_zw9j8wh6TPK1" style="text-align: right" title="Number of Warrants, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1902">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_pid_c20250701__20251231_fKg_____zhFJ8FOjhhNc" style="text-align: right" title="Weighted Average Price Per Share, Cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1904">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20250701__20251231_zDiqszIGmNh2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1906">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_pid_c20250701__20251231_z9i4S3lduhdk" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1908">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2025</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20250701__20251231_zj01gIEMn4zb" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">40,150</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iE_pid_c20250701__20251231_zXnUS6inRzh3" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">2,484.21</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable at December 31, 2025</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20250701__20251231_zoKy4TvOTERk" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">10,150</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_iE_pid_c20250701__20251231_z15g7zvUBI03" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">9,768.47</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding and Exercisable:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining contractual term</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20250701__20251231_zLagjQytB2Pb" style="font-family: Times New Roman, Times, Serif">1.81</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate intrinsic value <br/></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20250701__20251231_zx4Q1iL3WhX8" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1919">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A3_zntQfvZmgb64" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 14, 2025, the Company entered into an underwriting agreement with D. Boral Capital, LLC, as representative of the underwriters in connection with a public offering of the Company’s common stock. In connection with the Offering, the Company agreed to issue to the representative, warrants to purchase <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250814__20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativesWarrantsMember_zhePhBwreuKh">30,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of shares of common stock at a price equal $<span id="xdx_90A_eus-gaap--SaleOfStockPricePerShare_iI_c20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativesWarrantsMember_zNisgC4wq7y8">4.00</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the “Representative’s Warrants”). The Representative’s Warrants are exercisable at any time and from time to time, in whole or in part, from February 15, 2026 through August 15, 2030 and contains cashless exercise provision. The fair value of the warrants was approximately $<span id="xdx_900_eus-gaap--FairValueAdjustmentOfWarrants_c20250814__20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativesWarrantsMember_zIzbG3IEQAF7">86,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">which was based on a fair value determination using a Black-Scholes model and was recorded as an offering cost. Accordingly, there was no accounting effect on the date of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 4, 2025, the Company completed a private placement pursuant to a Securities Purchase Agreement with Hexstone. At closing, Hexstone purchased 100 shares of Series C Preferred Stock and also issued warrants to purchase up to <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251104__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--HexstoneCapitalLLCMember_zo7xDlFCSekf">9,900</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">additional shares of Series C Preferred Stock. Each warrant is exercisable for one share of Series C Preferred Stock at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20251104__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--HexstoneCapitalLLCMember_zHKvajPKmaG8">10,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (subject to equitable adjustments by the Company relating to stock-splits, reclassifications, combination, extraordinary distributions and similar events) and expires two years from issuance. The Series C Preferred Stock and warrants were issued in a private placement (see Note 7).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Stock Options:</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zEswQDeIsGdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s option activity during the six months ended December 31, 2025 is presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_z5KSNvCBB7E1" style="display: none">SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average Exercise</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price Per Share</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2025</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20250701__20251231_znhFe0hLBB4i" style="width: 16%; text-align: right" title="Number of Shares, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">0.000001</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20250701__20251231_zsLvH5MFsQFj" style="width: 16%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">271,980,000,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20250701__20251231_zLwRA2bwXbK8" style="text-align: right" title="Number of Shares, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1932">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20250701__20251231_z2EgpyyHxAs8" style="text-align: right" title="Weighted Average Price Per Share, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1934">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20250701__20251231_z7199PtiO1Bh" style="text-align: right" title="Number of Shares, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1936">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20250701__20251231_zRzxQ8J6g1p1" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1938">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20250701__20251231_zSP7tIBTQRG1" style="text-align: right" title="Number of Shares, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1940">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20250701__20251231_zonR4ZH2Phbk" style="text-align: right" title="Weighted Average Price Per Share, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1942">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20250701__20251231_zVAoMGKbZpga" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Shares, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1944">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20250701__20251231_z04ENdxOOrGf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1946">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2025</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20250701__20251231_zn1gzA3TSDj7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Shares, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">0.000001</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20250701__20251231_zsHiqzo2p4lk" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">271,980,000,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Exercisable at December 31, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20250701__20251231_zPjVWb8kvc3b" style="text-align: right" title="Number of Shares, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">0.000001</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20250701__20251231_zRCKtI0Wxiuk" style="text-align: right" title="Weighted Average Price Per Share, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">271,980,000,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding and Exercisable:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining contractual term</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250701__20251231_zytc7uzn4qE2" style="font-family: Times New Roman, Times, Serif">3.37</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average fair value of options granted during the period</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20250701__20251231_zSpXdMg4s9Lc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average fair value of options granted during the period"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1957">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate intrinsic value</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20250701__20251231_zH29jKMvxZQ" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1959">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A1_zpKwVe8rIAHg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On the Effective Date, the Company’s board of directors approved and adopted the Company’s 2019 Equity Incentive Plan (the “2019 Plan”), which reserves a total of <span id="xdx_902_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20251231__us-gaap--PlanNameAxis__custom--TwoThousandNinteenEquityIncentivePlanMember_zitlc5ZCT3yb">234</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company’s common stock for issuance under the 2019 Plan. Incentive awards authorized under the 2019 Plan include, but are not limited to, incentive stock options, non-qualified stock options, restricted stock awards and restricted stock units.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six months ended December 31, 2025 and 2024, the Company recognized stock-based compensation of $<span id="xdx_905_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20241231_z9UivRq68oZ9">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for both periods from vested stock options. There was $<span id="xdx_909_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20251231_ziW3WRNYyDs2">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of unvested stock options expense as of December 31, 2025. <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_do_c20250701__20251231_zMUvfOxiDtF3">No</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock options were granted during the six months ended December 31, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1500005 0.01 500000 0 0.01 1 0 1000000 4.00 30000 4.00 150000 535000 1000000 4000000 3300000 686000 281773 194966 1.75 298797 37053 4906 127667 1.75 76000 4441 937 145650 14960 2343 293968 131015 303743 172728 114399 117882 100000 300000 500000 2.73 1365000 1365000 43748 10937 4.00 43748 43748 4336 1.73 7500 7500 2025000 P6M P3Y 12 7 15 23881110 4621230 1789262 4813867 8334046 10925835 7127203 7347310 497240 248620 248620 <p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zpP9SXGQmCh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes warrant activity for the six months ended December 31, 2025:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zTDd94AZ3hmh" style="display: none">SUMMARY OF WARRANT ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price Per Share</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2025</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250701__20251231_zPXf3YrUJTp8" style="width: 16%; text-align: right" title="Number of Warrants, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iS_pid_c20250701__20251231_zEelqHQfIn6l" style="width: 16%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">600.00</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted – Common stock warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20250701__20251231_zVJxWWXH4M25" style="text-align: right" title="Number of Warrants, Granted"><span style="font-family: Times New Roman, Times, Serif">30,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_pid_c20250701__20251231_zjsBj95g8cm" style="text-align: right" title="Weighted Average Price Per Share, Granted"><span style="font-family: Times New Roman, Times, Serif">4.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted – Series C preferred stock warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20250701__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zp9LNuhMBzJc" style="text-align: right" title="Number of Warrants, Granted"><span style="font-family: Times New Roman, Times, Serif">9,900</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_pid_c20250701__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zGPnE3wKsRqk" style="text-align: right" title="Weighted Average Price Per Share, Granted"><span style="font-family: Times New Roman, Times, Serif">10,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20250701__20251231_z6OMmq875QS7" style="text-align: right" title="Number of Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1898">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_pid_c20250701__20251231_zDFqhZENDq0l" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1900">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20250701__20251231_zw9j8wh6TPK1" style="text-align: right" title="Number of Warrants, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1902">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_pid_c20250701__20251231_fKg_____zhFJ8FOjhhNc" style="text-align: right" title="Weighted Average Price Per Share, Cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1904">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20250701__20251231_zDiqszIGmNh2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1906">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_pid_c20250701__20251231_z9i4S3lduhdk" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1908">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2025</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20250701__20251231_zj01gIEMn4zb" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">40,150</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageOutstanding_iE_pid_c20250701__20251231_zXnUS6inRzh3" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">2,484.21</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable at December 31, 2025</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20250701__20251231_zoKy4TvOTERk" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">10,150</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_iE_pid_c20250701__20251231_z15g7zvUBI03" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">9,768.47</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding and Exercisable:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining contractual term</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20250701__20251231_zLagjQytB2Pb" style="font-family: Times New Roman, Times, Serif">1.81</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate intrinsic value <br/></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20250701__20251231_zx4Q1iL3WhX8" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1919">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 250 600.00 30000 4.00 9900 10000 40150 2484.21 10150 9768.47 P1Y9M21D 30000 4.00 86000 9900 10000 <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zEswQDeIsGdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s option activity during the six months ended December 31, 2025 is presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_z5KSNvCBB7E1" style="display: none">SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average Exercise</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price Per Share</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2025</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20250701__20251231_znhFe0hLBB4i" style="width: 16%; text-align: right" title="Number of Shares, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">0.000001</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20250701__20251231_zsLvH5MFsQFj" style="width: 16%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">271,980,000,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20250701__20251231_zLwRA2bwXbK8" style="text-align: right" title="Number of Shares, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1932">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20250701__20251231_z2EgpyyHxAs8" style="text-align: right" title="Weighted Average Price Per Share, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1934">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20250701__20251231_z7199PtiO1Bh" style="text-align: right" title="Number of Shares, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1936">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20250701__20251231_zRzxQ8J6g1p1" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1938">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20250701__20251231_zSP7tIBTQRG1" style="text-align: right" title="Number of Shares, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1940">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20250701__20251231_zonR4ZH2Phbk" style="text-align: right" title="Weighted Average Price Per Share, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1942">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20250701__20251231_zVAoMGKbZpga" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Shares, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1944">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20250701__20251231_z04ENdxOOrGf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1946">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2025</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20250701__20251231_zn1gzA3TSDj7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Shares, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">0.000001</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20250701__20251231_zsHiqzo2p4lk" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">271,980,000,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Exercisable at December 31, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20250701__20251231_zPjVWb8kvc3b" style="text-align: right" title="Number of Shares, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">0.000001</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20250701__20251231_zRCKtI0Wxiuk" style="text-align: right" title="Weighted Average Price Per Share, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">271,980,000,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding and Exercisable:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining contractual term</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250701__20251231_zytc7uzn4qE2" style="font-family: Times New Roman, Times, Serif">3.37</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average fair value of options granted during the period</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20250701__20251231_zSpXdMg4s9Lc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average fair value of options granted during the period"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1957">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate intrinsic value</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20250701__20251231_zH29jKMvxZQ" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1959">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 0.000001 271980000000 0.000001 271980000000 0.000001 271980000000 P3Y4M13D 234 0 0 0 <p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zTRYbc2ojK0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 – <span id="xdx_82A_zcx5lmt7c3rj">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Legal Matters </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 9, 2025, <span id="xdx_90A_eus-gaap--LossContingencyDamagesSought_c20251209__20251209__us-gaap--LossContingenciesByNatureOfContingencyAxis__us-gaap--IndemnificationGuaranteeMember_zGCWl5Owoatl" title="Loss contingency">the Company was served with a complaint (the “Complaint”) filed in the Superior Court of the State Delaware by Helena Partners, Inc. (“Helena”). In the Complaint, Helena alleges breach of an engagement agreement dated August 3, 2025 (the “Engagement Agreement”) between the Company and Helena and argues that the Company owes Helena a $15,000 deal deposit fee for entering into the Engagement Agreement and a $250,000 break fee for not completing an equity financing with Helena.</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 15, 2026, the Company filed an answer to the Complaint with the Superior Court of the State of Delaware and intends to vigorously defend the action. Other than as described above, there is no other action, suit, or proceeding by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our Company or our subsidiary, threatened against or affecting our Company, our Common Stock, our subsidiary or of our companies or our subsidiary’s officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">IRS Liability</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of its requirement for having a foreign operating subsidiary, the Company is required to file an informational Form 5471 to the Internal Revenue Service (the “IRS”), which is a form that explains the nature of the relationship between the foreign subsidiary and the parent company. From 2012 through the 2014, the Company did not file this form in a timely manner. As a result of the non-timely filings, the Company incurred a penalty from the IRS in the amount of $<span id="xdx_905_ecustom--PenaltyAmount_c20250701__20251231__us-gaap--AwardDateAxis__custom--From2012ThroughThe2014Member_zcf8b7HJC9ml">10,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per year, or $<span id="xdx_901_ecustom--PenaltyAmount_c20250701__20251231_zfCp2S78Ynp">30,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in total, plus accrued interest, such penalty and interest having been accrued and is included in the accrued expenses and other payable figure on the December 31, 2025 and June 30, 2025 consolidated balance sheets. The Company recorded the penalties for all three years during the year ended June 30, 2018. The Company is current on all subsequent filings.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Operating Agreements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2009, the Company entered into a commercialization agreement with the University of Bath (UK) (the “UK University”), whereby the Company and the UK University co-owned the intellectual property relating to the Company’s pro-enzyme formulations. In June 2012, the Company and the UK University entered into an assignment and amendment whereby the Company assumed full ownership of the intellectual property, while agreeing to pay royalties of <span id="xdx_908_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_pid_dp_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--RoyaltyAgreementTermsMember_zcARTJuwa217">2</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of net revenues to the UK University. Additionally, the Company agreed to pay <span id="xdx_907_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_pid_dp_uPure_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--LicenseAgreementTermsMember_zMpIF63yuJxe">5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of each and every license agreement subscribed for. The contract is cancellable at any time by either party. To date, no amounts are owed under the agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Collaboration Agreement</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 13, 2018, the Company entered into a two-year collaboration agreement with the University of Jaén (the “University”) to provide certain research services to the Company. In consideration of such services, the Company agreed to pay the University approximately <span id="xdx_90F_ecustom--PaymentForServices_uEUR_c20180913__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember_znofD8CEeH62">52,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Euros ($<span id="xdx_90C_ecustom--PaymentForServices_c20180913__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember_zzTrEKJHXYHd">59,508</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) in year one and a maximum of <span id="xdx_90D_ecustom--PaymentForServices_uEUR_c20180913__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_zREcWI7Nnc8i">40,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Euros ($<span id="xdx_908_ecustom--PaymentForServices_c20180913__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_znJwggEaTyT9">45,775</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) in year two. Additionally, in exchange for full ownership of the intellectual property, the Company agreed to pay royalties of <span id="xdx_905_ecustom--RoyaltyPercentage_pid_dp_uPure_c20180913__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_ztuPI974FAQ3">2</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of net revenues to the University.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 1, 2020, the Company entered into another two-year collaboration agreement with the University to provide certain research services to the Company. In consideration of such services, the Company agreed to pay the University approximately <span id="xdx_90D_ecustom--PaymentForServices_uEUR_c20201001__20201001__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_z88CtjkgaHN5">30,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Euros ($<span id="xdx_907_ecustom--PaymentForServices_c20201001__20201001__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_z5Tm28LdsZw9">35,145</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD), which were paid in four installment payment of <span id="xdx_90C_ecustom--PaymentForServices_uEUR_c20201101__20201130__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentOneMember_zn778kU0zQO8">5,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Euros in November 2020, <span id="xdx_909_ecustom--PaymentForServices_uEUR_c20210301__20210331__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember_zqMwXPtHlBY1">5,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Euros ($<span id="xdx_903_ecustom--PaymentForServices_c20210301__20210331__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember_zRkRIV8fXF96">5,858</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) in March 2021, <span id="xdx_908_ecustom--PaymentForServices_uEUR_c20211201__20211231__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember_zhekL5ciJT0k">10,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Euros ($<span id="xdx_90A_ecustom--PaymentForServices_c20211201__20211231__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember_z8bqitkgEYT">11,715</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) in December 2021 and <span id="xdx_908_ecustom--PaymentForServices_uEUR_c20220901__20220930__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember_zPL6IXiUaaz4">10,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Euros ($<span id="xdx_902_ecustom--PaymentForServices_c20220901__20220930__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember_zehWZYAXIPL1">11,715</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) in September 2022. Additionally, the University agreed to hire and train a doctoral student for this project and the Company agreed to pay the University <span id="xdx_902_ecustom--PaymentForServices_uEUR_c20201001__20201001__dei--LegalEntityAxis__custom--UniversityOfJaenMember_zZl6LJGMmMva">25,837</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Euros ($<span id="xdx_909_ecustom--PaymentForServices_c20201001__20201001__dei--LegalEntityAxis__custom--UniversityOfJaenMember_z6oac6mtRRfa">30,268</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD). In exchange for full ownership of the intellectual property, the Company agreed to pay royalties of <span id="xdx_906_ecustom--RoyaltiesPercentage_pid_dp_uPure_c20201001__20201001_zE6A1z4pZgOf">2</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of net revenues to the University.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 27, 2022, the Company entered into a two-year research agreement with the University to provide certain research and experiment services to the Company. One of the Company’s Scientific Advisory Board is the lead joint researcher of the University. In exchange for full ownership of the intellectual property, the Company agreed to pay royalties of <span id="xdx_906_ecustom--RoyaltyPercentage_pid_dp_uPure_c20220727__20220727__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_z1ugPSpPo1O7">1</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of net revenues each to two members of the Scientific Advisory Board. In consideration of such services, the Company agreed to pay the University approximately <span id="xdx_905_ecustom--PaymentForServices_uEUR_c20220727__20220727__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_z5PeseiZNOLj">53,200</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Euros ($<span id="xdx_903_ecustom--PaymentForServices_c20220727__20220727__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zFfOtZSICSbd">53,806</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) payable as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_90E_ecustom--PaymentForServices_uEUR_c20220801__20220831__us-gaap--AwardDateAxis__custom--InstallmentOneMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_z4LX2nyX5jsh">18,200</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Euros ($<span id="xdx_903_ecustom--PaymentForServices_c20220801__20220831__us-gaap--AwardDateAxis__custom--InstallmentOneMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zfYZycMhTwpb">18,407</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) upon execution (paid in August 2022),</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_90C_ecustom--PaymentForServices_uEUR_c20220901__20220930__us-gaap--AwardDateAxis__custom--InstallmentTwoMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zcVk1NvZ4Lk3">8,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Euros ($<span id="xdx_90B_ecustom--PaymentForServices_c20220901__20220930__us-gaap--AwardDateAxis__custom--InstallmentTwoMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zqH3GBSDGAWg">8,091</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) in September 2022 (paid in September 2025),</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_905_ecustom--PaymentForServices_uEUR_c20221201__20221231__us-gaap--AwardDateAxis__custom--InstallmentThreeMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zgpyIXrKpgS5">7,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Euros ($<span id="xdx_909_ecustom--PaymentForServices_c20221201__20221231__us-gaap--AwardDateAxis__custom--InstallmentThreeMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zPK5hku9cb9f">7,080</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) in December 2022 (paid in September 2025),</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_90D_ecustom--PaymentForServices_uEUR_c20230301__20230331__us-gaap--AwardDateAxis__custom--InstallmentFourMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zv8ec3CXSmb8">10,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Euros ($<span id="xdx_90D_ecustom--PaymentForServices_c20230301__20230331__us-gaap--AwardDateAxis__custom--InstallmentFourMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_z9OcaJjU09q7">10,114</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) in March 2023 (paid in October 2025), and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_90A_ecustom--PaymentForServices_uEUR_c20230701__20230731__us-gaap--AwardDateAxis__custom--InstallmentFiveMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zkSlXScffcPi">10,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Euros ($<span id="xdx_901_ecustom--PaymentForServices_c20230701__20230731__us-gaap--AwardDateAxis__custom--InstallmentFiveMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zH3OfEjdOeF9">10,114</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) in July 2023 (paid in October 2025).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The commencement date for the experiments was on September 1, 2022, and the length of time for completion was 24 months. A doctoral thesis was completed in December 2024. A subsequent 12-month addendum for additional experiments is currently under negotiation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2025 and June 30, 2025, the Company has $<span id="xdx_90A_ecustom--UnreimbursedLabFees_iI_c20251231_zbBoiBlHU6ye">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90F_ecustom--UnreimbursedLabFees_iI_c20250630_z0MOHtI7a5ad">51,468</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, balance due to the University for unreimbursed lab fees, which are included in accrued expenses and other liabilities in the accompanying consolidated balance sheets. As of December 31, 2025 and June 30, 2025, there are no royalty fees owed to the University.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Consulting Agreements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 14, 2025, the Company entered into an underwriting agreement with D. Boral Capital, LLC, as representative (the “Representative”) of the underwriters (the “Underwriters”) in connection with a public offering of the Company’s common stock, par value $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--DBoralCapitalLLCMember_zH23QVAZOnv7">0.001</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the “Common Stock”). The Underwriting Agreement provides for the offer and sale of <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250814__20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--DBoralCapitalLLCMember_zWm2AfTRk2a6">1,000,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Common Stock at a price to the public of $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_c20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--DBoralCapitalLLCMember_zXKFOccTDsP2">4.00</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the “Offering”). In connection therewith, the Company agreed to issue to the Representative, warrants to purchase <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250814__20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--DBoralCapitalLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zP5sQiuI9mj4">30,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of shares of common stock at a price equal $<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_c20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--DBoralCapitalLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7IgRAyJjua6">4.00</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the “Representative’s Warrants”). The Representative’s Warrants are exercisable at any time and from time to time, in whole or in part, from <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20250814__20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--DBoralCapitalLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zqQR27yP3Fvb">February 15, 2026</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through <span id="xdx_902_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20250814__20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--DBoralCapitalLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zuAlEpl8ZIvl">August 15, 2030</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and contain provisions for cashless exercise. The Company also granted the Underwriters an overallotment option for a period of 45 days to purchase up to an additional <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250814__20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--DBoralCapitalLLCMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zJNoojAc1Hhf">150,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock. The Offering was made pursuant to a Registration Statement on Form S-1 and a related prospectus filed with the Securities and Exchange Commission (“SEC”), which was declared effective by the SEC on August 13, 2025. The Underwriting Agreement includes customary representations, warranties and covenants by the Company. It also provides that the Company will indemnify the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended or contribute to payments the Underwriter may be required to make because of any of those liabilities. The Company paid underwriting commissions and offering expenses of $<span id="xdx_90B_eus-gaap--PaymentsForUnderwritingExpense_c20250814__20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_z8whC6jew3Nh">535,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in August 2025 upon closing of the Offering (see Note 8).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 25, 2025, the Company and a consultant agreed to enter into a one-year Advisory Agreement (the “Advisory Agreement”) to provide capital market advisory and strategic business analysis related services for a monthly fee of $<span id="xdx_907_ecustom--MonthlyFeeForServices_c20250925__20250925__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zbxK4qVEL7fk">2,500</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and shall issue shares of the Company’s common stock worth $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20250925__20250925__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2cVG544z9ta">2,500</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per month. In October 2025, the Company issued an aggregate of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20251001__20251031__us-gaap--TypeOfArrangementAxis__custom--AdvisoryAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUFMaTfZ9eCk">4,336</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">share of common stock for services rendered and to be rendered from September 25, 2025 to December 25, 2025 in connection with the Advisory agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Operating Leases</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 4, 2022, the Company entered in a three-year<span id="xdx_90D_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20220504__us-gaap--TypeOfArrangementAxis__custom--NewThreeYearOperatingLeaseAgreementMember_zop1X9UlFL66" style="display: none">3</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lease agreement with North Horizon Pty Ltd., a related party, for a monthly rent of $<span id="xdx_90F_eus-gaap--PaymentsForRent_uAUD_c20220504__20220504__us-gaap--TypeOfArrangementAxis__custom--NewThreeYearOperatingLeaseAgreementMember_zjo2Ok8TDHse">3,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD or $<span id="xdx_90B_eus-gaap--PaymentsForRent_uUSD_c20220504__20220504__us-gaap--TypeOfArrangementAxis__custom--NewThreeYearOperatingLeaseAgreementMember_zZsNdln733yi">2,176</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD (depending on exchange rate) per month plus taxes. On May 4, 2022, the Company recorded right-of-use assets $<span id="xdx_901_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20220504__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__custom--AccountingStandardUpdate201602Member_z6fpJiKbaAch">66,201</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and total lease liabilities of $<span id="xdx_908_eus-gaap--OperatingLeaseLiability_iI_c20220504__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__custom--AccountingStandardUpdate201602Member_z5lCzb37g6Hl">66,201</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">based on an incremental borrowing rate of <span id="xdx_90D_ecustom--IncrementalBorrowingRate_pid_dp_uPure_c20220504__20220504_zjdPdCaKh9Rj">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 4, 2025, the Company entered in a one-year<span id="xdx_903_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20250504__us-gaap--TypeOfArrangementAxis__custom--NewOneYearOperatingLeaseAgreementMember_zkVYQzOHkvw" style="display: none">1</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lease agreement with North Horizon Pty Ltd., a related party, for a monthly rent of $<span id="xdx_901_eus-gaap--PaymentsForRent_uAUD_c20250504__20250504__us-gaap--TypeOfArrangementAxis__custom--NewOneYearOperatingLeaseAgreementMember_zn2yY17sooc8">3,300</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD or $<span id="xdx_909_eus-gaap--PaymentsForRent_uUSD_c20250504__20250504__us-gaap--TypeOfArrangementAxis__custom--NewOneYearOperatingLeaseAgreementMember_zmRGmbNe28wk">2,127</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD (depending on exchange rate) per month plus taxes with an option to renew the lease for an additional two-year<span id="xdx_900_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dtY_c20250504__us-gaap--TypeOfArrangementAxis__custom--NewOneYearOperatingLeaseAgreementMember_zDhyxXkN6rya" style="display: none">2</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">term. On May 4, 2025, the Company recorded right-of-use assets of $<span id="xdx_901_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20250504_zkYY0HQ08oN6">62,126</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and total lease liabilities of $<span id="xdx_907_eus-gaap--OperatingLeaseLiability_iI_c20250504_zrRgfwedQwul">62,126</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">based on an incremental borrowing rate of <span id="xdx_90D_ecustom--IncrementalBorrowingRate_pid_dp_uPure_c20250504__20250504_znaA6lWwW634">12</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_ecustom--ScheduleOfRightUseOfAssetTableTextBlock_zj0UShR93HY6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU is summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zbLKD5P0eRB2" style="display: none">SCHEDULE OF RIGHT OF USE ASSET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20251231_zs8675s4Vnag" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2025</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20250630_zYMI8mxt6mDl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--OperatingLeaseRightOfUseAssets_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maOLROUzZkA_zzip1vcMn6a2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Office lease</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">128,327</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">128,327</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--AccumulatedReduction_iNI_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_msOLROUzZkA_zg0eBZgFKURa" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: accumulated amortization</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(77,426</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,914</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseRightOfUseAsset_iTI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_mtOLROUzZkA_zEMAYsPmkPrf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Right-of-use asset, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,901</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59,413</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AE_zqQ1gwemEjVe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--OperatingLeaseLeaseIncomeTableTextBlock_z8fXR4DIlWF9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating Lease liabilities are summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zrHpRIHTx813" style="display: none">SCHEDULE OF OPERATING LEASE LIABILITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20251231_zaKel7a3s6rk" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2025</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20250630_zgP5BOKyi1ee" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_ecustom--OfficeLeaseLiability_iI_pp0p0_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zqRCYsMcTxPb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Office lease</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">128,327</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">128,327</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_ecustom--ReductionOfLeaseLiability_iNI_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zG4iDHKDK818" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Reduction of lease liability</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(71,474</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,914</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zTDdro2WTsnb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: office lease, current portion</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21,604</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17,664</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zdAzldx3RHMh" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Long term portion of lease liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,249</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,749</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A0_zz75Un7QlE8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z0NZ2TPdfVua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining future minimum lease payments under non-cancelable operating lease at December 31, 2025 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zwpJbwWpQt0l" style="display: none">SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_491_20251231_z8N9hreUkwYi" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_maLOLLPzcO8_z6gaZT96lZhb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fiscal Year 2026- remainder</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,421</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzcO8_z3iUoJajfbm2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fiscal Year 2027</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,952</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzcO8_ziS2CkGTaGr2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fiscal Year 2028</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,256</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--ReceivableWithImputedInterestNetAmount_iNI_di_msLOLLPzcO8_zn9xRTtRXbFd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Imputed interest</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,776</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzcO8_zfowa65A7Tkg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total operating lease liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">56,853</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A0_ztFncjR49O9f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average remaining lease term for the operating lease is <span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20251231_z5dvuRvssVzj">2.26</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years as of December 31, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> the Company was served with a complaint (the “Complaint”) filed in the Superior Court of the State Delaware by Helena Partners, Inc. (“Helena”). In the Complaint, Helena alleges breach of an engagement agreement dated August 3, 2025 (the “Engagement Agreement”) between the Company and Helena and argues that the Company owes Helena a $15,000 deal deposit fee for entering into the Engagement Agreement and a $250,000 break fee for not completing an equity financing with Helena. 10000 30000 0.02 0.05 52000 59508 40000 45775 0.02 30000 35145 5000 5000 5858 10000 11715 10000 11715 25837 30268 0.02 0.01 53200 53806 18200 18407 8000 8091 7000 7080 10000 10114 10000 10114 0 51468 0.001 1000000 4.00 30000 4.00 2026-02-15 2030-08-15 150000 535000 2500 2500 4336 P3Y 3000 2176 66201 66201 0.08 P1Y 3300 2127 P2Y 62126 62126 0.12 <p id="xdx_898_ecustom--ScheduleOfRightUseOfAssetTableTextBlock_zj0UShR93HY6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU is summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zbLKD5P0eRB2" style="display: none">SCHEDULE OF RIGHT OF USE ASSET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20251231_zs8675s4Vnag" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2025</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20250630_zYMI8mxt6mDl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--OperatingLeaseRightOfUseAssets_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maOLROUzZkA_zzip1vcMn6a2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Office lease</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">128,327</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">128,327</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--AccumulatedReduction_iNI_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_msOLROUzZkA_zg0eBZgFKURa" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: accumulated amortization</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(77,426</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,914</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseRightOfUseAsset_iTI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_mtOLROUzZkA_zEMAYsPmkPrf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Right-of-use asset, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,901</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59,413</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 128327 128327 77426 68914 50901 59413 <p id="xdx_89D_eus-gaap--OperatingLeaseLeaseIncomeTableTextBlock_z8fXR4DIlWF9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating Lease liabilities are summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zrHpRIHTx813" style="display: none">SCHEDULE OF OPERATING LEASE LIABILITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20251231_zaKel7a3s6rk" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2025</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20250630_zgP5BOKyi1ee" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_ecustom--OfficeLeaseLiability_iI_pp0p0_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zqRCYsMcTxPb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Office lease</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">128,327</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">128,327</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_ecustom--ReductionOfLeaseLiability_iNI_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zG4iDHKDK818" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Reduction of lease liability</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(71,474</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,914</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zTDdro2WTsnb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: office lease, current portion</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21,604</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17,664</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zdAzldx3RHMh" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Long term portion of lease liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,249</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,749</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 128327 128327 71474 68914 21604 17664 35249 41749 <p id="xdx_890_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z0NZ2TPdfVua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining future minimum lease payments under non-cancelable operating lease at December 31, 2025 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zwpJbwWpQt0l" style="display: none">SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_491_20251231_z8N9hreUkwYi" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_maLOLLPzcO8_z6gaZT96lZhb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fiscal Year 2026- remainder</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,421</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzcO8_z3iUoJajfbm2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fiscal Year 2027</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,952</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzcO8_ziS2CkGTaGr2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fiscal Year 2028</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,256</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--ReceivableWithImputedInterestNetAmount_iNI_di_msLOLLPzcO8_zn9xRTtRXbFd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Imputed interest</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,776</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzcO8_zfowa65A7Tkg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total operating lease liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">56,853</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 13421 27952 24256 8776 56853 P2Y3M3D <p id="xdx_80A_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zA6W2VjC8m98" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 – <span id="xdx_821_z0VaJ9waAf0k">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lease Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective May 5, 2016, the Company entered into an agreement for the lease of its principal executive offices with North Horizon Pty Ltd., a related party, of which Mr. Nathanielsz, our CEO, CFO and a director, and his wife are owners and directors. The lease had a <span id="xdx_903_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zfEM8Z8pvChk" style="display: none">5</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">five-year term and provided for annual rental payments of $<span id="xdx_90D_ecustom--OperatingLeasesRentExpenseMinimumRental_uAUD_c20160505__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zbXwxMQvpEQ8">39,600</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD or $<span id="xdx_900_ecustom--OperatingLeasesRentExpenseMinimumRental_c20160505__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zfGm5fNEhOk5">28,325</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD, which includes $<span id="xdx_90A_ecustom--GoodsAndServiceTax_uAUD_c20160505__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zvMCkSZtSUx7">3,600</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD or $<span id="xdx_90E_ecustom--GoodsAndServiceTax_c20160505__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_z6SylzKi5kci">2,575</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD of goods and service tax for total payments of $<span id="xdx_904_ecustom--OperatingLeaseFutureMinimumPaymentsDue_iI_uAUD_c20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NathanielszMember_zIYJ9RNhx7b7">198,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD or $<span id="xdx_901_ecustom--OperatingLeaseFutureMinimumPaymentsDue_iI_c20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NathanielszMember_zhzxVKq6nNRb">141,629</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD during the term of the lease. Such lease expired in May 2021 and was renewed for another one-year term from May 2021 to May 2022. On May 4, 2022, the Company entered into a <span id="xdx_905_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20220504__us-gaap--TypeOfArrangementAxis__custom--NewThreeYearOperatingLeaseAgreementMember_z9xMsugoZtOl" style="display: none">3</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">three-year lease agreement with North Horizon Pty Ltd. for a monthly rent of $<span id="xdx_906_eus-gaap--PaymentsForRent_uAUD_c20220504__20220504__us-gaap--TypeOfArrangementAxis__custom--ThreeYearOperatingLeaseAgreementMember__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_za4ghSMZoahg">3,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD or $<span id="xdx_905_eus-gaap--PaymentsForRent_c20220504__20220504__us-gaap--TypeOfArrangementAxis__custom--ThreeYearOperatingLeaseAgreementMember__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zypschaVsHKl">2,176</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD (depending on exchange rate) per month plus taxes. On May 4, 2025, the Company renewed for another one-year lease agreement with North Horizon Pty Ltd., a related party, for a monthly rent of $<span id="xdx_90D_eus-gaap--PaymentsForRent_uAUD_c20250504__20250504__us-gaap--TypeOfArrangementAxis__custom--OneYearOperatingLeaseAgreementMember__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zFsXHF0qbT7h">3,300</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD or $<span id="xdx_907_eus-gaap--PaymentsForRent_uUSD_c20250504__20250504__us-gaap--TypeOfArrangementAxis__custom--OneYearOperatingLeaseAgreementMember__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zjnMpzFkUF5l">2,127</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD (depending on exchange rate) per month plus taxes with an option to renew the lease for an additional two-year term (See Note 9). As of December 31, 2025 and June 30, 2025, total rent payable of $<span id="xdx_909_ecustom--RentPayable_iI_uAUD_c20251231_zBlgid8LDTQe">131,400</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_904_ecustom--RentPayable_iI_uUSD_c20251231_zXrRSSYOtMQ2">87,604</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) and $<span id="xdx_901_ecustom--RentPayable_iI_uAUD_c20250630_zqvX9WS0YDK2">200,402</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_903_ecustom--RentPayable_iI_uUSD_c20250630_ztglf86WOHRb">131,684</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD), respectively, was included in accrued expenses in the accompanying condensed consolidated balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent expense under the lease was $<span id="xdx_90F_eus-gaap--PaymentsForRent_c20251001__20251231_zoNf0Nb6bRmk">6,600</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_904_eus-gaap--PaymentsForRent_c20241001__20241231_zJKdsy7FVn2i">5,401</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">during the three months ended December 31, 2025 and 2024, respectively, and $<span id="xdx_904_eus-gaap--PaymentsForRent_c20250701__20251231_zxFTIh2nENM2">21,389</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90E_eus-gaap--PaymentsForRent_c20240701__20241231_zXoI0yhRPRV9">13,718</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">during the six months ended December 31, 2025 and 2024, respectively reflected as occupancy expenses in the accompanying condensed consolidated statements of operations and comprehensive income (loss).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loans payable - Related Party</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between July 3, 2025 and August 14, 2025, an institutional investor affiliated with one of our directors, Josef Zelinger, loaned the Company an aggregate of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20250814__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zoykjK7dH95f">120,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20250814__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zW55SjmI86Vd">78,249</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD). These loans bore no interest and were payable on demand (see Note 5).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 21, 2025, the Company fully repaid certain loans payable to a related party with loan dates from December 2024 to August 2025 with aggregate principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_uAUD_c20250821__20250821__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z84dQAAluRG7">235,188</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_90E_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_uUSD_c20250821__20250821__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zsEHLTras1Rk">150,808</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD), and accrued interest of $<span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPaymentInterest_uAUD_c20250821__20250821__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zbWjvwFT8urk">6,205</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPaymentInterest_uUSD_c20250821__20250821__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zPWfvGScmR7j">3,994</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) (see Note 5).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total remaining balance of all the loans payable – related parties, net of discount amounted to $<span id="xdx_907_eus-gaap--LoansPayableCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zIO8JFCjeLMi">472,083</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90A_eus-gaap--LoansPayableCurrent_iI_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zNyR430DKEL8">415,329</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2025 and June 30, 2025, respectively. The total principal outstanding under loan payable – long term - related party, net of discount, was $<span id="xdx_901_eus-gaap--LongTermLoansPayable_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zuys6um2X7b7">0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_903_eus-gaap--LongTermLoansPayable_iI_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zTTma8BI5r1c">105,627</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2025 and June 30, 2025 (see Note 5).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employment and Services Agreements with Management</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and Mr. Nathanielsz entered into an employment agreement as of February 25, 2015 (the “Nathanielsz Employment Agreement”) setting forth the terms and conditions of Mr. Nathanielsz’s employment as the Company’s President and Chief Executive Officer. The Nathanielsz Employment Agreement was scheduled to expire on <span id="xdx_901_eus-gaap--RelatedPartyTransactionDate_dd_c20150225__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zv4p6ed4vzQl">February 25, 2019</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">; however, the term of the Nathanielsz Employment Agreement automatically renews for successive one-year periods unless either party provides 30 days’ prior written notice of his or its intent not to renew. The Nathanielsz Employment Agreement continues in effect as amended on October 26, 2022 (see below). The Nathanielsz Employment Agreement provides Mr. Nathanielsz with a base salary of $<span id="xdx_906_ecustom--BaseSalaryPerMonth_uAUD_c20150225__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zdLtT12FPDS5">25,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD per month ($<span id="xdx_900_eus-gaap--SalariesAndWages_uAUD_c20150225__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zdYLZwIsj0Dd">300,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD annually or $<span id="xdx_908_eus-gaap--SalariesAndWages_c20150225__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zTpmGksCcZDe">205,680</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) and a monthly contribution to Mr. Nathanielsz’s pension equal to <span id="xdx_90A_ecustom--PercentageOfPensionOfMonthlySalary_pid_dp_uPure_c20150225__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zw2rEfYMy79b">9.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of his monthly salary. Mr. Nathanielsz has the ability to convert any accrued but unpaid salary into common stock at the end of each fiscal year at a conversion price to be determined by Mr. Nathanielsz and the Company, which will in no event be lower than par value or higher than the closing bid price on the date of conversion. Pursuant to the Nathanielsz Employment Agreement, Mr. Nathanielsz is entitled to an annual discretionary bonus in an amount up to <span id="xdx_907_ecustom--PercentageOfBonusOfAnnualBaseSalary_pid_dp_c20150225__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_zdqHWAyDnt66">200</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of his annual base salary, which bonus shall be determined by the Company’s board of directors based upon the performance of the Company. On March 16, 2018, the Company’s board of directors approved an increase of Mr. Nathanielsz’s annual base salary from $<span id="xdx_90A_eus-gaap--SalariesAndWages_uAUD_c20180316__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember_zrKF0UctaNCi">300,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_909_eus-gaap--SalariesAndWages_c20180316__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember_zJa3FD0DCG16">205,680</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) to $<span id="xdx_90D_eus-gaap--SalariesAndWages_uAUD_c20180316__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_zuFR0lAr4pOh">400,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_90B_eus-gaap--SalariesAndWages_c20180316__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_z8BgKIVhzIUa">274,240</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD), effective February 2018. On August 1, 2022, the Company’s board of directors approved an increase of Mr. Nathanielsz’s annual base salary from $<span id="xdx_90A_eus-gaap--SalariesAndWages_uAUD_c20220801__20220801__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember_zDCQicQon9df">400,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_900_eus-gaap--SalariesAndWages_c20220801__20220801__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember_zAjupc81PXkc">309,313</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) to $<span id="xdx_903_eus-gaap--SalariesAndWages_uAUD_c20220801__20220801__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_zacUmlUJi4pi">600,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_90B_eus-gaap--SalariesAndWages_c20220801__20220801__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_zVWfRe1dkvv3">414,900</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD), effective July 1, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Nathanielsz’s wife, Sylvia Nathanielsz, is and has been a non-executive, part-time employee of the Company since October 2015. Effective February 1, 2018, Mrs. Nathanielsz receives an annual salary of $<span id="xdx_905_eus-gaap--SalariesAndWages_uAUD_c20180201__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_zx48DDwzphu4">120,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_909_eus-gaap--SalariesAndWages_c20180201__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_zAd2GNpQU3va">80,904</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) and is entitled to customary benefits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 12, 2021, the Board approved a bonus of $<span id="xdx_902_eus-gaap--OfficersCompensation_c20210812__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zD8sPF7s9GP6">177,840</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD. A total of $<span id="xdx_90D_eus-gaap--PaymentsToEmployees_uAUD_c20200701__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zwuY92GWRUXb">221,890</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_90C_eus-gaap--PaymentsToEmployees_c20200701__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zhYqDmapPp24">166,418</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) in payments were made against the bonuses during the year ended June 30, 2021 resulting in a remaining balance of $<span id="xdx_901_ecustom--BonusPayable_iI_pp0p0_uAUD_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_z0qQP4bTOI14">422,610</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_90F_ecustom--BonusPayable_iI_pp0p0_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zmW70CDXIDwh">316,957</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) bonus payable as of June 30, 2021 which was included in accrued expenses in the accompanying consolidated balance sheet. On August 12, 2021, pursuant to the Cancellation Agreement, Mr. Nathanielsz agreed to cancel $<span id="xdx_90F_eus-gaap--DebtConversionOriginalDebtAmount1_c20210812__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zCSMdN8LhxLd">177,840</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the bonus payable in exchange for <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210812__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zZzPhJBmhEej">99</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company’s Common Stock. On August 1, 2022, the Board approved a bonus of $<span id="xdx_900_eus-gaap--OfficersCompensation_uAUD_c20220801__20220801__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_z6jSFOSvrpN4">140,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD or $<span id="xdx_90D_eus-gaap--OfficersCompensation_c20220801__20220801__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zgClw2oCDvU">96,810</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD. A total of $<span id="xdx_901_eus-gaap--PaymentsToEmployees_uAUD_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_z9ny96guOWNg">25,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_902_eus-gaap--PaymentsToEmployees_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zQZqOzONCDJ9">16,070</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) in payments were made in respect of the bonuses during fiscal year 2024. In January 2024, the Board approved a bonus of $<span id="xdx_90A_eus-gaap--OfficersCompensation_uAUD_c20240101__20240131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zkAVdKf960wf">150,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD or $<span id="xdx_900_eus-gaap--OfficersCompensation_c20240101__20240131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_z0H6rniwDcNc">102,195</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD resulting in a remaining balance of $<span id="xdx_907_ecustom--BonusPayable_iI_pp0p0_uAUD_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zClp1kPCLRe9">217,540</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_902_ecustom--BonusPayable_iI_pp0p0_uUSD_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zVLzbbrTPZul">141,118</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) bonus payable as of June 30, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2025, the Board approved a bonus of $<span id="xdx_908_eus-gaap--OfficersCompensation_uAUD_c20250601__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zve1FC6J7Cn7">198,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD or $<span id="xdx_903_eus-gaap--OfficersCompensation_c20250601__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zIY31sPSjKi3">130,106</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD resulting in a remaining balance of $<span id="xdx_90A_ecustom--BonusPayable_iI_pp0p0_uAUD_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zmSIDq5OJ6q3">415,540</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_90A_ecustom--BonusPayable_iI_pp0p0_uUSD_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zKdgyrTAwINb">273,051</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) bonus payable as of June 30, 2025. A total bonus payments of $<span id="xdx_905_ecustom--BonusPayable_iI_pp0p0_uAUD_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zu8C2tx8eWCi">70,214</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_909_ecustom--BonusPayable_iI_pp0p0_uUSD_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_znq0jTvCpa6a">45,787</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) were made during the six months ended December 31, 2025 resulting in a remaining balance of $<span id="xdx_90D_ecustom--RemainingBalanceOfBonusPayable_iI_pp0p0_uAUD_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_z9vvT42cL1R4">345,389</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_901_ecustom--RemainingBalanceOfBonusPayable_iI_pp0p0_uUSD_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zM2uzdgORNi">230,271</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) bonus payable as of December 31, 2025 which was included in accrued expenses in the accompanying condensed consolidated balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Amended and Restated Employment Agreement</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 14, 2019 (the “Effective Date”), the Company entered into an Amended and Restated Employment Agreement (the “Employment Agreement”) with Mr. Nathanielsz for a term of <span id="xdx_905_ecustom--AgreementTerm_dc_c20190514__20190514__us-gaap--TypeOfArrangementAxis__custom--AmendedAndRestatedEmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zUUegL0YSXmc">three years</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, subject to automatic one-year renewals, at an annual salary of $<span id="xdx_90B_eus-gaap--SalariesAndWages_uAUD_c20190514__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zuzWSvWE6as9">400,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_90F_eus-gaap--SalariesAndWages_c20190514__20190514__us-gaap--TypeOfArrangementAxis__custom--AmendedAndRestatedEmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zOkpPS7mIKZ2">309,313</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD). Pursuant to the Employment Agreement, Mr. Nathanielsz was granted options to purchase a de minimis share of common stock (the “Nathanielsz Options”), de minimis restricted stock units of the Company (the “Initial Nathanielsz RSUs”), and an additional de minimis restricted stock units of the Company (the “Additional Nathanielsz RSUs”). Such options and restricted stock units were granted pursuant to the 2019 Plan approved by the Board on the Effective Date. The Nathanielsz Options have a term of <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20190514__20190514__us-gaap--TypeOfArrangementAxis__custom--AmendedAndRestatedEmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zgj6nsFGyjbi">10</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years from the date of grant. The Nathanielsz Options and Additional Nathanielsz RSU’s are subject to vesting periods pursuant to the Employment Agreement. There are de minimis vested options and restricted stock units that are considered issuable as of December 31, 2025 and June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 26, 2022, the Company entered into an Amended and Restated Employment Agreement (the “Amended Agreement”) with Mr. Nathanielsz, effective as of July 1, 2022, (the “2022 Effective Date”). The Amended Agreement provides Mr. Nathanielsz with a base salary of $<span id="xdx_904_eus-gaap--SalariesAndWages_uAUD_c20221026__20221026__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zBfTxrFn4AG3">600,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_905_eus-gaap--SalariesAndWages_c20221026__20221026__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zMCOhHCwz8Al">414,900</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) per annum. The Company has also agreed to pay Mr. Nathanielsz an annual discretionary bonus in an amount up to <span id="xdx_90A_ecustom--PercentageOfBonusOfAnnualBaseSalary_pid_dp_uPure_c20221026__20221026__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember_zeWwnMgwAxr3">100</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of his annual base salary, reduced from <span id="xdx_90A_ecustom--PercentageOfBonusOfAnnualBaseSalary_pid_dp_uPure_c20221026__20221026__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_zzSgKaCU0sdd">200</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, which bonus shall be determined by the Board and based upon the performance of the Company. The Amended Agreement has a term of three (3) years from the 2022 Effective Date, with automatic one-year renewal periods unless either party elects not to renew.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Amended and Restated Employment Agreement</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 14, 2019, the Company entered into an Amended and Restated Services Agreement (the “Services Agreement”) with Dr. Kenyon, the Company’s Chief Scientific Officer and a director, for a term of <span id="xdx_907_ecustom--AgreementTerm_dc_c20190514__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zhpmeOLrDbqc">three years</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, subject to automatic one-year renewals, at an annual salary of $<span id="xdx_90F_eus-gaap--SalariesAndWages_uAUD_c20190514__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zbbMRceIrUK9">54,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_90A_eus-gaap--SalariesAndWages_c20190514__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zixLwAR3m3y6">41,580</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD). In connection with the execution of the Services Agreement, Dr. Kenyon was designated as an executive officer of the Company and assumed a more active executive role with the Company. Pursuant to the Services Agreement, Dr. Kenyon was granted options to purchase a de minimis share of common stock (the “Kenyon Options”), a de minimis restricted stock units of the Company (the “Initial Kenyon RSUs”), and an additional de minimis restricted stock units of the Company (the “Additional Kenyon RSUs”). Such options and restricted stock units were granted pursuant to the 2019 Plan. The Kenyon Options have a term of <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20190514__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zPD4w4JxB98c">10</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years from the date of grant. The Kenyon Options and Additional Kenyon RSU’s are subject to vesting periods pursuant to the Services Agreement. There are de minimis vested options and restricted stock units that are considered issuable as of December 31, 2025 and June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Starting October 1, 2025, the Company agreed to pay Dr. Kenyon an annual director’s fee of $<span id="xdx_90C_eus-gaap--AdministrativeFeePayable_iI_uAUD_c20251001__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_znKA8ltYCzT2">45,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2025 and June 30, 2025, total accrued salaries of $<span id="xdx_903_eus-gaap--AccruedSalariesCurrent_iI_uAUD_c20251231_zA8icaEoZZt7">222,813</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_90C_eus-gaap--AccruedSalariesCurrent_iI_uUSD_c20251231_zMMtXKgWLsqh">148,549</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD) and $<span id="xdx_90C_eus-gaap--AccruedSalariesCurrent_iI_uAUD_c20250630_zFw7wYPqvQNl">202,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD ($<span id="xdx_90D_eus-gaap--AccruedSalariesCurrent_iI_c20250630_zXoEP2he4GP8">132,734</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD), respectively, were included in accrued expenses in the accompanying condensed consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Employee Benefit Liability</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2025 and June 30, 2025, total employee benefit liability of $<span id="xdx_907_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_c20251231_zGu3QKuRsRMa">703,190</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_904_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_c20250630_zymjvaxakR5h">667,901</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, consist of unpaid or unused annual leave and long service leave by Mr. Nathanielsz and Sylvia Nathanielsz, as reflected in the accompanying condensed consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Intercompany Loans</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All intercompany loans were made by the parent to the Company’s subsidiary, Propanc PTY LTD, none of which has been repaid as of December 31, 2025. Effective fiscal year 2021, the parent company determined that intercompany loans will not be repaid in the foreseeable future and thus, per ASC 830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment on the condensed consolidated balance sheet as accumulated other comprehensive income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P5Y 39600 28325 3600 2575 198000 141629 P3Y 3000 2176 3300 2127 131400 87604 200402 131684 6600 5401 21389 13718 120000 78249 235188 150808 6205 3994 472083 415329 0 105627 2019-02-25 25000 300000 205680 0.095 2 300000 205680 400000 274240 400000 309313 600000 414900 120000 80904 177840 221890 166418 422610 316957 177840 99 140000 96810 25000 16070 150000 102195 217540 141118 198000 130106 415540 273051 70214 45787 345389 230271 P3Y 400000 309313 P10Y 600000 414900 1 2 P3Y 54000 41580 P10Y 45000 222813 148549 202000 132734 703190 667901 <p id="xdx_806_eus-gaap--ConcentrationRiskDisclosureTextBlock_zd3j1HCDah1d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 – <span id="xdx_82D_zwvlA2T2P172">CONCENTRATIONS AND RISKS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Concentration of Credit Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in banks and financial institutions in Australia. Bank deposits in Australian banks are uninsured. The Company has not experienced any losses in such accounts through December 31, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company primarily relied on funding from one convertible and two non-convertible debt lenders and received net proceeds after deductions of $<span id="xdx_901_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_c20250701__20251231_z9HAJpqttSEg">19,850</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for original issue discounts and debt issue costs during the six months ended December 31, 2025 from each of the three lenders of $<span id="xdx_906_eus-gaap--ProceedsFromConvertibleDebt_c20250701__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_zYLkuyR9EAR">100,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, $<span id="xdx_906_eus-gaap--ProceedsFromConvertibleDebt_c20250701__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zYISDMN99vJ4">75,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and $<span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_c20250701__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderThreeMember_z8fUzfkDywva">78,249</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively which represents approximately <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20250701__20251231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleAndNonconvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderOneMember_zqXvLnh83vR4">39</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20250701__20251231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleAndNonconvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderTwoMember_zsJk9RDdn1g">30</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20250701__20251231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleAndNonconvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderThreeMember_zz8NMSX8Cp2c">31</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, respectively of total proceeds received by the Company during the six months ended December 31, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company primarily relied on funding from one convertible and two non-convertible debt lenders and received net proceeds after deductions of $<span id="xdx_90A_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_c20240701__20241231_zwG5oVxyEqY6">16,200</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for original issue discounts and debt issue costs during the six months ended December 31, 2024 from each of the four lenders of $<span id="xdx_90D_eus-gaap--ProceedsFromConvertibleDebt_c20240701__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_zXPjW5FeZ87f">60,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, $<span id="xdx_908_eus-gaap--ProceedsFromConvertibleDebt_c20240701__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zfez4jcDzEq1">35,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, $<span id="xdx_90A_eus-gaap--ProceedsFromConvertibleDebt_c20240701__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderThreeMember_zIjbwAFoJst5">180,855</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20240701__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderFourMember_zfNHz19rN9ag">98,060</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively which represents approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20241231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleAndNonconvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderOneMember_z81yJIdDj6h8">18</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20241231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleAndNonconvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderTwoMember_zx0TjX6O0hV">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20241231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleAndNonconvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderThreeMember_z6H0Ixa1mY4d">53</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20241231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleAndNonconvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderFourMember_zlvRfesP6U04">29</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, respectively of total proceeds received by the Company during the six months ended December 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Receivable Concentration</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2025 and June 30, 2025, the Company’s receivables were <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--ReceivableMember_z8uNREZoWDA9">100</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% related to reimbursements on GST taxes paid.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Patent and Patent Concentration</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has filed multiple patent applications relating to its lead product, PRP. The Company’s lead patent application has been granted and remains in force in the United States, Belgium, Czech Republic, Denmark, France, Germany, Ireland, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Liechtenstein, Turkey, United Kingdom, Australia, China, Japan, Indonesia, Israel, New Zealand, Singapore, Malaysia, South Africa, Republic of Korea, India and Brazil. In Canada and Mexico, the patent applications have been accepted as of fiscal year 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2016 and early 2017, the Company filed other patent applications. Three applications were filed under the Patent Cooperation Treaty (the “PCT”). The PCT assists applicants in seeking patent protection by filing one international patent application under the PCT, applicants can simultaneously seek protection for an invention in over 150 countries. Once filed, the application is placed under the control of the national or regional patent offices, as applicable, in what is called the national phase. One of the PCT applications filed in November 2016, entered national phase in July 2018 and another PCT application entered national phase in August 2018. A third PCT application entered the national phase in October 2018.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2020, a world-first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 85 granted, allowed, or accepted patents and 7 patents filed, or under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering the lead product candidate PRP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further patent applications are expected to be filed to capture and protect additional patentable subject matter based on the Company’s field of technology relating to pharmaceutical compositions of proenzymes for treating cancer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign Operations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2025 and June 30, 2025, the Company’s operations are based in Camberwell, Australia; however, the majority of research and development is being conducted in the European Union.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 22, 2016, the Company formed a wholly-owned subsidiary, Propanc (UK) Limited under the laws of England and Wales, for the purpose of submitting an orphan drug application with the European Medicines Agency as a small and medium-sized enterprise. As of December 31, 2025, there has been no activity within this entity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 19850 100000 75000 78249 0.39 0.30 0.31 16200 60000 35000 180855 98060 0.18 0.10 0.53 0.29 1 <p id="xdx_80B_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zD5i7lBUXnbf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 - <span id="xdx_821_zovP73s0H3K1">DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Derivative Financial Instruments:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applies the provisions of ASC 815-40, <i>Contracts in Entity’s Own Equity</i>, under which convertible instruments and warrants, which contain terms that protect holders from declines in the stock price (reset provisions), may not be exempt from derivative accounting treatment. As a result, warrants and embedded conversion options in convertible debt are recorded as a liability and are revalued at fair value at each reporting date. If the fair value of the warrants exceeds the face value of the related debt, the excess is recorded as change in fair value in operations on the issuance date. The Company had $<span id="xdx_900_eus-gaap--ConvertibleDebt_iI_c20251231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_zIWBFQfE51b8">55,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1 note) and $<span id="xdx_90A_eus-gaap--ConvertibleDebt_iI_c20250630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_zeW7Sjn4SKl5">291,650</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9 notes) of convertible debt, which were treated as derivative instruments outstanding at December 31, 2025 and June 30, 2025, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company calculates the estimated fair values of the liabilities for derivative instruments using the Binomial Trees Method. The closing price of the Company’s common stock at December 31, 2025, the last trading day of the period ended December 31, 2025, was $<span id="xdx_90D_eus-gaap--SharePrice_iI_c20251231_zhhvHLH5vukb">0.54</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The volatility, expected remaining term and risk-free interest rates used to estimate the fair value of derivative liabilities at December 31, 2025 are indicated in the table that follows. The expected term is equal to the remaining term of the warrants or convertible instruments and the risk-free rate is based upon rates for treasury securities with the same term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Convertible Debt</b></span></p> <p id="xdx_895_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z18tnjaVcWe8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zKAnOSUtgj08" style="display: none">SCHEDULE OF FAIR VALUE MEASUREMENTS OF CONVERTIBLE DEBT VALUATION TECHNIQUES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial Valuations<br/> (on new derivative<br/> instruments entered</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>into during the three<br/> months ended<br/> December 31, 2025)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Volatility</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zqAIUpQh8sJ1" style="font-family: Times New Roman, Times, Serif" title="Volatility"><span style="-sec-ix-hidden: xdx2ixbrl2184">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zfnmVVHvF3di" style="font-family: Times New Roman, Times, Serif" title="Volatility">413</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected Remaining Term (in years)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span id="xdx_90E_eus-gaap--DebtInstrumentTerm_dtY_c20240701__20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_ziCb1Rpt0u7k" style="font-family: Times New Roman, Times, Serif" title="Expected remaining term">0.002</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk Free Interest Rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zujhSf50mvu4" style="font-family: Times New Roman, Times, Serif" title="Risk free Interest rate"><span style="-sec-ix-hidden: xdx2ixbrl2190">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span id="xdx_904_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z8cisaJPdJA2" style="font-family: Times New Roman, Times, Serif" title="Risk free Interest rate">4.40</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A2_zJ21Igzboxz3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair Value Measurements:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable warrants and embedded conversion options have been recorded as determined utilizing the Binomial Trees model. The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis As of December 31, 2025 and June 30, 2025:</span></p> <p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zwJVryj560V5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zlgZFb14ddc7">SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20251231_zXs2HigJrezl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance at<br/> December 31, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZ11gkAd1vml" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Markets for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identical<br/> Assets</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zCAoflUPihP8" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable<br/> Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zj9gdxnAItVk" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 1)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 2)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 3)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--WarrantLiability_iI_z1FW17p6Fjrg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrant liability</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">288,635</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2197">—</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2198">—</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">288,635</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_zHGnrOham9rk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Embedded conversion option liabilities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2202">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2203">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DerivativeLiabilities_iI_zlKruLgBOri7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">320,763</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2207">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2208">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">320,763</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20250630_zQvlbXh6AMe4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance at<br/> June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2qfiv5nSqwk" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Markets for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identical<br/> Assets</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zSqnEVoVquo9" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable<br/> Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49B_20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp3NdLeU8XHa" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 1)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 2)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 3)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_zpXFjSfaLMd6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Embedded conversion option liabilities</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2212">—</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2213">—</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DerivativeLiabilities_iI_zbFOtUVABxm5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2217">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2218">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A6_z8i7kUsBW23b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zAZsGkKCPDkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a roll forward for the six months ended December 31, 2025 of the fair value liability of price adjustable derivative instruments:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: justify; text-indent: 0.5in; background-color: White"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zRMNf7LtMTt2" style="display: none">SCHEDULE OF FAIR VALUE LIABILITY OF PRICE ADJUSTABLE DERIVATIVE INSTRUMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Fair Value of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liability for</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Derivative</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Instruments</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance at June 30, 2025</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--DerivativeLiabilities_iS_c20250701__20251231__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_z5yFBCqXPA76" style="width: 16%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on debt extinguishment</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20250701__20251231__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zQAouCzRXe15" style="text-align: right" title="Gain on debt extinguishment"><span style="font-family: Times New Roman, Times, Serif">(303,742</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value included in statements of operations</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20250701__20251231__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zMrFEkxmCd5b" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value included in statements of operations"><span style="font-family: Times New Roman, Times, Serif">(68,022</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--DerivativeLiabilities_iE_c20250701__20251231__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_z70wMH5Pfqwl" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif">32,128</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A5_z2xnGHTPAwDg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_ecustom--ScheduleOfWarrantLiabilitiesAtFairValueTableTextBlock_zxgslZhidemk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth a summary of the changes in the fair value of the Level 3 warrant liability for the six months ended December 31, 2025:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zZY4QpALYoQ4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY OF THE CHANGES IN THE FAIR VALUE OF THE LEVEL 3 WARRANT LIABILITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrant<br/> Liability</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Fair value as of June 30, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iS_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zG7ZmZQQ9Zgi" style="text-align: right" title="Initial valuation of warrant liability"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2233">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Initial fair value of warrant liability upon issuance</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--InitialFairValueOfWarrantLiabilityUponIssuance_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z9AFOnLEEqCa" style="width: 16%; text-align: right" title="Initial fair valuation of warrant liability"><span style="font-family: Times New Roman, Times, Serif">882,345</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of warrant liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--FairValueAdjustmentOfWarrants_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYN0bIribrg2" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value of warrant liability"><span style="font-family: Times New Roman, Times, Serif">(593,710</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair value as of December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstanding_iE_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z00ULDuhmDe7" style="border-bottom: Black 2.5pt double; text-align: right" title="Initial valuation of warrant liability"><span style="font-family: Times New Roman, Times, Serif">288,635</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AA_zdalSVlxUqX5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 55000 291650 0.54 <p id="xdx_895_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z18tnjaVcWe8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zKAnOSUtgj08" style="display: none">SCHEDULE OF FAIR VALUE MEASUREMENTS OF CONVERTIBLE DEBT VALUATION TECHNIQUES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial Valuations<br/> (on new derivative<br/> instruments entered</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>into during the three<br/> months ended<br/> December 31, 2025)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Volatility</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zqAIUpQh8sJ1" style="font-family: Times New Roman, Times, Serif" title="Volatility"><span style="-sec-ix-hidden: xdx2ixbrl2184">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zfnmVVHvF3di" style="font-family: Times New Roman, Times, Serif" title="Volatility">413</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected Remaining Term (in years)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span id="xdx_90E_eus-gaap--DebtInstrumentTerm_dtY_c20240701__20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_ziCb1Rpt0u7k" style="font-family: Times New Roman, Times, Serif" title="Expected remaining term">0.002</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk Free Interest Rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span id="xdx_90D_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zujhSf50mvu4" style="font-family: Times New Roman, Times, Serif" title="Risk free Interest rate"><span style="-sec-ix-hidden: xdx2ixbrl2190">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span id="xdx_904_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20241231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z8cisaJPdJA2" style="font-family: Times New Roman, Times, Serif" title="Risk free Interest rate">4.40</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 413 P0Y 4.40 <p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zwJVryj560V5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zlgZFb14ddc7">SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20251231_zXs2HigJrezl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance at<br/> December 31, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZ11gkAd1vml" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Markets for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identical<br/> Assets</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zCAoflUPihP8" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable<br/> Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zj9gdxnAItVk" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 1)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 2)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 3)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--WarrantLiability_iI_z1FW17p6Fjrg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrant liability</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">288,635</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2197">—</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2198">—</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">288,635</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_zHGnrOham9rk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Embedded conversion option liabilities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2202">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2203">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,128</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DerivativeLiabilities_iI_zlKruLgBOri7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">320,763</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2207">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2208">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">320,763</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> December 31, 2025 <br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20250630_zQvlbXh6AMe4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance at<br/> June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2qfiv5nSqwk" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Markets for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identical<br/> Assets</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zSqnEVoVquo9" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable<br/> Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49B_20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp3NdLeU8XHa" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 1)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 2)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 3)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_zpXFjSfaLMd6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Embedded conversion option liabilities</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2212">—</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2213">—</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DerivativeLiabilities_iI_zbFOtUVABxm5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2217">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2218">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 288635 288635 32128 32128 320763 320763 403892 403892 403892 403892 <p id="xdx_890_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zAZsGkKCPDkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a roll forward for the six months ended December 31, 2025 of the fair value liability of price adjustable derivative instruments:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: justify; text-indent: 0.5in; background-color: White"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zRMNf7LtMTt2" style="display: none">SCHEDULE OF FAIR VALUE LIABILITY OF PRICE ADJUSTABLE DERIVATIVE INSTRUMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Fair Value of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liability for</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Derivative</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Instruments</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance at June 30, 2025</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--DerivativeLiabilities_iS_c20250701__20251231__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_z5yFBCqXPA76" style="width: 16%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on debt extinguishment</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20250701__20251231__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zQAouCzRXe15" style="text-align: right" title="Gain on debt extinguishment"><span style="font-family: Times New Roman, Times, Serif">(303,742</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value included in statements of operations</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20250701__20251231__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zMrFEkxmCd5b" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value included in statements of operations"><span style="font-family: Times New Roman, Times, Serif">(68,022</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance at December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--DerivativeLiabilities_iE_c20250701__20251231__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_z70wMH5Pfqwl" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif">32,128</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 403892 -303742 68022 32128 <p id="xdx_89D_ecustom--ScheduleOfWarrantLiabilitiesAtFairValueTableTextBlock_zxgslZhidemk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth a summary of the changes in the fair value of the Level 3 warrant liability for the six months ended December 31, 2025:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zZY4QpALYoQ4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY OF THE CHANGES IN THE FAIR VALUE OF THE LEVEL 3 WARRANT LIABILITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrant<br/> Liability</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Fair value as of June 30, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iS_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zG7ZmZQQ9Zgi" style="text-align: right" title="Initial valuation of warrant liability"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2233">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Initial fair value of warrant liability upon issuance</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--InitialFairValueOfWarrantLiabilityUponIssuance_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z9AFOnLEEqCa" style="width: 16%; text-align: right" title="Initial fair valuation of warrant liability"><span style="font-family: Times New Roman, Times, Serif">882,345</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of warrant liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--FairValueAdjustmentOfWarrants_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYN0bIribrg2" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value of warrant liability"><span style="font-family: Times New Roman, Times, Serif">(593,710</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair value as of December 31, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstanding_iE_c20250701__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z00ULDuhmDe7" style="border-bottom: Black 2.5pt double; text-align: right" title="Initial valuation of warrant liability"><span style="font-family: Times New Roman, Times, Serif">288,635</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 882345 -593710 288635 <p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zwBhpCASCjT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 – <span id="xdx_823_zLjeTSJ41g3l">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares issued for conversion of Series C Preferred stock</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2026, the Company issued an aggregate of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zKkHkhSvhzb1">2,000,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock as a result of the conversion of <span id="xdx_907_eus-gaap--ConversionOfStockSharesConverted1_c20260101__20260131__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4wyoUbJVn4h">50</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series C Preferred stock during such period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares issued for exercise of Series C Warrants</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2026, the Company received aggregate gross proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromWarrantExercises_c20260201__20260228__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPm5rSMdMfTc">500,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">from the exercise of approximately <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20260228__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhJt8l1ulBQ9">50</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series C Warrants with an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260228__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8lQ5vv5y1F8">10,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and issued <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_pid_c20260228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1wUBMXdquz">50</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series C preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares issued for services </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2026, the Company issued an aggregate of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260101__20260131__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPqF1HxdYoki">14,805</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock for services rendered and to be rendered from December 26, 2025 to March 26, 2026 in connection with the Advisory agreement dated on September 25, 2025 (see Note 9).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares issued in connection with an Exchange Agreement </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 7, 2026, the Company entered into an Exchange Agreement with Crown Bridge (see Note 5) and issued <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260107__20260107__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zgBJYYCuwdAk">394,788</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock in exchange for the total outstanding loan balance of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20260107__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zlqC1tIuM765">65,280</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accrued interest of $<span id="xdx_907_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20260107__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztsvf5FFkIz9">60,484</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Those shares were valued at approximately $<span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20260107__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zU6zFJfKUAm3">0.51</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share or $<span id="xdx_909_eus-gaap--CommonStockValue_iI_c20260107__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zATUFnu24HEi">200,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, being the closing price of the stock on the date of grant, resulting in a loss on extinguishment of debt at the time of exchange of $<span id="xdx_90C_eus-gaap--GainsLossesOnExtinguishmentOfDebt_iN_di_c20260107__20260107__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zgtewbFublp">74,236</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> 2000000 50 500000 50 10000 50 14805 394788 65280 60484 0.51 200000 -74236 12088 21085 5302 2950 8334046 1380 1406 8352816 25441 291773 27117 10925835 1971 2008 59413 17799 19631808 72365 1249596 1213335 1486550 792190 190795 94612 65280 145091 415329 71629 543312 204694 537921 399325 17664 19362 403892 133886 29759 49528 49528 667901 639371 5578240 3792782 105627 58642 41749 147376 58642 5725616 3851424 1500005 1500005 0.01 0.01 0.01 0.01 5 5 1 1 1 1 0.001 0.001 10000000000 10000000000 11611782 11611782 7980 7980 11612 8 7750 0 8 138243652 61696049 1318917 1269581 -125621520 -66698220 0.001 0.001 46477 46477 13906192 -3779059 19631808 72365 57027850 1253797 26560 34150 223721 248102 57278131 1536049 -57278131 -1536049 563757 665841 9 60 333596 141012 212450 316537 -871032 54565 -89243 22080 -1645169 -413611 -58923300 -1949660 -129132 -58923300 -1820528 192960 -58923300 -2013488 -14.85 -14.85 -1420.53 -1420.53 3968176 3968176 1417 1417 -58923300 -2013488 49336 -25295 49336 -25295 -58873964 -2038783 1 101 27 60319154 -64684732 1294876 -46477 -3117179 7432 8 773540 773548 315 23057 23057 105 27 -27 246254 246254 141084 141084 192960 -192960 -25295 -25295 -1820528 -1820528 1 7980 8 61696049 -66698220 1269581 -46477 -3779059 1 7980 8 61696049 -66698220 1269581 -46477 -3779059 8826 9 176366 176375 8555750 8556 51339444 51348000 2025000 2025 23879085 23881110 111000 111 7750 8 1143382 1143501 900000 900 -900 10229 10229 3226 3 -3 49336 49336 -58923300 -58923300 -58923300 -58923300 1 11611782 11612 7750 8 138243652 -125621520 1318917 -46477 13906192 1 11611782 11612 7750 8 138243652 -125621520 1318917 -46477 13906192 -58923300 -1820528 51348000 4621230 -89243 22080 297 120958 303563 294005 20187 21359 212450 316537 333596 141012 -871032 54565 5519 3832 -279711 2405 71 -1379 -4746 120958 25000 187732 242408 40184 49196 677889 209962 255155 78733 -21722 -21598 -405168 -935118 222500 567050 8000 142909 122788 23057 320000 190000 79811 343700 224885 264656 490756 941894 -94585 4262 -8997 11038 21085 10047 12088 21085 30715 9491 10229 246254 79686 560483 129354 74395 86248 222500 150000 62126 141084 19259880 192960 <p id="xdx_80B_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zLUPX3jLNKX6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_822_zwlvy2qaVmC">NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--NatureOfOperationsPolicyTextBlock_za81EbURJaxk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zXkfN4Bcucbf">Nature of Operations</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Propanc Biopharma, Inc. (the “Company,” “we,” “us” or “our”) is based in Camberwell, Victoria Australia. Since its inception, substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. It is currently in the preclinical phase of development.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company was originally formed in Melbourne, Victoria, Australia on October 15, 2007, as Propanc PTY LTD. On November 23, 2010, Propanc Health Group Corporation was incorporated in the State of Delaware, and in January 2011, to reorganize the Company, all of the outstanding shares of Propanc PTY LTD were acquired on a one-for-one basis by Propanc Health Group Corporation, with Propanc PTY LTD becoming a wholly owned subsidiary of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 22, 2016, the Company formed another wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose of submitting an orphan drug application to the European Medicines Agency as a small and medium-sized enterprise. As of June 30, 2025, there has been no activity within this entity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective April 20, 2017, the Company changed its name to “Propanc Biopharma, Inc.” to reflect the Company’s stage of operations and development better.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2020, a world-first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 85 granted, allowed, or accepted patents and 5 patents filed, or under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering the lead product candidate PRP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 7, 2024, the Company received written consent in lieu of a meeting by the holders of a majority of the voting power of the Company’s outstanding capital stock as of August 7, 2024 and the Company’s Board of Directors approving such actions as are necessary for the Company to proceed to, and the Company accordingly intends to, effectuate and execute a reverse stock split of the Company’s issued and outstanding shares of common stock at a ratio of <span id="xdx_906_eus-gaap--StockholdersEquityNoteStockSplit_c20240807__20240807_zV1WmP9Q8WJe" title="Reverse stock split">one post-split share per sixty thousand pre-split shares (1:60,000)</span> (the “Reverse Stock Split”). The Reverse Stock Split became effective as of January 29, 2025. Proportional adjustments for the Reverse Stock Split were made to the Company’s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company hopes to capture and protect additional patentable subject matter based on the Company’s field of technology relating to pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product candidate, PRP, through various stages of development.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zqqPNJWySHWf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_zLtDfNqG3NTc">Principles of Consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of Propanc Biopharma, Inc., the parent entity, and its wholly owned subsidiary, Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. Propanc (UK) Limited was an inactive wholly owned subsidiary through June 30, 2025 and remains inactive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_zKviczWKN6v2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zUI7gVJIaEM1">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated financial statements include the estimates of useful lives of long-lived assets, valuation of the collectability of a refundable advance deposit, present value of the operating lease liability and related right-of-use asset, valuation of derivatives, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zItZ4o9vAYSb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zNL15Npng3z2">Foreign Currency Translation and Other Comprehensive Income (Loss)</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholly owned subsidiary’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into the Company’s reporting currency, which is the United States dollar ($) and/or (USD). Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “Accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency translations are included in the statements of operations and comprehensive income (loss) as a component of other comprehensive income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at the consolidated balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency included in the consolidated results of operations as incurred. Effective fiscal year 2021, the parent company determined that the intercompany loans will not be repaid in the foreseeable future and thus, per Accounting Standards Codification (“ASC”) 830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment, a component of accumulated other comprehensive income (loss). As of June 30, 2025 and 2024, the Company recognized a cumulative exchange gain (loss) of approximately ($<span id="xdx_90D_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20240701__20250630_zuG8WyFco1Cc" title="Foreign currency transaction gain loss">316,000</span>) and $<span id="xdx_906_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20230701__20240630_zaqgsYeLte3c" title="Foreign currency transaction gain loss">90,000</span>, respectively, on intercompany loans made by the parent to the subsidiary that have not been repaid as of June 30, 2025, which is included as a component of accumulated other comprehensive income on the accompanying consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_zQtZFujuGvm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2025 and 2024, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing the consolidated financial statements were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_zzi5UNRInz0e" style="display: none">SCHEDULE OF TRANSACTION EXCHANGE RATES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exchange rate on balance sheet dates</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20250630_z8o3YffmnISe" style="width: 16%; text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6571</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20240630_zh7I6VlA2Ojd" style="width: 16%; text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6693</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Average exchange rate for the period</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20250630__srt--RangeAxis__srt--WeightedAverageMember_zFPkNFKPyc36" style="text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6468</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20240630__srt--RangeAxis__srt--WeightedAverageMember_zY1Lv1NrYQWd" style="text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6557</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AF_zHdbRmBpnL7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zBQGVcXCUhX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in Accumulated Other Comprehensive Income (Loss) by component during the years ended June 30, 2025 and 2024 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zhchyngio3ye" style="display: none">SCHEDULE OF ACCUMULATED OTHER COMPREHENSIVE INCOME</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Foreign<br/> Currency Items:</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif">Beginning balance, June 30, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20230701__20240630_zCUGoaVvT4E9" style="width: 16%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,294,876</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Foreign currency translation loss</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20230701__20240630_zo9fBgnp2CBc" style="border-bottom: Black 1pt solid; text-align: right" title="Unrealized foreign currency translation gain (loss)"><span style="font-family: Times New Roman, Times, Serif">(25,295</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Balance, June 30, 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20240701__20250630_zta3aFSrLcSh" style="text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,269,581</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Foreign currency translation gain</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20240701__20250630_zLvAu1wn7f32" style="border-bottom: Black 1pt solid; text-align: right" title="Unrealized foreign currency translation gain (loss)"><span style="font-family: Times New Roman, Times, Serif">49,336</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance, June 30, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20240701__20250630_zx0cPcncAj22" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif">1,318,917</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/></span></p> <p id="xdx_8A3_zfco91Q7d01f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zMBfu4baljbd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zhJ7kG9TQUig">Fair Value of Financial Instruments and Fair Value Measurements</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company measures its financial assets and liabilities in accordance with US GAAP. For certain financial instruments, including cash and cash equivalents, receivables, accounts payable and accrued liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for notes payable, net of discount, and loans payable also approximate fair value because current interest rates available for debt with similar terms and maturities are substantially the same.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows accounting guidance for financial assets and liabilities. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Inputs, other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also see Note 12 - Derivative Financial Instruments and Fair Value Measurements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zt68q7IewOk8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zP4ITAnpCYv3">Cash and Cash Equivalents</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts, as applicable, are reflected as a current liability on the balance sheets. There were <span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20250630_zZz36OEnyiHk" title="Cash and cash equivalents"><span id="xdx_900_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240630_zhSHq28pSYf5" title="Cash and cash equivalents">no</span></span> cash equivalents as of June 30, 2025 and 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--RefundableAdvanceDepositPolicyTextBlock_z2VrzfI20dJ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zjC6IxWPx0Rh">Refundable Advance Deposit</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2023, the Company paid a refundable advance deposit of $<span id="xdx_903_ecustom--RefundableAdvanceDeposit_iI_c20230831_z214hA6k9K5f" title="Refundable advance deposit">120,958</span> which consisted primarily of a deposit paid to a potential lender to be used as payment for a loan insurance premium related to a future loan transaction with the Company. In the event, the future loan transaction does not close, the potential lender shall return the refundable advance deposit. During fiscal year 2024, the Company recorded an allowance for the recoverability of this refundable advance deposit of $<span id="xdx_90F_ecustom--AllowanceForRecoverabilityOfRefundableAdvanceDeposit_c20230701__20240630_zLJ4yHhlkEO6" title="Allowance for recoverability of refundable advance deposit">120,958</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_ecustom--PrepaidExpensesPolicyTextBlock_zBcc1n7IOy2c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zmQZbr8wGt17">Prepaid expenses</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses – current portion and long-term portion of $<span id="xdx_900_eus-gaap--PrepaidExpenseCurrent_iI_c20250630_zUECIwSPUIPj" title="Prepaid expenses">8,334,046</span> and $<span id="xdx_90F_eus-gaap--PrepaidExpenseNoncurrent_iI_c20250630_zSp2i9ORGT97" title="Prepaid expenses noncurrent">10,925,835</span>, respectively, at June 30, 2025, consist primarily of costs paid for future services which will occur between 6 months to three years. Prepaid expenses principally include prepayments in fully vested, non-forfeitable equity instruments for general consulting, investor relations, and business advisory services, which are being amortized over the terms of their respective agreements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--DeferredOfferingCostsPolicyTextBlock_zstpevn1Fw94" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zS5Anjm5PNI1">Deferred Offering Costs</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company complies with the requirements of ASC 340, Other Assets and Deferred Costs, with regards to offering costs. Prior to the completion of an offering, offering costs are capitalized and consist principally of professional, underwriting and other expenses incurred through the balance sheet date that are directly related to the Company’s proposed public offering. The deferred offering costs are charged to additional paid-in capital or as a discount to debt, as applicable, upon the completion of an offering or to expense if the offering is not completed. As of June 30, 2025 and 2024 the Company had recorded $<span id="xdx_907_eus-gaap--DeferredCosts_iI_c20250630_zE9QoZ85azMe" title="Deferred offering cost">291,773</span> and $<span id="xdx_906_eus-gaap--DeferredCosts_iI_c20240630_zRGfe6ndnhqg" title="Deferred offering cost">27,117</span> in deferred offering costs, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zVddBFf03BX8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_z50eH5YFhtGc">Property and Equipment</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred; additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_zBuellK2YHdc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated useful lives are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zG8giBnggg0j" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zJBhR2OPaMwj" title="Property plant and equipment, useful life">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z5BEKEEW39E3" title="Property plant and equipment, useful life">7</span> years</span></td></tr> </table> <p id="xdx_8A7_zn9KXx41GGbd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zs9o1QKCFIXg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_z4XAc57nxqwb">Patents</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents are stated at cost and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency. However, the Company will expense any patent costs as long as we are in the startup stage. Accordingly, as the Company’s products are not currently approved for market, all patent costs incurred from 2013 through June 30, 2025 were expensed immediately. This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zm0ig2r5KbX8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zsRcbBzGkiKa">Impairment of Long-Lived Assets</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 360-10, “Long-lived assets,” which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--EmployeeStockOwnershipPlanESOPPolicy_z7fyPePyNXu4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zPEkzeEXKgIb">Employee Benefit/Liability</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities arising in respect of wages and salaries, accumulated annual leave, accumulated long service leave and any other employee benefits expected to be settled within twelve months of the reporting date are measured based on the employee’s remuneration rates applicable at the reporting date. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_ecustom--GoodsAndServicesTaxPolicyTextBlock_zp90DIUtVyra" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_znBlesIL82Hh">Australian Goods and Services Tax (“GST”)</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues, expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2025 and 2024, the Company was owed $<span id="xdx_908_ecustom--GoodsAndServicesTaxReceivableCurrent_iI_c20250630_zPPNw1n9wQO8" title="GST tax receivable">5,302</span> and $<span id="xdx_90B_ecustom--GoodsAndServicesTaxReceivableCurrent_iI_c20240630_zeIwZbMZ3MPb" title="GST tax receivable">2,950</span>, respectively, from the Australian Taxation Office. These amounts were fully collected subsequent to the balance sheet reporting dates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--DerivativesPolicyTextBlock_zCYSE36DoQVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_z9Bswafq5RQh">Derivative Instruments</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 815, <i>Derivatives and Hedging</i> (“ASC Topic 815”), establishes accounting and reporting standards for derivative instruments and for hedging activities by requiring that all derivatives be recognized in the balance sheet and measured at fair value. Gains or losses resulting from changes in the fair value of derivatives are recognized in earnings. On the date of conversion or payoff of debt, the Company records the fair value of the conversion shares, removes the fair value of the related derivative liability, removes any discounts and records a net gain or loss on debt extinguishment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--ConvertibleNotesPolicyTextBlock_zupyJNTfeIX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zAMLRbhBu5B7">Convertible Notes With Variable Conversion Options</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into shares of the Company’s common stock, par value $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20250630_zEK5oanNDD37" title="Common stock, par value">0.001</span> per share (“common stock”) at a fixed discount to the price of the common stock at or around the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, “<i>Distinguishing Liabilities from Equity</i>” and measures the fair value of the notes at the time of issuance, which is the result of the share price discount at the time of conversion and records the put premium as interest expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zYc59rN7uZx7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zTpSe8CHwNci">Income Taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows ASC 740 “<i>Accounting for Income Taxes</i>,” when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 740, Sections 25 through 60, “<i>Accounting for Uncertainty in Income Taxes</i>.” These sections provide detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized upon the adoption of ASC 740 and in subsequent periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zVwgf2RhwRZi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_z7ctO9Ndxlh">Research and Development Costs and Tax Credits</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 730-10, <i>“Research and Development-Overall,”</i> research and development costs are expensed when incurred. Total research and development costs for the years ended June 30, 2025 and 2024 were $<span id="xdx_901_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20240701__20250630_zKIgA6b8RQPi" title="Research and development costs">223,721</span> and $<span id="xdx_900_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20230701__20240630_zTFOJrU7xIRa" title="Research and development costs">248,102</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company’s net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as a tax benefit, in operations, upon receipt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During each of the fiscal years ended June 30, 2025 and 2024, the Company applied for, and received from the Australian Taxation Office, a research and development tax credit in the amount of $<span id="xdx_900_eus-gaap--IncomeTaxCreditsAndAdjustments_c20240701__20250630_zKXV790K0T1a" title="Research and development tax credit">0</span> and $<span id="xdx_908_eus-gaap--IncomeTaxCreditsAndAdjustments_c20230701__20240630_zOoORQDIEj2l" title="Research and development tax credit">129,132</span>, respectively, which is reflected as a tax benefit in the accompanying consolidated statements of operations and comprehensive income (loss). The Company has submitted its request for the refundable credit covering the period for the year ended June 30, 2025 and is still waiting receipt of the funds.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zIKA0jPfGdug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zjykOvnBZsH9">Stock Based Compensation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records stock-based compensation in accordance with ASC 718, “<i>Stock Compensation</i>”. ASC 718 requires the fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the shorter of the service period or the vesting period. The Company values employee and non-employee stock-based compensation at fair value using the Black-Scholes Option Pricing Model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z5rNTZOlJf1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zLZ5lYtS82Yc">Revenue Recognition</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applies ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). ASC 606 establishes a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most of the existing revenue recognition guidance. This standard requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services and also requires certain additional disclosures. Subject to these criteria, the Company intends to recognize revenue relating to royalties on product sales in the period in which the sale occurs and the royalty term has begun.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--LegalCostsPolicyTextBlock_z2Czgcc8gHnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_z5ds4aE4EbH1">Legal Expenses</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All legal costs for litigation are charged to expense as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--LesseeLeasesPolicyTextBlock_zd4UdSI02BB3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_z7lyfUEGdYi5">Leases</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC Topic 842, Leases (Topic 842) and applies the package of practical expedients, which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less. Operating lease right of use assets (“ROU”) represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the adoption date in determining the present value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included in general and administrative expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zo1lbaE91OQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_ze9B02BQyPv9">Basic and Diluted Net Loss Per Common Share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. <span id="xdx_904_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20240701__20250630_zQvCt4vxCpI8" title="Beneficial ownership conversion description">Each holder of the convertible notes has agreed to a 4.99% beneficial ownership conversion limitation (subject to certain noteholders’ ability to increase such limitation to 9.99% upon 60 days’ notice to the Company), and each note may not be converted during the first six-month period from the date of issuance.</span> The Company’s CEO holds Series B Preferred Stock that, when combined, confers upon him a majority vote, including regarding authorization of additional common shares and/or the authorization of a reverse split the stock as considered necessary. Such securities are considered dilutive securities which were excluded from the computation since the effect is anti-dilutive.</span></p> <p id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zn6gljizMTL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span style="display: none"><span id="xdx_8BE_zocrAHNwHRXg">SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Warrants with no designations</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zw4KiWdgDd4g" style="width: 16%; text-align: right" title="Stock Warrants with no designations"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230701__20240630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zW8LkavLAP46" style="width: 16%; text-align: right" title="Stock Warrants with no designations"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Series A Warrants as if converted at alternate cashless exercise prices</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zdFOt11Vwxva" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3125">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20240630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zTxGTbTTqrRc" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif">33,173</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Series C Warrants as if converted at alternate cashless exercise prices <span id="xdx_F44_zpZP06N3z4M9">*</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCWarrantsMember_fKg_____zATPocqfw3C9" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3129">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20240630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCWarrantsMember_fKg_____ztiPtUlOare8" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif">152,933</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Convertible Debt</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zAxQxtJvOsx7" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif">189,896</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230701__20240630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zxAAgeqrHdV1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif">6,562</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20250630_zvSwSx9Rue6j" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif">190,146</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230701__20240630_zU0PmCI35jQa" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif">192,918</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-right: 0.8pt; text-align: right"></td> <td style="width: 0.25in"><span id="xdx_F00_zYmR68THTvSf" style="font-family: Times New Roman, Times, Serif">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"><span id="xdx_F11_zfpm9jBU3wFe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only convertible ratably upon exercise of Series B Warrants</span></td></tr> </table> <p id="xdx_8AD_z3XAMAc54t42" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zVAUAsPixiMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_ztxfpMhW0SBf">Segment Reporting</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses “the management approach” in determining reportable operating segments. Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker (“CODM”). The management approach considers the internal organization and reporting used by the Company’s CODM for making operating decisions and assessing performance as the source for determining the Company’s reportable segments. All activities are related to the development of cancer treatment and the Company has not commenced commercial operations or generated revenues to date. All activities are related to the development of the cancer treatment and the Company has not commenced commercial operations or generated revenues to date. The CODM is the chief executive officer of the Company, who reviews operating results and utilizes consolidated financial information, including operating expenses, operating loss, and net loss as reported on the consolidated statements of operations, to make decisions about operating decisions, allocate resources and assess performance for the entire Company. Consolidated net loss is our segment’s primary measure of loss. The measure of segment assets is reported on the consolidated balance sheets as total consolidated assets. The single segment constitutes all the consolidated entity, and the accompanying consolidated financial statements and the notes to the accompanying consolidated financial statements are representative of such amounts. For the years ended June 30, 2025 and 2024, the Company operates in <span id="xdx_90E_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20240701__20250630_zWFbrtd09io" title="Number of operating segments"><span id="xdx_900_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20230701__20240630_zA4wzycdQ4Ba" title="Number of operating segments">one</span></span> operating segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zNFRyhSFKaf3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_znWAXK2ey4Ol">Recent Accounting Pronouncements</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have reviewed the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting principles and do not believe that any new or modified principles will have a material impact on the Company’s reported financial position or operations in the near term with the exception of those disclosed below. The applicability of any standard is subject to formal review of the Company’s financial management.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 4, 2024, the FASB issued ASU 2024-03, <i>Disaggregation of Income Statement Expenses</i> (DISE) requiring additional disclosure of the nature of expenses included in the income statement in response to longstanding requests from investors for more information about an entity’s expenses. This standard requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. ASU 2024-03 applies to all public business entities (PBEs) and is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. The requirements will be applied prospectively with the option for retrospective application. Early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2024-03 may have on the Company’s consolidated financial statements.</span></p> <p id="xdx_85B_zi8vtWf5q6dk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--NatureOfOperationsPolicyTextBlock_za81EbURJaxk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zXkfN4Bcucbf">Nature of Operations</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Propanc Biopharma, Inc. (the “Company,” “we,” “us” or “our”) is based in Camberwell, Victoria Australia. Since its inception, substantially all of the operations of the Company have been focused on the development of new cancer treatments targeting high-risk patients, particularly cancer survivors, who need a follow-up, non-toxic, long-term therapy designed to prevent the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. Our lead product candidate, which we refer to as PRP, is an enhanced pro-enzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. It is currently in the preclinical phase of development.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company was originally formed in Melbourne, Victoria, Australia on October 15, 2007, as Propanc PTY LTD. On November 23, 2010, Propanc Health Group Corporation was incorporated in the State of Delaware, and in January 2011, to reorganize the Company, all of the outstanding shares of Propanc PTY LTD were acquired on a one-for-one basis by Propanc Health Group Corporation, with Propanc PTY LTD becoming a wholly owned subsidiary of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 22, 2016, the Company formed another wholly owned subsidiary, Propanc (UK) Limited under the laws of England and Wales for the purpose of submitting an orphan drug application to the European Medicines Agency as a small and medium-sized enterprise. As of June 30, 2025, there has been no activity within this entity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective April 20, 2017, the Company changed its name to “Propanc Biopharma, Inc.” to reflect the Company’s stage of operations and development better.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2020, a world-first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 85 granted, allowed, or accepted patents and 5 patents filed, or under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering the lead product candidate PRP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 7, 2024, the Company received written consent in lieu of a meeting by the holders of a majority of the voting power of the Company’s outstanding capital stock as of August 7, 2024 and the Company’s Board of Directors approving such actions as are necessary for the Company to proceed to, and the Company accordingly intends to, effectuate and execute a reverse stock split of the Company’s issued and outstanding shares of common stock at a ratio of <span id="xdx_906_eus-gaap--StockholdersEquityNoteStockSplit_c20240807__20240807_zV1WmP9Q8WJe" title="Reverse stock split">one post-split share per sixty thousand pre-split shares (1:60,000)</span> (the “Reverse Stock Split”). The Reverse Stock Split became effective as of January 29, 2025. Proportional adjustments for the Reverse Stock Split were made to the Company’s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company hopes to capture and protect additional patentable subject matter based on the Company’s field of technology relating to pharmaceutical compositions of proenzymes for treating cancer by filing additional patent applications as it advances its lead product candidate, PRP, through various stages of development.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> one post-split share per sixty thousand pre-split shares (1:60,000) <p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zqqPNJWySHWf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_zLtDfNqG3NTc">Principles of Consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of Propanc Biopharma, Inc., the parent entity, and its wholly owned subsidiary, Propanc PTY LTD. All inter-company balances and transactions have been eliminated in consolidation. Propanc (UK) Limited was an inactive wholly owned subsidiary through June 30, 2025 and remains inactive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_zKviczWKN6v2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zUI7gVJIaEM1">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated financial statements include the estimates of useful lives of long-lived assets, valuation of the collectability of a refundable advance deposit, present value of the operating lease liability and related right-of-use asset, valuation of derivatives, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zItZ4o9vAYSb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zNL15Npng3z2">Foreign Currency Translation and Other Comprehensive Income (Loss)</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholly owned subsidiary’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into the Company’s reporting currency, which is the United States dollar ($) and/or (USD). Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “Accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency translations are included in the statements of operations and comprehensive income (loss) as a component of other comprehensive income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Comprehensive Income (Loss) for all periods presented includes only foreign currency translation gains (losses).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at the consolidated balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency included in the consolidated results of operations as incurred. Effective fiscal year 2021, the parent company determined that the intercompany loans will not be repaid in the foreseeable future and thus, per Accounting Standards Codification (“ASC”) 830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment, a component of accumulated other comprehensive income (loss). As of June 30, 2025 and 2024, the Company recognized a cumulative exchange gain (loss) of approximately ($<span id="xdx_90D_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20240701__20250630_zuG8WyFco1Cc" title="Foreign currency transaction gain loss">316,000</span>) and $<span id="xdx_906_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20230701__20240630_zaqgsYeLte3c" title="Foreign currency transaction gain loss">90,000</span>, respectively, on intercompany loans made by the parent to the subsidiary that have not been repaid as of June 30, 2025, which is included as a component of accumulated other comprehensive income on the accompanying consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_zQtZFujuGvm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2025 and 2024, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing the consolidated financial statements were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_zzi5UNRInz0e" style="display: none">SCHEDULE OF TRANSACTION EXCHANGE RATES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exchange rate on balance sheet dates</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20250630_z8o3YffmnISe" style="width: 16%; text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6571</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20240630_zh7I6VlA2Ojd" style="width: 16%; text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6693</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Average exchange rate for the period</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20250630__srt--RangeAxis__srt--WeightedAverageMember_zFPkNFKPyc36" style="text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6468</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20240630__srt--RangeAxis__srt--WeightedAverageMember_zY1Lv1NrYQWd" style="text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6557</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AF_zHdbRmBpnL7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zBQGVcXCUhX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in Accumulated Other Comprehensive Income (Loss) by component during the years ended June 30, 2025 and 2024 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zhchyngio3ye" style="display: none">SCHEDULE OF ACCUMULATED OTHER COMPREHENSIVE INCOME</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Foreign<br/> Currency Items:</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif">Beginning balance, June 30, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20230701__20240630_zCUGoaVvT4E9" style="width: 16%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,294,876</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Foreign currency translation loss</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20230701__20240630_zo9fBgnp2CBc" style="border-bottom: Black 1pt solid; text-align: right" title="Unrealized foreign currency translation gain (loss)"><span style="font-family: Times New Roman, Times, Serif">(25,295</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Balance, June 30, 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20240701__20250630_zta3aFSrLcSh" style="text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,269,581</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Foreign currency translation gain</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20240701__20250630_zLvAu1wn7f32" style="border-bottom: Black 1pt solid; text-align: right" title="Unrealized foreign currency translation gain (loss)"><span style="font-family: Times New Roman, Times, Serif">49,336</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance, June 30, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20240701__20250630_zx0cPcncAj22" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif">1,318,917</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/></span></p> <p id="xdx_8A3_zfco91Q7d01f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 316000 90000 <p id="xdx_89A_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_zQtZFujuGvm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2025 and 2024, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing the consolidated financial statements were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_zzi5UNRInz0e" style="display: none">SCHEDULE OF TRANSACTION EXCHANGE RATES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exchange rate on balance sheet dates</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20250630_z8o3YffmnISe" style="width: 16%; text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6571</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20240630_zh7I6VlA2Ojd" style="width: 16%; text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6693</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Average exchange rate for the period</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">USD : AUD exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20250630__srt--RangeAxis__srt--WeightedAverageMember_zFPkNFKPyc36" style="text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6468</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20240630__srt--RangeAxis__srt--WeightedAverageMember_zY1Lv1NrYQWd" style="text-align: right" title="Foreign currency exchange rate, translation"><span style="font-family: Times New Roman, Times, Serif">0.6557</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 0.6571 0.6693 0.6468 0.6557 <p id="xdx_89F_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zBQGVcXCUhX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in Accumulated Other Comprehensive Income (Loss) by component during the years ended June 30, 2025 and 2024 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zhchyngio3ye" style="display: none">SCHEDULE OF ACCUMULATED OTHER COMPREHENSIVE INCOME</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Foreign<br/> Currency Items:</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif">Beginning balance, June 30, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20230701__20240630_zCUGoaVvT4E9" style="width: 16%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,294,876</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Foreign currency translation loss</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20230701__20240630_zo9fBgnp2CBc" style="border-bottom: Black 1pt solid; text-align: right" title="Unrealized foreign currency translation gain (loss)"><span style="font-family: Times New Roman, Times, Serif">(25,295</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Balance, June 30, 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_pp0p0_c20240701__20250630_zta3aFSrLcSh" style="text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,269,581</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Foreign currency translation gain</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20240701__20250630_zLvAu1wn7f32" style="border-bottom: Black 1pt solid; text-align: right" title="Unrealized foreign currency translation gain (loss)"><span style="font-family: Times New Roman, Times, Serif">49,336</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance, June 30, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20240701__20250630_zx0cPcncAj22" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif">1,318,917</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/></span></p> 1294876 -25295 1269581 49336 1318917 <p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zMBfu4baljbd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zhJ7kG9TQUig">Fair Value of Financial Instruments and Fair Value Measurements</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company measures its financial assets and liabilities in accordance with US GAAP. For certain financial instruments, including cash and cash equivalents, receivables, accounts payable and accrued liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for notes payable, net of discount, and loans payable also approximate fair value because current interest rates available for debt with similar terms and maturities are substantially the same.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows accounting guidance for financial assets and liabilities. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Inputs, other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also see Note 12 - Derivative Financial Instruments and Fair Value Measurements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zt68q7IewOk8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zP4ITAnpCYv3">Cash and Cash Equivalents</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts, as applicable, are reflected as a current liability on the balance sheets. There were <span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20250630_zZz36OEnyiHk" title="Cash and cash equivalents"><span id="xdx_900_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240630_zhSHq28pSYf5" title="Cash and cash equivalents">no</span></span> cash equivalents as of June 30, 2025 and 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_842_ecustom--RefundableAdvanceDepositPolicyTextBlock_z2VrzfI20dJ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zjC6IxWPx0Rh">Refundable Advance Deposit</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2023, the Company paid a refundable advance deposit of $<span id="xdx_903_ecustom--RefundableAdvanceDeposit_iI_c20230831_z214hA6k9K5f" title="Refundable advance deposit">120,958</span> which consisted primarily of a deposit paid to a potential lender to be used as payment for a loan insurance premium related to a future loan transaction with the Company. In the event, the future loan transaction does not close, the potential lender shall return the refundable advance deposit. During fiscal year 2024, the Company recorded an allowance for the recoverability of this refundable advance deposit of $<span id="xdx_90F_ecustom--AllowanceForRecoverabilityOfRefundableAdvanceDeposit_c20230701__20240630_zLJ4yHhlkEO6" title="Allowance for recoverability of refundable advance deposit">120,958</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 120958 120958 <p id="xdx_848_ecustom--PrepaidExpensesPolicyTextBlock_zBcc1n7IOy2c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zmQZbr8wGt17">Prepaid expenses</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses – current portion and long-term portion of $<span id="xdx_900_eus-gaap--PrepaidExpenseCurrent_iI_c20250630_zUECIwSPUIPj" title="Prepaid expenses">8,334,046</span> and $<span id="xdx_90F_eus-gaap--PrepaidExpenseNoncurrent_iI_c20250630_zSp2i9ORGT97" title="Prepaid expenses noncurrent">10,925,835</span>, respectively, at June 30, 2025, consist primarily of costs paid for future services which will occur between 6 months to three years. Prepaid expenses principally include prepayments in fully vested, non-forfeitable equity instruments for general consulting, investor relations, and business advisory services, which are being amortized over the terms of their respective agreements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 8334046 10925835 <p id="xdx_847_ecustom--DeferredOfferingCostsPolicyTextBlock_zstpevn1Fw94" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zS5Anjm5PNI1">Deferred Offering Costs</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company complies with the requirements of ASC 340, Other Assets and Deferred Costs, with regards to offering costs. Prior to the completion of an offering, offering costs are capitalized and consist principally of professional, underwriting and other expenses incurred through the balance sheet date that are directly related to the Company’s proposed public offering. The deferred offering costs are charged to additional paid-in capital or as a discount to debt, as applicable, upon the completion of an offering or to expense if the offering is not completed. As of June 30, 2025 and 2024 the Company had recorded $<span id="xdx_907_eus-gaap--DeferredCosts_iI_c20250630_zE9QoZ85azMe" title="Deferred offering cost">291,773</span> and $<span id="xdx_906_eus-gaap--DeferredCosts_iI_c20240630_zRGfe6ndnhqg" title="Deferred offering cost">27,117</span> in deferred offering costs, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 291773 27117 <p id="xdx_842_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zVddBFf03BX8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_z50eH5YFhtGc">Property and Equipment</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred; additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_zBuellK2YHdc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated useful lives are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zG8giBnggg0j" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zJBhR2OPaMwj" title="Property plant and equipment, useful life">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z5BEKEEW39E3" title="Property plant and equipment, useful life">7</span> years</span></td></tr> </table> <p id="xdx_8A7_zn9KXx41GGbd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_zBuellK2YHdc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated useful lives are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zG8giBnggg0j" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zJBhR2OPaMwj" title="Property plant and equipment, useful life">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z5BEKEEW39E3" title="Property plant and equipment, useful life">7</span> years</span></td></tr> </table> P5Y P7Y <p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zs9o1QKCFIXg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_z4XAc57nxqwb">Patents</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents are stated at cost and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency. However, the Company will expense any patent costs as long as we are in the startup stage. Accordingly, as the Company’s products are not currently approved for market, all patent costs incurred from 2013 through June 30, 2025 were expensed immediately. This practice of expensing patent costs immediately ends when a product receives market authorization from a government regulatory agency.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zm0ig2r5KbX8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zsRcbBzGkiKa">Impairment of Long-Lived Assets</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 360-10, “Long-lived assets,” which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--EmployeeStockOwnershipPlanESOPPolicy_z7fyPePyNXu4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zPEkzeEXKgIb">Employee Benefit/Liability</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities arising in respect of wages and salaries, accumulated annual leave, accumulated long service leave and any other employee benefits expected to be settled within twelve months of the reporting date are measured based on the employee’s remuneration rates applicable at the reporting date. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_ecustom--GoodsAndServicesTaxPolicyTextBlock_zp90DIUtVyra" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_znBlesIL82Hh">Australian Goods and Services Tax (“GST”)</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues, expenses and balance sheet items are recognized net of the amount of GST, except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2025 and 2024, the Company was owed $<span id="xdx_908_ecustom--GoodsAndServicesTaxReceivableCurrent_iI_c20250630_zPPNw1n9wQO8" title="GST tax receivable">5,302</span> and $<span id="xdx_90B_ecustom--GoodsAndServicesTaxReceivableCurrent_iI_c20240630_zeIwZbMZ3MPb" title="GST tax receivable">2,950</span>, respectively, from the Australian Taxation Office. These amounts were fully collected subsequent to the balance sheet reporting dates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 5302 2950 <p id="xdx_844_eus-gaap--DerivativesPolicyTextBlock_zCYSE36DoQVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_z9Bswafq5RQh">Derivative Instruments</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 815, <i>Derivatives and Hedging</i> (“ASC Topic 815”), establishes accounting and reporting standards for derivative instruments and for hedging activities by requiring that all derivatives be recognized in the balance sheet and measured at fair value. Gains or losses resulting from changes in the fair value of derivatives are recognized in earnings. On the date of conversion or payoff of debt, the Company records the fair value of the conversion shares, removes the fair value of the related derivative liability, removes any discounts and records a net gain or loss on debt extinguishment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--ConvertibleNotesPolicyTextBlock_zupyJNTfeIX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zAMLRbhBu5B7">Convertible Notes With Variable Conversion Options</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into shares of the Company’s common stock, par value $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20250630_zEK5oanNDD37" title="Common stock, par value">0.001</span> per share (“common stock”) at a fixed discount to the price of the common stock at or around the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480, “<i>Distinguishing Liabilities from Equity</i>” and measures the fair value of the notes at the time of issuance, which is the result of the share price discount at the time of conversion and records the put premium as interest expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.001 <p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zYc59rN7uZx7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zTpSe8CHwNci">Income Taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows ASC 740 “<i>Accounting for Income Taxes</i>,” when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 740, Sections 25 through 60, “<i>Accounting for Uncertainty in Income Taxes</i>.” These sections provide detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized upon the adoption of ASC 740 and in subsequent periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zVwgf2RhwRZi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_z7ctO9Ndxlh">Research and Development Costs and Tax Credits</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 730-10, <i>“Research and Development-Overall,”</i> research and development costs are expensed when incurred. Total research and development costs for the years ended June 30, 2025 and 2024 were $<span id="xdx_901_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20240701__20250630_zKIgA6b8RQPi" title="Research and development costs">223,721</span> and $<span id="xdx_900_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20230701__20240630_zTFOJrU7xIRa" title="Research and development costs">248,102</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income, then the Company can receive the credit which reduces its income tax liability. If the Company has net losses, then the Company may still receive a cash payment for the credit, however, the Company’s net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as a tax benefit, in operations, upon receipt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During each of the fiscal years ended June 30, 2025 and 2024, the Company applied for, and received from the Australian Taxation Office, a research and development tax credit in the amount of $<span id="xdx_900_eus-gaap--IncomeTaxCreditsAndAdjustments_c20240701__20250630_zKXV790K0T1a" title="Research and development tax credit">0</span> and $<span id="xdx_908_eus-gaap--IncomeTaxCreditsAndAdjustments_c20230701__20240630_zOoORQDIEj2l" title="Research and development tax credit">129,132</span>, respectively, which is reflected as a tax benefit in the accompanying consolidated statements of operations and comprehensive income (loss). The Company has submitted its request for the refundable credit covering the period for the year ended June 30, 2025 and is still waiting receipt of the funds.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 223721 248102 0 129132 <p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zIKA0jPfGdug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zjykOvnBZsH9">Stock Based Compensation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records stock-based compensation in accordance with ASC 718, “<i>Stock Compensation</i>”. ASC 718 requires the fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the shorter of the service period or the vesting period. The Company values employee and non-employee stock-based compensation at fair value using the Black-Scholes Option Pricing Model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z5rNTZOlJf1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zLZ5lYtS82Yc">Revenue Recognition</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applies ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). ASC 606 establishes a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most of the existing revenue recognition guidance. This standard requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services and also requires certain additional disclosures. Subject to these criteria, the Company intends to recognize revenue relating to royalties on product sales in the period in which the sale occurs and the royalty term has begun.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--LegalCostsPolicyTextBlock_z2Czgcc8gHnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_z5ds4aE4EbH1">Legal Expenses</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All legal costs for litigation are charged to expense as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--LesseeLeasesPolicyTextBlock_zd4UdSI02BB3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_z7lyfUEGdYi5">Leases</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC Topic 842, Leases (Topic 842) and applies the package of practical expedients, which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less. Operating lease right of use assets (“ROU”) represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the adoption date in determining the present value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included in general and administrative expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zo1lbaE91OQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_ze9B02BQyPv9">Basic and Diluted Net Loss Per Common Share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. <span id="xdx_904_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20240701__20250630_zQvCt4vxCpI8" title="Beneficial ownership conversion description">Each holder of the convertible notes has agreed to a 4.99% beneficial ownership conversion limitation (subject to certain noteholders’ ability to increase such limitation to 9.99% upon 60 days’ notice to the Company), and each note may not be converted during the first six-month period from the date of issuance.</span> The Company’s CEO holds Series B Preferred Stock that, when combined, confers upon him a majority vote, including regarding authorization of additional common shares and/or the authorization of a reverse split the stock as considered necessary. Such securities are considered dilutive securities which were excluded from the computation since the effect is anti-dilutive.</span></p> <p id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zn6gljizMTL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span style="display: none"><span id="xdx_8BE_zocrAHNwHRXg">SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Warrants with no designations</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zw4KiWdgDd4g" style="width: 16%; text-align: right" title="Stock Warrants with no designations"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230701__20240630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zW8LkavLAP46" style="width: 16%; text-align: right" title="Stock Warrants with no designations"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Series A Warrants as if converted at alternate cashless exercise prices</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zdFOt11Vwxva" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3125">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20240630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zTxGTbTTqrRc" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif">33,173</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Series C Warrants as if converted at alternate cashless exercise prices <span id="xdx_F44_zpZP06N3z4M9">*</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCWarrantsMember_fKg_____zATPocqfw3C9" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3129">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20240630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCWarrantsMember_fKg_____ztiPtUlOare8" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif">152,933</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Convertible Debt</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zAxQxtJvOsx7" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif">189,896</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230701__20240630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zxAAgeqrHdV1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif">6,562</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20250630_zvSwSx9Rue6j" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif">190,146</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230701__20240630_zU0PmCI35jQa" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif">192,918</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-right: 0.8pt; text-align: right"></td> <td style="width: 0.25in"><span id="xdx_F00_zYmR68THTvSf" style="font-family: Times New Roman, Times, Serif">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"><span id="xdx_F11_zfpm9jBU3wFe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only convertible ratably upon exercise of Series B Warrants</span></td></tr> </table> <p id="xdx_8AD_z3XAMAc54t42" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> Each holder of the convertible notes has agreed to a 4.99% beneficial ownership conversion limitation (subject to certain noteholders’ ability to increase such limitation to 9.99% upon 60 days’ notice to the Company), and each note may not be converted during the first six-month period from the date of issuance. <p id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zn6gljizMTL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span style="display: none"><span id="xdx_8BE_zocrAHNwHRXg">SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Warrants with no designations</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zw4KiWdgDd4g" style="width: 16%; text-align: right" title="Stock Warrants with no designations"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230701__20240630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zW8LkavLAP46" style="width: 16%; text-align: right" title="Stock Warrants with no designations"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Series A Warrants as if converted at alternate cashless exercise prices</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zdFOt11Vwxva" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3125">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20240630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zTxGTbTTqrRc" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif">33,173</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Series C Warrants as if converted at alternate cashless exercise prices <span id="xdx_F44_zpZP06N3z4M9">*</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCWarrantsMember_fKg_____zATPocqfw3C9" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3129">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20240630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesCWarrantsMember_fKg_____ztiPtUlOare8" style="text-align: right" title="Number of warrants"><span style="font-family: Times New Roman, Times, Serif">152,933</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Convertible Debt</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zAxQxtJvOsx7" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif">189,896</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230701__20240630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zxAAgeqrHdV1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"><span style="font-family: Times New Roman, Times, Serif">6,562</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240701__20250630_zvSwSx9Rue6j" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif">190,146</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230701__20240630_zU0PmCI35jQa" style="border-bottom: Black 2.5pt double; text-align: right" title="Anti-dilutive securities"><span style="font-family: Times New Roman, Times, Serif">192,918</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-right: 0.8pt; text-align: right"></td> <td style="width: 0.25in"><span id="xdx_F00_zYmR68THTvSf" style="font-family: Times New Roman, Times, Serif">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"><span id="xdx_F11_zfpm9jBU3wFe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only convertible ratably upon exercise of Series B Warrants</span></td></tr> </table> 250 250 33173 152933 189896 6562 190146 192918 <p id="xdx_842_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zVAUAsPixiMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_ztxfpMhW0SBf">Segment Reporting</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses “the management approach” in determining reportable operating segments. Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision maker (“CODM”). The management approach considers the internal organization and reporting used by the Company’s CODM for making operating decisions and assessing performance as the source for determining the Company’s reportable segments. All activities are related to the development of cancer treatment and the Company has not commenced commercial operations or generated revenues to date. All activities are related to the development of the cancer treatment and the Company has not commenced commercial operations or generated revenues to date. The CODM is the chief executive officer of the Company, who reviews operating results and utilizes consolidated financial information, including operating expenses, operating loss, and net loss as reported on the consolidated statements of operations, to make decisions about operating decisions, allocate resources and assess performance for the entire Company. Consolidated net loss is our segment’s primary measure of loss. The measure of segment assets is reported on the consolidated balance sheets as total consolidated assets. The single segment constitutes all the consolidated entity, and the accompanying consolidated financial statements and the notes to the accompanying consolidated financial statements are representative of such amounts. For the years ended June 30, 2025 and 2024, the Company operates in <span id="xdx_90E_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20240701__20250630_zWFbrtd09io" title="Number of operating segments"><span id="xdx_900_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20230701__20240630_zA4wzycdQ4Ba" title="Number of operating segments">one</span></span> operating segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 1 <p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zNFRyhSFKaf3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_znWAXK2ey4Ol">Recent Accounting Pronouncements</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have reviewed the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting principles and do not believe that any new or modified principles will have a material impact on the Company’s reported financial position or operations in the near term with the exception of those disclosed below. The applicability of any standard is subject to formal review of the Company’s financial management.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 4, 2024, the FASB issued ASU 2024-03, <i>Disaggregation of Income Statement Expenses</i> (DISE) requiring additional disclosure of the nature of expenses included in the income statement in response to longstanding requests from investors for more information about an entity’s expenses. This standard requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. ASU 2024-03 applies to all public business entities (PBEs) and is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. The requirements will be applied prospectively with the option for retrospective application. Early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2024-03 may have on the Company’s consolidated financial statements.</span></p> <p id="xdx_80B_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z5pVB1id4b43" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – <span id="xdx_82B_z3tkbjsIaT2d">GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared in conformity with US GAAP, which contemplate continuation of the Company as a going concern. For the fiscal year ended June 30, 2025, the Company had no revenues, had a net loss of $<span id="xdx_905_eus-gaap--NetIncomeLoss_iN_di_c20240701__20250630_zswUXpKADB7g" title="Net loss">58,923,300</span> and had net cash used in operations of $<span id="xdx_90A_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20240701__20250630_zkrojCNhztr7" title="Net cash used in operations">405,168</span>. Additionally, as of June 30, 2025, the Company had accumulated deficit of $<span id="xdx_90E_ecustom--WorkingCapitalDeficit_iI_c20250630_z0s564sPlM1c" title="Working capital deficit">125,621,520</span>. It is management’s opinion that these conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of at least twelve months from the date of this filing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of this uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 18, 2025, the Company sold <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250818__20250818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcBpqHuFmsh9" title="Shares of common stock">1,000,000</span> shares of common stock for total gross proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20250818__20250818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCoWfc3ILnx" title="Gross proceeds">4,000,000</span>. After deducting the underwriting commissions and offering expenses, the Company received net proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20250818__20250818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zX68gFBsnbkf" title="Net proceeds">3,340,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company’s patent applications, obtaining additional sources of suitable and adequate financing and ultimately achieving a level of sales adequate to support the Company’s cost structure and business plan. The Company’s ability to continue as a going concern is also dependent on its ability to further develop and execute its business plan. However, there can be no assurances that any or all of these endeavors will be successful.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -58923300 -405168 125621520 1000000 4000000 3340000 <p id="xdx_80F_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zVqSo4hKlgT1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_820_zd1c5ma8B9b9">PROPERTY AND EQUIPMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_zCte8KOxSNAi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of the following as of June 30:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zBCy32zvjNve" style="display: none">SCHEDULE OF PROPERTY PLANT AND EQUIPMENT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20250630_zWNYhSHLOZv" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20240630_z7wX7OJbppLc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzBVB_zU0FNBo50A12" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office equipment at cost</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,078</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,543</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzBVB_zsqSuSKYgq2c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: Accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25,078</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25,543</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzBVB_zabdinYO5O6c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total property, plant, and equipment</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3174">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3175">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A5_zgShOk1WiKR3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the years ended June 30, 2025 and 2024 was $<span id="xdx_901_eus-gaap--Depreciation_dxL_c20240701__20250630_zz37ZUTAOeI8" title="Depreciation::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl3177">0</span></span> and $<span id="xdx_905_eus-gaap--Depreciation_c20230701__20240630_z4LMaLg0Dumh" title="Depreciation expense">297</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_zCte8KOxSNAi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of the following as of June 30:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zBCy32zvjNve" style="display: none">SCHEDULE OF PROPERTY PLANT AND EQUIPMENT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20250630_zWNYhSHLOZv" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20240630_z7wX7OJbppLc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzBVB_zU0FNBo50A12" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office equipment at cost</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,078</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,543</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzBVB_zsqSuSKYgq2c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: Accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25,078</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25,543</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzBVB_zabdinYO5O6c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total property, plant, and equipment</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3174">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl3175">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 25078 25543 25078 25543 297 <p id="xdx_80F_eus-gaap--OtherLiabilitiesDisclosureTextBlock_zBwAluMwdlD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_822_zzdzEukW4K4">DUE TO AND LOANS FROM FORMER DIRECTOR - RELATED PARTY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Due to former director – related party</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to former director – related party represented unsecured advances made primarily by a former director for operating expenses on behalf of the Company, such as intellectual property and formation expenses. The expenses were paid for on behalf of the Company and were due upon demand. The Company was not charged interest under these advances. The total amount owed the former director at June 30, 2025 and 2024 were $<span id="xdx_909_eus-gaap--OtherLiabilitiesCurrent_iI_pp0p0_dxL_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_zCvJhlX8gjBf" title="Due to related parties current::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl3183">0</span></span> and $<span id="xdx_901_eus-gaap--OtherLiabilitiesCurrent_iI_pp0p0_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_zBNs2stscHA9" title="Due to related parties current">29,759</span>, respectively. On January 23, 2025, the Company entered into a Debt Exchange Agreement (“the Debt Exchange”) with the former director (see below) to settle such debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Loan from Former Director - Related Party</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan from the Company’s former director at June 30, 2025 and 2024 were $<span id="xdx_906_eus-gaap--LoansPayableCurrent_iI_dxL_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorsMember_zsELoTXHUNO7" title="Loan payable::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl3187">0</span></span> and $<span id="xdx_900_eus-gaap--LoansPayableCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorsMember_zYzTCfvGTzkc" title="Loan payable">49,528</span>, respectively. The loan bore no interest and was payable on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 23, 2025, the Company entered into a Debt Exchange with the former director and issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250123__20250123__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zlKeRngkhfDe" title="Number of shares of common stock issued in exchange on loan">30,000</span> shares of common stock in exchange for the total outstanding loans of $<span id="xdx_906_ecustom--SettlementOfLoansForSharesOfCommonStock_pp0p0_c20250123__20250123__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zmCZysyBN5D6" title="Settlement of loans for shares of common stock">74,395</span> (which also includes the $<span id="xdx_901_eus-gaap--OtherLiabilitiesCurrent_iI_pp0p0_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_zVZcTseidtzk" title="Due to related parties current">29,759</span> amount as noted above under due to former director). Those shares were valued at approximately $<span id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20250123__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_ze16jB7zWzAk" title="Conversion price per share">13</span> per share or $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pp0p0_c20250123__20250123__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zyOVZAJx1wB8" title="Value of shares of common stock issued in exchange on loan">375,000</span>, being the closing price of the stock on the date of grant to the former director. Accordingly, the fair market value of the shares issued was $<span id="xdx_90A_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20250630__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zQVFcQTPvo5b" title="Debt instrument fair value">375,000</span>, resulting in a loss on extinguishment of debt at the time of exchange of $<span id="xdx_903_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zjOdYrARi4Di" title="Loss on extinguishment debt conversion">300,605</span> during the year ended June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 29759 49528 30000 74395 29759 13 375000 375000 300605 <p id="xdx_80F_eus-gaap--DebtDisclosureTextBlock_zlK5HEAym22i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_82A_z413NfpMNBS5">LOANS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Loans payable - Related Party</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between November 2023 and May 2024, an institutional investor affiliated with one of our directors, Josef Zelinger, loaned the Company an aggregate of $<span id="xdx_90F_eus-gaap--LoansPayableCurrent_iI_c20231130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z2iYq3g6RG77" title="Loan payable"><span id="xdx_905_eus-gaap--LoansPayableCurrent_iI_c20240531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zkaigKVgJ2Se" title="Loan payable">71,629</span></span>. Additionally, in August 2024, the same affiliated institutional investor loaned the Company an amount of $<span id="xdx_902_eus-gaap--LoansPayableCurrent_iI_uAUD_c20240831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zSrsJm7wk3kl" title="Loan payable">85,000</span> AUD ($<span id="xdx_906_eus-gaap--LoansPayableCurrent_iI_uUSD_c20240831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zqR7Zp7TBkd2" title="Loan payable">57,639</span> USD). These loans bear no interest and are payable on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective August 1, 2024, the Company entered and closed a loan agreement with an institutional investor affiliated with one of our directors, Josef Zelinger, pursuant to which the investor loaned the Company an aggregate principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zqygDLVysBAi" title="Aggregate principal amount">150,000</span> AUD ($<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z4Fv6P3SZ6nf" title="Aggregate principal amount">98,060</span> USD). The Company used the net proceeds for general working capital purposes. The maturity date of the loan is <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20240801__20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z9xilJqXzab1" title="Debt instrument maturity date">November 1, 2024</span>, or sooner at the discretion of the Company, and the loan bears an interest rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20240801__20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zlbIWfHw2l3h" title="Debt instrument loan bears interest rate">12</span>% per annum and default interest rate of <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zPndQcBY7R7h" title="Debt instrument interest rate">18</span>% per annum. The Company has the right to prepay in full at any time with no prepayment penalty. By mutual consent the amount can be repaid via the issuance of common stock of the Company (upon uplisting on NASDAQ) and the strike price shall be at a <span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20240801__20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zUZmD0r8SMX7" title="Debt instrument strike price">35</span>% discount to lowest daily balance of the five preceding trading days. Such loan is past due and currently in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between November 2024 and December 2024, an institutional investor affiliated with one of our directors, Josef Zelinger, loaned the Company an aggregate of $<span id="xdx_90F_eus-gaap--RepaymentsOfRelatedPartyDebt_uAUD_c20241101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zrc6xf1jzvOg" title="Loan payable">15,000 </span>AUD ($<span id="xdx_907_eus-gaap--RepaymentsOfRelatedPartyDebt_uUSD_c20241101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zMixnFnI0908" title="Loan payable">9,731 </span>USD). These loans bear no interest and are payable on demand. The Company repaid $<span id="xdx_90B_eus-gaap--RepaymentsOfBankDebt_c20250819__20250819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zjnGvhIriFig" title="Repaid loan amount">12,000</span> AUD of this loan on August 19, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective December 3, 2024, the Company entered and closed a loan agreement with an institutional investor affiliated with one of our directors, Josef Zelinger, pursuant to which the investor loaned the Company an aggregate principal amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20241203__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zMtBpGQ0Uakj" title="Aggregate principal amount">175,000</span> AUD ($<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20241203__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z8MyBq4k2mZg" title="Aggregate principal amount">113,485</span> USD). The Company used the net proceeds for general working capital purposes. The term of the loan is four months or less (to be determined at the discretion of the Company), with $<span id="xdx_90B_eus-gaap--LoansPayable_iI_uAUD_c20250228__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z2FVdsaQmL6k" title="Loans payable">70,000</span> AUD was due on <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20241203__20241203__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zLjNngxLLGQk" title="Debt instrument maturity date">February 28, 2025</span>, and $<span id="xdx_909_eus-gaap--LoansPayable_iI_uAUD_c20250402__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zXIoZGVIEKm" title="Loans payable">105,000</span> AUD was due on April 2, 2025. The loan bears an interest rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20241203__20241203__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z0rb1TP95Yy6" title="Debt instrument loan bears interest rate">12</span>% per annum and default interest rate of <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20241203__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zXLrAhzo00gc" title="Debt instrument interest rate">18</span>% per annum. Such loan is past due and currently in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2025, an institutional investor affiliated with one of our directors, Josef Zelinger, loaned the Company an aggregate of $<span id="xdx_90C_eus-gaap--RepaymentsOfRelatedPartyDebt_uAUD_c20250101__20250131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zPRVwRV4m9F6" title="Loan payable">25,000 </span>AUD ($<span id="xdx_90F_eus-gaap--RepaymentsOfRelatedPartyDebt_uUSD_c20250101__20250131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z3U6sMb2q7v9" title="Loan payable">15,485</span> USD). This loan bore no interest and was payable on demand. The Company fully repaid this loan on August 19, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 12, 2025, the Company entered and closed a loan agreement with an institutional investor affiliated with one of our directors, Josef Zelinger, pursuant to which the investor loaned the Company an aggregate principal amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20250412__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z8t3WpT0PAcc" title="Aggregate principal amount">63,188</span> AUD ($<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20250412__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zmEy6EsHwwL2" title="Aggregate principal amount">39,625</span> USD). The Company used the net proceeds for general working capital purposes. The maturity date was June 30, 2025. The loan bore an interest rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20250412__20250412__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zDRmeXj5fk6k" title="Debt instrument loan bears interest rate">12</span>% per annum and default interest rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250412__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zHZWrXNsGT1g" title="Debt instrument interest rate">18</span>% per annum. The Company fully repaid this loan on August 19, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 13, 2025, the Company entered and closed a loan agreement with an institutional investor affiliated with one of our directors, Josef Zelinger, pursuant to which the investor loaned the Company an aggregate principal amount of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20250613__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zhzo3MGkydcb" title="Aggregate principal amount">15,000</span> AUD ($<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20250613__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zTVhH9sXHg9k" title="Aggregate principal amount">9,675</span> USD). The Company used the net proceeds for general working capital purposes. The maturity date was on June 30, 2025. The loan bore an interest rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20250613__20250613__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zjKrqTjEDk18" title="Debt instrument loan bears interest rate">12</span>% per annum and default interest rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250613__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z7nLJ9BYSKoa" title="Debt instrument interest rate">18</span>% per annum. The Company fully repaid this loan on August 19, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The loans payable – related parties amounted to $<span id="xdx_905_eus-gaap--LoansPayableCurrent_iI_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zZdeywxfYHT8" title="Loan payable">415,329</span> and $<span id="xdx_90B_eus-gaap--LoansPayableCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zKzVgB6Nsb85" title="Loan payable">71,629</span> as of June 30, 2025 and 2024, respectively. Accrued interest as of June 30, 2025, and 2024 was $<span id="xdx_901_ecustom--InterestLoanPayable_iI_c20250630_zaQAqNrVvJba" title="Interest payable">26,452</span> and $<span id="xdx_90B_ecustom--InterestLoanPayable_iI_c20240630_z73v1zTm96lg" title="Interest payable">0</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Loan payable -long-term- Related Party</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 5, 2023, the Company and an institutional investor affiliated with one of our directors, Josef Zelinger, entered into a letter agreement, pursuant to which such investor loaned the Company an aggregate of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zKpMTZabTtid" title="Investor loan, value">230,000</span> AUD ($<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_z1j1wVb1VGrj" title="Investor loan, value">153,256</span> USD). Pursuant to such agreement, the term of such loan is three (<span id="xdx_902_eus-gaap--DebtInstrumentTerm_dtY_c20230705__20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zylWRm1F5xp6" title="Term of agreement">3</span>) years, ending on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20230705__20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zLUIjQjKNbgc" title="Debt instrument maturity date">July 5, 2026</span>, with an interest rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zj1RiHSyROc2" title="Debt instrument interest rate">10</span>% to be paid monthly in arrears. In connection with such loan, the Company issued 250 warrants to purchase common stock to such investor immediately exercisable at an initial exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zuPUhhjjY1I1" title="Share price">600</span> per share (subject to certain adjustments such as stock dividend, stock splits, subsequent right offering and pro-rata distribution) with an expiry date of July 5, 2026. The Company accounted for the<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20230705__20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zDIuEbcMrtZ" title="Issue of warrants"> 250</span> warrants issued with this loan payable as debt discount by using the relative fair value method. The total debt discount which is equivalent to the relative fair value of the warrants of $<span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_c20230705__20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zY2vUecAsgHb" title="Fair value adjustment of warrants">141,084</span> was based on a fair value determination using a Black-Scholes model with the following assumptions: stock price at valuation date of $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20230705__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zZWkATmdBvK2" title="Stock valuation price per share">7,140</span> based on the closing price of common stock at date of grant, exercise price of $<span id="xdx_903_eus-gaap--WarrantExercisePriceIncrease_c20230705__20230705__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zip157ZDXZE5" title="Warrant exercise price">600</span>, dividend yield of zero, expected term of <span id="xdx_901_eus-gaap--DebtInstrumentTerm_dtY_c20230705__20230705__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zaZnZseOvOE1" title="Maturity term">3.00</span>, a risk-free rate of <span id="xdx_900_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20230705__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zI8a3HJj3l7i" title="Measurement input">4.59</span>%, and expected volatility of <span id="xdx_900_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20230705__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zsEUOpy081yj" title="Measurement input">268</span>%. The debt discount shall be amortized over the term of this loan. A portion of the proceeds of such loan were used to repay an outstanding balance of approximately $<span id="xdx_903_eus-gaap--RepaymentsOfConvertibleDebt_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zbdWIZbPWYJg" title="Settlement of convertible debt">143,000</span> due on a convertible note held by a third-party investor which had been in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued interest from this loan amounted to $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zIRkfPeccuvk" title="Interest payable">15,158</span> as of June 30, 2024. Amortization of debt discount from this loan for fiscal year 2024 was $<span id="xdx_90B_eus-gaap--AmortizationOfDebtDiscountPremium_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zz2RKX9FEZVf" title="Amortization of debt discounts">46,470</span>. The total principal outstanding under this loan was $<span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zc6ZC0rTkQ0c" title="Remaining debt amount">153,256</span> and remaining unamortized debt discount of $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zr3B9oBfsekj" title="Remaining debt discount">94,614</span> as of June 30, 2024, as reflected in the accompanying consolidated balance sheet as loan payable – long-term – related party, net of discount of $<span id="xdx_90A_eus-gaap--LongTermLoansPayable_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zCeuXGchfwk" title="Loan payable - long-term - related party, net of discount">58,642</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued interest from this loan amounted to $<span id="xdx_901_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z0oxlGdFp0Vl" title="Interest payable">30,483</span> as of June 30, 2025. Amortization of debt discount for fiscal year 2025 was $<span id="xdx_90F_eus-gaap--AmortizationOfDebtDiscountPremium_c20240701__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zAQ1wg9mu036" title="Amortization of debt discounts">46,985</span>. The total principal outstanding under this loan was $<span id="xdx_908_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zI6P6c7ug3Pf" title="Remaining debt amount">153,256</span> and remaining debt discount of $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_za0Oh9W0hp3i" title="Remaining debt discount">47,629</span> as of June 30, 2025, as reflected in the accompanying consolidated balance sheet as loan payable – long-term – related party, net of discount of $<span id="xdx_906_eus-gaap--LongTermLoansPayable_iI_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zZ7jSUYwzYrh" title="Loan payable - long-term - related party, net of discount">105,627</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Loans Payable</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective October 3, 2019, the Company entered into a securities purchase agreement with Crown Bridge Partners, LLC (“Crown Bridge”), pursuant to which Crown Bridge purchased a convertible promissory note from the Company (the “Crown Bridge Note”), which had a remaining principal balance of $<span id="xdx_903_eus-gaap--ConvertibleDebt_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zcmOcXjtaYa3" title="Convertible debt"><span id="xdx_90B_eus-gaap--ConvertibleDebt_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zwWOfjFc8kX2" title="Convertible debt">65,280</span></span> as of June 30, 2025 and 2024. The maturity date of the Crown Bridge Note was October 3, 2020 and is currently past due. The Crown Bridge Note bore interest at a default interest rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20191003__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zKx4aSeUcxkk" title="Debt instrument interest rate stated percentage">15</span>% per annum. In August 2022, the SEC filed a complaint against Crown Bridge due to its violation of Section 15(a)(1) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Crown Bridge agreed to surrender all conversion rights in its currently held convertible notes, including the Crown Bridge Note. Consequently, during fiscal year 2023, the Company reclassified the remaining principal balance of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zK6b5NfWvfX5" title="Debt instrument face amount"><span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zEBwZ4VxEyDj" title="Debt instrument face amount">65,280</span></span> from a convertible note into a loan payable which is the principal balance at June 30, 2025, and 2024. Additionally, the Company recorded the remaining put premium of $<span id="xdx_900_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20220701__20230630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zGpTLJOU9yKj" title="Gain on extinguishment of debt">43,520</span> into gain on extinguishment of debt during fiscal year 2023. The total accrued interest from this loan amounted to $<span id="xdx_908_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zViMqJidTf08" title="Interest payable">55,360 </span>and $<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zqMu3nX6EcAa" title="Interest payable">45,541</span> as of June 30, 2025, and 2024, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Loans Payable - others</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2024, the Company entered into loan agreements with two investors who loaned the Company an aggregate of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20240630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zchFkuC6fy4l" title="Debt instrument face amount">120,000</span> AUD ($<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20240630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zWt0yQu687Fc" title="Debt instrument face amount">79,811</span> USD). The maturity dates of these loans were both in June 2025. These loans bore interest at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zDpAg0qWoNV9" title="Debt instrument interest rate stated percentage">12</span>% per annum. On February 5, 2025, the Company entered into a Debt Exchange Agreements with the two investors and issued an aggregate of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250205__20250205__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_zH9fcKuzRYS8" title="Number of shares of common stock in exchange of loans">30,000 </span>shares of common stock in exchange for the total outstanding loan including accrued interest of $<span id="xdx_908_eus-gaap--LoansPayable_iI_c20250205__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_zzM7nViY7KUf" title="Outstanding loan including accrued interest">86,248</span>. Those shares were valued at $<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250205__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_zc8enGeNmrW6" title="Conversion price per share">10 </span>per share or $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20250205__20250205__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_zi9hae0VKOve" title="Value of shares of common stock in exchange of loans">300,000</span>, being the closing price of the stock on the date of grant to the two investors. Accordingly, the fair market value of the shares issued was $<span id="xdx_905_eus-gaap--DebtInstrumentFairValue_iI_c20250205__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_z1hY6q82nW3j" title="Debt instrument fair value">300,000</span>, resulting in a loss on extinguishment of debt at the time of exchange of $<span id="xdx_901_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_zv1YECNknwRd" title="Loss on extinguishment debt conversion">213,752</span> during the year ended June 30, 2025. As of June 30, 2025, and 2024, the total balance of these loans amounted to $<span id="xdx_903_eus-gaap--DebtInstrumentFeeAmount_iI_c20250630_zVCuAuvv7Lda" title="Debt remaining">0</span> and $<span id="xdx_908_eus-gaap--DebtInstrumentFeeAmount_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zWr49XGBbJ76" title="Debt remaining">79,811</span>, respectively, and accrued interest of $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zXOoUqOL3Wzl" title="Interest payable">6,286</span> and $<span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zTcXPeWfDu6i" title="Interest payable">665</span>, respectively. The Company fully paid the accrued interest of $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250827__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zRWdUDGnLZVa" title="Interest payable">6,286</span> on August 27, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate principal outstanding on the above loans was $<span id="xdx_90D_eus-gaap--LoansPayable_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zmUJMwN2A3j4" title="Loans payable">65,280</span> and $<span id="xdx_90B_eus-gaap--LoansPayable_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zO4fQKIWh2v6" title="Loans payable">145,091</span> as of June 30, 2025 and 2024, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Loans in default</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Crown Bridge Note is currently past due and in default, consisting of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20250630__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zi5sT3wxZQYd" title="Debt instrument face amount">65,280</span> principal and $<span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_znxSecHHFoj7" title="Interest payable current and non current">55,360</span> accrued interest, which includes interest accruing at the default interest rate at <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20250630__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zHt4rV02Ye16" title="Debt instrument interest rate stated percentage">15</span>%. Loans payable – related party <span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; line-height: 115%">for total principal amount of $<span id="xdx_90E_eus-gaap--LoansPayableCurrent_iI_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zbjVqaKdVdwf" title="Loan payable">260,485</span> and accrued interest of $<span id="xdx_90C_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zWow4hdAiZeh" title="Interest payable current and non current">26,452</span> with maturity dates between November 2024 and June 2025 were in default as of June 30, 2025.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 71629 71629 85000 57639 150000 98060 2024-11-01 0.12 0.18 0.35 15000 9731 12000 175000 113485 70000 2025-02-28 105000 0.12 0.18 25000 15485 63188 39625 0.12 0.18 15000 9675 0.12 0.18 415329 71629 26452 0 230000 153256 P3Y 2026-07-05 0.10 600 250 141084 7140 600 P3Y 4.59 268 143000 15158 46470 153256 94614 58642 30483 46985 153256 47629 105627 65280 65280 0.15 65280 65280 43520 55360 45541 120000 79811 0.12 30000 86248 10 300000 300000 213752 0 79811 6286 665 6286 65280 145091 65280 55360 0.15 260485 26452 <p id="xdx_80F_ecustom--NotesPayableAndConvertibleNotesTextBlock_zR4Za1qMvEVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – NOTE PAYABLE AND CONVERTIBLE NOTES <span id="xdx_829_zISOzCOfI0A8" style="display: none">NOTES PAYABLE AND CONVERTIBLE NOTES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89B_eus-gaap--ScheduleOfDebtTableTextBlock_zNo0kftXfNt" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s promissory notes outstanding at June 30, 2025 and 2024 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zNSTdUbXMrVd" style="display: none">SCHEDULE OF PROMISSORY NOTES OUTSTANDING</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z4BkE0JINWPd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20240630__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zt2clR8wxrMa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--NotesPayable_iI_maDICAzqJo_zomgedq6zotc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Principal amounts of notes payable</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">589,277</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">230,400</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_msDICAzqJo_zjIexWzZH0Ad" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Unamortized discounts</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(45,965</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25,706</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40A_eus-gaap--DebtInstrumentCarryingAmount_iTI_mtDICAzqJo_zUP9IE2LOnz5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Notes payable, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">543,312</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">204,694</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AD_zLXlpF0Igrpa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Promissory Notes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 15, 2023, the Company issued to an institutional investor (the “August 2023 Lender”) a <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20230815__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_z1KzaHbFiX9c" title="Debt instrument original issue discount rate">10</span>% original issue discount promissory note (the “Promissory Note”) in consideration for $<span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20230815__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_z9AT1otFAxie" title="Debt instrument, discount amount">120,000</span>, which has a principal face amount of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20230815__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zeNxcK8c9dJf" title="Debt instrument, face amount">132,000</span>, matured on <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20230815__20230815__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_z8N9257DCiY1" title="Debt instrument maturity date">November 15, 2023</span> and accrued interest at a rate of <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230815__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zkYceiL0WrHa" title="Debt instrument interest rate">10</span>% per annum, and was increased to <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateIncreaseDecrease_pid_dp_uPure_c20230815__20230815__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zHB2fHrQhKsh" title="Debt instrument increase interest rate">18</span>% due to the event of a default. The Company had the right to prepay the principal and accrued but unpaid interest due under the Promissory Note, together with any other amounts that the Company may owe the August 2023 Lender under the terms of the Promissory Note, on or before September 14, 2023 at a 110% premium of the face amount plus accrued and unpaid interest and any other amounts owed to the August 2023 Lender, which increases to (i) 120% if prepaid after such date, but on or before October 14, 2023, and (ii) 130% if prepaid after October 14, 2023 (including on the maturity date), unless the Company and the Lender agree to otherwise effect repayment. The Promissory Note contains certain customary events of default set forth in the Promissory Note, including, among others, breach of covenants, representations or warranties, insolvency, bankruptcy, liquidation and failure by the Company to pay the principal and interest due under the Promissory Note. On May 7, 2024, August 2023 Lender notified the Company that the 130% default repayment plus interest will be waived and shall extend the maturity of the Promissory Note to September 30, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective May 7, 2025, the Company entered into a Maturity Extension Agreement with the August 2023 Lender whereby the August 2023 Lender agreed to extend the maturity date of the promissory note dated August 15, 2023, which was amended on May 7, 2024 (the “Old Note”) to June 15, 2025 and increasing the principal amount by a default penalty of $<span id="xdx_905_eus-gaap--DebtDefaultLongtermDebtAmount_iI_c20250507__us-gaap--TypeOfArrangementAxis__custom--MaturityExtensionAgreementMember_zCi7xIwN1bp3" title="Debt Default penalty">39,600</span> and adding accrued interest of $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250507__us-gaap--TypeOfArrangementAxis__custom--MaturityExtensionAgreementMember_zlMv4T8gOmri" title="Interest payable current and non current">30,805</span> into the principal amount thereby increasing the current principal amount to $<span id="xdx_906_eus-gaap--DebtInstrumentAnnualPrincipalPayment_iI_c20250507__us-gaap--TypeOfArrangementAxis__custom--MaturityExtensionAgreementMember_zaTG6sBLubp4" title="Amount repaid for covertible debt">202,405</span>. All other terms of the Old Note shall remain unchanged and in full force and effect. As of June 30, 2025, the Promissory Note was in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 7, 2025, the Company entered into a promissory note agreement with an institutional investor, pursuant to which the investor agreed to purchase a promissory note from the Company in the aggregate principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20250507__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zZBsYd6WZjEg" title="Principal amount">90,000</span>, for a purchase price of $<span id="xdx_905_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20250507__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zKx96n5Y106e" title="Purchase amount">75,000</span>. Such note is a non-convertible note. The maturity date of the note was on <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20250507__20250507__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zNhEDWo2VJ6d" title="Debt instrument maturity date">June 15, 2025</span> and bears interest at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20250507__20250507__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zHOqXZ8O4iM3" title="Debt instrument loan bears interest rate">10</span>% per annum and default interest rate of <span id="xdx_904_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20250507__20250507__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zTlMYdW4SZQa" title="Debt instrument default interest rate">18</span>% per annum. <span id="xdx_904_eus-gaap--DebtInstrumentPaymentTerms_c20250507__20250507_zSGMxq1bRYQ5" title="Debt instrument repayment term">Repayment of the note may occur as follows: (a) if the Company repays this note on or before June 7, 2025, then Company shall pay investor in cash the sum of one hundred percent (100%) of the sum of the outstanding principal amount of the note (the “Principal Amount”) at such time, all accrued interest unpaid at such time, and any other payment due; and (b) if the Company repays the note after June 7, 2025 and on or before July 7, 2025, then Company shall pay investor in cash the sum of one hundred twenty percent (120%) of the sum of the outstanding Principal Amount at such time, all accrued interest unpaid at such time, and any other payment due (the “Maximum Repayment Amount”) or (b) at such time as the Company and the investor may agree to effect repayment. As of June 30, 2025, the promissory note was in default.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 2, 2025, the Company entered into a promissory note agreement with an institutional investor, pursuant to which the investor agreed to purchase a promissory note from the Company in the aggregate principal amount of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20250602__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zczaglDg8Uf3" title="Debt instrument face amount">60,000</span>, for a purchase price of $<span id="xdx_90A_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20250602__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zEmwhup5uz84" title="Purchase amount">50,000</span>. Such note is a non-convertible note. The maturity date of the note is on July 15, 2025 and bears interest at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20250602__20250602__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z3t5HSbl7HJe" title="Debt instrument loan bears interest rate">10</span>% per annum and default interest rate of <span id="xdx_908_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20250602__20250602__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zQTMIzdvzPpl" title="Debt instrument default interest rate">18</span>% per annum. <span id="xdx_90B_eus-gaap--DebtInstrumentPaymentTerms_c20250602__20250602_z2ZeoQTkB164" title="Debt instrument repayment term">Repayment of the note may occur as follows: (a) if the Company repays this note on or before July 7, 2025, then Company shall pay investor in cash the sum of one hundred percent (100%) of the sum of the outstanding principal amount of the note (the “Principal Amount”) at such time, all accrued interest unpaid at such time, and any other payment due; and (b) if the Company repays the note after July 7, 2025 and on or before August 7, 2025, then Company shall pay investor in cash the sum of one hundred twenty percent (120%) of the sum of the outstanding Principal Amount at such time, all accrued interest unpaid at such time, and any other payment due (the “Maximum Repayment Amount”) or (b) at such time as the Company and the investor may agree to effect repayment.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued interest from these notes amounted to $<span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zEXmGkENWPCi" title="Interest payable">5,718</span> and $<span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20240630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zfzjnuWyFZ95" title="Interest payable">15,536</span> as of June 30, 2025 and 2024, respectively. Amortization of debt discount from these notes for fiscal year 2025 and 2024 was $<span id="xdx_904_eus-gaap--AmortizationOfDebtDiscountPremium_c20240701__20250630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zaSONXRaqYF2" title="Amortization of debt discounts">21,512</span> and $<span id="xdx_90F_eus-gaap--AmortizationOfDebtDiscountPremium_c20230701__20240630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zjaWkf7hEw4e" title="Amortization of debt discounts">12,000</span>, respectively. As of June 30, 2025 and 2024, the total principal outstanding under these notes was $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zP1xdzg7r4C4" title="Debt remaining">352,405</span> and $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zQYTNvQsuHg" title="Debt remaining">132,000</span>, respectively, and remaining debt discount of $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_z9VQFrt4Hsp6" title="Remaining debt discount">3,488</span> and $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zwSXp4O8Ota9" title="Remaining debt discount">0</span> as of June 30, 2025 and 2024, respectively, as reflected in the accompanying consolidated balance sheet as notes payable, net of discount.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 19, 2025, the Company fully repaid the total principal for all the above mentioned promissory notes amounting $<span id="xdx_909_eus-gaap--DebtInstrumentRepaidPrincipal_c20250819__20250819__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7x077hng2F3" title="Debt instrument repaid principal amount">352,405</span> including total accrued interest and default penalty of $<span id="xdx_908_eus-gaap--DebtDefaultLongtermDebtAmount_iI_c20250819__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zEH6puASgV2d" title="Debt default long term debt amount">34,320</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">1800 Diagonal Lending Promissory Notes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 24, 2024, the Company entered into a <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20240524__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zbcav7I3FNCh" title="Debt instrument original issue discount rate">15</span>% promissory note in the amount of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20240524__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zcoGf3Qwju4a" title="Principal amount">49,200</span> less original issue discount of $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20240524__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zctXTbfR8UBd" title="Original issue discounts amount">8,200</span> and legal and financing costs of $<span id="xdx_907_eus-gaap--PaymentsOfFinancingCosts_c20240524__20240524__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zoSO0ZZkYpJf" title="legal and financing costs">6,000</span> for net proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_c20240524__20240524__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zOBYiD1SIJvh" title="Net proceeds">35,000</span> with 1800 Diagonal Lending, LLC. The principal and accrued interest is payable on or before March 30, 2025. Any amount of principal or interest on this note which is not paid when due shall bear interest at the rate of twenty two percent (<span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240524__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zrNf2yKqeqSb" title="Debt instrument interest rate">22</span>%) per annum from the due date thereof until the same is paid. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid on November 30, 2024 in the amount of $<span id="xdx_908_eus-gaap--DebtInstrumentPeriodicPayment_c20241130__20241130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zGhzFCFh5vf8" title="Debt periodic payment">28,290</span> and 4 payments each in the amount of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20241130__20241130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z4wWoS9LRKo7" title="Debt repayment">7,072.50</span> (a total payback to the Holder of $<span id="xdx_905_eus-gaap--RepaymentsOfShortTermDebt_c20241130__20241130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zcSBbXB8rCy2" title="Payment of debt">56,580</span>). The first payment of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp2d_c20241230__20241230__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_znKHzNTJasl9" title="Debt repayment">7,072.50</span> shall be due on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20241230__20241230__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zlJ3el5aovSf" title="Maturity date">December 30, 2024</span> with 3 subsequent payments each month thereafter. The Company shall have a five (5) day grace period with respect to each payment. In November 2024, the Company fully paid the principal of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20241130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z5ZbphnF28E1" title="Principal amount">49,200</span> and accrued interest of $<span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20241130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z3P4b3kmZgyb" title="Accrued interest">5,683</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 10, 2024, the Company entered a <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20240610__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z48WVdJOYW8i" title="Debt instrument original issue discount rate">15</span>% promissory note in the amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20240610__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zjDCT8UEBsnj" title="principal amount">49,200</span> less original issue discount of $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20240610__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zrB3NN6WE3Cj" title="Original issue discounts amount">8,200</span> and legal and financing costs of $<span id="xdx_901_eus-gaap--PaymentsOfFinancingCosts_c20240610__20240610__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zTelOWiqZTjl" title="legal and financing costs">6,000</span> for net proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfDebt_c20240610__20240610__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zhTeNopldCD3" title="Net proceeds">35,000</span> with 1800 Diagonal Lending, LLC. The principal and accrued interest is payable on or before April 15, 2025. Any amount of principal or interest on this note which is not paid when due shall bear interest at the rate of twenty-two percent (<span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240610__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zgnRXLUa8De5" title="Debt instrument interest rate">22</span>%) per annum from the due date thereof until the same is paid. Accrued unpaid interest and outstanding principal, subject to adjustment, shall be paid on December 15, 2024 in the amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPayment_c20241215__20241215__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zIX3qnoJfVgj" title="Debt periodic payment">28,290</span> and 4 payments each in the amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPaymentInterest_c20241215__20241215__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zfEDeBcwJj0d" title="Debt repayment">7,073</span> (a total payback to the Holder of $<span id="xdx_90E_eus-gaap--RepaymentsOfShortTermDebt_c20241215__20241215__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zAcUeAmveNV6" title="Payment of debt">56,580</span>). The first payment of $<span id="xdx_90B_eus-gaap--DebtInstrumentPeriodicPaymentInterest_c20250115__20250115__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z3UJ1HijwDa1" title="Debt repayment">7,073</span> shall be due on January 15, 2025, with 3 subsequent payments each month thereafter. The Company shall have a five (5) day grace period with respect to each payment. In November 2024, the Company fully paid the principal of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20241130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zyXKmiCepmV8" title="Payment of debt">49,200</span> and accrued interest of $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20241130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember_zI0pIfVLdpc4" title="Accrued interest">5,683</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 31, 2025, the Company entered into and closed a securities purchase agreement 1800 Diagonal (the “Investor”), pursuant to which the Investor agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20250131__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zmEvAb0mu9L3" title="Principal amount">65,000</span>, for a purchase price of $<span id="xdx_908_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20250131__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zbiCdY3iaWD4" title="Purchase amount">56,000</span>. <span id="xdx_906_eus-gaap--DebtInstrumentDescription_c20250131__20250131__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_znk7KBoq8iP2" title="Debt instrument description">The Company intends to use the net proceeds therefrom for general working capital purposes. The maturity date of the note is <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20250131__20250131__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zUKCsA6tI8ai" title="Maturity date">November 30, 2025</span> and the note bears a one-time interest charge of fifteen percent that shall be applied on the issuance date. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in five (5) payments</span>, with the first on July 30, 2025, for $<span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPayment_c20250730__20250730__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z7IeGd29Fpgb" title="Debt periodic payment">37,375</span>, and the other four payments of $<span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20250830__20250830__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zF8tujIsJu28" title="Debt periodic payment"><span id="xdx_90C_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20250930__20250930__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zOQtj9KBAqF5" title="Debt periodic payment"><span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20251030__20251030__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_ztknkVVDqkz" title="Debt periodic payment"><span id="xdx_90E_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20251130__20251130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zGCkanTuwtLc" title="Debt periodic payment">9,344</span></span></span></span> on August 30, 2025, September 30, 2025, October 30, 2025 and November 30, 2025 (a total payback to the Holder of $<span id="xdx_901_eus-gaap--RepaymentsOfShortTermDebt_c20251130__20251130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zwVVdHhLMMpa" title="Payment of debt">74,750</span>). The Company shall have a five (5) day grace period with respect to each payment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 25, 2025, the Company entered and closed a securities purchase agreement 1800 Diagonal (the “Investor”), pursuant to which the Investor agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20250325__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zPyXVybYWM2" title="Principal amount">79,200</span>, for a purchase price of $<span id="xdx_907_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20250325__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zRIhYDvXcFm8" title="Purchase amount">67,000</span>. <span id="xdx_905_eus-gaap--DebtInstrumentDescription_c20250325__20250325__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember_zP0hZwlx8CY6" title="Debt instrument description">The Company intends to use the net proceeds therefrom for general working capital purposes. The maturity date of the note is <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20250325__20250325__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zKQo1MdyzrEa" title="Maturity date">January 30, 2026</span>, and the note bears a one-time interest charge of fifteen percent that shall be applied on the issuance date. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in five (5) payments</span>, with the first on September 30, 2025, for $<span id="xdx_90C_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20250930__20250930__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zCQdp2JrKcDa" title="Debt periodic payment">45,540</span>, and the other four payments of $<span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20251030__20251030__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zHqi3ZNo6Mo7" title="Debt periodic payment"><span id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20251130__20251130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zRU0M6gc5le6" title="Debt periodic payment"><span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20251230__20251230__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zBPaFAEnHxXd" title="Debt periodic payment"><span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20260130__20260130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zWkD27eS8qn5" title="Debt periodic payment">11,385</span></span></span></span> on October 30, 2025, November 30, 2025, December 30, 2025 and January 30, 2026 (a total payback to the Holder of $<span id="xdx_901_eus-gaap--RepaymentsOfShortTermDebt_c20260130__20260130__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementOneMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zwYk5Kc99jZ4" title="Payment of debt">91,080</span>). The Company shall have a five (5) day grace period with respect to each payment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 13, 2025, the Company entered into a <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20250613__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zGfm8Oy889He">15</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% promissory note in the aggregate principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20250613__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zd1Vjj4T9I7d">67,860</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, for a purchase price of $<span id="xdx_90E_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20250613__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zUST8VEEZZcg">58,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. This note contains original issue discount of $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20250613__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zr10XhF3VcZd">8,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and legal and financing costs of $<span id="xdx_90C_eus-gaap--PaymentsOfFinancingCosts_c20250613__20250613__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zKofgtJvHBJf">9,860</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for net proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfDebt_c20250613__20250613__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z4JE33XEz1Za">50,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with 1800 Diagonal Lending, LLC. The maturity date of the note is <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20250613__20250613__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zxnPRriCLu4g">April 15, 2026</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and the note bears a one-time interest charge of fifteen percent that shall be applied on the issuance date. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in five (5) payments, with the first on December 15, 2025 for $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20251215__20251215__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zoBpJWHNPUIb">39,020</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and the other four payments on January 15, 2026, February 15, 2026, March 15, 2026 and April 15, 2026, each for $ <span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_pp2d_c20260415__20260415__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zqlPb7wMww4d">9,755</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a total payback to the Holder of $<span id="xdx_90E_eus-gaap--RepaymentsOfShortTermDebt_c20260415__20260415__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z9Zv8DYnCeq8">78,039</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">). The Company shall have a five (5) day grace period with respect to each payment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had the right to accelerate payments or prepay in full at any time with no prepayment penalty. At any time following an event of default, the noteholder shall have the right, to convert all or any part of the outstanding and unpaid amount of these notes into shares of common stock. The conversion price of the above notes shall mean <span id="xdx_909_ecustom--DebtInstrumentDebtConversionRate_pid_dp_uPure_c20240701__20250630__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zrjFR8SyiEH1" title="Debt conversion rate">65</span>% multiplied by the lowest trading price for the common stock during the 10 trading days prior to the conversion date (representing a discount rate of <span id="xdx_905_ecustom--DebtInstrumentDiscountRate_dp_uPure_c20240701__20250630__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zb8H2RYALs0d" title="Debt instrument discount rate">35</span>%) subject to a <span id="xdx_90D_ecustom--BeneficialOwnershipLimitationPercentage_dp_uPure_c20240701__20250630__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zGR8xQxertT5" title="Ownership limitations">4.99</span>% beneficial ownership limitations. Upon the occurrence of any event of defaults, these notes shall be immediately due and payable in an amount equal to <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20250630__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zQrbxPuUWEca" title="Debt instrument original issue discount rate">150</span>% default percentage multiplied by the sum of the outstanding principal balances plus accrued interest and default interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2025 and 2024 the total balance of these 1800 Diagonal Lending promissory notes amounted to $<span id="xdx_900_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zGVdQbXtjnMj" title="Debt remaining">212,060</span> and $<span id="xdx_905_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240630__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zHUqoAghoKV1" title="Debt remaining">98,400</span>, respectively and accrued interest of $<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zzdNHXfichoj" title="Accrued interest">7,638</span> and $<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20240630__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zT0fGlS8UmC6" title="Accrued interest">1,193</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between July 2025 and August 2025, the Company fully repaid the total principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentRepaidPrincipal_c20250731__20250731__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zIvEvmzbpwKi" title="Debt instrument repaid principal amount"><span id="xdx_901_eus-gaap--DebtInstrumentRepaidPrincipal_c20250831__20250831__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWOrKZTFNkGd" title="Debt instrument repaid principal amount">212,060</span></span> including accrued interest for the above 1800 Diagonal Lending promissory notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Red Road Holdings Promissory Note</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 4, 2024, the Company entered into a <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zlyG6nZBjGo1" title="Debt instrument original issue discount rate">15</span>% promissory note in the amount of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zgI2vGonjjk5" title="Promissory note amount">49,200</span> less original issue discount of $<span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zudCJBhuNXLj" title="Original issue discounts amount">8,200</span> and legal and financing costs of $<span id="xdx_906_eus-gaap--PaymentsOfFinancingCosts_c20241204__20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_z1n0ckSYl3Pg" title="Legal and financing costs">6,000</span> for net proceeds of $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfDebt_c20241204__20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zebNMO3cUJwf" title="Net proceeds">35,000</span> with Red Road Holdings. The principal and accrued interest was payable on or before October 15, 2025. Any amount of principal or interest on this note which was not paid when due shall bear interest at the rate of twenty two percent (<span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zoEkGZPOz72" title="Debt instrument interest rate">22</span>%) per annum from the due date thereof until the same was paid. Accrued interest and outstanding principal, subject to adjustment, shall be paid on June 15, 2025 in the amount of $<span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPayment_c20241204__20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zX8DBIXA5cFj" title="Debt periodic payment">28,290</span> and 4 payments each in the amount of $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentInterest_c20241204__20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zQ49A5MsROLh" title="Debt repayment">7,072 </span>(a total payback to the Holder of $<span id="xdx_900_eus-gaap--RepaymentsOfShortTermDebt_c20250615__20250615__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_z8kgQKOddha4" title="Payment of debt">56,580</span>). The first payment of $<span id="xdx_90C_eus-gaap--DebtInstrumentPeriodicPaymentInterest_c20250715__20250715__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zX3KvslYuzb5" title="Debt repayment">7,072</span> is due on July 15, 2025 with 3 subsequent payments each month thereafter. The Company had a five (5) day grace period with respect to each payment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had the right to accelerate payments or prepay in full at any time with no prepayment penalty. At any time following an event of default, the noteholder has the right, to convert all or any part of the outstanding and unpaid amount of the note into shares of common stock. The conversion price of the note is equal to <span id="xdx_90C_ecustom--DebtInstrumentDebtConversionRate_pid_dp_uPure_c20241204__20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zBtPUFTmndL1" title="Debt conversion rate">65</span>% multiplied by the lowest trading price for the common stock during the 10 trading days prior to the conversion date (representing a discount rate of <span id="xdx_906_ecustom--DebtInstrumentDiscountRate_pid_dp_uPure_c20241204__20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zHDY30Bemyud" title="Debt instrument discount rate">35</span>%) subject to a <span id="xdx_901_ecustom--BeneficialOwnershipLimitationPercentage_pid_dp_uPure_c20241204__20241204__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zI7MC2lPsi3b" title="Ownership limitations">4.99</span>% beneficial ownership limitations. Upon the occurrence of any event of defaults, the note shall be immediately due and payable in an amount equal to <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zdbTITN4yOpb" title="Debt instrument original issue discount rate">150</span>% default percentage multiplied by the sum of the outstanding principal balances plus accrued interest and default interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2025, the total balance of principal and accrued interest of the Red Road Holdings promissory note amounted to $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zD36HZ5N8h34" title="Balance principal">24,812</span> and $<span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zrTr9wvFdsqc" title="Accrued interest">303</span>, respectively, after the payment of the first installment of $<span id="xdx_90E_eus-gaap--DebtInstrumentPeriodicPayment_c20240701__20250630__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zWgEw8LUg4be" title="Debt periodic payment">28,290</span> in June 2025. In August 2025, the Company paid the 3 installment payments of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPaymentInterest_c20250831__20250831_zSrx5Drgnqhj" title="Debt repayment">7,072</span> for a total amount of $<span id="xdx_90E_eus-gaap--DebtInstrumentPeriodicPayment_c20250831__20250831__us-gaap--ShortTermDebtTypeAxis__custom--RedRoadHoldingsPromissoryNoteMember_zlapnbQbzszk" title="Debt periodic payment">21,217</span> for the above Red Road Holdings promissory note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total balance of the above nine promissory notes, net of unamortized discount of $<span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zsYH2cnIFgvh" title="Unamortized discounts">45,965</span> was $<span id="xdx_90F_eus-gaap--NotesPayable_iI_c20250630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zRN2Z2bKIn9" title="Debt remaining">543,312</span> at June 30, 2025. The total balance of the above three promissory notes, net of unamortized discount of $<span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zX2Zb9tEcy2d" title="Unamortized discounts">25,706</span> was $<span id="xdx_909_eus-gaap--NotesPayable_iI_c20240630__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zxqo9JamF8Q2" title="Debt remaining">204,694</span> at June 30, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Convertible Notes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ConvertibleDebtTableTextBlock_zz5qUiVhf8E4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s convertible notes outstanding at June 30, 2025 and 2024 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_zJD00OUQs0x9" style="display: none">SCHEDULE OF CONVERTIBLE NOTES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20250630_zKb10qTRxfs8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20240630_zu5xRDHp4Bt8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleNotesPayableCurrent_iI_maLTDzcuB_zeT4rDRQ3Txc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Convertible notes and debenture</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">520,797</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">313,550</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_msLTDzcuB_zCjpQD2r2mog" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Unamortized discounts</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(97,276</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(38,854</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40A_eus-gaap--DebtInstrumentUnamortizedPremium_iI_maLTDzcuB_zmt7KDHrEuX4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Premium, net</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">114,400</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">124,629</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebt_iTI_mtLTDzcuB_zO48WrNova2j" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Convertible notes, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">537,921</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">399,325</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A7_zcmMHD7iPHw6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>1800 Diagonal Lending (formerly known as Sixth Street Lending) Securities Purchase Agreements</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>June 30, 2022 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 30, 2022, the Company entered into a securities purchase agreement with 1800 Diagonal Lending LLC (“1800 Diagonal”), which closed on July 11, 2022, pursuant to which 1800 Diagonal purchased a convertible promissory note (the “July 11, 2022 1800 Diagonal Note”) from the Company in the aggregate principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20220711__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyElevenTwentyTwentyTwoThousandEighthundredDiagonalNoteMember_zxe7EIN1PQwc" title="Debt instrument face amount">105,000</span>, such principal and the interest thereon were convertible into shares of common stock at the option of 1800 Diagonal any time after 180 days of the July 11, 2022 1800 Diagonal Note. The July 11, 2022 1800 Diagonal Note contained debt issue cost of $<span id="xdx_901_eus-gaap--DeferredFinanceCostsNet_iI_c20220711__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyElevenTwentyTwentyTwoThousandEighthundredDiagonalNoteMember_z2ezk7iI3052" title="Debt issuance costs">3,750</span>. The Company used the net proceeds from the July 11, 2022 1800 Diagonal Note for general working capital purposes. The maturity date of the July 11, 2022 1800 Diagonal Note was <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_c20220711__20220711__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyElevenTwentyTwentyTwoThousandEighthundredDiagonalNoteMember_zDOgW9FBQsoi" title="Maturity date">June 30, 2023</span>. The 1800 Diagonal Note bore interest at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20220711__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyElevenTwentyTwentyTwoThousandEighthundredDiagonalNoteMember_zP81sYW3saIa" title="Debt instrument interest rate percentage">8</span>% per annum, which interest was payable in shares of common stock; but was not payable until the maturity date or upon acceleration or by prepayment of such note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>June 29, 2023 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 29, 2023, the Company entered into a securities purchase agreement with 1800 Diagonal, which closed on July 6, 2023, pursuant to which 1800 Diagonal purchased a convertible promissory note (the “July 6, 2023 1800 Diagonal Note”) from the Company in the aggregate principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230706__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulySixTwentyTwentyThreeThousandEighthundredDiagonalNoteMember_zciIfgGKzagi" title="Debt instrument face amount">65,000</span>, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of 1800 Diagonal any time after 180 days of the July 6, 2023 1800 Diagonal Note. The July 6, 2023 1800 Diagonal Note contained debt issue costs of $<span id="xdx_90A_eus-gaap--DeferredFinanceCostsNet_iI_c20230706__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulySixTwentyTwentyThreeThousandEighthundredDiagonalNoteMember_zqbm2VOXQgU8" title="Debt issuance costs">5,000</span>. The Company used the net proceeds for general working capital purposes. The maturity date was <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_c20230706__20230706__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulySixTwentyTwentyThreeThousandEighthundredDiagonalNoteMember_zPz2buAqLiaj" title="Maturity date">June 29, 2024</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>July 19, 2023 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 19, 2023, the Company entered into a securities purchase agreement with 1800 Diagonal Lending LLC pursuant to which 1800 Diagonal purchased a convertible promissory note (the “July 19, 2023 1800 Diagonal Note”) from the Company in the aggregate principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230719__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyNineteenTwentyTwentyThreeThousandEighthundredDiagonalNoteMember_zBlLPtuZnu57" title="Debt instrument face amount">45,000</span>, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of 1800 Diagonal any time after 180 days of the July 19, 2023 1800 Diagonal Note. The July 19, 2023 1800 Diagonal Note contained debt issue costs of $<span id="xdx_906_eus-gaap--DeferredFinanceCostsNet_iI_c20230719__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyNineteenTwentyTwentyThreeThousandEighthundredDiagonalNoteMember_z6wt9tN1Rwd7" title="Debt issuance costs">5,000</span>. The Company used the net proceeds for general working capital purposes. The maturity date was <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_c20230719__20230719__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--JulyNineteenTwentyTwentyThreeThousandEighthundredDiagonalNoteMember_zhpLhOLW4y0k" title="Maturity date">July 19, 2024</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>August 16, 2023 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 16, 2023, the Company entered into a securities purchase agreement with 1800 Diagonal Lending LLC pursuant to which 1800 Diagonal purchased a convertible promissory note (the “August 16, 2023 1800 Diagonal Note”) from the Company in the aggregate principal amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20230816__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustSixteenTwentyTwentyThreeThousandEighthundredDiagonalNoteMember_zHARAYKhde1f" title="Debt instrument face amount">55,000</span>, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of 1800 Diagonal any time after 180 days of the August 16, 2023 1800 Diagonal Note. The August 16, 2023 1800 Diagonal Note contained debt issue costs of $<span id="xdx_900_eus-gaap--DeferredFinanceCostsNet_iI_c20230816__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustSixteenTwentyTwentyThreeThousandEighthundredDiagonalNoteMember_zms5313tSF54" title="Debt issuance costs">5,000</span>. The Company used the net proceeds for general working capital purposes. The maturity date was <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_c20230816__20230816__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustSixteenTwentyTwentyThreeThousandEighthundredDiagonalNoteMember_zVtxSsDNnfVg" title="Maturity date">August 16, 2024</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>October 20, 2023 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 20, 2023, the Company entered into a securities purchase agreement with 1800 Diagonal Lending LLC pursuant to which 1800 Diagonal purchased a convertible promissory note (the “October 20, 2023 1800 Diagonal Note”) from the Company in the aggregate principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20231020__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwentyTwentyTwentyThreeThousandEighthundredDiagonalNoteMember_zRCOQihvQe83" title="Debt instrument face amount">40,000</span>, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of 1800 Diagonal any time after 180 days of the October 20, 2023 1800 Diagonal Note. The October 20, 2023 1800 Diagonal Note contained debt issue costs of $<span id="xdx_900_eus-gaap--DeferredFinanceCostsNet_iI_c20231020__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwentyTwentyTwentyThreeThousandEighthundredDiagonalNoteMember_zkXaLBAhQt84" title="Debt issuance costs">5,000</span>. The Company used the net proceeds for general working capital purposes. The maturity date was <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_c20231020__20231020__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--OctoberTwentyTwentyTwentyThreeThousandEighthundredDiagonalNoteMember_zomM0Mj0ee25" title="Maturity date">October 20, 2024</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>November 29, 2023 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 29, 2023, the Company entered into a securities purchase agreement with 1800 Diagonal Lending LLC pursuant to which 1800 Diagonal purchased a convertible promissory note (the “November 29, 2023 1800 Diagonal Note”) from the Company in the aggregate principal amount of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20231129__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentyNineTwentyTwentyThreeThousandEighthundredDiagonalNoteMember_zUER7iQUCYyb" title="Debt instrument face amount">45,000</span>, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of 1800 Diagonal any time after 180 days of the November 29, 2023 1800 Diagonal Note. The November 29, 2023 1800 Diagonal Note contained debt issue costs of $<span id="xdx_900_eus-gaap--DeferredFinanceCostsNet_iI_c20231129__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentyNineTwentyTwentyThreeThousandEighthundredDiagonalNoteMember_zKJ1htHWo00c" title="Debt issuance costs">5,000</span>. The Company used the net proceeds for general working capital purposes. The maturity date was <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_c20231129__20231129__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__us-gaap--DebtInstrumentAxis__custom--NovemberTwentyNineTwentyTwentyThreeThousandEighthundredDiagonalNoteMember_zA0PGSEJ90h6" title="Maturity date">September 15, 2024</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following terms shall apply to all the above 1800 Diagonal notes:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 1800 Diagonal Notes bore interest at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20231129__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zH92A7KP9vQk" title="Interest rate percentage">8</span>% per annum, which interest may be paid by the Company to 1800 Diagonal in shares of the Company’s common stock; but shall not be payable until the 1800 Diagonal Note becomes payable, whether at the maturity date or upon acceleration or by prepayment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid interest due under all of the above notes, together with any other amounts that the Company may owe the holder under the terms of the note, at a premium ranging from <span id="xdx_905_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20231129__20231129__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__srt--RangeAxis__srt--MinimumMember_z2Cs56Zc7TJd" title="Debt instrument debt default interest rate">110</span>% to <span id="xdx_904_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20231129__20231129__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__srt--RangeAxis__srt--MaximumMember_zPbKJc19sQ35" title="Debt instrument debt default interest rate">129</span>% as defined in the note agreement. After this initial 180-day period, the Company does not have a right to prepay such note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The conversion price for the above notes was equal to a <span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionRatio1_pid_dp_uPure_c20231129__20231129__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zzeTP3itmAkg" title="Debt instrument conversion discount">35</span>% discount of the market price which means the average of the lowest three trading prices of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion. Notwithstanding the foregoing, 1800 Diagonal shall be restricted from effecting a conversion if such conversion, along with other shares of the Company’s common stock beneficially owned by 1800 Diagonal and its affiliates, exceeds <span id="xdx_909_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20231129__20231129__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember__srt--RangeAxis__srt--MaximumMember_zbVGC0mhSw9c" title="Percentage of outstanding shares of common stock">9.99</span>% of the outstanding shares of the Company’s common stock. The Company treats these convertible notes as stock settled debt under ASC 480 and accordingly the Company recorded a total debt premium of $<span id="xdx_902_ecustom--DebtInstrumentSettlementDebtAmount_c20231129__20231129__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zXOht5RzpFne" title="Debt instrument settlement debt amount">134,615</span> which was recorded during the year ended June 30, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The above notes contained certain events of default, upon which principal and accrued interest will become immediately due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate of <span id="xdx_901_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20231129__20231129__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zebLtv2D6Ff9" title="Debt instrument default interest rate">22</span>% per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further, certain events of default may trigger penalty and liquidated damage provisions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failure to deliver shares of common stock upon conversion of the above 1800 Diagonal notes within three business days of notice of conversion will result in the Company paying a penalty of $<span id="xdx_904_ecustom--PenaltyAmount_c20231129__20231129__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zZ9AVIKYJKeh" title="Penalty amount">1,000</span> per day, subject to certain exceptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon certain events of default, the above 1800 Diagonal notes will become immediately due and payable and the Company must pay 1800 Diagonal <span id="xdx_90E_ecustom--PercentageOfOutstandingSharesOfCommonStock_pid_dp_uPure_c20231129__20231129__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z1OmQ055JBB3" title="Percentage of outstanding shares of common stock">150</span>% of the then-outstanding principal amount of the above 1800 Diagonal notes, plus any interest accrued upon such event of default or prior events of default (the “Default Amount”). Further, upon any event of default relating to the failure to issue shares of common stock upon the conversion of such notes, such notes become immediately due and payable in an amount equal to twice the Default Amount.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total principal amount outstanding under all of the above 1800 Diagonal financing agreements was $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_ziYHz7Pxy11e" title="Principal amount outstanding">0</span> as of June 30, 2024 following conversion of $<span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20230701__20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zeZWDF8vzzgk" title="Convertible debt principal amount">250,000</span> of the principal balance and $<span id="xdx_902_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20230701__20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z33T3iQzxzug" title="Accrued interest">9,863</span> accrued interest during the year ended June 30, 2024. Accordingly, $<span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zOqaB54RXnIa" title="Convertible debt principal amount">134,615</span> of the put premium was released to additional paid in capital in respect to the 1800 Diagonal financing agreements during the year ended June 30, 2024 following conversion of the principal balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>ONE44 Capital Securities Purchase Agreements</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>August 15, 2022 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 15, 2022, the Company entered into a securities purchase agreement with ONE44, pursuant to which ONE44 purchased a convertible redeemable note (the “August 15, 2022 ONE44 Note”) from the Company in the aggregate principal amount of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20220815__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zZ6lKP5FqAEk" title="Debt instrument face amount">110,000</span>, such principal and the interest thereon were convertible into shares of the common stock at the option of ONE44 any time after the six-month anniversary of the August 15, 2022 ONE44 Note. The transaction contemplated by such purchase agreement closed on August 16, 2022. The August 15, 2022 One44 Note contained an original issue discount amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20220815__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zhq1szFYG3Jj" title="Original issue discounts amount">10,000</span>. Pursuant to the terms of such purchase agreement, the Company paid $<span id="xdx_901_eus-gaap--LegalFees_c20220815__20220815__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zJJqJlAiD0xc" title="Legal fees">5,500</span> for ONE44’s legal fees. The Company used the net proceeds from the <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20220815__20220815__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zx7nJv2zFdj3" title="Maturity date">August 15, 2022</span> ONE44 Note for general working capital purposes. The maturity date of the August 15, 2022 One44 Note was August 15, 2023. The August 15, 2022 ONE44 Note bore interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20220815__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zeq2XpE4FZV6" title="Debt instrument interest rate stated percentage">10</span>% per annum, which was payable in shares of common stock, but was not payable until the maturity date or upon acceleration or by prepayment of such note. The August 15, 2022 ONE44 Note was fully converted in fiscal year 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>February 14, 2023 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 14, 2023, the Company entered into a securities purchase agreement with ONE44, pursuant to which ONE44 purchased a convertible redeemable note (the “February 14, 2023 ONE44 Note”) from the Company in the aggregate principal amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20230214__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_z4EdNoE13cBj" title="Debt instrument face amount">111,111</span>, such principal and the interest thereon were convertible into shares of the common stock at the option of ONE44 any time after the six-month anniversary of the February 14, 2023 ONE44 Note. The transaction contemplated by such purchase agreement closed on February 14, 2023. The February 14, 2023 One44 Note contained an original issue discount amount of $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20230214__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zC4GOYEt5R52" title="Original issue discounts amount">11,111</span>. Pursuant to the terms of such purchase agreement, the Company paid $<span id="xdx_90D_eus-gaap--LegalFees_c20230214__20230214__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zotvBsj4vyPk" title="Legal fees">5,500</span> for ONE44’s legal fees. The Company used the net proceeds from the February 14, 2023 ONE44 Note for general working capital purposes. The maturity date of the February 14, 2023 One44 Note was February 14, 2024. The February 14, 2023 ONE44 Note bore interest at a rate of <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230214__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zXfEZay8Rtpg" title="Debt instrument interest rate stated percentage">10</span>% per annum, which interest was payable in shares of common stock, but was not payable until the maturity date or upon acceleration or by prepayment of such note. The February 14, 2023 One44 Note was fully converted in fiscal year 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>December 8, 2023 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 8, 2023, the Company entered into a securities purchase agreement with ONE44, pursuant to which ONE44 purchased a convertible redeemable note (the “December 8, 2023 ONE44 Note”) from the Company in the aggregate principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zKSMmn92CZR9" title="Debt instrument face amount">150,000</span>, such principal and the interest thereon are convertible into shares of the common stock at the option of ONE44 any time after the six-month anniversary of the December 8, 2023 ONE44 Note. The transaction contemplated by such purchase agreement closed on December 8, 2023. The December 8, 2023 One44 Note contains an original issue discount amount of $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_z6XnUs26IRx7" title="Original issue discounts amount">15,000</span>. Pursuant to the terms of such purchase agreement, the Company paid $<span id="xdx_907_eus-gaap--LegalFees_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zNcaAysNNbol" title="Legal fees">7,500</span> for ONE44’s legal fees. The Company used the net proceeds from the December 8, 2023 ONE44 Note for general working capital purposes. The maturity date of the December 8, 2023 One44 Note was December 8, 2024. The December 8, 2023 ONE44 Note bears interest at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zMKbBNluqe04" title="Debt instrument interest rate stated percentage">10</span>% per annum, which interest is payable in shares of common stock, but is not payable until the maturity date or upon acceleration or by prepayment of such note. The December 8, 2023 One44 Note was fully converted in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following terms shall apply to all of the above ONE44 note:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first 60 to 180 days following the date of these notes, the Company has the right to prepay the principal and accrued but unpaid interest due under all of the above notes issued to ONE44, together with any other amounts that the Company may owe ONE44 under the terms of the note, at a premium ranging from <span id="xdx_909_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember__srt--RangeAxis__srt--MinimumMember_zgSQPFfG4cNf" title="Debt instrument premium percentage">120</span>% to <span id="xdx_90B_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember__srt--RangeAxis__srt--MaximumMember_zw4PcyjhcNT8" title="Debt instrument premium percentage">135</span>% as defined in the relevant note. After this initial 180-day period, the Company does not have a right to prepay such note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The conversion price for the above ONE44 notes ranges from <span id="xdx_90C_ecustom--DebtInstrumentDebtConversionRate_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember__srt--RangeAxis__srt--MinimumMember_zpyctk15IHw2" title="Debt instrument conversion rate">60</span>% to <span id="xdx_908_ecustom--DebtInstrumentDebtConversionRate_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember__srt--RangeAxis__srt--MaximumMember_zsXLOv8AAPya" title="Debt instrument conversion rate">65</span>% (representing a <span id="xdx_90B_ecustom--DebtInstrumentDiscountRate_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember__srt--RangeAxis__srt--MinimumMember_zdJ7hMUnR5h2" title="Debt instrument discount rate">35</span>% to <span id="xdx_90A_ecustom--DebtInstrumentDiscountRate_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember__srt--RangeAxis__srt--MaximumMember_zqB1FybnbJI" title="Debt instrument discount rate">40</span>% discount) of the market price of the common stock, which is based on the lowest closing bid prices of the common stock between ten and fifteen trading days immediately prior to the delivery of a notice of conversion. Notwithstanding the foregoing, such notes are subject to <span id="xdx_908_ecustom--BeneficialOwnershipLimitationPercentage_pid_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zeldJnXQx4xl" title="Ownership limitations">4.99</span>% beneficial ownership limitations. All of the above ONE44 notes are treated as stock settled debt under ASC 480 and accordingly the Company recorded a total debt premium of $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20230630__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zMwiQDYtE877" title="Debt instrument premium">133,305</span> during the year ended June 30, 2023 and recorded a total debt premium of $<span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20240630__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zZODiYPqEs2a" title="Debt instrument premium">100,000</span> was recorded during the year ended June 30, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The above ONE44 notes contain certain events of default, upon which principal and accrued interest will become immediately due and payable. In addition, upon an event of default, interest on the outstanding principal shall accrue at a default interest rate of <span id="xdx_904_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zzxYoBXY1j7g">24</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, or if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. Further, certain events of default may trigger penalty and liquidated damage provisions. In the event that the Company fails to deliver to ONE44 shares of common stock issuable upon conversion of principal or interest under a ONE44 note, it will incur a penalty of $<span id="xdx_90F_ecustom--PenaltyAmount_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember__srt--RangeAxis__srt--MinimumMember_zpGKZXS9E6B8">250</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per day the shares are not issued beginning on the 4^th day after the conversion notice was delivered to the Company. This penalty increases to $<span id="xdx_90F_ecustom--PenaltyAmount_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember__srt--RangeAxis__srt--MaximumMember_zjUhPYBvvs28">500</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per day beginning on the 10^th day. In the event that the Company loses the bid price of its common stock on OTC markets, such ONE44 note does not incur penalty and instead the outstanding principal amount increases by <span id="xdx_906_ecustom--DebtInstrumentIncreasePrincipalPercentage_pid_dp_uPure_c20231208__20231208__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zikMIzHrIxbd">20</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total principal amount outstanding under all of the above ONE44 financing agreements was $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zz3YbxaAp6Q6" title="Debt instrument, face amount">119,300</span> and accrued interest was $<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_z0QRXtHbnLsj" title="Interest payable">6,726</span> as of June 30, 2024 following conversion of $<span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20230701__20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zFouS9UPetXj" title="Debt conversion converted instrument">148,811</span> of the principal balance and $<span id="xdx_901_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20240630__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zJdCyuuySlZ7" title="Interest payable">9,909</span> accrued interest during the year ended June 30, 2024. Accordingly, $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zLRuh84NBxp5" title="Debt premium">98,311</span> of the put premium was released to additional paid in capital in respect to the ONE44 financing agreements during the year ended June 30, 2024 following conversion of the principal balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total principal amount outstanding under all the above ONE44 financing agreements was $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zWORfI5pBaAh" title="Debt instrument, face amount">104,460</span> and accrued interest was $<span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zXRyC5qUCQS7" title="Interest payable">24,962</span> as of June 30, 2025 following conversion of $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zGun7Pqo2eNc" title="Debt conversion converted instrument">14,840</span> of the principal balance and $<span id="xdx_908_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zL8mc9qikT3f" title="Interest payable">1,006 </span>accrued interest during the year ended June 30, 2025. Accordingly, $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zCZ0wIxxKzVj" title="Debt premium">9,893</span> of the put premium was released to additional paid in capital in respect to the ONE44 financing agreements during the year ended June 30, 2025, following conversion of the principal balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One ONE44 note with principal amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20250831__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zPzBvvyXvJG5" title="Debt instrument, face amount">104,460</span> was in default and accrued default interest rate at <span id="xdx_900_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20250831__20250831__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OneFortyFourCapitalMember_zMskHl121PQ" title="Debt instrument default interest rate">24</span>% per annum before it was fully converted in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>GS Capital Partners Securities Purchase Agreements</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>August 12, 2022 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 12, 2022, the Company entered into a securities purchase agreement (the “GS Capital Purchase Agreement”) with GS Capital Partners, LLC (“GS Capital”), pursuant to which GS Capital purchased a convertible redeemable note (the “GS Capital Note”) from the Company in the aggregate principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20220812__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zAzUH0XLLAj5">93,000</span>, such principal and the interest thereon were convertible into shares of common stock at the option of GS Capital. The transaction contemplated by the GS Capital Purchase Agreement closed on August 16, 2022. The GS Capital Note contained a $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20220812__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zR7klFU23Kz3">5,000</span> original issue discount. Pursuant to the terms of the GS Purchase Agreement, the Company paid $<span id="xdx_902_eus-gaap--LegalFees_c20220811__20220812__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zDUdStLdXqdj" title="Legal fees">3,000</span> for GS Capital’s legal fees. The Company used the net proceeds ($<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfDebt_c20220811__20220812__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zZOupC5oMghc">85,000</span>) from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note was <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_dd_c20220811__20220812__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zChoGAPYtexi" title="Debt instrument maturity date">April 12, 2023</span>, but was extended to August 12, 2023 in April 2023. The GS Capital Note bore interest at a rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220812__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zcrOnAqipi45" title="Debt instrument, interest rate, stated percentage">8</span>% per annum, which interest was payable in shares of common stock, but was not payable until the maturity date or upon acceleration or by prepayment of such note. <span id="xdx_902_eus-gaap--DebtConversionDescription_c20220811__20220812__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zdF9OsF1rmv4" title="Conversion price, description">The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital by surrendering the same. GS Capital was entitled, at its option, at any time after cash payment, to convert all or any amount of the principal face amount of the GS Capital Note then outstanding into shares of common stock at a price per share equal to $168,000 per share (the “Fixed Price”). However, in the event the common stock trades below $120,000 per share for more than five consecutive trading days, then the Fixed Price becomes $78,000 per share.</span> In the event of default, such conversion price was equal to <span id="xdx_901_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20220811__20220812__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zx8921yIYXJ" title="Lowest trading price percentage">65</span>% of the lowest trading price of the common stock reported on the OTC markets or other exchange for the ten prior trading days, including the day upon which a notice of conversion is received by the Company. The GS Capital Note was subject to a <span id="xdx_90D_ecustom--BeneficialOwnershipLimitationPercentage_pid_dp_uPure_c20220811__20220812__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zQ5gXtlcjcPg" title="Beneficial ownership">4.99</span>% beneficial ownership limitation. Such note was fully converted during fiscal year 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>September 21, 2022 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 21, 2022, the Company entered into a securities purchase agreement with GS Capital, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20220921__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_ziCPY8fFGwH9">71,500</span>, such principal and the interest thereon were convertible into shares of common stock at the option of GS Capital. The transaction contemplated by such purchase agreement closed on September 26, 2022. Such note contains a $<span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20220921__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zJISCjG5xh73" title="Original issue discount">4,000</span> original issue discount. Pursuant to the terms of such purchase agreement, the Company paid $<span id="xdx_901_eus-gaap--LegalFees_c20220921__20220921__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_z4MN1fX1Xxu9" title="Legal fees">2,500</span> for GS Capital’s legal fees. The Company used the net proceeds ($<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfDebt_c20220921__20220921__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_z4awdTH7v6b" title="Net proceeds">65,000</span>) from such note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of such note was <span id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_dd_c20220921__20220921__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zqR7VinWTxUa" title="Debt instrument maturity date">March 21, 2023</span> but was extended to March 21, 2024 in April 2023. Such note bore interest at a rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220921__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_z6qmPPlkaaje" title="Debt instrument, interest rate percentage">8</span>% per annum, which interest was payable in shares of common stock, but was not payable until the maturity date or upon acceleration or by prepayment of such note. <span id="xdx_904_eus-gaap--DebtConversionDescription_c20220921__20220921__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zWoYpEuOe7i6" title="Debt conversion description">Such note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. GS Capital was entitled, at its option, at any time after cash payment, to convert all or any amount of the principal face amount of the GS Capital Note then outstanding into shares of common stock at a price per share equal to $120,000 (the “September Fixed Price”). However, in the event the common stock trades below $84,000 per share for more than five consecutive trading days, then the September Fixed Price becomes $54,000 per share.</span> In the event of default under such note, such conversion price was equal to <span id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20220921__20220921__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zGM5qsfweYp6" title="Conversion price percentage">65</span>% of the lowest trading price of the common stock as reported on the OTC markets or other exchange for the ten prior trading days, including the day upon which a notice of conversion is received by the Company. Such note was subject to <span id="xdx_909_ecustom--BeneficialOwnershipLimitationPercentage_pid_dp_uPure_c20220921__20220921__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zRh6PnI4db9e" title="Beneficial ownership">4.99</span>% beneficial ownership limitations. Such note was fully converted during fiscal year 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>August 23, 2023 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 23, 2023, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20230823__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zbelFxbDCvFg">77,500</span>, such principal and the interest thereon are convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contained a $<span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20230823__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zb4mB3Vy9u08">5,000</span> original issue discount. Pursuant to the terms of the GS Purchase Agreement, the Company paid GS Capital’s legal fees of $<span id="xdx_90B_eus-gaap--LegalFees_c20230823__20230823__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zZmz7BqHuJVb" title="Legal fees">2,500</span>. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note was <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20230823__20230823__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z0lqsRNH20Hf" title="Debt instrument maturity date">February 23, 2024</span>. The GS Capital Note bore an interest at a rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230823__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zHn4dnW5mUV6" title="Debt instrument, interest rate, stated percentage">8</span>% per annum and was increased to 24% due to the event of a default, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note became payable, whether at the Maturity Date or upon acceleration or by prepayment. The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note was equal to $2,400 per share, provided that the fixed price will be reduced to $1,200 per share in the event that the market price of the Common Stock trades below $1,800 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price was lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price was subject to re-adjustment every thirty calendar days during the period in which the Company remained in default. The August 23, 2023 GS Capital Note was fully converted in July 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>October 12, 2023 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 12, 2023, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20231012__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zwRq7qYOAlgb">61,000</span>, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contained a $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20231012__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zHQ1j4QMd2ll" title="Debt instrument discount">3,500</span> original issue discount. Pursuant to the terms of the GS Purchase Agreement, the Company paid GS Capital’s legal fees of $<span id="xdx_904_eus-gaap--LegalFees_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zqaagLjMDww6" title="Legal fees">2,500</span>. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note was <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20231012__20231012__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zAr9C4gU5B3g" title="Debt instrument maturity date">April 12, 2024</span> and was in default. The GS Capital Note bore interest at a rate of <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231012__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zVwEwtUtuwue" title="Debt instrument, interest rate, stated percentage">8</span>% per annum and was increased to 24% due to the event of a default, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note became payable, whether at the Maturity Date or upon acceleration or by prepayment. The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note was equal to $900 per share (the “Fixed Price”), provided that the Fixed Price will be reduced to $600 per share in the event that the market price of the Common Stock trades below $450 per share for ten consecutive trading days. In the event of a default under the Note and unless the Fixed Price was lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price was subject to re-adjustment every thirty calendar days during the period in which the Company remained in default. The October 12, 2023 GS Capital Note was fully converted in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>April 12, 2024 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 12, 2024, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20240412__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_z2vRnR8FovDl">27,500</span>, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contained a $<span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240412__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zqGli1aQYD8c">2,500</span> original issue discount. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note was <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_dd_c20240412__20240412__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zk28RtJW54pd" title="Debt instrument maturity date">October 12, 2024</span> and was in default. The GS Capital Note bore interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240412__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zpgwiesBvKrd" title="Debt instrument, interest rate, stated percentage">8</span>% per annum, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note became payable, whether at the Maturity Date or upon acceleration or by prepayment. The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note was equal to $102 per share, provided that the fixed price will be reduced to $60 per share in the event that the market price of the Common Stock trades below $84 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price was lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price was subject to re-adjustment every thirty calendar days during the period in which the Company remained in default. The April 12, 2024 GS Capital Note was fully converted in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>August 2, 2024 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 2, 2024, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20240802__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zEkXznV4VU2">33,000</span>, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contained a $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240802__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zegEXEbylmnl">3,000</span> original issue discount. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note was <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20240802__20240802__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zUSTdxZFmTqf" title="Debt instrument maturity date">February 2, 2025</span> and was in default. The GS Capital Note bore interest at a rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240802__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zUgC1cOFrEj" title="Debt instrument, interest rate, stated percentage">8</span>% per annum, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note became payable, whether at the Maturity Date or upon acceleration or by prepayment. The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note was equal to $102 per share, provided that the fixed price will be reduced to $60 per share in the event that the market price of the Common Stock trades below $84 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price was lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price was subject to re-adjustment every thirty calendar days during the period in which the Company remained in default. The August 2, 2024 GS Capital Note was fully repaid in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>September 20, 2024 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 20, 2024, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zL0Gw2lT074k" title="Debt instrument face amount">33,000</span>, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contained a $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zH0phhDyBZ46" title="Original issue discount">3,000</span> original issue discount. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note was <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zDVCTr6ZNlAk" title="Maturity date">March 20, 2025</span> and was in default. The GS Capital Note shall bore interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zyHlW3mwXvv5">8</span>% per annum, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note became payable, whether at the Maturity Date or upon acceleration or by prepayment. The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note was equal to $18 per share, provided that the fixed price will be reduced to $6 per share in the event that the market price of the Common Stock trades below $18 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price was lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price was subject to re-adjustment every thirty calendar days during the period in which the Company remained in default. The September 20, 2024 GS Capital Note was fully repaid in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>February 7, 2025 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 7, 2025, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20250207__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zF9YGLxC77eb" title="Debt instrument face amount">43,000</span>, such principal and the interest thereon are convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contains a $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250207__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zhHLBFu9ENZf" title="Original issue discount">3,000</span> original issue discount. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note is <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20250207__20250207__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zvU5oLMmXFw" title="Maturity date">October 7, 2025</span>. The GS Capital Note shall bear interest at a rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250207__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zDtuP2kZo8w4">8</span>% per annum, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note becomes payable, whether at the Maturity Date or upon acceleration or by prepayment. <span id="xdx_902_eus-gaap--DebtConversionDescription_c20250207__20250207__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zVY2kFpftNGi" title="Conversion price, description">The GS Capital Note is exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note is equal to $9 per share, provided that the fixed price will be reduced to $6 per share in the event that the market price of the Common Stock trades below $8 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price is lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price is subject to re-adjustment every thirty calendar days during the period in which the Company remains in default.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>March 11, 2025 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 11, 2025, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20250311__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zyX73xPItLW4" title="Debt instrument face amount">33,000</span>, such principal and the interest thereon are convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contains a $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250311__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zTa10sEE8xK4" title="Original issue discount">3,000</span> original issue discount. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note is <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20250311__20250311__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zXlJB3bVMzBg">November 11, 2025</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The GS Capital Note shall bear interest at a rate of <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250311__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zUdUZc3DZEX8">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note becomes payable, whether at the Maturity Date or upon acceleration or by prepayment. <span id="xdx_90F_eus-gaap--DebtConversionDescription_c20250311__20250311__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zi5lnHaVYpD4">The GS Capital Note is exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note is equal to $6 per share, provided that the fixed price will be reduced to $3 per share in the event that the market price of the Common Stock trades below $5 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price is lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price is subject to re-adjustment every thirty calendar days during the period in which the Company remains in default.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>April 15, 2025 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 15, 2025, the Company entered into a securities purchase agreement with GS Capital Partners, LLC, pursuant to which GS Capital purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20250415__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zBmz6grIxG7" title="Debt instrument face amount">55,000</span>, such principal and the interest thereon are convertible into shares of the Company’s common stock at the option of GS Capital. The GS Capital Note contains a $<span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250415__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zVcqNfCyCqVg" title="Original issue discount">5,000</span> original issue discount. The Company used the net proceeds from the GS Capital Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the GS Capital Note is <span id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_dd_c20250415__20250415__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zNK3QJSCCAuj">December 15, 2025</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The GS Capital Note shall bear interest at a rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250415__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zix6N8eeUzbi">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, which interest may be paid by the Company to GS Capital in shares of common stock but shall not be payable until the GS Capital Note becomes payable, whether at the Maturity Date or upon acceleration or by prepayment. The GS Capital Note is exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note is equal to $5 per share, provided that the fixed price will be reduced to $2.50 per share in the event that the market price of the Common Stock trades below $4 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price is lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price is subject to re-adjustment every thirty calendar days during the period in which the Company remains in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following terms shall apply to all of the above GS Capital notes:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the above <span id="xdx_90A_eus-gaap--DebtConversionDescription_c20240701__20250630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zzSgzUDTpu5k" title="Conversion price, description">GS Capital notes, in the event that such conversion price is below the par value of the Common Stock, the Company has agreed to take all steps to reduce such par value or conduct a reverse split of its Common Stock, as applicable. Notwithstanding the foregoing, such conversion price and lookback periods are subject to adjustment in favor of the Investor in the event the Company issues securities to another party with more favorable conversion terms, and such conversions are subject to a <span id="xdx_90D_ecustom--BeneficialOwnershipLimitationPercentage_dp_uPure_c20240701__20250630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zMxB3mOrzOVk" title="Ownership limitations">4.99</span>% beneficial ownership limitation (which may be increased to 9.9% upon 60 days’ prior written notice from the holder of the Note) and adjustments for mergers, consolidations, reorganizations and similar events set forth in the Note, other than a transfer or sale of all or substantially all Company assets. Pursuant to the Note, the Company is required to maintain an initial reserve of at least 400% of the number of Conversion Shares, subject to any increase of such reserved amount to reflect the Company’s obligations under the Note.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, the conversion prices of the above GS Capital notes will be adjusted in favor of the note holder if the Company issues securities with more favorable conversion terms. The effective conversion price of the outstanding GS Capital notes are <span id="xdx_90D_ecustom--DebtInstrumentDebtConversionRate_dp_uPure_c20250415__20250415__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zU9bglHJfAG3" title="Debt instrument conversion rate">60</span>% (representing a <span id="xdx_90E_ecustom--DebtInstrumentDiscountRate_dp_uPure_c20250415__20250415__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zyENh5ETRJTl" title="Debt instrument discount rate">40</span>% discount) of the market price, which means the lowest closing bid prices of the Common Stock for the ten trading days immediately prior to the delivery of a Notice of Conversion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The above GS Capital notes were bifurcated from the embedded conversion option which was recorded as derivative liabilities at fair value (see Note 12).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first 60 to 180 days following the date of the above GS Capital notes, the Company has the right to prepay the principal and accrued but unpaid interest due under all of the above notes issued to GS Capital, together with any other amounts that the Company may owe GS Capital under the terms of the notes, at a premium ranging from <span id="xdx_909_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20240412__20240412__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__srt--RangeAxis__srt--MinimumMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zdje7RHdya7a" title="Debt instrument debt default interest rate">110</span>% to <span id="xdx_90A_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20240412__20240412__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zKBBSziiI198" title="Debt instrument debt default interest rate">125</span>% of the principal amount and interest of such note. After this initial 180-day period, the Company does not have a right to prepay such notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon the occurrence and during the continuation of certain events of default, interest accrues at a default interest rate of <span id="xdx_90F_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20240412__20240412_zFN1L7ezjbQi" title="Debt instrument debt default interest rate">24</span>% per annum or, if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law. In the event that the Company fails to deliver to GS Capital shares of common stock issuable upon conversion of principal or interest under all of the above GS Capital notes, the penalty becomes $<span id="xdx_904_ecustom--PenaltyAmount_c20240412__20240412__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zajp5fkMdqJi" title="Penalty amount">250</span> per day for each day that the shares are not issued beginning on the 4^th day after the conversion notice was delivered to the Company. This penalty increases to $<span id="xdx_905_ecustom--PenaltyAmount_c20240412__20240412__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zaSCgtqZvJ46" title="Penalty amount">500</span> per day beginning on the 10^th day. In the event that the Company loses the bid price of its common stock on OTC markets, such GS Capital note does not incur penalty and instead the outstanding principal amount increases by <span id="xdx_90D_ecustom--DebtInstrumentIncreasePrincipalPercentage_pid_dp_uPure_c20240412__20240412__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zGsB11BHOdYa" title="Debt instrument increase principal percentage">20</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total principal outstanding and accrued interest under all of the above GS Capital notes were $<span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zRtRWXmBV6J3" title="Debt remaining">110,500</span> and $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20240630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z6pAXUNg2ba1" title="Accrued interest">8,364</span>, respectively, as of June 30, 2024, following conversion of $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20230701__20240630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_z5BZdVY8cNSe" title="Debt conversion converted instrument">130,800</span> of the principal balance, $<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20240630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zvpGaHcSoLi1" title="Interest payable current and non current">8,700</span> accrued interest (including $<span id="xdx_906_eus-gaap--DebtDefaultShorttermDebtAmount_iI_c20240630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zGWMAzR9Xua5" title="Derivative fixed interest rate">1,254</span> at default interest rate) and $<span id="xdx_900_eus-gaap--DebtInstrumentFeeAmount_iI_c20240630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zYJyOf6FjqYk" title="Fee amount">3,832</span> conversion fees during the year ended June 30, 2024. During fiscal year 2024, an aggregate total of $<span id="xdx_904_eus-gaap--DerivativeLiabilities_iI_c20240630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zEGxiGrQODH" title="Derivative liabilities">110,500</span> of the above GS Capital notes were bifurcated with the embedded conversion option which were recorded as derivative liabilities at fair value as of June 30, 2024 (see Note 12).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total principal outstanding and accrued interest under all of the above GS Capital notes were $<span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zc4PwiRTftii" title="Debt remaining">252,650</span> and $<span id="xdx_908_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zf6B27g5Qk2f" title="Accrued interest">23,676</span>, respectively, as of June 30, 2025, following conversion of $<span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--AugustTenTwoThousandAndSeventeenConsultingAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zsC67aHgKKle" title="Debt conversion converted instrument">54,850</span> of the principal balance and $<span id="xdx_901_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_zNSjgdiP2BJf" title="Interest payable current and non current">4,365</span> accrued interest during the year ended June 30, 2025. During the year ended June 30, 2025, an aggregate total of $<span id="xdx_902_eus-gaap--DerivativeLiabilities_iI_c20250630__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zEzwXyBgL0ge" title="Derivative liabilities">252,650</span> of the above GS Capital notes were bifurcated with the embedded conversion option which were recorded as derivative liabilities at fair value (see Note 12).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Four GS Capital notes with total principal amounts of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20250831__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember_z8xpJRPggB16" title="Debt instrument, face amount">121,650</span> were in default and accrued a default interest rate at <span id="xdx_906_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_uPure_c20250831__20250831__dei--LegalEntityAxis__custom--GSCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zfP6DRk83Rwi" title="Debt instrument default interest rate">24</span>% per annum before such notes were fully converted or repaid in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Coventry Enterprises, LLC Securities Purchase Agreement</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 3, 2022, the Company entered into a Securities Purchase Agreement with Coventry Enterprises, LLC (“Coventry”), pursuant to which the Company issued Coventry a promissory note from the Company in the aggregate principal amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20221103__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zo1y8JtSyJZ6" title="Principal amount">125,000</span>, such principal and the interest thereon were convertible into shares of the Company’s common stock following an event of default (the “Coventry Note”). The Coventry Note contains a $<span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20221103__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zWTUUHErruk7" title="Debt instrument unamortized discount">25,000</span> original issue discount. The Company used the net proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_c20221103__20221103__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_z1MZbi5yP6f2" title="Proceeds from convertible debt">100,000</span> from the Coventry Note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Coventry Note bears interest at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221103__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_z9RMDYXImJ1b" title="Debt instrument, interest rate, stated percentage">10</span>% per annum, with $<span id="xdx_90A_ecustom--DebtInstrumentGuaranteedInterest_iI_c20221103__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zP5nn7wOK1ud" title="Debt instrument guaranteed interest">12,500</span> in guaranteed interest. The principal amount and the guaranteed interest is due and payable in seven equal monthly payments of $<span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPayment_c20221103__20221103__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_z49vWLXR19w2" title="Monthly payment amount">19,643</span>, commencing on March 24, 2023 and continuing on the 24th day of each month thereafter until paid in full not later than October 24, 2023, or such earlier date as the Coventry Note is required or permitted to be repaid and to pay such other interest to Coventry on the aggregate unconverted and then-outstanding principal amount of the Coventry Note in accordance with the provisions thereof. Any or all of the principal amount and guaranteed interest may be pre-paid at any time and from time to time, in each case without penalty or premium.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, in the event that the Company files with the SEC a qualified offering statement on Form 1-A and such note has been outstanding for four months since its issuance, Coventry has the right to convert all or portion of such note, including guaranteed interest, into shares of common stock at the offering price used in connection with such offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At any time following an event of default under the Coventry Note, it becomes convertible, in whole or in part, into shares of Common Stock at the option of Coventry, at any time and from time to time thereafter (subject to the beneficial ownership limitations set forth therein). The conversion price of the Coventry Note is ninety percent (90%) per share of the lowest per-share VWAP during the twenty (20) trading-day period before the conversion (each, a “Calculated Conversion Price”). In the event that, within 30 calendar days either before or after any conversion, the conversion price of which is based upon a Calculated Conversion Price, the Company consummates (in whole or in part) any financing (whether such financing is equity, equity-equivalent, or debt or any combination thereof) or for any other reason issues any shares of common stock or any common stock equivalents at a price less than the most recent Calculated Conversion Price (the “Alternative Conversion Price”), regardless of when that note or instrument was originated, then, at the option of Coventry, (i) if the conversion has not yet occurred, then the Alternative Conversion Price will be substituted for the Calculated Conversion Price and (ii) if the conversion has occurred, then, within two trading days following Coventry’s written request, the Company is required to issue to Coventry that number of shares of Common Stock equivalent to the difference between the number of shares of Common Stock that had been issued using the Calculated Conversion Price and the number of shares of Common Stock that would have been issued using the Alternative Conversion Price. Accordingly, the Coventry note is treated as stock settled debt under ASC 480 and the Company recorded a total of $<span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20230630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CrownBridgePartnersLLCMember_zKDsfpgy9vhe" title="Settled debt premium">13,889</span> put premium during the year ended June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon the occurrence and during the continuation of certain events of default, interest on the Coventry Note accrues at a default interest rate equal to the lesser of (i) 18% per annum or (ii) the maximum rate permitted by law. Subject to the beneficial ownership limitation in the Coventry Note, if any event of default occurs, then the outstanding principal amount guaranteed interest plus accrued but unpaid default rate interest, liquidated damages and other amounts owing on the Coventry Note through the date of acceleration becomes immediately due and payable at Coventry’s option, in cash or in shares of common stock at the mandatory default amount, which is equal to 120% of all such amounts due on the Coventry Note. If the Company fails to deliver to Coventry such shares, the Company is required to pay in cash an amount equal to the amount that the value of such shares exceeds the principal amount and interest of the attempted conversion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As an additional inducement to Coventry entering into such agreement, the Company issued to Coventry <span id="xdx_901_eus-gaap--SharesIssued_iI_pid_c20221103__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zNoKq1O4ovlb" title="Number of shares issued">1</span> share of common stock on the issuance date of the Coventry Note, which was valued using the relative fair value method at $<span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_c20221103__20221103__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zzgZHAsxYnx2" title="Debt discount to be amortized">37,500</span> and recognized as debt discount to be amortized over the term of such note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company failed to make the first installment payment due in March 2023 which is considered an event of default. The Company recorded a default penalty of $<span id="xdx_908_eus-gaap--DebtDefaultLongtermDebtAmount_iI_c20230630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zHhGdQHhirDg" title="Debt Default penalty">25,000</span> as additional principal as of June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total principal amount outstanding and accrued interest under all of the above Coventry note was $<span id="xdx_90C_eus-gaap--LongTermDebtAverageAmountOutstanding_c20220701__20230630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zIKXSsLE12t5" title="Amount of convertible debt outstanding with penalty">144,951</span> including the default penalty as of June 30, 2023 following conversion of $<span id="xdx_905_eus-gaap--DebtInstrumentAnnualPrincipalPayment_iI_c20230630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zAmlcqUhLXEc" title="Amount repaid for covertible debt">5,049</span> of the principal balance and $<span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20230630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_z0psXngnnqk6" title="Interest payable current and non current">22,749</span> accrued interest during the year ended June 30, 2023. Accordingly, $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20220701__20230630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zAuT5c0xsG61" title="Additional debt issued">561</span> of the put premium was released to additional paid in capital in respect of such purchase agreements with Coventry during the year ended June 30, 2023 following conversion of the principal balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2023, the Company fully paid the remaining principal of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20230731__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zWc94dHAbMIa" title="Debt instrument face amount">142,909</span> and accrued interest of $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20230731__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zQ6YYuRVOpL8" title="Interest payable current and non current">70</span> for a total of $<span id="xdx_905_eus-gaap--RepaymentsOfConvertibleDebt_c20230701__20230731__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zOesn836XQIe" title="Settlement of convertible debt">142,979</span>. The total principal amount outstanding and accrued interest under all of the above Coventry note was $<span id="xdx_906_eus-gaap--LongTermDebtAverageAmountOutstanding_c20230701__20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zZKwxcWSGQSa" title="Amount of convertible debt outstanding with penalty">0</span> following conversion of the principal balance of $<span id="xdx_905_eus-gaap--DebtInstrumentAnnualPrincipalPayment_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zJRAZ9rjmVVb" title="Amount repaid for covertible debt">2,043</span> and interest of $<span id="xdx_90D_ecustom--InterestPayable_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_z4BsgvnlYsn4" title="Interest payable current and non current">357</span> during the year ended June 30, 2024. Accordingly, $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--CoventryEnterprisesLLCSecuritiesPurchaseAgreementMember_zs7jgLhPE7y1" title="Debt premium">13,328</span> of the put premium was released to additional paid in capital in respect of such purchase agreements with Coventry during the year ended June 30, 2024 following conversion of the principal balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>104 LLC Securities Purchase Agreement</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>March 5, 2024 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective March 5, 2024, the Company entered into and closed a securities purchase agreement with 104 LLC (“104”), pursuant to which 104 agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20240305__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zJPbgL1pex71" title="Principal amount">50,000</span>, for a purchase price of $<span id="xdx_907_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20240305__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zCjjp2G6ftyi" title="Purchase amount">46,875</span>, after an original issue discount of $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240305__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zecOU90OkNPl" title="Original issue discount">3,125</span>. The Company paid legal and financing costs of $<span id="xdx_909_eus-gaap--PaymentsOfFinancingCosts_c20240305__20240305__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_z2migs8RACFi" title="Legal and financing costs">7,500</span>. The Company used the net proceeds therefrom for general working capital purposes. The maturity date of the note was <span id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_dd_c20240305__20240305__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zXTJFMMrudV9" title="Debt instrument maturity date">March 1, 2025</span> and was in default. The note bore interest at a rate of eight percent (<span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20240305__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__srt--RangeAxis__srt--MinimumMember_zEuzmesxhWrk" title="Debt instrument interest rate percentage">8</span>%) per annum, which may be increased to sixteen percent (<span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20240305__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__srt--RangeAxis__srt--MaximumMember_zmFI32uj6hd6" title="Debt instrument interest rate percentage">16</span>%) in the event of a default. The March 5, 2024 104 note was fully converted in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>June 20, 2024 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective June 20, 2024, Company entered into and closed a securities purchase agreement with 104 LLC, pursuant to which 104 agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zEoZdMAXPI14" title="Principal amount">33,750</span>, for a purchase price of $<span id="xdx_908_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zwiIzAxwgw0h" title="Purchase amount">30,375</span>, after an original issue discount of $<span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_z75MPmQVUVe1" title="Original issue discount">3,375</span>. The Company paid legal and financing costs of $<span id="xdx_90B_eus-gaap--PaymentsOfFinancingCosts_c20240620__20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zOdOKW4M7inc" title="Legal and financing costs">5,200</span>. The Company used the net proceeds therefrom for general working capital purposes. The maturity date of the note was <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20240620__20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zgJeZ0awIqe7" title="Debt instrument maturity date">June 20, 2025</span> and was in default. The note bore interest at a rate of eight percent (<span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__srt--RangeAxis__srt--MinimumMember_z07QGnfrUxU2" title="Debt instrument interest rate percentage">8</span>%) per annum, which may be increased to sixteen percent (<span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__srt--RangeAxis__srt--MaximumMember_zqSMAEcmraOc" title="Debt instrument interest rate percentage">16</span>%) in the event of a default. The June 20, 2024 104 note was fully converted in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The principal and interest on the notes were convertible into shares of common stock of the Company at the option of 104 at any time following the issuance date of the notes (the “Conversion Shares”) at a price per share equal to <span id="xdx_900_ecustom--DebtInstrumentDebtConversionRate_dp_uPure_c20240620__20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zDZQjWvGbBU8" title="Debt instrument conversion rate">65</span>% of the lowest closing trade price of the common stock during the ten (10) trading days prior to conversion (representing a discount of <span id="xdx_90D_ecustom--DebtInstrumentDiscountRate_dp_uPure_c20240620__20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_ze1s11k2nd8" title="Debt instrument discount rate">35</span>%). Notwithstanding the foregoing, such conversions were subject to a <span id="xdx_907_ecustom--BeneficialOwnershipLimitationPercentage_dp_uPure_c20240620__20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zwIpCwElchbj" title="Ownership limitations">4.99</span>% beneficial ownership limitation and adjustments for mergers, consolidations, reorganizations and similar events set forth in the notes, other than a transfer or sale of all or substantially all Company assets. Pursuant to the notes, the Company was required to maintain an initial reserve of at least 500% of the number of conversion shares, subject to any increase of such reserved amount to reflect the Company’s obligations under the notes. The above 104 notes were treated as stock settled debt under ASC 480 and accordingly the Company recorded a total of $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_z4h20T3Scf52" title="Settled debt premium">45,096</span> was recorded as a put premium during the year ended June 30, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first 60 days following the date of the notes, <span id="xdx_902_eus-gaap--DebtInstrumentDescription_c20240620__20240620__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zTo7QtSHDFha" title="Debt Instrument description">the Company had the right to prepay the principal and accrued but unpaid interest due under the notes, at a one hundred ten percent (110%) premium of the face amount plus accrued and unpaid interest, which increases to (i) one hundred fifteen percent (115%) if prepaid after 60 days, but less than 91 days from the issuance date, (ii) one hundred twenty percent (120%) if prepaid after 90 days, but less than 121 days from the issuance date, (iii) one hundred twenty five percent (125%) if prepaid after 120 days, but less than 181 days from the issuance date. After this initial 180-day period, the Company does not have a right to prepay the notes.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 104 notes contained certain events of default, including failure to pay principal and interest when due, failure to timely issue the conversion shares, failure to maintain the listing of the common stock on at least one of the OTC markets (which specifically includes the quotation platforms maintained by the OTC Markets Group) or an equivalent replacement exchange, failure to comply with its reporting requirements with the U.S. Securities and Exchange Commission, a breach of certain covenants in the purchase agreement, default by the Company under any other note issued to the investor, as well as certain customary events of default set forth in the notes, including, among others, breach of covenants, representations or warranties, insolvency, bankruptcy, and liquidation. Upon an event of default, the notes became immediately due and payable by the Company. Upon the occurrence of any event of defaults, these notes shall be immediately due and payable in an amount equal to 150% default percentage multiplied by the sum of the outstanding principal balances plus accrued interest and default interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total principal amount outstanding under all of the above 104 financing agreements was $<span id="xdx_906_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240630__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zO30foopFob2" title="Debt remaining">83,750</span> and accrued interest was $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20240630__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zqA5LBa76Re6" title="Accrued interest">1,429</span> as of June 30, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded a total default penalty of $<span id="xdx_907_eus-gaap--LongTermDebtAverageAmountOutstanding_c20240701__20250630__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zLbCJ2RrjfBi" title="Amount of convertible debt outstanding with penalty">41,563</span> as additional principal as of June 30, 2025. The total principal amount outstanding and accrued interest under all of the above 104 notes was $<span id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zEFua4blqPpl" title="Debt remaining">124,688</span> including the default penalty and accrued interest of $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zhN49Nb6zyAb" title="Accrued interest">9,093</span> as of June 30, 2025, following conversion of $<span id="xdx_907_eus-gaap--DebtInstrumentAnnualPrincipalPayment_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_ztMuz6hWUdii" title="Amount repaid for covertible debt">625</span> of the principal balance and $<span id="xdx_905_ecustom--InterestPayable_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zaWNgW3A35Bl" title="Interest payable current and non current">4,000</span> accrued interest during the year ended June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two 104 notes with total principal amounts of $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250831__dei--LegalEntityAxis__custom--HundredAndFourLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zxLjD0el1H3i" title="Debt remaining">124,688</span> were in default and accrued a default interest rate at <span id="xdx_90A_ecustom--DebtInstrumentDebtDefaultInterestRate_dp_c20250831__20250831__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--HundredAndFourLLCMember_zNmSruejg2Zh" title="Debt instrument default interest rate">16</span>% per annum before such notes were fully converted in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Geebis Consulting Purchase Agreement</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>December 13, 2024 Securities Purchase Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 13, 2024, the Company entered into a securities purchase agreement with Geebis Consulting, LLC (“Geebis”), pursuant to which Geebis purchased a convertible redeemable note from the Company in the aggregate principal amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20241213__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_zH0ZG0zZqtme" title="Aggregate principal amount">22,000</span>, such principal and the interest thereon were convertible into shares of the Company’s common stock at the option of Geebis. The Geebis note contained a $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241213__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_zLg3SSQtHv3a" title="Debt instrument unamortized discount">2,000</span> original issue discount. The Company used the net proceeds from the Geebis note for general working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity date of the Geebis note was June 15, 2025 and was in default. The Geebis note shall bore interest at a rate of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250615__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_zyveQZgTHXo4" title="Debt instrument interest rate percentage">8</span>% per annum, which interest may be paid by the Company to Geebis in shares of common stock but shall not be payable until the Geebis note became payable, whether at the Maturity Date or upon acceleration or by prepayment. <span id="xdx_90D_eus-gaap--DebtConversionDescription_c20250615__20250615__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z7P1TP9ds5t4" title="Conversion price, description">The Geebis note was exchangeable for an equal aggregate principal amount of note of different authorized denominations, as requested by Geebis surrendering the same. The initial conversion price for the Geebis note was equal to $18 per share, provided that the fixed price will be reduced to $6 per share in the event that the market price of the common stock trades below $18 per share for five consecutive trading days. In the event of default, the conversion price shall be equal to the lowest trading price of the common stock on which the Company’s shares were then traded or any exchange upon which the common stock may be traded in the future. Notwithstanding the foregoing, such conversions were subject to a 4.99% beneficial ownership limitation and adjustments for mergers, consolidations, reorganizations and similar events set forth in the note, other than a transfer or sale of all or substantially all Company assets. Pursuant to the note, the Company was required to maintain an initial reserve of at least 500% of the number of conversion shares, subject to any increase of such reserved amount to reflect the Company’s obligations under the note.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, the conversion price of the Geebis note will be adjusted in favor of the note holder if the Company issues securities with more favorable conversion terms. The effective conversion price of the outstanding Geebis note was <span id="xdx_908_ecustom--DebtInstrumentDebtConversionRate_pid_dp_uPure_c20241213__20241213__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_zjBQyQhBzdPk" title="Debt instrument conversion rate">60</span>% (representing a <span id="xdx_90F_ecustom--DebtInstrumentDiscountRate_pid_dp_uPure_c20241213__20241213__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_zhCqdhm3UBre" title="Debt instrument discount rate">40</span>% discount) of the market price, which was the lowest closing bid prices of the common stock for the ten trading days immediately prior to the delivery of a notice of conversion. The above Geebis note was bifurcated from the embedded conversion option which was recorded as derivative liabilities at fair value (see Note 12).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first 60 to 180 days following the date of the above Geebis note, the Company had the right to prepay the principal and accrued but unpaid interest due under all of the above notes issued to Geebis, together with any other amounts that the Company may owe Geebis under the terms of the note, at a premium ranging from <span id="xdx_90F_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20241213__20241213__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__srt--RangeAxis__srt--MinimumMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z8sAENvrqAjb" title="Debt instrument debt default interest rate">110</span>% to <span id="xdx_90A_ecustom--DebtInstrumentDebtDefaultInterestRate_pid_dp_uPure_c20241213__20241213__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zBWo0IQ9X8Yi" title="Debt instrument debt default interest rate">125</span>% of the principal amount and interest of such note. After this initial 180-day period, the Company does not have a right to prepay such notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon the occurrence and during the continuation of certain events of default, interest accrued at a default interest rate of <span id="xdx_90B_ecustom--DebtDefaultAmountPercentage_pid_dp_uPure_c20250615__20250615__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_zjhTaY4VPVJc" title="Debt instrument default interest rate">24</span>% per annum or, if such rate was usurious or not permitted by current law, then at the highest rate of interest permitted by law. In the event that the Company failed to deliver to Geebis shares of common stock issuable upon conversion of principal or interest under all of the above Geebis note, the penalty became $<span id="xdx_90B_ecustom--PenaltyAmount_c20241213__20241213__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MinimumMember_z7hexFzTdjy9" title="Penalty amount">250</span> per day for each day that the shares were not issued beginning on the 4^th day after the conversion notice was delivered to the Company. This penalty increased to $<span id="xdx_903_ecustom--PenaltyAmount_c20241213__20241213__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zCnu0syp9Bg6" title="Penalty amount">500</span> per day beginning on the 10^th day. In the event that the Company loss the bid price of its common stock on OTC markets, such Geebis note does not incur penalty and instead the outstanding principal amount increases by <span id="xdx_904_ecustom--DebtInstrumentIncreasePrincipalPercentage_pid_dp_uPure_c20241213__20241213__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zJeMRGHlKv09" title="Debt instrument increase principal percentage">20</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2025, the Company repaid $<span id="xdx_90A_eus-gaap--DebtInstrumentRepaidPrincipal_c20250201__20250228__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z28FQU7AUWt6" title="Repayment of principal amount">8,000</span> of the principal amount. The total principal outstanding and accrued interest under all of the above Geebis note was $<span id="xdx_906_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zgxea9sEmNFg" title="Debt remaining">14,000</span> and $<span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_zQxNLmNRW0A7" title="Accrued interest">1,348</span>, respectively, as of June 30, 2025. As of June 30, 2025, an aggregate total of $<span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zDDYGOPuEDtj" title="Debt conversion converted instrument">14,000</span> of the above Geebis note was bifurcated with the embedded conversion option which was recorded as derivative liabilities at fair value as of June 30, 2025 (see Note 12).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Geebis note with principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250630__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_zGtgzCD4HPNi" title="Debt remaining">14,000</span> was in default and accrued a default interest rate at <span id="xdx_90B_ecustom--DebtDefaultAmountPercentage_pid_dp_uPure_c20250615__20250615__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--GeebisConsultingLLCMember_zrWmlqmgMP86" title="Debt instrument default interest rate">24</span>% per annum before such note was fully converted in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Outstanding convertible notes in default</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eight outstanding convertible notes for total principal amount of $<span id="xdx_90A_eus-gaap--ConvertibleNotesPayableCurrent_iI_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--ThreeOutstandingConvertibleNotesMember_z0l3jDQwJsxl" title="Convertible note">364,798</span> with maturity dates between April 2024 and June 2025 were in default as of June 30, 2025 before these six convertible notes were fully converted and two convertible notes were fully repaid in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Amortization of debt discounts</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded $<span id="xdx_902_eus-gaap--AmortizationOfDebtDiscountPremium_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zkcrqqPWacT9" title="Amortization of debt discount">244,000</span> and $<span id="xdx_901_eus-gaap--AmortizationOfDebtDiscountPremium_c20230701__20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zADpWj6bM8Ng" title="Amortization of debt discount">232,700</span> of debt discounts related to the above note issuances during the years ended June 30, 2025 and 2024, respectively. The Company recorded $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zGmQqXn6c96a" title="Debt premium">0</span> and $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zR0gbdyFWd2e" title="Debt premium">279,711</span> of put premiums related to the above note issuances during the years ended June 30, 2025 and 2024, respectively. The debt discounts are being amortized over the term of the debt and the put premiums are expensed on issuance of the debt with the liability released to additional paid in capital on conversion of the principal.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization of all debt discounts for the years ended June 30, 2025 and 2024 was $<span id="xdx_906_eus-gaap--AmortizationOfDebtDiscountPremium_c20240701__20250630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesOneMember_zPDicwteWX09" title="Amortization of debt discount">303,563</span> and $<span id="xdx_908_eus-gaap--AmortizationOfDebtDiscountPremium_c20230701__20240630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesOneMember_zluKakeIzHl8" title="Amortization of debt discount">294,005</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reclassified $<span id="xdx_908_eus-gaap--ConversionOfStockAmountConverted1_c20240701__20250630_zSXNa5dnQinb" title="Conversion of stock amount converted">10,229</span> and $<span id="xdx_900_eus-gaap--ConversionOfStockAmountConverted1_c20230701__20240630_z84U9sph89k6" title="Conversion of stock amount converted">246,254</span> in put premiums to additional paid in capital following conversions during the years ended June 30, 2025 and 2024, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfDebtTableTextBlock_zNo0kftXfNt" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s promissory notes outstanding at June 30, 2025 and 2024 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zNSTdUbXMrVd" style="display: none">SCHEDULE OF PROMISSORY NOTES OUTSTANDING</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20250630__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z4BkE0JINWPd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20240630__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zt2clR8wxrMa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--NotesPayable_iI_maDICAzqJo_zomgedq6zotc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Principal amounts of notes payable</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">589,277</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">230,400</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_msDICAzqJo_zjIexWzZH0Ad" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Unamortized discounts</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(45,965</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25,706</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40A_eus-gaap--DebtInstrumentCarryingAmount_iTI_mtDICAzqJo_zUP9IE2LOnz5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Notes payable, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">543,312</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">204,694</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 589277 230400 45965 25706 543312 204694 0.10 120000 132000 2023-11-15 0.10 0.18 39600 30805 202405 90000 75000 2025-06-15 0.10 0.18 Repayment of the note may occur as follows: (a) if the Company repays this note on or before June 7, 2025, then Company shall pay investor in cash the sum of one hundred percent (100%) of the sum of the outstanding principal amount of the note (the “Principal Amount”) at such time, all accrued interest unpaid at such time, and any other payment due; and (b) if the Company repays the note after June 7, 2025 and on or before July 7, 2025, then Company shall pay investor in cash the sum of one hundred twenty percent (120%) of the sum of the outstanding Principal Amount at such time, all accrued interest unpaid at such time, and any other payment due (the “Maximum Repayment Amount”) or (b) at such time as the Company and the investor may agree to effect repayment. As of June 30, 2025, the promissory note was in default. 60000 50000 0.10 0.18 Repayment of the note may occur as follows: (a) if the Company repays this note on or before July 7, 2025, then Company shall pay investor in cash the sum of one hundred percent (100%) of the sum of the outstanding principal amount of the note (the “Principal Amount”) at such time, all accrued interest unpaid at such time, and any other payment due; and (b) if the Company repays the note after July 7, 2025 and on or before August 7, 2025, then Company shall pay investor in cash the sum of one hundred twenty percent (120%) of the sum of the outstanding Principal Amount at such time, all accrued interest unpaid at such time, and any other payment due (the “Maximum Repayment Amount”) or (b) at such time as the Company and the investor may agree to effect repayment. 5718 15536 21512 12000 352405 132000 3488 0 352405 34320 0.15 49200 8200 6000 35000 0.22 28290 7072.50 56580 7072.50 2024-12-30 49200 5683 0.15 49200 8200 6000 35000 0.22 28290 7073 56580 7073 49200 5683 65000 56000 The Company intends to use the net proceeds therefrom for general working capital purposes. The maturity date of the note is November 30, 2025 and the note bears a one-time interest charge of fifteen percent that shall be applied on the issuance date. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in five (5) payments 2025-11-30 37375 9344 9344 9344 9344 74750 79200 67000 The Company intends to use the net proceeds therefrom for general working capital purposes. The maturity date of the note is January 30, 2026, and the note bears a one-time interest charge of fifteen percent that shall be applied on the issuance date. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in five (5) payments 2026-01-30 45540 11385 11385 11385 11385 91080 0.15 67860 58000 8000 9860 50000 2026-04-15 39020 9755 78039 0.65 0.35 0.0499 1.50 212060 98400 7638 1193 212060 212060 0.15 49200 8200 6000 35000 0.22 28290 7072 56580 7072 0.65 0.35 0.0499 1.50 24812 303 28290 7072 21217 45965 543312 25706 204694 <p id="xdx_89F_eus-gaap--ConvertibleDebtTableTextBlock_zz5qUiVhf8E4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s convertible notes outstanding at June 30, 2025 and 2024 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_zJD00OUQs0x9" style="display: none">SCHEDULE OF CONVERTIBLE NOTES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20250630_zKb10qTRxfs8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20240630_zu5xRDHp4Bt8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleNotesPayableCurrent_iI_maLTDzcuB_zeT4rDRQ3Txc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Convertible notes and debenture</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">520,797</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">313,550</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_msLTDzcuB_zCjpQD2r2mog" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Unamortized discounts</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(97,276</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(38,854</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40A_eus-gaap--DebtInstrumentUnamortizedPremium_iI_maLTDzcuB_zmt7KDHrEuX4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Premium, net</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">114,400</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">124,629</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebt_iTI_mtLTDzcuB_zO48WrNova2j" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Convertible notes, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">537,921</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">399,325</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 520797 313550 97276 38854 114400 124629 537921 399325 105000 3750 2023-06-30 0.08 65000 5000 2024-06-29 45000 5000 2024-07-19 55000 5000 2024-08-16 40000 5000 2024-10-20 45000 5000 2024-09-15 0.08 1.10 1.29 0.35 0.0999 134615 0.22 1000 1.50 0 250000 9863 134615 110000 10000 5500 2022-08-15 0.10 111111 11111 5500 0.10 150000 15000 7500 0.10 1.20 1.35 0.60 0.65 0.35 0.40 0.0499 133305 100000 0.24 250 500 0.20 119300 6726 148811 9909 98311 104460 24962 14840 1006 9893 104460 0.24 93000 5000 3000 85000 2023-04-12 0.08 The GS Capital Note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital by surrendering the same. GS Capital was entitled, at its option, at any time after cash payment, to convert all or any amount of the principal face amount of the GS Capital Note then outstanding into shares of common stock at a price per share equal to $168,000 per share (the “Fixed Price”). However, in the event the common stock trades below $120,000 per share for more than five consecutive trading days, then the Fixed Price becomes $78,000 per share. 0.65 0.0499 71500 4000 2500 65000 2023-03-21 0.08 Such note was exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. GS Capital was entitled, at its option, at any time after cash payment, to convert all or any amount of the principal face amount of the GS Capital Note then outstanding into shares of common stock at a price per share equal to $120,000 (the “September Fixed Price”). However, in the event the common stock trades below $84,000 per share for more than five consecutive trading days, then the September Fixed Price becomes $54,000 per share. 0.65 0.0499 77500 5000 2500 2024-02-23 0.08 61000 3500 2500 2024-04-12 0.08 27500 2500 2024-10-12 0.08 33000 3000 2025-02-02 0.08 33000 3000 2025-03-20 0.08 43000 3000 2025-10-07 0.08 The GS Capital Note is exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note is equal to $9 per share, provided that the fixed price will be reduced to $6 per share in the event that the market price of the Common Stock trades below $8 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price is lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price is subject to re-adjustment every thirty calendar days during the period in which the Company remains in default. 33000 3000 2025-11-11 0.08 The GS Capital Note is exchangeable for an equal aggregate principal amount of notes of different authorized denominations, as requested by GS Capital surrendering the same. The initial conversion price for the GS Capital Note is equal to $6 per share, provided that the fixed price will be reduced to $3 per share in the event that the market price of the Common Stock trades below $5 per share for five consecutive trading days. In the event of a default under the note and unless the fixed price is lower, such conversion price will equal the lowest trading price of the Common Stock for the ten trading days immediately preceding such default, which price is subject to re-adjustment every thirty calendar days during the period in which the Company remains in default. 55000 5000 2025-12-15 0.08 GS Capital notes, in the event that such conversion price is below the par value of the Common Stock, the Company has agreed to take all steps to reduce such par value or conduct a reverse split of its Common Stock, as applicable. Notwithstanding the foregoing, such conversion price and lookback periods are subject to adjustment in favor of the Investor in the event the Company issues securities to another party with more favorable conversion terms, and such conversions are subject to a 4.99% beneficial ownership limitation (which may be increased to 9.9% upon 60 days’ prior written notice from the holder of the Note) and adjustments for mergers, consolidations, reorganizations and similar events set forth in the Note, other than a transfer or sale of all or substantially all Company assets. Pursuant to the Note, the Company is required to maintain an initial reserve of at least 400% of the number of Conversion Shares, subject to any increase of such reserved amount to reflect the Company’s obligations under the Note. 0.0499 0.60 0.40 1.10 1.25 0.24 250 500 0.20 110500 8364 130800 8700 1254 3832 110500 252650 23676 54850 4365 252650 121650 0.24 125000 25000 100000 0.10 12500 19643 13889 1 37500 25000 144951 5049 22749 561 142909 70 142979 0 2043 357 13328 50000 46875 3125 7500 2025-03-01 0.08 0.16 33750 30375 3375 5200 2025-06-20 0.08 0.16 0.65 0.35 0.0499 45096 the Company had the right to prepay the principal and accrued but unpaid interest due under the notes, at a one hundred ten percent (110%) premium of the face amount plus accrued and unpaid interest, which increases to (i) one hundred fifteen percent (115%) if prepaid after 60 days, but less than 91 days from the issuance date, (ii) one hundred twenty percent (120%) if prepaid after 90 days, but less than 121 days from the issuance date, (iii) one hundred twenty five percent (125%) if prepaid after 120 days, but less than 181 days from the issuance date. After this initial 180-day period, the Company does not have a right to prepay the notes. 83750 1429 41563 124688 9093 625 4000 124688 0.16 22000 2000 0.08 The Geebis note was exchangeable for an equal aggregate principal amount of note of different authorized denominations, as requested by Geebis surrendering the same. The initial conversion price for the Geebis note was equal to $18 per share, provided that the fixed price will be reduced to $6 per share in the event that the market price of the common stock trades below $18 per share for five consecutive trading days. In the event of default, the conversion price shall be equal to the lowest trading price of the common stock on which the Company’s shares were then traded or any exchange upon which the common stock may be traded in the future. Notwithstanding the foregoing, such conversions were subject to a 4.99% beneficial ownership limitation and adjustments for mergers, consolidations, reorganizations and similar events set forth in the note, other than a transfer or sale of all or substantially all Company assets. Pursuant to the note, the Company was required to maintain an initial reserve of at least 500% of the number of conversion shares, subject to any increase of such reserved amount to reflect the Company’s obligations under the note. 0.60 0.40 1.10 1.25 0.24 250 500 0.20 8000 14000 1348 14000 14000 0.24 364798 244000 232700 0 279711 303563 294005 10229 246254 <p id="xdx_80D_eus-gaap--IncomeTaxDisclosureTextBlock_zkggEkcaiMe1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_82D_zQzg51M9Qpm4">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 740-10-10, under which an entity recognizes deferred tax assets and liabilities for future tax consequences or for events that were previously recognized in the Company’s financial statements or tax returns. The measurement of deferred tax assets and liabilities is based on enacted tax law provisions. The effects of future changes in tax laws or rates are not anticipated. Through June 30, 2010, the Company operated exclusively in Australia. The Company was wholly subject to Australian income tax laws and regulations, which are administered by the Australian Taxation Office for the years ended June 30, 2010 and all prior years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 23, 2010, the Company was incorporated in the state of Delaware. In January 2011, the Company acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis with Propanc PTY LTD becoming a wholly owned subsidiary of the Company. As a result of these transactions, the Company is subject to the income tax laws of both the United States and Australia for the years ended June 30, 2014 through June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zJAMGIAvNBic" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reconciliation of income tax expense computed at the U.S. federal statutory rate of 21% to the income tax provision for the years ended June 30, 2025 and 2024 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zxGherxZ6Rh3" style="display: none">SCHEDULE OF INCOME TAX PROVISION</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif">US</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20240701__20250630__srt--StatementGeographicalAxis__country--US_zmE5Ki49veY4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_49F_20230701__20240630__srt--StatementGeographicalAxis__country--US_z6mhkDdTUlQa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year Ended</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>%</b></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>%</b></td> <td style="padding-bottom: 1pt"> </td> </tr> <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zdYrtdboipRa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Loss before Income taxes</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(58,923,300</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; text-align: right; width: 12%"> </td> <td style="padding-bottom: 1pt; width: 1%"> </td> <td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,820,528</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; text-align: right; width: 12%"> </td> <td style="padding-bottom: 1pt; width: 1%"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> </tr> <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzYyp_zDWRHxWTziW6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Taxes under statutory US tax rates</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(12,373,893</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maABC_c20240701__20250630__srt--StatementGeographicalAxis__country--US_zL1tBY9M74Jl" title="Taxes under statutory US tax rates">21</span></td> <td>%</td> <td> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(393,732</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maABC_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zRNLsY97EIEg" title="Taxes under statutory US tax rates">0.7</span></td> <td>%</td> </tr> <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzYyp_zqCQyMiBdXx1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Increase (decrease) in valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,383,827</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maABC_c20240701__20250630__srt--StatementGeographicalAxis__country--US_zXVr9J5B2bf4" title="Incrase decrease in valuation allowance">(21</span></td> <td>)%</td> <td> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">306,682</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maABC_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zn9kDPW07wXd" title="Incrase decrease in valuation allowance">(0.5</span></td> <td>)%</td> </tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_maITEBzYyp_zKHypxNqO1Ja" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign tax rate differential</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(54,939</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td style="text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_maABC_c20240701__20250630__srt--StatementGeographicalAxis__country--US_ztu7iVMaQJw5" title="Foreign tax rate differential">0.1</span></td> <td>%</td> <td> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(55,358</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_maABC_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zzSeSrmKkzb5" title="Foreign tax rate differential">0.1</span></td> <td>%</td> </tr> <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_maITEBzYyp_zBSTTow3tuca" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Prior period adjustment</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(47,566</span></td><td style="text-align: left">)</td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td style="text-align: right"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_pid_dp_uPure_maABC_c20240701__20250630__srt--StatementGeographicalAxis__country--US_zSElH4EC74q2" title="Prior period adjustment">0.1</span></td> <td>%</td> <td> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">76,194</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_pid_dp_uPure_maABC_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zUZ8rJfKPgFh" title="Prior period adjustment">(0.1</span></td> <td>)%</td> </tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzYyp_zeVDvD09Ozd1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">92,571</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maABC_c20240701__20250630__srt--StatementGeographicalAxis__country--US_z6GSDd10UdFc" title="Other">(0.2</span></td> <td style="padding-bottom: 1pt">)%</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,214</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maABC_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zpwfvTkRzht" title="Other">(0.1</span></td> <td style="padding-bottom: 1pt">)%</td> </tr> <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzYyp_zY4z5BVGJ0J1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Income tax (expense) benefit</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4102">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mtABC_c20240701__20250630__srt--StatementGeographicalAxis__country--US_zkxyNyWLAKj4" title="Income tax expense benefit">0</span></td> <td style="padding-bottom: 1pt">%</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4103">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mtABC_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zwCs3QDhz0L2" title="Income tax expense benefit">0</span></td> <td style="padding-bottom: 1pt">%</td> </tr> </table> <p id="xdx_8AA_zBc4no5V0s82" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reflects a tax benefit on its consolidated statement of operations and comprehensive income (loss) in 2025 and 2024 of $<span id="xdx_907_eus-gaap--IncomeTaxExpenseBenefit_dixL_c20240701__20250630_zKflgNPn4M56" title="Tax benefit::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl4109">0</span></span> and $<span id="xdx_907_eus-gaap--IncomeTaxExpenseBenefit_di_c20230701__20240630_zPUD102Nvjvl" title="Tax benefit">129,132</span>, respectively. These amounts are research and development tax credits and are not considered income tax.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. <span id="xdx_907_eus-gaap--IncomeTaxExaminationDescription_c20200324__20200327__us-gaap--TypeOfArrangementAxis__custom--CaresActMember_zNevg4fybHob" title="Income tax examination, description">The CARES Act, among other things, permits NOL carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021.</span> In addition, the CARES Act allows NOLs incurred in 2018, 2019, and 2020 to be carried back to each of the five preceding taxable years to generate a refund of previously paid income taxes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities consist of the following:</span></p> <p id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z7CYBlP57Zg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zCp8ypnuKZp5" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20250630_zHyXH81Esgwg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20240630_zXmMinXzxead" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year Ended</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--DeferredTaxAssetsWarrantDerivativeLiability_iI_maDTAGz4rc_zawrZyY26o8j" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrant Derivative Liability</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">468,457</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">513,071</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_iI_pp0p0_maDTAGz4rc_zjIKQeKm8nLa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued Expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">614,493</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">559,723</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--DeferredTaxAssetsPrepaidInvestorServices_iI_pp0p0_maDTAGz4rc_zn6bQ3ethUN6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid Investor Services</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">582,409</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">551,796</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_ecustom--DeferredTaxAssetsNonCashInterest_iI_pp0p0_maDTAGz4rc_zWg5Lc9gPCc9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-cash interest</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">817,536</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">817,536</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_pp0p0_maDTAGz4rc_zmTRdKZCYOgi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangibles (Intellectual Property and Patent Cost)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">367,347</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">351,144</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_iI_pp0p0_maDTAGz4rc_zg6yI8DF06d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred Rent</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,114</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,492</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_iI_pp0p0_maDTAGz4rc_z96Aec5qpX8b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Formation Expense</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,553</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,553</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGz4rc_z1SFCrWrOmob" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net Operating Loss carryforward</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,483,996</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,075,029</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--DeferredTaxAssetsGainOnExtinguishmentOfDebt_iI_pp0p0_maDTAGz4rc_z9TspMILJYZ7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on extinguishment of debt</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">102,604</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">97,992</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGz4rc_zG7h2NvbWAUa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Stock Based Compensation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4144">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">84,028</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGz4rc_maDTANz5Nr_zdr580Kexob9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,447,509</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,061,364</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_iNI_pp0p0_di_maDITLziMD_zXTm5pwV66ke" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and Development</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(202,718</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(170,435</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxLiabilitiesOther_iNI_pp0p0_di_maDITLziMD_zbEdA8HO7ABa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stock Based Compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,960,547</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4154">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--DeferredTaxLiabilitiesForeignExchangeLoss_iNI_pp0p0_di_maDITLziMD_zLtUHzWa4W9a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign Exchange Loss (OCI)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(39,379</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(39,379</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_iNI_pp0p0_di_maDITLziMD_zzABS5hw6wDk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Capital Raising Costs</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(398,746</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(389,258</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_407_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pp0p0_di_mtDITLziMD_msDTANz5Nr_zR8Q57dYm7h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,601,390</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(599,072</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANz5Nr_maDTALNzm1P_z4ni5QMnAet3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,846,119</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,462,292</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTALNzm1P_z9c2Ec17qsU3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(23,846,119</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(11,462,292</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzm1P_zhUPJFJF18K7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4171">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4172">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AD_z0ZnsRtvc3Vg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At June 30, 2025, the Company had U.S. net operating loss carry forwards of $<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20250630__srt--StatementGeographicalAxis__country--US_zE7Ocb4YpoC4">87,182,865</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that may be offset against future taxable income, subject to limitation under IRC Section 382. At June 30, 2025, the Company had Australia net operating loss carry forwards of approximately $<span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20250630__srt--StatementGeographicalAxis__country--AU_zJjS5eBRQcJ3" title="Operating loss carryforwards">28,702,379</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">which can be carried forward without expiration. <span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_do_c20240701__20250630__srt--StatementGeographicalAxis__country--AU_zsiAmJB35Z0d" title="Income tax expense benefit"><span id="xdx_90B_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_do_c20230701__20240630__srt--StatementGeographicalAxis__country--AU_zQx3mE2AqT6" title="Income tax expense benefit">No</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax benefit has been reported in the June 30, 2025 and 2024 consolidated financial statements due to the uncertainty surrounding the realizability of the benefit, based on a more likely than not criteria and in consideration of available positive and negative evidence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applied the “more-likely-than-not” recognition threshold to all tax positions taken or expected to be taken in a tax return, which resulted in no unrecognized tax benefits as of June 30, 2025 and 2024, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management has determined that the realization of the net deferred tax asset is not assured and has created a valuation allowance for the entire amount of such benefits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 740-10, which provides guidance for the recognition and measurement of certain tax positions in an enterprise’s financial statements. Recognition involves a determination whether it is more likely than not that a tax position will be sustained upon examination with the presumption that the tax position will be examined by the appropriate taxing authority having full knowledge of all relevant information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the consolidated statement of operations. As of June 30, 2025, the Company had <span id="xdx_902_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20250630_zGo7CLVznZJg" title="Unrecognized tax benefits">no</span> unrecognized tax benefits. There were <span id="xdx_901_ecustom--UnrecognizedTaxBenefitPeriodIncreaseDecrease_pp0p0_do_c20240701__20250630_zmcNKvHSc5u" title="Changes in unrecognized tax benefits"><span id="xdx_901_ecustom--UnrecognizedTaxBenefitPeriodIncreaseDecrease_pp0p0_do_c20230701__20240630_zDhhqMFoxLI1" title="Changes in unrecognized tax benefits">no</span></span> changes in the Company’s unrecognized tax benefits during the years ended June 30, 2025 and 2024. The Company did not recognize any interest or penalties during fiscal 2025 or 2024 related to unrecognized tax benefits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The income tax returns filed for the tax years from inception will be subject to examination by the relevant taxing authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zJAMGIAvNBic" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reconciliation of income tax expense computed at the U.S. federal statutory rate of 21% to the income tax provision for the years ended June 30, 2025 and 2024 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zxGherxZ6Rh3" style="display: none">SCHEDULE OF INCOME TAX PROVISION</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif">US</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20240701__20250630__srt--StatementGeographicalAxis__country--US_zmE5Ki49veY4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_49F_20230701__20240630__srt--StatementGeographicalAxis__country--US_z6mhkDdTUlQa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year Ended</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>%</b></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>%</b></td> <td style="padding-bottom: 1pt"> </td> </tr> <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zdYrtdboipRa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Loss before Income taxes</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(58,923,300</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; text-align: right; width: 12%"> </td> <td style="padding-bottom: 1pt; width: 1%"> </td> <td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,820,528</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; text-align: right; width: 12%"> </td> <td style="padding-bottom: 1pt; width: 1%"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> </tr> <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzYyp_zDWRHxWTziW6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Taxes under statutory US tax rates</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(12,373,893</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maABC_c20240701__20250630__srt--StatementGeographicalAxis__country--US_zL1tBY9M74Jl" title="Taxes under statutory US tax rates">21</span></td> <td>%</td> <td> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(393,732</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maABC_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zRNLsY97EIEg" title="Taxes under statutory US tax rates">0.7</span></td> <td>%</td> </tr> <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzYyp_zqCQyMiBdXx1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Increase (decrease) in valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,383,827</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maABC_c20240701__20250630__srt--StatementGeographicalAxis__country--US_zXVr9J5B2bf4" title="Incrase decrease in valuation allowance">(21</span></td> <td>)%</td> <td> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">306,682</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maABC_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zn9kDPW07wXd" title="Incrase decrease in valuation allowance">(0.5</span></td> <td>)%</td> </tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_maITEBzYyp_zKHypxNqO1Ja" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign tax rate differential</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(54,939</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td style="text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_maABC_c20240701__20250630__srt--StatementGeographicalAxis__country--US_ztu7iVMaQJw5" title="Foreign tax rate differential">0.1</span></td> <td>%</td> <td> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(55,358</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_maABC_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zzSeSrmKkzb5" title="Foreign tax rate differential">0.1</span></td> <td>%</td> </tr> <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_maITEBzYyp_zBSTTow3tuca" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Prior period adjustment</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(47,566</span></td><td style="text-align: left">)</td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td style="text-align: right"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_pid_dp_uPure_maABC_c20240701__20250630__srt--StatementGeographicalAxis__country--US_zSElH4EC74q2" title="Prior period adjustment">0.1</span></td> <td>%</td> <td> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">76,194</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_pid_dp_uPure_maABC_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zUZ8rJfKPgFh" title="Prior period adjustment">(0.1</span></td> <td>)%</td> </tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzYyp_zeVDvD09Ozd1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">92,571</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maABC_c20240701__20250630__srt--StatementGeographicalAxis__country--US_z6GSDd10UdFc" title="Other">(0.2</span></td> <td style="padding-bottom: 1pt">)%</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,214</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_maABC_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zpwfvTkRzht" title="Other">(0.1</span></td> <td style="padding-bottom: 1pt">)%</td> </tr> <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzYyp_zY4z5BVGJ0J1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Income tax (expense) benefit</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4102">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mtABC_c20240701__20250630__srt--StatementGeographicalAxis__country--US_zkxyNyWLAKj4" title="Income tax expense benefit">0</span></td> <td style="padding-bottom: 1pt">%</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4103">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mtABC_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zwCs3QDhz0L2" title="Income tax expense benefit">0</span></td> <td style="padding-bottom: 1pt">%</td> </tr> </table> -58923300 -1820528 -12373893 0.21 -393732 0.007 12383827 -0.21 306682 -0.005 -54939 0.001 -55358 0.001 -47566 0.001 76194 -0.001 92571 -0.002 66214 -0.001 0 0 -129132 The CARES Act, among other things, permits NOL carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021. <p id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z7CYBlP57Zg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zCp8ypnuKZp5" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20250630_zHyXH81Esgwg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20240630_zXmMinXzxead" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year Ended</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--DeferredTaxAssetsWarrantDerivativeLiability_iI_maDTAGz4rc_zawrZyY26o8j" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrant Derivative Liability</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">468,457</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">513,071</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_iI_pp0p0_maDTAGz4rc_zjIKQeKm8nLa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued Expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">614,493</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">559,723</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--DeferredTaxAssetsPrepaidInvestorServices_iI_pp0p0_maDTAGz4rc_zn6bQ3ethUN6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid Investor Services</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">582,409</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">551,796</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_ecustom--DeferredTaxAssetsNonCashInterest_iI_pp0p0_maDTAGz4rc_zWg5Lc9gPCc9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-cash interest</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">817,536</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">817,536</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_pp0p0_maDTAGz4rc_zmTRdKZCYOgi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangibles (Intellectual Property and Patent Cost)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">367,347</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">351,144</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_iI_pp0p0_maDTAGz4rc_zg6yI8DF06d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred Rent</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,114</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,492</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_iI_pp0p0_maDTAGz4rc_z96Aec5qpX8b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Formation Expense</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,553</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,553</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGz4rc_z1SFCrWrOmob" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net Operating Loss carryforward</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,483,996</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,075,029</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--DeferredTaxAssetsGainOnExtinguishmentOfDebt_iI_pp0p0_maDTAGz4rc_z9TspMILJYZ7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on extinguishment of debt</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">102,604</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">97,992</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGz4rc_zG7h2NvbWAUa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Stock Based Compensation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4144">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">84,028</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGz4rc_maDTANz5Nr_zdr580Kexob9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,447,509</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,061,364</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_iNI_pp0p0_di_maDITLziMD_zXTm5pwV66ke" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and Development</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(202,718</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(170,435</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxLiabilitiesOther_iNI_pp0p0_di_maDITLziMD_zbEdA8HO7ABa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stock Based Compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,960,547</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4154">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--DeferredTaxLiabilitiesForeignExchangeLoss_iNI_pp0p0_di_maDITLziMD_zLtUHzWa4W9a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign Exchange Loss (OCI)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(39,379</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(39,379</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_iNI_pp0p0_di_maDITLziMD_zzABS5hw6wDk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Capital Raising Costs</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(398,746</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(389,258</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_407_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pp0p0_di_mtDITLziMD_msDTANz5Nr_zR8Q57dYm7h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,601,390</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(599,072</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANz5Nr_maDTALNzm1P_z4ni5QMnAet3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,846,119</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,462,292</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTALNzm1P_z9c2Ec17qsU3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(23,846,119</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(11,462,292</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzm1P_zhUPJFJF18K7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4171">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4172">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 468457 513071 614493 559723 582409 551796 817536 817536 367347 351144 4114 4492 6553 6553 25483996 9075029 102604 97992 84028 28447509 12061364 202718 170435 3960547 39379 39379 398746 389258 4601390 599072 23846119 11462292 23846119 11462292 87182865 28702379 0 0 0 0 0 <p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zTWTxJGwKQF9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span>STOCKHOLDERS’ DEFICIT <span id="xdx_82C_zXe9ezkOxrDa" style="display: none">STOCKHOLDERS’ EQUITY</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Reverse Stock Split</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 7, 2024, the Company received written consent in lieu of a meeting by the holders of a majority of the voting power of the Company’s outstanding capital stock as of August 7, 2024 and the Company’s Board of Directors approving such actions as are necessary for the Company to proceed to, and the Company accordingly intends to, effectuate and execute a reverse stock split of the Company’s issued and outstanding shares of common stock at a ratio of one post-split share per <span id="xdx_90A_eus-gaap--StockholdersEquityReverseStockSplit_c20240807__20240807_z3F1XeadTgUf" title="Stockholders equity reverse stock split">sixty thousand pre-split shares (1:60,000)</span> (the “Reverse Stock Split”). The Reverse Stock Split became effective as of January 29, 2025. Proportional adjustments for the Reverse Stock Split were made to the Company’s outstanding stock options, warrants and equity incentive plans. All share and per-share data and amounts have been retroactively adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock Split.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Preferred Stock</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total number of shares of preferred stock that the Company is authorized to issue is <span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_c20250630_z9IpZZ3S5xl6" title="Preferred stock, shares authorized">1,500,005</span>, $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250630_zqCYZOyEC0f1" title="Preferred stock, par value">0.01</span> par value per share. These preferred shares have no rights to dividends, profit sharing or liquidation preferences, subject to any such rights provided for such shares in any certificate of designation filed by the Company with the State of Delaware.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of the total preferred shares authorized, <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zrbGUqmfPn8h" title="Preferred stock, shares authorized">500,000</span> had been designated as Series A Preferred Stock (“Series A Preferred Stock”), pursuant to the Certificate of Designation for the Series A Preferred Stock filed with the Secretary of State of the State of Delaware on December 9, 2014. There were <span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_do_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zehwplZsyAH9" title="Preferred stock, shares issued"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zdGoZ0sC8jD6" title="Preferred stock, shares outstanding"><span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_do_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zT9z0CvHPD5l" title="Preferred stock, shares issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z8JpcwgJ6ckf" title="Preferred stock, shares outstanding">no</span></span></span></span> shares of Series A Preferred Stock issued and outstanding as of June 30, 2025 and 2024 for both periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to a certificate of designation filed with the Secretary of State of the State of Delaware on June 16, 2015, five shares of preferred stock have been designated as Series B Preferred Stock, par value $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zbQXQ87RioEi" title="Preferred stock, par value">0.01</span> per share, of the Company (“Series B Preferred Stock”). Each holder of shares of Series B Preferred Stock is entitled to voting power equivalent to the number of votes equal to the total number of shares of common stock outstanding as of the record date for the determination of stockholders entitled to vote at each meeting of stockholders of the Company and entitled to vote on all matters submitted or required to be submitted to a vote of the stockholders of the Company. <span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_pid_dc_uShares_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zHyFA6FdY8u9" title="Preferred stock shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_pid_dc_uShares_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_znUwR13gkCAe" title="Preferred stock shares outstanding"><span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_pid_dc_uShares_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zxpl9H9ruC1g" title="Preferred stock shares issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_pid_dc_uShares_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zaH6rvFnyR6l" title="Preferred stock shares outstanding">One</span></span></span></span> share of Series B Preferred Stock is issued and outstanding as of June 30, 2025 and 2024. Mr. Nathanielsz, the Company’s Chief Executive Officer, directly beneficially owns such one share of Series B Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharesIssued_iI_pid_do_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zNy8XtLPALgc" title="Shares issued"><span id="xdx_908_eus-gaap--SharesIssued_iI_pid_do_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zbVweimwafal" title="Shares issued"><span id="xdx_906_eus-gaap--SharesIssued_iI_pid_do_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zlSU9BLLh3jk" title="Shares issued"><span id="xdx_905_eus-gaap--SharesIssued_iI_pid_do_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z4h50Ayfq8pd" title="Shares issued">No</span></span></span></span> additional shares of Series A Preferred Stock or Series B Preferred Stock were issued during fiscal year 2025 and 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Common Stock</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares issued under the Equity Lines</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Dutchess Capital Growth Fund LP</span> (“Dutchess”)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 13, 2022, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220712__20220713__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2nYGNZypAA" title="Issuance of aggregate shares">0.24</span> shares of its common stock at an average price per share of approximately $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_c20220713__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYCLKLTEkgGk" title="Share issued price per share">120,000</span>, as a result of delivering one Dutchess Draw Down Notice to Dutchess. Consequently, the Company received gross aggregate proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220712__20220713_zFwODrM0sXpc" title="Gross proceeds">24,711</span> from such Dutchess Draw Down Notice. The Company received $<span id="xdx_901_ecustom--SubscriptionReceivableValue_c20220701__20230630_zguAUGwwd2bi" title="Subscription receivable value">23,758</span> of a previously recorded subscription receivable during the year ended June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 20, 2023, the Company entered into a common stock purchase agreement (the “Equity Line Agreement”) with Dutchess Capital Growth Fund LP (the “Investor”) providing for an equity financing facility, pursuant to which Company has the option to request that the Investor commit to purchase up to $<span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230719__20230720__us-gaap--TypeOfArrangementAxis__custom--CommonStockPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zYWjxkgnKx5i" title="Sale of stock, value">5,000,000</span> of the Company’s shares (the “Shares”) of common stock, par value $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230720__us-gaap--TypeOfArrangementAxis__custom--CommonStockPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zPWFTP03j5yl" title="Common stock, par value">0.001</span> per share (the “Common Stock”), over a <span id="xdx_90C_ecustom--AgreementTerm_pid_dtM_c20230719__20230720__us-gaap--TypeOfArrangementAxis__custom--CommonStockPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zjY0KIOzpW15" title="Agreement term">24</span>-month term commencing on the date on which a registration statement filed by the Company to register the offer and resale of the Shares by the Investor (the “Registration Statement”) is declared effective by the U.S. Securities and Exchange Commission (the “SEC”). Pursuant to the Equity Line Agreement, the Company has the option to exercise this right by providing a notice (a “Drawdown Notice”) from the Company to the Investor setting forth the number of Shares that the Investor will purchase. The Company has agreed to use the proceeds from such issuances for the purpose of financing its research and product development activities, finished product manufacture for clinical studies, working capital requirements and general corporate purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Equity Line Agreement, purchases of Shares cannot occur unless and until certain conditions are met, including but not limited to, the SEC declaring the Registration Statement effective, and the maximum number of Shares that may be purchased <span id="xdx_90C_ecustom--EquityLineAgreementDrawdownNoticeDescription_c20230719__20230720__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--CommonStockPurchaseAgreementMember_zauEvysCjYLh" title="Drawdown description">pursuant to a Drawdown Notice cannot exceed the lesser of (i) 200% of the average daily traded value of the Common Stock during the five (5) business days immediately preceding a Drawdown Notice or (ii) $200,000; provided that in no event may a Drawdown Notice be for less than $5,000, exceed 875 Shares or cause the Investor’s ownership to exceed 4.99% of the outstanding number of shares of Common Stock immediately prior to the issuance of such Shares. The actual amount of proceeds that the Company will receive in connection with each Drawdown Notice is determined under the Equity Line Agreement by multiplying the number of Shares to be sold by the applicable purchase price per share, which is equal to 85% of the lowest traded price of the Common Stock during the 7 business days immediately following the Clearing Date, less Clearing Costs (as each such term is defined in the Equity Line Agreement).</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 13, 2023, the Company issued <span id="xdx_904_eus-gaap--SharesIssued_iI_c20231213_zELadXig7gI6" title="Shares, issued">23</span> shares of its common stock at an average price per share of approximately $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20231213_zT029HAUCkHl" title="Shares, issued average price per share">360</span>, as a result of delivering one draw down notice to the Investor for a subscription receivable of $<span id="xdx_903_ecustom--SubscriptionReceivable_iI_c20231213_z2OuPZEcRwb" title="Subscription receivable">8,822</span>. The Company collected the subscription receivable of $<span id="xdx_90F_ecustom--SubscriptionReceivable_iI_c20240131_zHFQDsm6iuTi" title="Subscription receivable">8,822</span> in January 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 20, 2024, the Company issued <span id="xdx_903_eus-gaap--SharesIssued_iI_c20240220_z62Mg2nPpiz2" title="Shares, issued">29</span> shares of its common stock at an average price per share of approximately $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20240220_zG651DP1ZEBd" title="Shares, issued average price per share">78</span>, as a result of delivering one draw down notice to the Investor for $<span id="xdx_906_ecustom--SubscriptionReceivable_iI_c20240220_zyodII6ZgpYc" title="Subscription receivable">2,260</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 11, 2024, the Company issued <span id="xdx_906_eus-gaap--SharesIssued_iI_c20240611_zAxbklNox4xc" title="Shares, issued">263</span> shares of its common stock at an average price per share of approximately $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20240611_zmF3nzP2PlMl" title="Shares, issued average price per share">48</span> as a result of delivering one draw down notice to the Investor for $<span id="xdx_905_ecustom--SubscriptionReceivable_iI_c20240611_zbNYPlb2s7Cl" title="Subscription receivable">11,975</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Coventry Enterprises, LLC</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 3, 2022, the Company entered into a Common Stock Purchase Agreement (the “Coventry Purchase Agreement”) with Coventry providing for an equity financing facility (the “Coventry Equity Line”). The Purchase Agreement provides that, upon the terms and subject to the conditions in the Purchase Agreement, Coventry is committed to purchase up to Five Million Dollars ($<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20221102__20221103__us-gaap--TypeOfArrangementAxis__custom--CommonStockPurchaseAgreementMember__dei--LegalEntityAxis__custom--DutchessMember__srt--RangeAxis__srt--MaximumMember_zrv5S2yY0Vtk" title="Stock issued during period, value">5,000,000</span>) of shares of common stock over the <span id="xdx_909_ecustom--AgreementTerm_dtM_c20221102__20221103__dei--LegalEntityAxis__custom--DutchessMember__us-gaap--TypeOfArrangementAxis__custom--CommonStockPurchaseAgreementMember_zcoSSF7VKapc" title="Agreement term">36</span> month term of the Purchase Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the terms of the Coventry Purchase Agreement, Coventry will not be obligated to purchase shares of common stock unless and until certain conditions are met, including but not limited to a registration statement on Form S-1 becoming effective which registers Coventry’s resale of any common stock purchased by Coventry under the Coventry Equity Line. From time to time over the 36-month term of the Coventry Purchase Agreement, commencing on the trading day immediately following the date on which such registration statement becomes effective, the Company, in its sole discretion, may provide Coventry with a draw down notice (each, a “Coventry Draw Down Notice”), to purchase a specified number of shares of common stock (each, a “Coventry Draw Down Amount Requested”), subject to the limitations discussed below. The actual amount of proceeds the Company will receive pursuant to each Coventry Draw Down Notice (each, a “Coventry Draw Down Amount”) is to be determined by multiplying the Coventry Draw Down Amount Requested by the applicable purchase price. The purchase price of each share of common stock equals 80% of the lowest volume weighted average price of the Common Stock during the 10 business days immediately preceding the Coventry Drawdown Notice date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maximum number of shares of common stock requested to be purchased pursuant to any single Coventry Draw Down Notice cannot exceed the lesser of (i) <span id="xdx_900_ecustom--PercentageOfAverageDailyTradingVolume_pid_dp_uPure_c20221103__20221103__dei--LegalEntityAxis__custom--DutchessMember__us-gaap--TypeOfArrangementAxis__custom--CommonStockPurchaseAgreementMember_zo5FcdeFDH03" title="Percentage of average daily trading volume">200</span>% of the average daily traded value of the common stock during the 10 business days immediately preceding the Coventry Draw Down Notice, (ii) $<span id="xdx_903_eus-gaap--CommonStockValue_iI_c20221103__us-gaap--TypeOfArrangementAxis__custom--CommonStockPurchaseAgreementMember__dei--LegalEntityAxis__custom--DutchessMember_zjcg8uNClAD9" title="Aggregate value">250,000</span> or (iii) an amount that would cause Coventry’s beneficial ownership to exceed <span id="xdx_905_ecustom--BeneficialOwnershipLimitationPercentage_pid_dp_uPure_c20221103__20221103__dei--LegalEntityAxis__custom--DutchessMember__us-gaap--TypeOfArrangementAxis__custom--CommonStockPurchaseAgreementMember_zUQ4qp0TqJ67" title="Beneficial ownership limitation, percentage">9.99</span>% of the outstanding number of shares of common stock immediately after giving effect to the issuance of the Coventry Draw Down Notice. During the years ended June 30, 2025 and 2024, the Company has not received a Coventry Draw Down Notice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares issued for exercise of warrants</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended June 30, 2024, the Company issued an aggregate of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230701__20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zfrhWhE58dM3" title="Issuance of stock">105</span> shares of common stock from the alternate cashless exercise of <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zXnWpdrothl5" title="Warrants exercise price">0.000001</span> Series A warrants with an original exercise price of $<span id="xdx_90B_ecustom--ClassOfWarrantOrRightAlternateExercisePriceOfWarrantsOrRights1_iI_pid_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zjpTWx3IaQ1g" title="Warrants exercise price">12,000,000,000</span> and alternate cashless exercise price of $<span id="xdx_902_ecustom--ClassOfWarrantOrRightAlternateExercisePriceOfWarrantsOrRights2_iI_pid_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zwYuhWWvR03d" title="Alternate cashless warrant exercise price">60</span> or the par value of common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Alternate Cashless Exercise provision, for a cashless conversion at the holder’s option, is available should the trading price of the Company’s common stock fall below $<span id="xdx_906_ecustom--ClassOfWarrantOrRightAlternateExercisePriceOfWarrantsAtHolderOption_iI_pid_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantMember_zscFSS4n5oB8" title="Warrants exercise price">12,000,000</span> per share calculated based on the difference between the exercise price of the Series A Warrant and <span id="xdx_905_ecustom--PercentageOfExercisePriceAndMarketPrice_pid_dp_uPure_c20230701__20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_z0JIunzNXMs8" title="Percentage of exercise price and market price">70</span>% of the market price. The Company recognized the value of the effect of a down round feature in such warrants when triggered. Upon the occurrence of the triggering event that resulted in a reduction of the strike price, the Company measured the value of the effect of the feature as the difference between the fair value of the warrants without the down round feature or before the strike price reduction and the fair value of the warrants with a strike price corresponding to the reduced strike price upon the down round feature being triggered. Accordingly, the Company recognized deemed dividend of $<span id="xdx_90E_ecustom--DeemedDividend_c20240701__20250630_zcgF85o6Uxxj" title="Deemed dividend">0</span> and $<span id="xdx_90F_ecustom--DeemedDividend_c20230701__20240630_zik8Psbs2lnl" title="Deemed dividend">192,960</span>, during the years ended June 30, 2025 and 2024, respectively, and a corresponding reduction of income available to common stockholders upon the alternate cashless exercise of these warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares issued for conversion of convertible debt</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended June 30, 2024, the Company issued an aggregate of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230701__20240630__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zdC9l7Lm0pp2" title="Number of shares issued">7,433</span> shares of its common stock at average contractual conversion price of $<span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240630__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zA1cGszhWzZ2" title="Average contractual conversion prices">78</span>, as a result of the conversion of principal of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20240630__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zTiArKbmKkv1" title="Principal amount">531,654</span>, interest of $<span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20240630__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zpwLhg1AeWY1" title="Interest">28,829</span> and conversion fees $<span id="xdx_906_eus-gaap--DebtInstrumentFeeAmount_iI_pp0p0_c20240630__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z49wHWOPYQs5" title="Conversion fees">3,832</span> underlying certain outstanding convertible notes converted during the year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in the above conversion during the year ended June 30, 2024 were aggregate principal amounts of convertible notes of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20240630_zrvJiZQjQO58" title="Principal amount">130,800</span>, accrued interest of $<span id="xdx_90C_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20240630_z9VUwdwaHp37" title="Accrued interest">8,700</span> and conversion fees of $<span id="xdx_904_eus-gaap--DebtInstrumentFeeAmount_iI_pp0p0_c20240630_zWTCj4rdbsr3" title="Conversion fees">3,832</span> containing bifurcated embedded conversion option derivatives. Accordingly, the fair market value of the shares issued upon conversion was $<span id="xdx_90B_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20240630_zfLGhBwUHc4c" title="Debt instrument fair value">352,565</span>, resulting in a loss on extinguishment at the time of conversion of $<span id="xdx_900_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20240630_z7R8DMClOmsb" title="Loss on extinguishment debt conversion">209,233</span> and $<span id="xdx_909_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20240630_zQamtigQzebj" title=" Debt conversion fair value">263,798</span> of derivative liability fair value was recorded as a gain on extinguishment at the time of conversion, resulting in a net gain of $<span id="xdx_902_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20230701__20240630_z4o0NQ2QWppg" title="Gain (loss) on extinguishment of debt">54,565</span> which is included in gain on extinguishment of debt in the accompanying consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From July 1, 2024 through March 2025, the Company issued an aggregate of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240701__20250331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z6SatV1UYRo" title="Number of shares issued">8,826</span> shares of its common stock at an average contractual conversion price of $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20250331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zl0rCmrl3NIe" title="Average contractual conversion prices">12</span> as a result of the conversion of principal of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20250331_zMSEckTpzMhd" title="Principal amount">70,315</span>, interest of $<span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20250331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zvUNgWCpP1cj" title="Interest">9,371</span> and conversion fees of $<span id="xdx_904_eus-gaap--DebtInstrumentFeeAmount_iI_pp0p0_c20250331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_ztZ4vVn4aPx5" title="Conversion fees">5,520</span> underlying certain outstanding convertible notes converted during the year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in the above conversion during the year ended June 30, 2025, were principal aggregate amount of convertible notes of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20250630_zpsZEWeQI7Ob" title="Principal amount">54,850</span>, accrued interest of $<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20250630_zMKQcFXBfJSl" title="Accrued interest">4,365</span> and conversion fees of $<span id="xdx_90E_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20250630__20250630_z7wTY05eJnui" title="Conversion fees">3,770</span> containing bifurcated embedded conversion option derivatives which were converted into common stock. Accordingly, the fair market value of the shares issued upon conversion was $<span id="xdx_907_eus-gaap--ConversionOfStockAmountIssued1_c20240701__20250630_z4w9V6PcLIK8" title="Debt instrument fair value">154,154</span>, resulting in a loss on extinguishment at the time of conversion of $<span id="xdx_906_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20250630_zb7frMoyvoi3" title="Loss on extinguishment debt conversion">91,169</span> and $<span id="xdx_90D_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20250630_zWnrk8k15IZg" title=" Debt conversion fair value">73,640</span> of derivative liability fair value and was recorded as a gain on extinguishment at the time of conversion, resulting in a net loss of $<span id="xdx_907_eus-gaap--ExtinguishmentOfDebtGainLossNetOfTax_iN_di_c20240701__20250630_za0Scoxp1VNg" title="Gain on extinguishment time of conversion">17,529</span> which is included in gain (loss) on extinguishment of debt in the accompanying consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reclassified $<span id="xdx_90D_ecustom--ReclassifiedFromPremiumLiabilitiesToAdditionalPaidInCapital_c20240701__20250630_zEELCGv462nf" title="Reclassified from premium liabilities to additional paid in capital">10,229</span> from put premium liabilities to additional paid in capital following conversions and repayment during the year ended June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has <span id="xdx_903_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20250630__us-gaap--TypeOfArrangementAxis__custom--UnderlyingFinancingAgreementsMember_zYyyrkWRVxIg" title="Common stock reserved for future issuances">117,720</span> shares of its common stock reserved for future issuances based on lender reserve requirements pursuant to underlying financing agreements at June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares issued for services rendered</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 12, 2024, the Company entered into a consulting agreement with two consultants to provide investor relation services from August 12, 2024 to October 12, 2024 for a total fee of $<span id="xdx_90F_ecustom--MonthlyFeeForServices_c20240812__20241012__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_ztYXCe0ZTNPd" title="Monthly Fee">7,500</span> for each consultant. In August 2024, the Company issued an aggregate of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240812__20241012__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zNXvXQ3iUSGk" title="Number of shares issued">250</span> shares of common stock to the consultants related to this consulting agreement. Those shares were valued at approximately $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20241012__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zpdZaRwIGwm6" title="Common stock, par value">60</span> per share or $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240812__20241012__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zwKj3ze9Qo11" title="Number of shares issued, value">15,000</span>, being the closing price of the stock on the date of grant to such consultants. During the year ended June 30, 2025, the Company recorded stock-based compensation of $<span id="xdx_901_ecustom--PrepaidShareBasedCompensation_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zEtRfQSjBvqf" title="Prepaid stock-based compensation">15,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 3, 2025, the Company issued an aggregate of <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250303__20250303__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--OfficersEmployeesDirectorsAndConsultantsMember_zhe84nAwtLgf" title="Number of shares issued">8,555,500</span> shares of common stock to certain officers, employees, directors and consultants for services rendered. Those shares were valued at approximately $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250303__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--OfficersEmployeesDirectorsAndConsultantsMember_zaqBPzDFCx9k" title="Common stock, par value">6</span> per share or $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250303__20250303__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--OfficersEmployeesDirectorsAndConsultantsMember_zWO7bEatTr4g" title="Number of shares issued, value">51,333,000</span>, being the closing price of the stock on the date of grant. During the year ended June 30, 2025, the Company recorded stock-based compensation of $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_z3Bxs7TOJgw9" title="Stock-based compensation for service">51,333,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares issued for prepaid services</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between January 9, 2025 and March 23, 2025, the Company issued an aggregate of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250109__20250323__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember_zDhJksSBkDN5" title="Issuance of common stock for services, shares">2,025,000</span> shares of fully vested, non-forfeitable common stock to various consultants for consulting, investor relations and business advisory services with service terms ranging from <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_dtM_c20250109__20250323__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember__srt--RangeAxis__srt--MinimumMember_zJnt2YKeiuI6" title="Service term">6</span> months to three years. Those shares were valued at a weighted average price of approximately $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20250323__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember_zBGqwpF7aNZ3" title="Share issued price per share">12</span> (ranging from $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20250323__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MinimumMember__srt--TitleOfIndividualAxis__custom--ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember_z9l3osqLhwxk" title="Share issued price per share">7</span> to $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20250323__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MaximumMember__srt--TitleOfIndividualAxis__custom--ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember_z9JWYXMeB1Kc" title="Share issued price per share">15</span>) or $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20250109__20250323__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultingInvestorRelationsAndBusinessAdvisoryServicesMember_zJUcv7Wqx1Tf" title="Issuance of common stock for services, value">23,881,110</span>, being the closing prices of the stock on each respective date of grants. During the year ended June 30, 2025, the Company recorded stock-based compensation of $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20240701__20250630_z63xBiSGvqC2" title="Stock-based compensation">4,621,230</span>. At June 30, 2025, the Company recorded prepaid expense – current portion of $<span id="xdx_905_eus-gaap--PrepaidExpenseCurrent_iI_c20250630_zKw0bf8xrVa5" title="Prepaid expenses, current portion">8,334,046</span> and prepaid expense – long-term portion of $<span id="xdx_906_eus-gaap--PrepaidExpenseNoncurrent_iI_c20250630_zmPy6SzlVuH3" title="Prepaid expenses, long-term portion">10,925,835</span> to be amortized over the terms of the respective agreements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares issued in connection with Debt Exchange Agreements</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between January 5, 2025 and March 5, 2025, the Company issued an aggregate of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250105__20250105_zGfLlBqKCD4h" title="Number of shares of common stock in exchange of loans"><span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250305__20250305_zT2s5SZgOYYd" title="Number of shares of common stock in exchange of loans">51,000</span></span> shares of common stock to certain vendors in exchange for payment of outstanding balance of accounts payable of $<span id="xdx_900_ecustom--SettlementOfAccountsPayableForSharesOfCommonStock_c20250105__20250105_znozia4XTTGg" title="Accounts payable for shares of common stock"><span id="xdx_901_ecustom--SettlementOfAccountsPayableForSharesOfCommonStock_c20250305__20250305_zffMeLAR8tPj" title="Accounts payable for shares of common stock">129,354</span></span> pursuant to debt exchange agreements. Those shares were valued at a weighted average price of approximately $<span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250105_z4LjF03smKUj" title="Conversion price per share"><span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250305_z9T1v0cikyu7" title="Conversion price per share">9</span></span> (ranging from $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250105__srt--RangeAxis__srt--MinimumMember_zcpF10LZNeei" title="Conversion price per share"><span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250305__srt--RangeAxis__srt--MinimumMember_zUmKjfucIeE6" title="Conversion price per share">7</span></span> to $<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250105__srt--RangeAxis__srt--MaximumMember_zlTTEeZhsAW8" title="Conversion price per share"><span id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250305__srt--RangeAxis__srt--MaximumMember_zn3PVrVISam5" title="Conversion price per share">13</span></span>) or $<span id="xdx_900_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20250105_zbsmoaKAg48l" title="Debt instrument fair value"><span id="xdx_90E_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20250305_zohqVfTpWOx6" title="Debt instrument fair value">437,500</span></span>, being the closing prices of the stock on each respective date of grants. Common stock issuable of <span id="xdx_90F_ecustom--CommonStockIssuableShares_iI_c20250105_zsw4N3gXCR55" title="Common stock issuable, shares"><span id="xdx_90B_ecustom--CommonStockIssuableShares_iI_c20250305_z1tdNzHGWos7" title="Common stock issuable, shares">7,750</span></span> shares shall be issued due to the reduced offering price provision as defined in the debt exchange agreement to such vendor. Accordingly, the fair market value of the shares issued and issuable was $<span id="xdx_904_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20250630_z7tATOn0UKcj" title="Debt instrument fair value">468,500</span>, resulting in a loss on extinguishment of debt at the time of exchange of $<span id="xdx_900_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zuMhNWV70gg1" title="Loss on extinguishment debt conversion">339,146</span> during the year ended June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 23, 2025, the Company entered into a Debt Exchange with the former director and issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250123__20250123__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zxSWxlFewHBa" title="Number of shares of common stock issued in exchange on loan">30,000</span> shares of common stock in exchange for the total outstanding loan of $<span id="xdx_906_ecustom--SettlementOfLoansForSharesOfCommonStock_pp0p0_c20250123__20250123__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zRoMpVkUY0pc" title="Settlement of loans for shares of common stock">74,395</span>. Those shares were valued at approximately $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20250123__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zhPVdbrTSlkg" title="Conversion price per share">13</span> per share or $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pp0p0_c20250123__20250123__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zpo6O1eJ3bj1" title="Value of shares of common stock issued in exchange on loan">375,000</span>, being the closing price of the stock on the date of grant to the former director. Accordingly, the fair market value of the shares issued was $<span id="xdx_909_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20250630__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zF1PpffF3Lq2" title="Debt instrument fair value">375,000</span>, resulting in a loss on extinguishment of debt at the time of exchange of $<span id="xdx_90F_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zK0Y9BT3NrL3" title="Loss on extinguishment debt conversion">300,605</span> during the year ended June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 5, 2025, the Company entered into debt exchange agreements with the two investors and issued an aggregate of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250205__20250205__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_zwZFiz2iWrN2" title="Number of shares of common stock in exchange of loans">30,000</span> shares of common stock in exchange for the total outstanding loan including accrued interest of $<span id="xdx_90A_eus-gaap--LoansPayable_iI_c20250205__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_zdUlTrYqNcw3" title="Outstanding loan including accrued interest">86,248</span>. Those shares were valued at $<span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250205__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_zyX1AJCPAqIc" title="Conversion price per share">10</span> per share or $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20250205__20250205__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_zvnLVYspyj5k" title="Value of shares of common stock in exchange of loans">300,000</span>, being the closing price of the stock on the date of grant to the two investors. Accordingly, the fair market value of the shares issued was $<span id="xdx_904_eus-gaap--DebtInstrumentFairValue_iI_c20250205__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_zALeIkiApGT8" title="Debt instrument fair value">300,000</span>, resulting in a loss on extinguishment of debt at the time of exchange of $<span id="xdx_903_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20250630__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoInvestorsMember_zxAKJ5rgl339" title="Loss on extinguishment debt conversion">213,752</span> during the year ended June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares issued in connection with a Warrant Exchange Agreement</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 3, 2025, the Company issued <span id="xdx_901_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommonStockRelatedToWarrantExchangeAgreement_c20250303__20250303_zITHZUhmxMSd" title="Common stock related to warrant exchange agreement">900,000</span> shares of common stock to an investor in exchange for all the existing warrants (the “Warrant Exchange Warrants”) that included an alternate cashless exercise provision held by the investor pursuant to a Warrant Exchange Agreement. The fair value of the surrendered Exchange Warrants exceeded the fair value of the <span id="xdx_90B_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommonStockRelatedToWarrantExchangeAgreement_c20250303__20250303_z88sTgxrt4e8" title="Common stock related to warrant">900,000</span> shares of common stock issued. Accordingly, there was no deemed dividend recorded in connection with the Warrant Exchange Agreement. The fair value of the <span id="xdx_907_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommonStockRelatedToWarrantExchangeAgreement_c20250303__20250303_zXY051BrciL4" title="Common stock related to warrant">900,000</span> shares of common stock issued was $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20250303_zr8qEj4tAWc3" title="Shares issued per share">6</span> per share or $<span id="xdx_905_eus-gaap--TradingGainsLosses_pn5n6_c20250303__20250303_zx28XpCR2D39" title="Trading price">5.4</span> million based on the quoted trading price on the exchange date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Restricted Stock Units</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to employment agreements dated in May 2019, the Company granted de minimis restricted stock unit (after the Reverse Stock Split) to the Company’s Chief Executive Officer and Chief Scientific Officer. Such restricted stock units are subject to vesting terms as defined in the employment agreements. Such restricted stock units were valued at the fair value of approximately $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190501__20190531__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zjO7f4oCxMOk" title="Restricted stock units, value">497,240</span> based on the quoted trading price on the date of grant. There were $<span id="xdx_904_ecustom--UnrecognizedRestrictedStockUnitsExpense_pp0p0_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zpDbxe7rheAl" title="Unrecognized restricted stock units expense"><span id="xdx_90C_ecustom--UnrecognizedRestrictedStockUnitsExpense_pp0p0_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zozG19AL6Cv9" title="Unrecognized restricted stock units expense">248,620</span></span> unrecognized restricted stock units expense as of June 30, 2025 and 2024. A de minimis amount of unvested restricted stock units which are subject to various performance conditions have not yet been met and have not yet vested as of June 30, 2025 to which the above amount of $<span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_iI_c20250630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhidUi2YgW06" title="Restricted stock units not yet vested, shares">248,620</span> relates to.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Stock Options</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zmpSz4C8mx2j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s stock option activity during the years ended June 30, 2025 and 2024 is presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zHJXeckE4L5l" style="display: none">SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price Per Share</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230701__20240630_zlBafY8Zwzu" style="width: 16%; text-align: right" title="Number of Shares, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">0.000001</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230701__20240630_zjGlCr2A2d5k" style="width: 16%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">271,980,000,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230701__20240630_zgbhNeXXQip1" style="text-align: right" title="Number of Shares, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4453">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230701__20240630_z0TkfOmSunLb" style="text-align: right" title="Weighted Average Price Per Share, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4455">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230701__20240630_zMI3kqKxgKS5" style="text-align: right" title="Number of Shares, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4457">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230701__20240630_zUb4VP8yQOE4" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4459">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20230701__20240630_zFaGDNMQcEZg" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Shares, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4461">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230701__20240630_zK3FSJBzYQe7" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4463">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240701__20250630_zruzLeDUMUSd" style="text-align: right" title="Number of Shares, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">0.000001</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240701__20250630_zN7uQ8Poyio7" style="text-align: right" title="Weighted Average Price Per Share, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">271,980,000,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240701__20250630_zklk39fMw1f3" style="text-align: right" title="Number of Shares, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4469">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240701__20250630_zyDiU84tei11" style="text-align: right" title="Weighted Average Price Per Share, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4471">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240701__20250630_zBvXN6JCCWrh" style="text-align: right" title="Number of Shares, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4473">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240701__20250630_zj2KpL8NPsE3" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4475">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20240701__20250630_z3V7nNbx5CPb" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Shares, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4477">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240701__20250630_zf7JS3FTEG3d" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4479">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2025</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240701__20250630_zK2YEz9EmUPa" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Shares, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">0.000001</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240701__20250630_zi5ucm3GVqWc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">271,980,000,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercisable at June 30, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20240701__20250630_zH9yleh71eob" style="text-align: right" title="Number of Shares, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">0.000001</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240701__20250630_zhlhnP9idVB1" style="text-align: right" title="Weighted Average Price Per Share, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">271,980,000,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding and Exercisable:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining contractual term</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240701__20250630_zCR6l0S56id3" title="Weighted average remaining contractual term">3.87</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average fair value of options granted during the year</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240701__20250630_zHAM3PfsVvui" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average fair value of options granted during the period"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4491">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate intrinsic value</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240701__20250630_zu0ueAPD0vpg" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4493">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A6_zbXHACgVppyj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On the Effective Date, the Company’s board of directors approved and adopted the Company’s 2019 Equity Incentive Plan (the “2019 Plan”), which reserves a total of <span id="xdx_90F_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20250630__us-gaap--PlanNameAxis__custom--TwoThousandNinteenEquityIncentivePlanMember_zB2kmsjr18gi" title="Number of common shares reserved for future issuance">1</span> share of the Company’s common stock for issuance under the 2019 Plan. Incentive awards authorized under the 2019 Plan include, but are not limited to, incentive stock options, non-qualified stock options, restricted stock awards and restricted stock units.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended June 30, 2025 and 2024, the Company recognized stock-based compensation of $<span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20250630_zYj6EgfAWurd" title="Company recognized stock-based compensation"><span id="xdx_902_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20240630_zESMwHUwS3r1" title="Company recognized stock-based compensation">0</span></span> for both periods. There was $<span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20250630_zYjkAijfL6Z4" title="Unvested stock option expense">0</span> of unvested stock options expense as of June 30, 2025. <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_do_c20240701__20250630_zBPUNapWYZq7" title="Stock options granted"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_do_c20230701__20240630_zRgfR0JY1la5" title="Stock options granted">No</span></span> stock options were granted during the years ended June 30, 2025 and 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Stock Warrants</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zT2zNvQCKjEh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes common stock warrant activity for the years ended June 30, 2025 and 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zRH065CMcPHd" style="display: none">SUMMARY OF WARRANT ACTIVITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price Per Share</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230701__20240630_zDKtnQgCtaR6" style="width: 16%; text-align: right" title="Number of Warrants, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">0.06</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstanding_iS_pid_c20230701__20240630_znlNMdHE8Iyf" style="width: 16%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">326,400,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230701__20240630_z3ZttUdE05W7" style="text-align: right" title="Number of Warrants, Issued"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_pid_c20230701__20240630_zfKTnVWUYjR6" style="text-align: right" title="Weighted Average Price Per Share, Issued"><span style="font-family: Times New Roman, Times, Serif">600</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20230701__20240630_zkPOMcfidqy6" style="text-align: right" title="Number of Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4517">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_pid_c20230701__20240630_zjBRNEPMgfA9" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4519">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20230701__20240630_zmKKP9wbt2F2" style="text-align: right" title="Number of Warrants, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4521">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_pid_c20230701__20240630_zHRIsWquyAZi" style="text-align: right" title="Weighted Average Price Per Share, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4523">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20230701__20240630_zlPZeOx6djkf" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4525">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_pid_c20230701__20240630_zyy1BE5Txox2" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4527">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20240701__20250630_z26HaKxbWHe5" style="text-align: right" title="Number of Warrants, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstanding_iS_pid_c20240701__20250630_zlZSNkj8yCUi" style="text-align: right" title="Weighted Average Price Per Share, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">1.24</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20240701__20250630_zOJYgzanhvN1" style="text-align: right" title="Number of Warrants, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4533">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_pid_c20240701__20250630_z3lwaXv9wlx9" style="text-align: right" title="Weighted Average Price Per Share, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4535">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20240701__20250630_zRjDcUxEDtUk" style="text-align: right" title="Number of Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4537">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_pid_c20240701__20250630_zcZQIWKROvD2" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4539">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Cancelled*</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20240701__20250630_fKg_____zWgd9EFwfawk" style="text-align: right" title="Number of Warrants, Cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4541">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_pid_c20240701__20250630_fKg_____zYyKCrxOAWe2" style="text-align: right" title="Weighted Average Price Per Share, Cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4543">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20240701__20250630_zaPVmDXTBGRk" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4545">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_pid_c20240701__20250630_zh2c0W89t2w4" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4547">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2025</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20240701__20250630_z10j1KKNX6Fl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstanding_iE_pid_c20240701__20250630_zCt8KqhNqdK7" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable at June 30, 2025</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20230701__20240630_z0GVrq7M3Ql8" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_iE_pid_c20240701__20250630_zBClNhvHUlM3" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding and Exercisable:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining contractual term</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20240701__20250630_zKNAptcg7Ro6" title="Weighted average remaining contractual term">1.01</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate intrinsic value</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20240701__20250630_zqPF5ULj9pu7" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif">1,035</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-right: 0.8pt; text-align: right"></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F0C_zAb4t5rtbik3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"><span id="xdx_F1C_zoZrSF7vCcQe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 3, 2025, the Company cancelled all the existing warrants (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgV0FSUkFOVCBBQ1RJVklUWSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20250303__20250303__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zMGqc6BClkt4" title="Number of warrants cancelled">0.0002</span> Series A warrants, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgV0FSUkFOVCBBQ1RJVklUWSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20250303__20250303__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zbi6HGxoXTB6" title="Number of warrants cancelled">0.0003</span> Series B warrants, and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgV0FSUkFOVCBBQ1RJVklUWSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20250303__20250303__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_z5SCjsfG5eji" title="Number of warrants cancelled">0.0008</span> Series C warrants) held by an investor pursuant to a Warrant Exchange Agreement (see above).</span></td></tr> </table> <p id="xdx_8A1_zct9FeezC9dc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the issuance of shares on April 3, 2020, <span id="xdx_90A_ecustom--EquityPurchaseAgreementDescription_c20200402__20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_ztAnSomZEHG4" title="Equity purchase agreement description">the Company closed on a transaction related to a Securities Purchase Agreement (the “Securities Purchase Agreement”) entered into on March 30, 2020, whereby an investor purchased from the Company, 0.0001 units, each consisting of (i) 0.0001 shares of the Company’s common stock, or pre-funded warrants upon investor’s election due to the 4.99% blocker provision and (ii) 0.00003 warrants to purchase one share of Common Stock (“Series A Warrants”, and collectively with the Common Stock the “Units”).</span> In addition to the Units, the investor was issued <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zwGVwSd9u38i" title="Warrants to purchase common stock">0.001</span> warrants to purchase one share of Common Stock (the “Series B Warrants”) and an additional <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_zEC6ovSZSIy1" title="Warrants to purchase common stock">0.001</span> warrants to purchase one share of Common Stock, subject to a vesting schedule (the “Series C Warrants” and, together with the Prefunded Warrants, the Series A Warrants, and the Series B Warrants, the “Warrants”). Due to the Beneficial Ownership Limitation, the Company granted <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrefundedWarrantsMember_zu39tlcJBdm5" title="Warrants to purchase common stock">0.0002</span> Prefunded Warrants with exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200403__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrefundedWarrantsMember_zId05jh7k838" title="Warrant exercise price">6,000,000</span> (but can be less than par value). The Prefunded Warrants were exercisable immediately and expired when exercised in full. (See shares issued in connection with a Warrant Exchange Agreement noted above)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Series A Warrants</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Securities Purchase Agreement entered into March 20, 2020 as discussed above, the investor purchased Series A Warrants to purchase up to <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_ztNZmWPdELFf" title="Purchase of warrant, shares">0.0002</span> shares of Common Stock, subject to adjustment as provided therein. The Series A Warrants had a cash exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zFsl85Ly1Xt8" title="Exercise price">12,000,000,000</span> per share and were immediately exercisable and expired in <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zZxwWAwPpft8" title="Warrants term">3</span> years (see extension noted below). The Series A Warrants contained a provision for cashless exercise in the event there was no effective registration statement registering the shares underlying the Series A Warrants calculated based on the difference between the exercise price of the Series A Warrant and the trading price of the stock (the “Cashless Exercise”). Additionally, <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20200319__20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zLSaAxEzumud" title="Warrant description">the Series A Warrants contained a provision for a cashless conversion at the Holder’s option should the trading price of the Common Stock fall below $12,000,000,000, per share calculated based on the difference between the exercise price of the Series A Warrant and 70% of the Market Price, as defined therein (the” Alternate Cashless Exercise”). The Alternate Cashless Exercise price was $0.001 or the par value. See above “Shares issued for exercise of warrants” for discussion of deemed dividend related to alternate cashless exercise.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Series B Warrants</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Securities Purchase Agreement entered into March 20, 2020 as discussed above, the investor purchased Series B Warrants to purchase up to <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zkHb24RLlKul" title="Warrants to purchase common stock">0.001</span> shares of Common Stock, subject to adjustment as provided therein; provided, however, commencing on the 90th day following the effective date, the Company may reduce the number of Warrant Shares issuable upon exercise thereof by <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20200319__20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zTCenlO2x4ne" title="Warrants exercisable">38</span> upon <span id="xdx_905_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_uInteger_c20200319__20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zIHnQmuPtlmb" title="Trading days">10</span> Trading Days’ prior written notice to the Holder provided that the Company issues to the Holder <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200319__20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember__srt--TitleOfIndividualAxis__custom--HolderMember_zFo3kbaa6fx3" title="Common stock issued during period">0.0001</span> shares of Common Stock (or, at the election of the Holder, an equivalent number of pre-funded warrants) and Series A Warrants to purchase up to <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zVgpbVbfsd4a" title="Warrants to purchase common stock">0.0001</span> shares of Common Stock, which shares shall be issued pursuant to a registration statement without restrictions on resale. The Series B Warrants had a cash exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zib8feI13Nj9" title="Warrant exercise price per share">2,400,000,000</span> per share and expired in <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zLdCzWQUgff3" title="Warrants term">3</span> years (see extension noted below). The Series B Warrants contained a provision for Cashless Exercise.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Series C Warrants</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Securities Purchase Agreement entered into March 20, 2020 as discussed above, the investor purchased Series C Warrants to purchase up to <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z4xpVP9esIQd" title="Warrants to purchase common stock">0.001</span> shares of Common Stock, subject to adjustment as provided therein and expired in <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zyTfhrztn51a" title="Warrants term">3</span> years (see extension noted below). The Series C Warrants had a cash exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200320__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zo7nR1jUZqsf" title="Warrant exercise price">12,000,000,000</span> per share, subject to a vesting schedule, which was based on such Holder’s exercise of the Series B Warrants (warrants shall be exercisable ratably upon exercise of Series B Warrants). The Series C Warrants contained provisions for Cashless Exercise and Alternate Cashless Exercise. See above “Shares issued for exercise of warrants” for discussion of deemed dividend related to alternate cashless exercise.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Letter Agreement to Extend Termination Dates.</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 8, 2023, the Company agreed with the holder of Series B Warrants (the “Holder”) pursuant to a letter agreement to exercise up to $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfWarrants_c20230308__20230308__us-gaap--StatementEquityComponentsAxis__custom--SeriesBWarrantsMember_zzOuEBBpIyuh" title="Offer from Series B warrants">250,000</span> of Series B Warrants currently held as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective upon the execution of such letter agreement, the Holder will exercise <span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_c20230308__20230308_z96N2BUBiEQl" title="Issuance of common stock for exercise of warrants">0.0001</span> Series B Warrants for an aggregate exercise price of $<span id="xdx_900_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_c20230308__20230308__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zDbZNIKHUvx2" title="Warrants aggregate price">150,000</span>, or <span id="xdx_901_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_c20230308__20230308__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0eJN2WoKZLf" title="Issuance of common stock for exercise of warrants">0.0001</span> shares of common stock (the “Existing Warrants”) and;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within 5 business days’ written notice to the Holder from the Company of receipt of approval by the Financial Industry Regulatory Authority, Inc. (“FINRA”) of the Company’s next anticipated reverse stock split, an additional $<span id="xdx_909_eus-gaap--StockIssued1_c20230308__20230308__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember_zSoErABIiuvc" title="Share issued value">100,000</span> of Series B Warrants for <span id="xdx_908_eus-gaap--SharesIssued_iI_c20230308__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantsMember_zEcTK8CMAD5k" title="Shares issued">0.0001</span> shares of common stock.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As an inducement to exercise the Existing Warrants, the Company agreed to extend the termination date of the Existing Warrants and the Series A Warrants held by the Holder to March 27, 2025, and to extend the termination date of the Series C Warrants held by the Holder to the third anniversary of the last vesting date of such warrants, effective upon the exercise of the first $<span id="xdx_90B_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_c20230308__20230308__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z8uqe9v6kUyf" title="Warrants aggregate price">150,000</span> of Existing Warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 815-40-35-17(c), the effect of a modification or an exchange of an equity classified freestanding written call option was measured as the difference between the fair value of the modified instrument and the fair value of that instrument immediately before it was modified. The Company recognized the effect of the modifications of the warrants above that was directly attributable to an actual equity offering as an equity issuance cost which amount was not material. The modified warrants were determined to be equity classified, accordingly, the incremental fair value and equity issuance cost were both recognized in additional paid in capital and therefore, there was no effect in equity and such value is de minimis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 3, 2025, the Company issued <span id="xdx_90A_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommonStockRelatedToWarrantExchangeAgreement_c20250303__20250303_zokgg28J3iIc">900,000</span> shares of common stock to the investor in exchange for all the Existing Warrants (the “Exchange Warrants”) that included an alternate cashless exercise provision held by the investor pursuant to a Warrant Exchange Agreement. The fair value of the surrendered Exchange Warrants exceeded the fair value of the <span id="xdx_90E_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommonStockRelatedToWarrantExchangeAgreement_c20250303__20250303_zgagv62OhJo3" title="Warrants exceeded">900,000</span> shares of common stock issued. Accordingly, there was no deemed dividend recorded in connection with the Warrant Exchange Agreement. The fair value of the <span id="xdx_901_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommonStockRelatedToWarrantExchangeAgreement_c20250303__20250303_z0SZH316ZkD4" title="Common stock related to warrant">900,000</span> shares issued was $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20250303_zFQ0O3AFq02i" title="Shares issued per share">6</span> per share or $<span id="xdx_908_eus-gaap--TradingGainsLosses_pn5n6_c20250303__20250303_z44XkOwW1o07" title="Trading price">5.4</span> million based on the quoted trading price on the exchange date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Warrants Granted to Lender – Related Party</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 5, 2023, the Company and an institutional investor affiliated with one of our directors, Josef Zelinger, entered into a letter agreement, pursuant to which such investor loaned the Company an aggregate of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zuPt69l4VsOi" title="Investor loan, value">230,000</span> AUD ($<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zfeZLGmUgklf" title="Investor loan, value">153,256</span> USD). Pursuant to such agreement, the term of such loan is three (<span id="xdx_908_eus-gaap--DebtInstrumentTerm_dtY_c20230705__20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zdEPFKzVdkeh" title="Term of agreement">3</span>) years, ending on July 5, 2026, with an interest rate of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230705__20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zJH3aXgCxyDl" title="Debt instrument loan bears interest rate">10</span>% to be paid monthly in arrears. In connection with such loan, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20230705__20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_z3ASlFah20sf" title="Issue of warrants">250</span> warrants to purchase common stock to such investor immediately exercisable at an initial exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_z3MQW5GUh0N6" title="Share price">600</span> per share (subject to certain adjustments such as stock dividend, stock splits, subsequent right offering and pro-rata distribution) with an expiry date of July 5, 2026. The Company accounted for the <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--AffiliatedEntityMember_zK2g2jQ180w2" title="Warrants to purchase common stock">250</span> warrants issued with this loan payable by using the relative fair value method. The total debt discount which is equivalent to the relative fair value of the warrants of $<span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--AuctusFundLLCMember__us-gaap--DebtInstrumentAxis__custom--AugustTwoThousandNineteenAuctusNoteMember_zMH0TZ7flE8g" title="Fair value adjustment of warrants">141,084</span> using a Black-Scholes model with the following assumptions: stock price at valuation date of $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_c20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zY9o2RUKVLei" title="Stock valuation price per share">7,140</span> based on the closing price of common stock at date of grant, exercise price of $<span id="xdx_907_eus-gaap--WarrantExercisePriceIncrease_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zqZcGa6Gmwbi" title="Warrant exercise price">600</span>, dividend yield of <span id="xdx_90E_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_dc_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6h16E2NMyTl" title="Measurement input">zero</span>, expected term of <span id="xdx_901_eus-gaap--DebtInstrumentTerm_dtY_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--AffiliatedEntityMember_zMLpH7ns6MCb" title="Maturity term">3.00</span>, a risk-free rate of <span id="xdx_900_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zG75AyxMvGMk" title="Measurement input">4.59</span>%, and expected volatility of <span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zA5MOCVELK68" title="Measurement input">268</span>% and was recorded to additional paid in capital (see Note 5).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Exercise of Warrants</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended June 30, 2024, the Company issued an aggregate of <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zOlcJeqe3KUd" title="Warrants exercised">105</span> shares of common stock from the alternate cashless exercise of <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zgjNJcdwnn8i" title="Warrants exercised">0.000001</span> Series A warrants with an original exercise price of $<span id="xdx_90D_ecustom--ClassOfWarrantOrRightAlternateExercisePriceOfWarrantsOrRights1_iI_pid_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_z484EKGECbLi" title="Warrants exercise price">12,000,000,000</span> and alternate cashless exercise price of $<span id="xdx_903_ecustom--ClassOfWarrantOrRightAlternateExercisePriceOfWarrantsOrRights2_iI_pid_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantsMember_zQHsIX93VXk9" title="Alternate cashless warrant exercise price">60</span> or the par value of common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> sixty thousand pre-split shares (1:60,000) 1500005 0.01 500000 0 0 0 0 0.01 1 1 1 1 0 0 0 0 0.24 120000 24711 23758 5000000 0.001 P24M pursuant to a Drawdown Notice cannot exceed the lesser of (i) 200% of the average daily traded value of the Common Stock during the five (5) business days immediately preceding a Drawdown Notice or (ii) $200,000; provided that in no event may a Drawdown Notice be for less than $5,000, exceed 875 Shares or cause the Investor’s ownership to exceed 4.99% of the outstanding number of shares of Common Stock immediately prior to the issuance of such Shares. The actual amount of proceeds that the Company will receive in connection with each Drawdown Notice is determined under the Equity Line Agreement by multiplying the number of Shares to be sold by the applicable purchase price per share, which is equal to 85% of the lowest traded price of the Common Stock during the 7 business days immediately following the Clearing Date, less Clearing Costs (as each such term is defined in the Equity Line Agreement). 23 360 8822 8822 29 78 2260 263 48 11975 5000000 P36M 2 250000 0.0999 105 0.000001 12000000000 60 12000000 0.70 0 192960 7433 78 531654 28829 3832 130800 8700 3832 352565 209233 263798 54565 8826 12 70315 9371 5520 54850 4365 3770 154154 91169 73640 -17529 10229 117720 7500 250 60 15000 15000 8555500 6 51333000 51333000 2025000 P6M 12 7 15 23881110 4621230 8334046 10925835 51000 51000 129354 129354 9 9 7 7 13 13 437500 437500 7750 7750 468500 339146 30000 74395 13 375000 375000 300605 30000 86248 10 300000 300000 213752 900000 900000 900000 6 5400000 497240 248620 248620 248620 <p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zmpSz4C8mx2j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s stock option activity during the years ended June 30, 2025 and 2024 is presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zHJXeckE4L5l" style="display: none">SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price Per Share</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230701__20240630_zlBafY8Zwzu" style="width: 16%; text-align: right" title="Number of Shares, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">0.000001</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230701__20240630_zjGlCr2A2d5k" style="width: 16%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">271,980,000,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230701__20240630_zgbhNeXXQip1" style="text-align: right" title="Number of Shares, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4453">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230701__20240630_z0TkfOmSunLb" style="text-align: right" title="Weighted Average Price Per Share, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4455">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230701__20240630_zMI3kqKxgKS5" style="text-align: right" title="Number of Shares, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4457">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230701__20240630_zUb4VP8yQOE4" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4459">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20230701__20240630_zFaGDNMQcEZg" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Shares, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4461">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230701__20240630_zK3FSJBzYQe7" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4463">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240701__20250630_zruzLeDUMUSd" style="text-align: right" title="Number of Shares, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">0.000001</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240701__20250630_zN7uQ8Poyio7" style="text-align: right" title="Weighted Average Price Per Share, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">271,980,000,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240701__20250630_zklk39fMw1f3" style="text-align: right" title="Number of Shares, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4469">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240701__20250630_zyDiU84tei11" style="text-align: right" title="Weighted Average Price Per Share, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4471">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240701__20250630_zBvXN6JCCWrh" style="text-align: right" title="Number of Shares, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4473">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240701__20250630_zj2KpL8NPsE3" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4475">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20240701__20250630_z3V7nNbx5CPb" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Shares, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4477">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240701__20250630_zf7JS3FTEG3d" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4479">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2025</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240701__20250630_zK2YEz9EmUPa" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Shares, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">0.000001</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240701__20250630_zi5ucm3GVqWc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">271,980,000,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercisable at June 30, 2025</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20240701__20250630_zH9yleh71eob" style="text-align: right" title="Number of Shares, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">0.000001</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240701__20250630_zhlhnP9idVB1" style="text-align: right" title="Weighted Average Price Per Share, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">271,980,000,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding and Exercisable:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining contractual term</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240701__20250630_zCR6l0S56id3" title="Weighted average remaining contractual term">3.87</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average fair value of options granted during the year</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240701__20250630_zHAM3PfsVvui" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average fair value of options granted during the period"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4491">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate intrinsic value</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240701__20250630_zu0ueAPD0vpg" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4493">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 0.000001 271980000000 0.000001 271980000000 0.000001 271980000000 0.000001 271980000000 P3Y10M13D 1 0 0 0 0 0 <p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zT2zNvQCKjEh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes common stock warrant activity for the years ended June 30, 2025 and 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zRH065CMcPHd" style="display: none">SUMMARY OF WARRANT ACTIVITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price Per Share</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230701__20240630_zDKtnQgCtaR6" style="width: 16%; text-align: right" title="Number of Warrants, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">0.06</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstanding_iS_pid_c20230701__20240630_znlNMdHE8Iyf" style="width: 16%; text-align: right" title="Weighted Average Price Per Share, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">326,400,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230701__20240630_z3ZttUdE05W7" style="text-align: right" title="Number of Warrants, Issued"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_pid_c20230701__20240630_zfKTnVWUYjR6" style="text-align: right" title="Weighted Average Price Per Share, Issued"><span style="font-family: Times New Roman, Times, Serif">600</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20230701__20240630_zkPOMcfidqy6" style="text-align: right" title="Number of Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4517">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_pid_c20230701__20240630_zjBRNEPMgfA9" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4519">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20230701__20240630_zmKKP9wbt2F2" style="text-align: right" title="Number of Warrants, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4521">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_pid_c20230701__20240630_zHRIsWquyAZi" style="text-align: right" title="Weighted Average Price Per Share, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4523">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20230701__20240630_zlPZeOx6djkf" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4525">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_pid_c20230701__20240630_zyy1BE5Txox2" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4527">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20240701__20250630_z26HaKxbWHe5" style="text-align: right" title="Number of Warrants, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstanding_iS_pid_c20240701__20250630_zlZSNkj8yCUi" style="text-align: right" title="Weighted Average Price Per Share, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">1.24</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20240701__20250630_zOJYgzanhvN1" style="text-align: right" title="Number of Warrants, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4533">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceIssued_pid_c20240701__20250630_z3lwaXv9wlx9" style="text-align: right" title="Weighted Average Price Per Share, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4535">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20240701__20250630_zRjDcUxEDtUk" style="text-align: right" title="Number of Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4537">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExercised_pid_c20240701__20250630_zcZQIWKROvD2" style="text-align: right" title="Weighted Average Price Per Share, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4539">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Cancelled*</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20240701__20250630_fKg_____zWgd9EFwfawk" style="text-align: right" title="Number of Warrants, Cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4541">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceForfeited_pid_c20240701__20250630_fKg_____zYyKCrxOAWe2" style="text-align: right" title="Weighted Average Price Per Share, Cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4543">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20240701__20250630_zaPVmDXTBGRk" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4545">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAveragePriceExpired_pid_c20240701__20250630_zh2c0W89t2w4" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4547">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2025</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20240701__20250630_z10j1KKNX6Fl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Outstanding, Balance"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstanding_iE_pid_c20240701__20250630_zCt8KqhNqdK7" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable at June 30, 2025</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20230701__20240630_z0GVrq7M3Ql8" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">250</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisable_iE_pid_c20240701__20250630_zBClNhvHUlM3" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Price Per Share, Exercisable, Balance"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding and Exercisable:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining contractual term</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20240701__20250630_zKNAptcg7Ro6" title="Weighted average remaining contractual term">1.01</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate intrinsic value</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20240701__20250630_zqPF5ULj9pu7" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif">1,035</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-right: 0.8pt; text-align: right"></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F0C_zAb4t5rtbik3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"><span id="xdx_F1C_zoZrSF7vCcQe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 3, 2025, the Company cancelled all the existing warrants (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgV0FSUkFOVCBBQ1RJVklUWSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20250303__20250303__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zMGqc6BClkt4" title="Number of warrants cancelled">0.0002</span> Series A warrants, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgV0FSUkFOVCBBQ1RJVklUWSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20250303__20250303__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zbi6HGxoXTB6" title="Number of warrants cancelled">0.0003</span> Series B warrants, and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgV0FSUkFOVCBBQ1RJVklUWSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20250303__20250303__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_z5SCjsfG5eji" title="Number of warrants cancelled">0.0008</span> Series C warrants) held by an investor pursuant to a Warrant Exchange Agreement (see above).</span></td></tr> </table> 0.06 326400000 250 600 250 1.24 250 0.01 250 0.01 P1Y3D 1035 0.0002 0.0003 0.0008 the Company closed on a transaction related to a Securities Purchase Agreement (the “Securities Purchase Agreement”) entered into on March 30, 2020, whereby an investor purchased from the Company, 0.0001 units, each consisting of (i) 0.0001 shares of the Company’s common stock, or pre-funded warrants upon investor’s election due to the 4.99% blocker provision and (ii) 0.00003 warrants to purchase one share of Common Stock (“Series A Warrants”, and collectively with the Common Stock the “Units”). 0.001 0.001 0.0002 6000000 0.0002 12000000000 P3Y the Series A Warrants contained a provision for a cashless conversion at the Holder’s option should the trading price of the Common Stock fall below $12,000,000,000, per share calculated based on the difference between the exercise price of the Series A Warrant and 70% of the Market Price, as defined therein (the” Alternate Cashless Exercise”). The Alternate Cashless Exercise price was $0.001 or the par value. See above “Shares issued for exercise of warrants” for discussion of deemed dividend related to alternate cashless exercise. 0.001 38 10 0.0001 0.0001 2400000000 P3Y 0.001 P3Y 12000000000 250000 0.0001 150000 0.0001 100000 0.0001 150000 900000 900000 900000 6 5400000 230000 153256 P3Y 0.10 250 600 250 141084 7140 600 0 P3Y 4.59 268 105 0.000001 12000000000 60 <p id="xdx_807_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zLaschfHhOX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 – <span id="xdx_821_zZuK6W0Twt9a">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Legal Matters</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, the Company may be subject to litigation and claims arising in the ordinary course of business. The Company is not currently a party to any material legal proceedings and the Company is not aware of any pending or threatened legal proceeding against the Company that we believe could have a material adverse effect on our business, operating results, cash flows or financial condition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">IRS Liability</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of its requirement for having a foreign operating subsidiary, the Company is required to file an informational Form 5471 to the Internal Revenue Service (the “IRS”), which is a form that explains the nature of the relationship between the foreign subsidiary and the parent company. From 2012 through the 2014, the Company did not file this form in a timely manner. As a result of the non-timely filings, the Company incurred a penalty from the IRS in the amount of $<span id="xdx_90A_ecustom--PenaltyAmount_c20240701__20250630__us-gaap--AwardDateAxis__custom--From2012ThroughThe2014Member_zf45Y1G8aFKh" title="Litigation penalty amount">10,000</span> per year, or $<span id="xdx_901_ecustom--PenaltyAmount_c20240701__20250630_zRLXVDseZMlk" title="Total litigation penalty amount">30,000</span> in total, plus accrued interest, such penalty and interest having been accrued and is included in the accrued expenses and other payable figure on the June 30, 2025 and 2024 consolidated balance sheets. The Company recorded the penalties for all three years during the year ended June 30, 2018. The Company is current on all subsequent filings.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Operating Agreements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2009, the Company entered into a commercialization agreement with the University of Bath (UK) (the “UK University”), whereby the Company and the UK University co-owned the intellectual property relating to the Company’s pro-enzyme formulations. In June 2012, the Company and the UK University entered into an assignment and amendment whereby the Company assumed full ownership of the intellectual property, while agreeing to pay royalties of <span id="xdx_900_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_pid_dp_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--RoyaltyAgreementTermsMember_zQ9950qztrdk" title="Operating leases income statement revenue percentage">2</span>% of net revenues to the UK University. Additionally, the Company agreed to pay <span id="xdx_908_ecustom--OperatingLeasesIncomeStatementRevenuePercentage_pid_dp_uPure_c20120601__20120630__us-gaap--TypeOfArrangementAxis__us-gaap--LicenseAgreementTermsMember_zdYv5OoQFJu5" title="Operating leases income statement revenue percentage">5</span>% of each and every license agreement subscribed for. The contract is cancellable at any time by either party. To date, no amounts are owed under the agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Collaboration Agreement</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 13, 2018, the Company entered into a two-year collaboration agreement with the University of Jaén (the “University”) to provide certain research services to the Company. In consideration of such services, the Company agreed to pay the University approximately <span id="xdx_90F_ecustom--PaymentForServices_uEUR_c20180913__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember_zXcVQd7sAnWb" title="Payment for services">52,000</span> Euros ($<span id="xdx_90C_ecustom--PaymentForServices_c20180913__20180913__us-gaap--TypeOfArrangementAxis__custom--OneYearCollaborationAgreementMember_zjQM027vcRal" title="Payment for services">59,508</span> USD) in year one and a maximum of <span id="xdx_90D_ecustom--PaymentForServices_uEUR_c20180913__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_ziqcI5O46iS8" title="Payment for services">40,000</span> Euros ($<span id="xdx_908_ecustom--PaymentForServices_c20180913__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_zANctuki2ZKh" title="Payment for services">45,775</span> USD) in year two. Additionally, in exchange for full ownership of the intellectual property, the Company agreed to pay royalties of <span id="xdx_905_ecustom--RoyaltyPercentage_pid_dp_uPure_c20180913__20180913__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_zLhtdxZSCvya" title="Royalty percentage">2</span>% of net revenues to the University.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 1, 2020, the Company entered into another two-year collaboration agreement with the University to provide certain research services to the Company. In consideration of such services, the Company agreed to pay the University approximately <span id="xdx_90D_ecustom--PaymentForServices_uEUR_c20201001__20201001__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_zj800vaoBHc5" title="Payment for services">30,000</span> Euros ($<span id="xdx_907_ecustom--PaymentForServices_c20201001__20201001__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember_zrVWlWOvIsA9" title="Payment for services">35,145</span> USD), which were paid in four installment payment of <span id="xdx_90C_ecustom--PaymentForServices_uEUR_c20201101__20201130__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentOneMember_zc5C6yet8QWi" title="Payment for services">5,000</span> Euros in November 2020, <span id="xdx_909_ecustom--PaymentForServices_uEUR_c20210301__20210331__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember_zADMyPM72IP8" title="Payment for services">5,000</span> Euros ($<span id="xdx_903_ecustom--PaymentForServices_c20210301__20210331__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentTwoMember_zrYX9yqD3hPg" title="Payment for services">5,858</span>) in March 2021, <span id="xdx_908_ecustom--PaymentForServices_uEUR_c20211201__20211231__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember_zU2q4n8MXzVi" title="Payment for services">10,000</span> Euros ($<span id="xdx_90A_ecustom--PaymentForServices_c20211201__20211231__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentThreeMember_zkg14FeY7tw1" title="Payment for services">11,715</span>) in December 2021 and <span id="xdx_908_ecustom--PaymentForServices_uEUR_c20220901__20220930__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember_z9Z5TCZT4NIb" title="Payment for services">10,000</span> Euros ($<span id="xdx_902_ecustom--PaymentForServices_c20220901__20220930__us-gaap--TypeOfArrangementAxis__custom--TwoYearCollaborationAgreementMember__us-gaap--AwardDateAxis__custom--InstallmentFourMember_zapmkkqm884l" title="Payment for services">11,715</span>) in September 2022. Additionally, the University agreed to hire and train a doctoral student for this project and the Company agreed to pay the University <span id="xdx_902_ecustom--PaymentForServices_uEUR_c20201001__20201001__dei--LegalEntityAxis__custom--UniversityOfJaenMember_z9XJ4hHYwoMb" title="Payment for services">25,837</span> Euros ($<span id="xdx_909_ecustom--PaymentForServices_c20201001__20201001__dei--LegalEntityAxis__custom--UniversityOfJaenMember_zSLJPPn73YEa" title="Payment for services">30,268</span> USD). In exchange for full ownership of the intellectual property, the Company agreed to pay royalties of <span id="xdx_906_ecustom--RoyaltiesPercentage_pid_dp_uPure_c20201001__20201001_zx5cIz7FvzK1" title="Royalties percentage">2</span>% of net revenues to the University.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 27, 2022, the Company entered into a two-year research agreement with the University to provide certain research and experiment services to the Company. One of the Company’s Scientific Advisory Board is the lead joint researcher of the University. In exchange for full ownership of the intellectual property, the Company agreed to pay royalties of <span id="xdx_906_ecustom--RoyaltyPercentage_pid_dp_uPure_c20220727__20220727__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zkvuksFM1BQ8" title="Royalty percentage">1</span>% of net revenues each to two members of the Scientific Advisory Board. In consideration of such services, the Company agreed to pay the University approximately <span id="xdx_905_ecustom--PaymentForServices_uEUR_c20220727__20220727__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zPBwc5jzF4Nf" title="Payment for services">53,200</span> Euros ($<span id="xdx_903_ecustom--PaymentForServices_c20220727__20220727__dei--LegalEntityAxis__custom--UniversityOfJaenMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zK9HGQosk3K9" title="Payment for services">53,806</span> USD) payable as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_90E_ecustom--PaymentForServices_uEUR_c20220801__20220831__us-gaap--AwardDateAxis__custom--InstallmentOneMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zQfEClPw1cJ3" title="Payment for services">18,200</span> Euros ($<span id="xdx_903_ecustom--PaymentForServices_c20220801__20220831__us-gaap--AwardDateAxis__custom--InstallmentOneMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_z2vKs8SBK6d6" title="Payment for services">18,407</span> USD) upon execution (paid in August 2022),</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_90C_ecustom--PaymentForServices_uEUR_c20220901__20220930__us-gaap--AwardDateAxis__custom--InstallmentTwoMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_z41wiAlDi73k" title="Payment for services"> 8,000</span> Euros ($<span id="xdx_90B_ecustom--PaymentForServices_c20220901__20220930__us-gaap--AwardDateAxis__custom--InstallmentTwoMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_z8lN5pz3mlza" title="Payment for services">8,091</span> USD) in September 2022 (unpaid),</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_905_ecustom--PaymentForServices_uEUR_c20221201__20221231__us-gaap--AwardDateAxis__custom--InstallmentThreeMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zWacCVJFfIG8" title="Payment for services">7,000</span> Euros ($<span id="xdx_909_ecustom--PaymentForServices_c20221201__20221231__us-gaap--AwardDateAxis__custom--InstallmentThreeMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zMCRxdMc0M2k" title="Payment for services">7,080</span> USD) in December 2022 (unpaid),</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_90D_ecustom--PaymentForServices_uEUR_c20230301__20230331__us-gaap--AwardDateAxis__custom--InstallmentFourMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zOYwU0bArZol" title="Payment for services">10,000</span> Euros ($<span id="xdx_90D_ecustom--PaymentForServices_c20230301__20230331__us-gaap--AwardDateAxis__custom--InstallmentFourMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_z6LovZLnF50k" title="Payment for services">10,114</span> USD) in March 2023 (unpaid), and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_90A_ecustom--PaymentForServices_uEUR_c20230701__20230731__us-gaap--AwardDateAxis__custom--InstallmentFiveMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_z4T3CNCZrv0d" title="Payment for services">10,000</span> Euros ($<span id="xdx_901_ecustom--PaymentForServices_c20230701__20230731__us-gaap--AwardDateAxis__custom--InstallmentFiveMember__us-gaap--TypeOfArrangementAxis__custom--ResearchAgreementMember_zfSPEePDpsRf" title="Payment for services">10,114</span> USD) in July 2023 (unpaid).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The commencement date for the experiments was on September 1, 2022, and the estimated length of time for completion is 24 months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2025 and 2024, the Company has $<span id="xdx_90F_ecustom--UnreimbursedLabFees_iI_c20250630_zbvNWxehOKm8" title="Unreimbursed lab fees">51,468</span> and $<span id="xdx_90D_ecustom--UnreimbursedLabFees_iI_c20240630_z6KlBGSz3We" title="Unreimbursed lab fees">47,531</span>, respectively, balance due to the University for unreimbursed lab fees, which are included in accrued expenses and other liabilities in the accompanying consolidated balance sheets. As of June 30, 2025 and 2024, there are no royalty fees owed to the University.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Consulting Agreements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 4, 2024, the Company entered into an Engagement Agreement (the “Agreement”) with EF Hutton LLC (the “Consultant”) which will act as an exclusive lead underwriter, financial advisor, placement agent and investment banker of the Company, whereby the Consultant will assist the Company to a public offering and uplisting of the Company’s equity, debt or equity derivative instruments. The engagement period shall end on the earlier of i) 12 months from the date of this agreement or ii) the final closing if any of the offering. The Consultant will prepare an Underwriting Agreement (the “Underwriting Agreement”) covering the sale of up to $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn6n6_c20240504__20240504__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--EFHuttonLLCMember_zAgyvPm3eaq5" title="Sale of underwriting agreements">15</span> million of equity, equity derivatives, and equity linked instruments of the Company. The Company shall pay compensation for:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Financing Fees:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) For private equity and equity-linked placements, pay the Consultant a cash fee of eight percent (<span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240504__us-gaap--DebtInstrumentAxis__custom--EquityAndEquityLinkedPlacementsMember_z1AHg4eHjzHd">8.0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%) of the amount of capital raised, invested or committed, payable in cash at the closing or closings of the financing to which it relates; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) For debt placements, pay the Consultant a cash fee of six percent (<span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240504__us-gaap--DebtInstrumentAxis__custom--DebtPlacementsMember_zLUjyieawQF1" title="Cash fee percentage">6.0</span>%) of the amount of capital raised, invested or committed, payable in cash at the closing or closings of the financing to which it relates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) As additional compensation for EF Hutton’s services, the Company shall issue to the Consultant or its designees at the closing warrants (the “Warrants”) to purchase that number of shares of common stock equal to three percent (<span id="xdx_906_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_pid_dp_uPure_c20240504__20240504__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbFH8RcG9Fvc" title="Sale of stock percentage">3.0</span>%) of the aggregate proceeds sold in an offering. The Warrants will be exercisable at any time in whole or in part, during the <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20240504_zZalO5UeTHz2" title="Warrants term">five years</span> (5) years from the effective date of the Offering at a price per share equal to the Offering price. The Warrants will provide for piggyback registration rights, Black Scholes change in control provisions and customary anti-dilution provisions and adjustments in the number and price of such warrants and the shares underlying such warrants resulting from corporate events which would include dividends, reorganizations, mergers, etc. and future issuance of Common Stock or Common Stock equivalents at prices or with exercise and/or conversion prices below the offering price as permitted under FINRA Rule 5110(f)(2)(G).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, the Consultant shall be entitled to a cash fee equal to eight percent (<span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240504__srt--RangeAxis__srt--MaximumMember_zplF1EK8vqF4" title="Cash fee percentage">8.0</span>%) of the gross proceeds received by the Company from the sale of any equity, debt and/or equity derivative instruments to any investor introduced by the Consultant to the Company during the engagement period, in connection with any public or private financing or capital raise.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Merger, acquisition or sale of stock or assets (the “M&amp;A Transaction”) Fees: The M&amp;A Transaction fees shall be payable to the Consultant in cash at the closing or closings of the M&amp;A Transaction to which it relates and shall be equal to five percent (<span id="xdx_908_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_dp_uPure_c20240504__20240504__srt--TitleOfIndividualAxis__custom--ConsultantMember_zbpLr82svJ4d" title="Sale of stock percent">5.0</span>%) of M&amp;A Transaction consideration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will be responsible for and will pay all expenses relating to the offering as defined in the Agreement. Additionally, the Company will provide an expense advance (the “Advance”) to the Consultant of $<span id="xdx_90F_eus-gaap--PrepaidExpenseCurrent_iI_c20240504__srt--TitleOfIndividualAxis__custom--ConsultantMember_z2QyeHlDgW1a" title="Expenses advance">50,000</span>, of which $<span id="xdx_907_eus-gaap--PrepaidExpenseCurrent_iI_c20240504__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--MergerAcquisitionAgreementMember_zdbt0jxe1AM1" title="Expenses advance">25,000</span> was payable upon the execution of the Agreement and $<span id="xdx_909_eus-gaap--PrepaidExpenseCurrent_iI_c20240504__srt--TitleOfIndividualAxis__custom--ConsultantMember__us-gaap--TypeOfArrangementAxis__custom--InitialPayableMember_zxvWL3dwJS0e" title="Expenses advance">25,000</span> of which is payable upon the initial filing of a registration statement. The Company paid $<span id="xdx_901_eus-gaap--DeferredOfferingCosts_iI_c20240504__srt--TitleOfIndividualAxis__custom--ConsultantMember_zL4xmaXB7iZ7" title="Deferred offering cost">25,000</span> in May 2024 which was recorded as deferred offering cost as of June 30, 2025 and 2024 for both periods. During the year ended June 30, 2025 and 2024, EF Hutton did not close any offering and the Company engaged another underwriter for an Offering that closed in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 14, 2025, the Company entered into an underwriting agreement with D. Boral Capital, LLC, as representative (the “Representative”) of the underwriters (the “Underwriters”) in connection with a public offering of the Company’s common stock, par value $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z2f8fOE6Q6Fb" title="Common stock, par value">0.001</span> (the “Common Stock”). The Underwriting Agreement provides for the offer and sale of <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250814__20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zVlahibmyIp5" title="Sale of stock, number of shares issued in transaction">1,000,000</span> shares of Common Stock at a price to the public of $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_c20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zDvB2EH8bF56" title="Sale of stock, price per share">4.00</span> per share (the “Offering”). In connection therewith, the Company agreed to issue to the Representative, warrants to purchase <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250814__20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativesWarrantsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQx80G5FD94f" title="Sale of stock, number of shares issued in transaction">30,000</span> of shares of common stock at a price equal $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativesWarrantsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zfnewh6Hbt9" title="Sale of stock, price per share">4.00</span> per share (the “Representative’s Warrants”). The Representative’s Warrants are exercisable at any time and from time to time, in whole or in part, from February 15, 2026 through August 15, 2030 and contain provisions for cashless exercise. The Company also granted the Underwriters an overallotment option for a period of 45 days to purchase up to an additional <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20250814__20250814__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zlhTN7Kka2R1" title="Granted overallotment option, shares">150,000</span> shares of common stock. The Offering was made pursuant to a Registration Statement on Form S-1 and a related prospectus filed with the Securities and Exchange Commission (“SEC”), which was declared effective by the SEC on August 13, 2025. The Underwriting Agreement includes customary representations, warranties and covenants by the Company. It also provides that the Company will indemnify the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended or contribute to payments the Underwriter may be required to make because of any of those liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accrued $<span id="xdx_90C_eus-gaap--DeferredOfferingCosts_iI_c20250630_zEZThEqrJSG9" title="Deferred offering costs">115,000</span> for services rendered by the Underwriters as of June 30, 2025 which was recorded as deferred offering cost. No payment was made during the year ended June 30, 2025. The Company paid the underwriting expenses in August 2025 upon closing of the Offering (see Note 13).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Operating Leases – Related Party</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 4, 2022, the Company entered in a three-year<span id="xdx_90D_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20220504__us-gaap--TypeOfArrangementAxis__custom--NewThreeYearOperatingLeaseAgreementMember_zSOPlpVBV036" style="display: none" title="Lessee operating lease term">3</span> lease agreement with North Horizon Pty Ltd., a related party, for a monthly rent of $<span id="xdx_90F_eus-gaap--PaymentsForRent_uAUD_c20220504__20220504__us-gaap--TypeOfArrangementAxis__custom--NewThreeYearOperatingLeaseAgreementMember_zSXQHxP6QTza" title="Payments for rent">3,000</span> AUD or $<span id="xdx_90B_eus-gaap--PaymentsForRent_uUSD_c20220504__20220504__us-gaap--TypeOfArrangementAxis__custom--NewThreeYearOperatingLeaseAgreementMember_zK0CZJIEvUE4" title="Payments for rent">2,176</span> USD (depending on exchange rate) per month plus taxes. On May 4, 2022, the Company recorded right-of-use assets $<span id="xdx_909_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20220504__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__custom--AccountingStandardUpdate201602Member_zPzxW0ryTiM" title="Operating lease right of use asset">66,201</span> and total lease liabilities of $<span id="xdx_909_eus-gaap--OperatingLeaseLiability_iI_c20220504__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__custom--AccountingStandardUpdate201602Member_zCFlcH8Iw19i" title="Operating lease liabilities">66,201</span> based on an incremental borrowing rate of <span id="xdx_90D_ecustom--IncrementalBorrowingRate_pid_dp_uPure_c20220504__20220504_zu26YoHqHvic" title="Incremental borrowing rate">8</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 4, 2025, the Company entered in a one-year<span id="xdx_903_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20250504__us-gaap--TypeOfArrangementAxis__custom--NewOneYearOperatingLeaseAgreementMember_zbfezdYvZ5U8" style="display: none" title="Lessee operating lease term">1</span> lease agreement with North Horizon Pty Ltd., a related party, for a monthly rent of $<span id="xdx_901_eus-gaap--PaymentsForRent_uAUD_c20250504__20250504__us-gaap--TypeOfArrangementAxis__custom--NewOneYearOperatingLeaseAgreementMember_z8QiRvpbvqz" title="Payments for rent">3,300</span> AUD or $<span id="xdx_909_eus-gaap--PaymentsForRent_uUSD_c20250504__20250504__us-gaap--TypeOfArrangementAxis__custom--NewOneYearOperatingLeaseAgreementMember_znrbzzlbsIJa" title="Payments for rent">2,127</span> USD (depending on exchange rate) per month plus taxes with an option to renew the lease for an additional two-year<span id="xdx_909_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dtY_c20250504__us-gaap--TypeOfArrangementAxis__custom--NewOneYearOperatingLeaseAgreementMember_zarDRSqREPig" style="display: none" title="Lessee operating renewal term">2</span> term. On May 4, 2025, the Company recorded right-of-use assets of $<span id="xdx_901_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20250504_zaZq2A385Sng" title="Operating lease right of use asset">62,126</span> and total lease liabilities of $<span id="xdx_907_eus-gaap--OperatingLeaseLiability_iI_c20250504_zm5FQFtSpN43" title="Operating lease liabilities">62,126</span> based on an incremental borrowing rate of <span id="xdx_90D_ecustom--IncrementalBorrowingRate_pid_dp_uPure_c20250504__20250504_zzGBVQjVsesd" title="Incremental borrowing rate">12</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_ecustom--ScheduleOfRightUseOfAssetTableTextBlock_zqyVIGRVXHBa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU is summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B9_zDOS5v4W04kc" style="display: none">SCHEDULE OF RIGHT OF USE ASSET</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20250630_zhWH0MyIuhT5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20240630_zsmJYFVEzO7k" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--OperatingLeaseRightOfUseAssets_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maOLROUzZkA_z0RwwCekDnCk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Office lease</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">128,327</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,201</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--AccumulatedReduction_iNI_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_msOLROUzZkA_z2X6lsgTbulf" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: accumulated amortization</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,914</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(48,402</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseRightOfUseAsset_iTI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_mtOLROUzZkA_zZ9cdfcLub2i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Right-of-use asset, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59,413</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,799</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A6_zq4AWTCeCgRk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--OperatingLeaseLeaseIncomeTableTextBlock_z3IZix3KkMSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating Lease liabilities are summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zCMHKOYFY0T4" style="display: none">SCHEDULE OF OPERATING LEASE LIABILITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20250630_zSjk4YDxwltg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20240630_zmSs70s15bfh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_ecustom--OfficeLeaseLiability_iI_pp0p0_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zzIS8wKG22u" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Office lease</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">128,327</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,201</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_ecustom--ReductionOfLeaseLiability_iNI_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVWFKh02rEB" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Reduction of lease liability</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,914</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(46,839</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zDgHyuZM02G4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: office lease, current portion</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17,664</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(19,362</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z4RXv3c2V965" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Long term portion of lease liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,749</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4823">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A4_zUU37A5G9VZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p id="xdx_89E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zCVm6L0yDuB2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining future minimum lease payments under non-cancelable operating lease at June 30, 2025 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zDZA0rGYhzMg" style="display: none">SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20250630_zCV1d88TNwU9" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_zCb8iAFkJXr4" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year I</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzcO8_zOcMANLyasu4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fiscal Year 2026</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,853</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzcO8_zP35CODlg2Jf" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year II</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzcO8_zlsqGBON1oSc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fiscal Year 2027</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,045</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzcO8_ziOhqqpoy6Zk" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Year III</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzcO8_z6HsLfJGkRSe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fiscal Year 2028</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">21,734</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzcO8_zqInLcQPUItc" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year IV</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ReceivableWithImputedInterestNetAmount_iNI_di_msLOLLPzcO8_zlEFwqB5rGB3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Imputed interest</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(11,219</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzcO8_z7bIKQzP2vpc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total operating lease liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59,413</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A6_zKqsY0FTjw8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average remaining lease term for the operating lease is <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20250630_zGjMhQ0jw4fg" title="Weighted average remaining lease term">2.77</span> years as of June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 10000 30000 0.02 0.05 52000 59508 40000 45775 0.02 30000 35145 5000 5000 5858 10000 11715 10000 11715 25837 30268 0.02 0.01 53200 53806 18200 18407 8000 8091 7000 7080 10000 10114 10000 10114 51468 47531 15000000 0.080 0.060 0.030 P5Y 0.080 0.050 50000 25000 25000 25000 0.001 1000000 4.00 30000 4.00 150000 115000 P3Y 3000 2176 66201 66201 0.08 P1Y 3300 2127 P2Y 62126 62126 0.12 <p id="xdx_894_ecustom--ScheduleOfRightUseOfAssetTableTextBlock_zqyVIGRVXHBa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU is summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B9_zDOS5v4W04kc" style="display: none">SCHEDULE OF RIGHT OF USE ASSET</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20250630_zhWH0MyIuhT5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20240630_zsmJYFVEzO7k" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--OperatingLeaseRightOfUseAssets_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maOLROUzZkA_z0RwwCekDnCk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Office lease</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">128,327</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,201</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--AccumulatedReduction_iNI_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_msOLROUzZkA_z2X6lsgTbulf" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: accumulated amortization</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,914</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(48,402</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseRightOfUseAsset_iTI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_mtOLROUzZkA_zZ9cdfcLub2i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Right-of-use asset, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59,413</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,799</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 128327 66201 68914 48402 59413 17799 <p id="xdx_897_eus-gaap--OperatingLeaseLeaseIncomeTableTextBlock_z3IZix3KkMSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating Lease liabilities are summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zCMHKOYFY0T4" style="display: none">SCHEDULE OF OPERATING LEASE LIABILITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20250630_zSjk4YDxwltg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20240630_zmSs70s15bfh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_ecustom--OfficeLeaseLiability_iI_pp0p0_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zzIS8wKG22u" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Office lease</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">128,327</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,201</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_ecustom--ReductionOfLeaseLiability_iNI_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVWFKh02rEB" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Reduction of lease liability</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,914</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(46,839</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zDgHyuZM02G4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: office lease, current portion</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17,664</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(19,362</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z4RXv3c2V965" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Long term portion of lease liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,749</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl4823">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 128327 66201 68914 46839 17664 19362 41749 <p id="xdx_89E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zCVm6L0yDuB2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining future minimum lease payments under non-cancelable operating lease at June 30, 2025 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zDZA0rGYhzMg" style="display: none">SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20250630_zCV1d88TNwU9" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_zCb8iAFkJXr4" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year I</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzcO8_zOcMANLyasu4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fiscal Year 2026</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,853</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzcO8_zP35CODlg2Jf" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year II</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzcO8_zlsqGBON1oSc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fiscal Year 2027</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,045</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzcO8_ziOhqqpoy6Zk" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Year III</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzcO8_z6HsLfJGkRSe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fiscal Year 2028</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">21,734</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzcO8_zqInLcQPUItc" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year IV</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ReceivableWithImputedInterestNetAmount_iNI_di_msLOLLPzcO8_zlEFwqB5rGB3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Imputed interest</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(11,219</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzcO8_z7bIKQzP2vpc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total operating lease liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59,413</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 23853 25045 21734 11219 59413 P2Y9M7D <p id="xdx_80A_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zRTjb6rnptrl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 – RELATED PARTY TRANSACTIONS AND BALANCES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_825_zc4bUB2OLlsc">RELATED PARTY TRANSACTIONS</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span></span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span></span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since its inception, the Company has conducted transactions with its directors and entities related to such directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These transactions have included the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2025 and 2024, the Company owed its former director a total of $<span id="xdx_905_eus-gaap--OtherLiabilitiesCurrent_iI_dxL_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_zxfjVtP6TUE2" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl4848">0</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_906_eus-gaap--OtherLiabilitiesCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember_zK8D5doCe72c">29,759</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, related to expenses paid on behalf of the Company related to corporate startup costs and intellectual property. Additionally, as of June 30, 2025 and 2024, the Company owed its former director a total of $<span id="xdx_90C_eus-gaap--LoansPayableCurrent_iI_dxL_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorsMember_zIQ0axvB8RTk" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl4850">0</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_902_eus-gaap--LoansPayableCurrent_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorsMember_zA3CGzdc7PIi">49,528</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, for money loaned to the Company, throughout the years. On January 23, 2025, the Company entered into a Debt Exchange with the former director and issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250123__20250123__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zMSiJIoxHXD2">30,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock in exchange for the total outstanding loans of $<span id="xdx_905_ecustom--SettlementOfLoansForSharesOfCommonStock_c20250123__20250123__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerDirectorMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeMember_zE17NE8OhM4f" title="Settlement of loans for shares of common stock">74,395</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(see Note 4).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective May 5, 2016, the Company entered into an agreement for the lease of its principal executive offices with North Horizon Pty Ltd., a related party, of which Mr. Nathanielsz, our CEO, CFO and a director, and his wife are owners and directors. The lease had a five-year<span id="xdx_903_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zrFQDGZWaWag" style="display: none">5</span> term and provided for annual rental payments of $<span id="xdx_90C_ecustom--OperatingLeasesRentExpenseMinimumRental_uAUD_c20160505__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zdQ2ZnU2pZQ" title="Operating leases rent expense, minimum rentals">39,600</span> AUD or $<span id="xdx_908_ecustom--OperatingLeasesRentExpenseMinimumRental_c20160505__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_znMxGFnwbmFd" title="Operating leases rent expense, minimum rentals">28,325</span> USD, which includes $<span id="xdx_90B_ecustom--GoodsAndServiceTax_uAUD_c20160505__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zqQfKzrHAe29" title="Goods and service tax">3,600</span> AUD or $<span id="xdx_909_ecustom--GoodsAndServiceTax_c20160505__20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zIOj2mY9V957" title="Goods and service tax">2,575</span> USD of goods and service tax for total payments of $<span id="xdx_901_ecustom--OperatingLeaseFutureMinimumPaymentsDue_iI_uAUD_c20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NathanielszMember_zjCl4oTAdKTh" title="Operating leases, future minimum payments due">198,000</span> AUD or $<span id="xdx_90B_ecustom--OperatingLeaseFutureMinimumPaymentsDue_iI_c20160505__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NathanielszMember_zfuqqdB1u9e6" title="Operating leases, future minimum payments due">141,629</span> USD during the term of the lease. <span id="xdx_902_eus-gaap--LesseeOperatingLeaseDescription_c20160505__20160505__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__custom--AccountingStandardUpdate201602Member_zYPApHXEkic4" title="Operating lease, description">Such lease expired in May 2021 and was renewed for another one-year term from May 2021 to May 2022.</span> On May 4, 2022, the Company entered into a three-year<span id="xdx_905_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20220504__us-gaap--TypeOfArrangementAxis__custom--NewThreeYearOperatingLeaseAgreementMember_z4rGAcSh4Fte" style="display: none" title="Lessee operating lease term">3</span> lease agreement with North Horizon Pty Ltd. for a monthly rent of $<span id="xdx_906_eus-gaap--PaymentsForRent_uAUD_c20220504__20220504__us-gaap--TypeOfArrangementAxis__custom--ThreeYearOperatingLeaseAgreementMember__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_ziIqWmUD9tta" title="Payments for rent">3,000</span> AUD or $<span id="xdx_905_eus-gaap--PaymentsForRent_c20220504__20220504__us-gaap--TypeOfArrangementAxis__custom--ThreeYearOperatingLeaseAgreementMember__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_z806tAbASc1d" title="Payments for rent">2,176</span> USD (depending on exchange rate) per month plus taxes (See Note 9). As of June 30, 2025 and 2024, total rent payable of $<span id="xdx_900_eus-gaap--PaymentsForRent_uAUD_c20240701__20250630__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zMWHAKOs5jc8" title="Payments for rent">200,402</span> AUD ($<span id="xdx_907_eus-gaap--PaymentsForRent_c20240701__20250630__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zi0W7qXHoqol" title="Payments for rent">131,684</span> USD) and $<span id="xdx_906_eus-gaap--PaymentsForRent_uAUD_c20230701__20240630__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zXKcUbjgxNid" title="Payments for rent">194,129</span> AUD ($<span id="xdx_903_eus-gaap--PaymentsForRent_c20230701__20240630__dei--LegalEntityAxis__custom--NorthHorizonPtyLtdMember_zZOd14DgKDL" title="Payments for rent">129,930</span> USD), respectively, was included in accrued expenses in the accompanying consolidated balance sheet. Rent expense under those lease was $<span id="xdx_904_eus-gaap--PaymentsForRent_c20240701__20250630_znGMKOmd6nDc" title="Payments for rent">34,150</span> and $<span id="xdx_90C_eus-gaap--PaymentsForRent_c20230701__20240630_zIJ93W35IwN4" title="Payments for rent">34,150</span> in fiscal 2025 and 2024, respectively and reflected as occupancy expenses in the accompanying consolidated statements of operations and comprehensive income (loss).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loans payable - Related Party (see Note 5)</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between November 2023 and May 2024, an institutional investor affiliated with one of our directors, Josef Zelinger, loaned the Company an aggregate of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20231130_zoMTSdzgvrIi" title="Investor loan, value"><span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20240531_zlpAohujCN9e" title="Investor loan, value">71,629</span></span>. Additionally, in August 2024, the same affiliated institutional investor loaned the Company an amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20240831_z7DvpLtS5xK2" title="Investor loan, value">85,000</span> AUD ($<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20240831_znYM1SP5oCIf" title="Investor loan, value">57,639</span> USD). These loans bear no interest and are payable on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective August 1, 2024, the Company entered into and closed a loan agreement with an institutional investor affiliated with one of our directors, Josef Zelinger, pursuant to which the investor loaned the Company an aggregate principal amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zBxbcCTf0X9l" title="Aggregate principal amount">150,000</span> AUD ($<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zC83rSMREzJ2" title="Aggregate principal amount">98,060</span> USD). The Company used the net proceeds for general working capital purposes. The maturity date of the loan is <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20240801__20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zXWnrGorr7Q4" title="Debt instrument maturity date">November 1, 2024</span>, or sooner at the discretion of the Company, and the loan bears an interest rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20240801__20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zufYyYqnbxff" title="Debt instrument loan bears interest rate">12</span>% per annum and default interest rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zlrudqhd4Etl" title="Debt instrument interest rate">18</span>% per annum. The Company has the right to prepay in full at any time with no prepayment penalty. By mutual consent the amount can be repaid via the issuance of common stock of the Company (upon uplisting on NASDAQ) and the strike price shall be at a <span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20240801__20240801__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zFbdHGFPFPS6" title="Debt instrument strike price">35</span>% discount to lowest daily balance of the five preceding trading days. Such loan is past due and currently in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between November 2024 and December 2024, an institutional investor affiliated with one of our directors, Josef Zelinger, loaned the Company an aggregate of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20241130__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zF4phELfcZs3" title="Investor loan, value"><span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20241231__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_znaTbK96reSb" title="Investor loan, value">15,000</span></span> AUD ($<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20241130__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_ze4xRN9vOgq1" title="Investor loan, value"><span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_ziu3VsBm4qNc" title="Investor loan, value">9,731</span></span> USD). These loans bear no interest and are payable on demand. The Company repaid $<span id="xdx_907_eus-gaap--RepaymentsOfBankDebt_uAUD_c20250819__20250819__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpGsys5zp7sl" title="Repaid loan amount">12,000</span> AUD of this loan on August 19, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective December 3, 2024, the Company entered into and closed a loan agreement with an institutional investor affiliated with one of our directors, Josef Zelinger, pursuant to which the investor loaned the Company an aggregate principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20241203__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zf91O44PrRo6" title="Aggregate principal amount">175,000</span> AUD ($<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20241203__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zLxdxM741IR5" title="Aggregate principal amount">113,485</span> USD). The Company used the net proceeds for general working capital purposes. The term of the loan is four months or less (to be determined at the discretion of the Company), with $<span id="xdx_90A_eus-gaap--LoansPayable_iI_uAUD_c20240228__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zjLG1H6srtr4" title="Loans payable">70,000</span> AUD was due on February 28, 2024 and $<span id="xdx_90A_eus-gaap--LoansPayable_iI_uAUD_c20240402__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zvKO7xSE77Wb" title="Loans payable">105,000</span> AUD was due on April 2, 2024. The loan bears an interest rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20241203__20241203__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zcRzP16QSwW4" title="Debt instrument loan bears interest rate">12</span>% per annum and default interest rate of <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20241203__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zhJGHZWtvJdf" title="Debt instrument interest rate">18</span>% per annum. Such loan is past due and currently in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2025, an institutional investor affiliated with one of our directors, Josef Zelinger, loaned the Company an aggregate of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20250131__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zQuLEvfx41q3" title="Investor loan, value">25,000</span> AUD ($<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20250131__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zXdkp4v9NLMh" title="Investor loan, value">15,485</span> USD). This loan bore no interest and was payable on demand. The Company fully repaid this loan on August 19, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 12, 2025, the Company entered into and closed a loan agreement with an institutional investor affiliated with one of our directors, Josef Zelinger, pursuant to which the investor loaned the Company an aggregate principal amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20250412__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z7t0N4zTgtY4" title="Aggregate principal amount">63,188</span> AUD ($<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20250412__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zWu4BtsBO4m5" title="Aggregate principal amount">39,625</span> USD). The Company used the net proceeds for general working capital purposes. The maturity date was on <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20250412__20250412__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zVa3tqwS7hXf" title="Debt instrument maturity date">June 30, 2025</span>. The loan bore an interest rate of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20250412__20250412__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zESt2XMLPvp9" title="Debt instrument loan bears interest rate">12</span>% per annum and default interest rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250412__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zpMM4rF93Fg6" title="Debt instrument interest rate">18</span>% per annum. The Company fully repaid this loan on August 19, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 13, 2025, the Company entered into and closed a loan agreement with an institutional investor affiliated with one of our directors, Josef Zelinger, pursuant to which the investor loaned the Company an aggregate principal amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20250613__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zqQKyd98GI0c" title="Aggregate principal amount">15,000</span> AUD ($<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20250613__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zjtFqZ3yh2I9" title="Aggregate principal amount">9,675</span> USD). The Company used the net proceeds for general working capital purposes. The maturity date was on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20250613__20250613__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zEOKPDVJnQPi" title="Debt instrument maturity date">June 30, 2025</span>. The loan bore an interest rate of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20250613__20250613__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zorwU1IcWmH6" title="Debt instrument loan bears interest rate">12</span>% per annum and default interest rate of <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250613__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zlPSEyOC8cTg" title="Debt instrument interest rate">18</span>% per annum. The Company fully repaid this loan on August 19, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loan payable -long-term- Related Party</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 5, 2023, the Company and an institutional investor affiliated with one of our directors, Josef Zelinger, entered into a letter agreement, pursuant to which such investor loaned the Company an aggregate of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zIGsd6HT7027" title="Investor loan, value">230,000</span> AUD ($<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zQjGQeBV0V1c" title="Investor loan, value">153,256</span> USD). Pursuant to such agreement, the term of such loan is three (<span id="xdx_902_eus-gaap--DebtInstrumentTerm_dtY_c20230705__20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zQPWURgrXJR" title="Term of agreement">3</span>) years, ending on July 5, 2026, with an interest rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zU0YvU4MST7h" title="Debt instrument interest rate">10</span>% to be paid monthly in arrears. In connection with such loan, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20230705__20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zbueB4VApyzd" title="Issue of warrants">250</span> warrants to purchase common stock to such investor immediately exercisable at an initial exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230705__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember_zTkC1YtPpNdk" title="Share price">600</span> per share (subject to certain adjustments such as stock dividend, stock splits, subsequent right offering and pro-rata distribution) with an expiry date of July 5, 2026 (see Note 5).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employment and Services Agreements with Management</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and Mr. Nathanielsz entered into an employment agreement as of February 25, 2015 (the “Nathanielsz Employment Agreement”) setting forth the terms and conditions of Mr. Nathanielsz’s employment as the Company’s President and Chief Executive Officer. The Nathanielsz Employment Agreement was scheduled to expire on <span id="xdx_901_eus-gaap--RelatedPartyTransactionDate_dd_c20150225__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zDHauxxqvdag" title="Expired date">February 25, 2019</span>; however, the term of the Nathanielsz Employment Agreement automatically renews for successive one-year periods unless either party provides 30 days’ prior written notice of his or its intent not to renew. The Nathanielsz Employment Agreement continues in effect, as amended on October 26, 2022 (see below). The Nathanielsz Employment Agreement provides Mr. Nathanielsz with a base salary of $<span id="xdx_906_ecustom--BaseSalaryPerMonth_uAUD_c20150225__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zwHhCeEHYtu5" title="Base salary per month">25,000</span> AUD per month ($<span id="xdx_900_eus-gaap--SalariesAndWages_uAUD_c20150225__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zGjGgfrCZgUg" title="Annual salary">300,000</span> AUD annually or $<span id="xdx_908_eus-gaap--SalariesAndWages_c20150225__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_znH9wQI2MaS1" title="Annual salary">205,680</span> USD) and a monthly contribution to Mr. Nathanielsz’s pension equal to <span id="xdx_908_ecustom--PercentageOfPensionOfMonthlySalary_pid_dp_uPure_c20220701__20230630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zzdofajhSvK2" title="Percentage of pension of monthly salary">9.5</span>% of his monthly salary. Mr. Nathanielsz has the ability to convert any accrued but unpaid salary into common stock at the end of each fiscal year at a conversion price to be determined by Mr. Nathanielsz and the Company, which will in no event be lower than par value or higher than the closing bid price on the date of conversion. Pursuant to the Nathanielsz Employment Agreement, Mr. Nathanielsz is entitled to an annual discretionary bonus in an amount up to <span id="xdx_907_ecustom--PercentageOfBonusOfAnnualBaseSalary_pid_dp_c20150225__20150225__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_zmjpmK2h2Pdk" title="Percentage of bonus of annual base salary">200</span>% of his annual base salary, which bonus shall be determined by the Company’s board of directors based upon the performance of the Company. On March 16, 2018, the Company’s board of directors approved an increase of Mr. Nathanielsz’s annual base salary from $<span id="xdx_90A_eus-gaap--SalariesAndWages_uAUD_c20180316__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember_zwsAsUm5zRC2" title="Annual salary">300,000</span> AUD ($<span id="xdx_909_eus-gaap--SalariesAndWages_c20180316__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember_zsYXO6LQXE51" title="Annual salary">205,680</span> USD) to $<span id="xdx_90D_eus-gaap--SalariesAndWages_uAUD_c20180316__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_zepyLqKKRL4" title="Annual salary">400,000</span> AUD ($<span id="xdx_90B_eus-gaap--SalariesAndWages_c20180316__20180316__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_zHbJexVOOU2d" title="Annual salary">274,240</span> USD), effective February 2018. On August 1, 2022, the Company’s board of directors approved an increase of Mr. Nathanielsz’s annual base salary from $<span id="xdx_90A_eus-gaap--SalariesAndWages_uAUD_c20220801__20220801__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember_zbrvifVJ2aZf" title="Annual salary">400,000</span> AUD ($<span id="xdx_900_eus-gaap--SalariesAndWages_c20220801__20220801__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember_z7S9mhIytYJ" title="Annual salary">309,313</span> USD) to $<span id="xdx_903_eus-gaap--SalariesAndWages_uAUD_c20220801__20220801__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_zNm3OHIgjk89" title="Annual salary">600,000</span> AUD ($<span id="xdx_90B_eus-gaap--SalariesAndWages_c20220801__20220801__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_zxfboKMfMJbd" title="Annual salary">414,900</span> USD), effective July 1, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Nathanielsz’s wife, Sylvia Nathanielsz, is and has been a non-executive, part-time employee of the Company since October 2015. Effective February 1, 2018, Mrs. Nathanielsz receives an annual salary of $<span id="xdx_905_eus-gaap--SalariesAndWages_uAUD_c20180201__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_ztZiYdmhl0ee" title="Annual salary">120,000</span> AUD ($<span id="xdx_909_eus-gaap--SalariesAndWages_c20180201__20180201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_z8rhlSvoATm8" title="Annual salary">80,904</span> USD) and is entitled to customary benefits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to a February 25, 2016 board resolution, James Nathanielsz was paid $<span id="xdx_904_eus-gaap--RepaymentsOfRelatedPartyDebt_uAUD_c20160225__20160225__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JamesNathanielszMember_zOfRSuPWIXXj" title="Payments form related party">4,481</span> AUD ($<span id="xdx_90C_eus-gaap--RepaymentsOfRelatedPartyDebt_c20160225__20160225__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JamesNathanielszMember_zHxZ9Y09fUki" title="Payments form related party">3,205</span> USD), on a monthly basis for the purpose of acquiring and maintaining an automobile which car allowance expired in August 2022. For the fiscal years ended June 30, 2025 and 2024, $<span id="xdx_909_eus-gaap--RepaymentsOfRelatedPartyDebt_c20240701__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_z4tbD4zTpgDl" title="Payments form related party">6,866</span> USD and $$<span id="xdx_90E_eus-gaap--RepaymentsOfRelatedPartyDebt_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrsNathanielszMember_zqFucTyRfF5l" title="Payments form related party">17,714</span> USD, respectively, was paid to Mr. Nathanielsz for vehicle related expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 12, 2021, the Board approved a bonus of $<span id="xdx_90E_eus-gaap--OfficersCompensation_c20210812__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zExtKXiQ4em3" title="Officers compensation">177,840</span> USD. A total of $<span id="xdx_900_ecustom--BonusPayable_iI_uAUD_c20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zAiqNac0jRfe" title="Bonus payable">221,890</span> AUD ($<span id="xdx_906_ecustom--BonusPayable_iI_c20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zuD35BgmuXEg" title="Bonus payable">166,418</span> USD) in payments were made against the bonuses during the year ended June 30, 2021 resulting in a remaining balance of $<span id="xdx_908_ecustom--BonusPayable_iI_pp0p0_uAUD_c20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--MrsNathanielszMember_z0y3Lxb47G2d" title="Bonus payable">422,610</span> AUD ($<span id="xdx_909_ecustom--BonusPayable_iI_pp0p0_c20210630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--MrsNathanielszMember_zKsrIE82mQ42" title="Bonus payable">316,957</span> USD) bonus payable as of June 30, 2021 which was included in accrued expenses in the accompanying consolidated balance sheet. On August 12, 2021, pursuant to the Cancellation Agreement, Mr. Nathanielsz agreed to cancel $<span id="xdx_903_eus-gaap--OfficersCompensation_c20210812__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zvpTOycH1MGk" title="Officers compensation">177,840</span> of the bonus payable in exchange for <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210812__20210812__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zqvo9FvsrC2b" title="Debt conversion, converted instrument, shares issued">99</span> shares of the Company’s Common Stock. On August 1, 2022, the Board approved a bonus of $<span id="xdx_90D_eus-gaap--OfficersCompensation_uAUD_c20220801__20220801__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zcRz9QiXJAMl" title="Officers compensation">140,000</span> AUD or $<span id="xdx_900_eus-gaap--OfficersCompensation_c20220801__20220801__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_ztxcUh3EdsA4" title="Officers compensation">96,810</span> USD. A total of $<span id="xdx_904_ecustom--BonusPayable_iI_uAUD_c20230630_znaRqP933Xtk" title="Bonus payable">73,387</span> AUD ($<span id="xdx_90B_ecustom--BonusPayable_iI_c20230630_zVHtr2amhwR" title="Bonus payable">48,905</span> USD) in payments were made in respect of the bonuses during the year ended June 30, 2023, resulting in a remaining balance of $<span id="xdx_905_ecustom--RemainingBonusAmount_uAUD_c20220701__20230630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zoOCrY2Qx4th" title="Remaining bonus amount">107,937</span> AUD ($<span id="xdx_909_ecustom--RemainingBonusAmount_c20220701__20230630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z69QzYohZiG7" title="Remaining bonus amount">71,929</span> USD) bonus payable as of June 30, 2023 which was included in accrued expenses in the accompanying consolidated balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A total of $<span id="xdx_90D_ecustom--BonusPayable_iI_uAUD_c20240630_zRFGEREXub0c" title="Bonus payable">25,000</span> AUD ($<span id="xdx_907_ecustom--BonusPayable_iI_c20240630_zbC7KJaLKUU5" title="Bonus payable">16,070</span> USD) in payments were made in respect of the bonuses during the year ended June 30, 2024. In January 2024, the Board approved a bonus of $<span id="xdx_90D_ecustom--BonusPayable_iI_uAUD_c20240131_zCs6akK7GhVd" title="Bonus payable">150,000</span> AUD or $<span id="xdx_900_ecustom--BonusPayable_iI_c20240131_z8hnZtiL9247" title="Bonus payable">102,195</span> USD resulting in a remaining balance of $<span id="xdx_905_ecustom--RemainingBonusAmount_uAUD_c20230701__20240630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zdhwYXei91O" title="Remaining bonus amount">217,540</span> AUD ($<span id="xdx_900_ecustom--RemainingBonusAmount_c20230701__20240630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zkKl9eBgSio2" title="Remaining bonus amount">141,118</span> USD) bonus payable as of June 30, 2024. In June 2025, the Board approved a bonus of $<span id="xdx_90A_ecustom--BonusPayable_iI_uAUD_c20250630_zTL4d3PYnhmh" title="Bonus payable">198,000</span> AUD or $<span id="xdx_900_ecustom--BonusPayable_iI_c20250630_zwlhL9IGlghf" title="Bonus payable">130,106</span> USD resulting in a remaining balance of $<span id="xdx_903_ecustom--RemainingBonusAmount_uAUD_c20240701__20250630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zT0jup6wzmrc" title="Remaining bonus amount">415,540</span> AUD ($<span id="xdx_901_ecustom--RemainingBonusAmount_c20240701__20250630__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zZCrheDtZ6ii" title="Remaining bonus amount">273,051</span> USD) bonus payable as of June 30, 2025 which was included in accrued expenses in the accompanying consolidated balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Amended and Restated Employment Agreement</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 14, 2019 (the “Effective Date”), the Company entered into an Amended and Restated Employment Agreement (the “Employment Agreement”) with Mr. Nathanielsz for a term of <span id="xdx_90B_ecustom--AgreementTerm_dc_c20190514__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_z5aeIW40Z0Y" title="Agreement term">three years</span>, subject to automatic one-year renewals, at an annual salary of $<span id="xdx_90F_eus-gaap--SalariesAndWages_uAUD_c20190514__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_zgx9F9Gt6LO6" title="Annual salary">400,000</span> AUD ($<span id="xdx_90B_eus-gaap--SalariesAndWages_c20190514__20190514__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrNathanielszMember_z9xwISQVtsK7" title="Annual salary">309,313</span> USD). Pursuant to the Employment Agreement, Mr. Nathanielsz was granted options to purchase a de minimis share of common stock (the “Nathanielsz Options”), de minimis restricted stock units of the Company (the “Initial Nathanielsz RSUs”), and an additional de minimis restricted stock units of the Company (the “Additional Nathanielsz RSUs”). Such options and restricted stock units were granted pursuant to the 2019 Plan approved by the Board on the Effective Date. The Nathanielsz Options have a term of 10 years from the date of grant. The Nathanielsz Options and Additional Nathanielsz RSU’s are subject to vesting periods pursuant to the Employment Agreement. There are de minimis vested options and restricted stock units that are considered issuable as of June 30, 2025 and 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 26, 2022, the Company entered into an Amended and Restated Employment Agreement (the “Amended Agreement”) with Mr. Nathanielsz, effective as of July 1, 2022, (the “2022 Effective Date”). The Amended Agreement provides Mr. Nathanielsz with a base salary of $<span id="xdx_904_eus-gaap--SalariesAndWages_uAUD_c20221026__20221026__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zEHqHRpCaD27" title="Annual salary">600,000</span> AUD ($<span id="xdx_905_eus-gaap--SalariesAndWages_c20221026__20221026__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_ziRAMj03jLM1" title="Annual salary">414,900</span> USD) per annum. The Company has also agreed to pay Mr. Nathanielsz an annual discretionary bonus in an amount up to <span id="xdx_905_ecustom--PercentageOfBonusOfAnnualBaseSalary_pid_dp_uPure_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember_zMPfkq4PrO6l" title="Percentage of bonus of annual base salary">100</span>% of his annual base salary, reduced from <span id="xdx_900_ecustom--PercentageOfBonusOfAnnualBaseSalary_pid_dp_uPure_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--NathanielszEmploymentAgreementMember_zbnwZG1u6drf" title="Percentage of bonus of annual base salary">200</span>%, which bonus shall be determined by the Board and based upon the performance of the Company. The Amended Agreement has a term of three (3) years from the 2022 Effective Date, with automatic one-year renewal periods unless either party elects not to renew.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Amended and Restated Employment Agreement</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 14, 2019, the Company entered into an Amended and Restated Services Agreement (the “Services Agreement”) with Dr. Kenyon, the Company’s Chief Scientific Officer and a director, for a term of <span id="xdx_907_ecustom--AgreementTerm_dc_c20190514__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zkILbtaOkMkb" title="Agreement term">three years</span>, subject to automatic one-year renewals, at an annual salary of $<span id="xdx_90F_eus-gaap--SalariesAndWages_uAUD_c20190514__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zOoxCpyGOULd" title="Annual salary">54,000</span> AUD ($<span id="xdx_90A_eus-gaap--SalariesAndWages_c20190514__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zWSiOa18vXcg" title="Annual salary">41,580</span> USD). In connection with the execution of the Services Agreement, Dr. Kenyon was designated as an executive officer of the Company and assumed a more active executive role with the Company. Pursuant to the Services Agreement, Dr. Kenyon was granted options to purchase a de minimis share of common stock (the “Kenyon Options”), a de minimis restricted stock units of the Company (the “Initial Kenyon RSUs”), and an additional de minimis restricted stock units of the Company (the “Additional Kenyon RSUs”). Such options and restricted stock units were granted pursuant to the 2019 Plan. The Kenyon Options have a term of <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20190514__20190514__us-gaap--TypeOfArrangementAxis__custom--ServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrKenyonMember_zO7qBGb0Jjdi" title="Option term">10</span> years from the date of grant. The Kenyon Options and Additional Kenyon RSU’s are subject to vesting periods pursuant to the Services Agreement. There are de minimis vested options and restricted stock units that are considered issuable as of June 30, 2025 and 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2025 and 2024, total accrued salaries of $<span id="xdx_908_eus-gaap--AccruedSalariesCurrent_iI_uAUD_c20250630_zHV7jFqXlTW5" title="Accrued salaries">202,000</span> AUD ($<span id="xdx_90D_eus-gaap--AccruedSalariesCurrent_iI_c20250630_zpBdz1dvSHM" title="Accrued salaries">132,734</span> USD) and $<span id="xdx_905_eus-gaap--AccruedSalariesCurrent_iI_uAUD_c20240630_zDx9iELL0lKh" title="Accrued salaries">148,000</span> AUD ($<span id="xdx_901_eus-gaap--AccruedSalariesCurrent_iI_c20240630_zGxu5YNkSsW9" title="Accrued salaries">97,044</span> USD), respectively, were included in accrued expenses in the accompanying consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="text-decoration: underline">Employee Benefit Liability</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As of June 30, 2025 and 2024, total employee benefit liability of $<span id="xdx_904_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_c20250630_zgOCW7A4c3cb" title="Employee related liabilities current">667,901</span> and $<span id="xdx_907_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_c20240630_zQFK87FcuhZb" title="Employee related liabilities current">639,371</span>, respectively, consist of unpaid or unused annual leave and long service leave by Mr. Nathanielsz and Sylvia Nathanielsz, as reflected in the accompanying consolidated balance sheets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Intercompany Loans</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All intercompany loans were made by the parent to the Company’s subsidiary, Propanc PTY LTD, none of which has been repaid as of June 30, 2025. Effective fiscal year 2021, the parent company determined that intercompany loans will not be repaid in the foreseeable future and thus, per ASC 830-20-35-3, gains and losses from measuring the intercompany balances are recorded within cumulative translation adjustment on the consolidated balance sheet as accumulated other comprehensive income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 29759 49528 30000 74395 P5Y 39600 28325 3600 2575 198000 141629 Such lease expired in May 2021 and was renewed for another one-year term from May 2021 to May 2022. P3Y 3000 2176 200402 131684 194129 129930 34150 34150 71629 71629 85000 57639 150000 98060 2024-11-01 0.12 0.18 0.35 15000 15000 9731 9731 12000 175000 113485 70000 105000 0.12 0.18 25000 15485 63188 39625 2025-06-30 0.12 0.18 15000 9675 2025-06-30 0.12 0.18 230000 153256 P3Y 0.10 250 600 2019-02-25 25000 300000 205680 0.095 2 300000 205680 400000 274240 400000 309313 600000 414900 120000 80904 4481 3205 6866 17714 177840 221890 166418 422610 316957 177840 99 140000 96810 73387 48905 107937 71929 25000 16070 150000 102195 217540 141118 198000 130106 415540 273051 P3Y 400000 309313 600000 414900 1 2 P3Y 54000 41580 P10Y 202000 132734 148000 97044 667901 639371 <p id="xdx_806_eus-gaap--ConcentrationRiskDisclosureTextBlock_zkVZhESePsig" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 – <span id="xdx_82A_zWm7BUStLOjl">CONCENTRATIONS AND RISKS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Concentration of Credit Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in banks and financial institutions in Australia. Bank deposits in Australian banks are uninsured. The Company has not experienced any losses in such accounts through June 30, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In fiscal 2024, the Company primarily relied on funding from five convertible and non-convertible debt lenders and received net proceeds after deductions of $<span id="xdx_901_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_c20230701__20240630_zNeL3vwKT0Rh" title="Discounts and debt issuance cost">103,900</span> for original issue discounts and debt issue costs from each of the five lenders of $<span id="xdx_901_eus-gaap--ProceedsFromConvertibleDebt_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_z3pteCnvW6s2" title="Proceeds from convertible promissory notes">295,000</span>, $<span id="xdx_90A_eus-gaap--ProceedsFromConvertibleDebt_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zfWx1edZOJ2c" title="Proceeds from convertible promissory notes">150,000</span>, $<span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderThreeMember_zqb6eDygfyDf" title="Proceeds from convertible promissory notes">127,500</span>, $<span id="xdx_900_eus-gaap--ProceedsFromConvertibleDebt_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderFourMember_zstH0WjSXpy" title="Proceeds from convertible promissory notes">120,000</span> and $<span id="xdx_901_eus-gaap--ProceedsFromConvertibleDebt_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderFiveMember_zrSQuvJ1YWQh" title="Proceeds from convertible promissory notes">224,885</span>, respectively which represents approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderOneMember_z4AUipq467qi" title="Concentration risk percentage">28</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderTwoMember_z81kcUiPVpA1" title="Concentration risk percentage">14</span>%, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderThreeMember_zVMuaIksjHVj" title="Concentration risk percentage">12</span>%, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderFourMember_zxCPisgfX82g" title="Concentration risk percentage">11</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderFiveMember_zs5chL7VU9n2" title="Concentration risk percentage">21</span>%, respectively of total net proceeds received by the Company during fiscal 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In fiscal 2025, the Company primarily relied on funding from five convertible debt lenders and received net proceeds after deductions of $<span id="xdx_906_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_c20240701__20250630_zLA4KCaBUWOh" title="Discounts and debt issuance cost">46,200</span> for original issue discounts and debt issue costs from each of the five lenders of $<span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_c20240701__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderOneMember_zgR6LXP2dmWk" title="Proceeds from convertible promissory notes">160,000</span>, $<span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_c20240701__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderTwoMember_zGB09jxRRl4b" title="Proceeds from convertible promissory notes">180,000</span>, $<span id="xdx_90E_eus-gaap--ProceedsFromConvertibleDebt_c20240701__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderThreeMember_z5M1LmzogRKb" title="Proceeds from convertible promissory notes">125,000</span>, $<span id="xdx_903_eus-gaap--ProceedsFromConvertibleDebt_c20240701__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderFourMember_zcB9qUNwwycl" title="Proceeds from convertible promissory notes">245,640</span> and $<span id="xdx_900_eus-gaap--ProceedsFromConvertibleDebt_c20240701__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderFiveMember_zUlYSuGUgt0k" title="Proceeds from convertible promissory notes">98,060</span>, respectively, which represents approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderOneMember_zo6yMtB9iuT1" title="Concentration risk percentage">18</span>%, <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderTwoMember_zGIKHfXLnVS4" title="Concentration risk percentage">20</span>%, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderThreeMember_zAHdEtPpGevk" title="Concentration risk percentage">14</span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderFourMember_zaJ5zExkbSXa" title="Concentration risk percentage">28</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--ConvertibleDebtBenchmarkMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--LenderFiveMember_zwIgPCYFEm4k" title="Concentration risk percentage">11</span>%, respectively, of total proceeds received by the Company during fiscal 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Receivable Concentration</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2025 and 2024, the Company’s receivables were <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--ReceivableMember_zhNReQJTT7af" title="Concentration risk percentage"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--ReceivableMember_zYfl8Y26hLsa" title="Concentration risk percentage">100</span></span>% related to reimbursements on GST taxes paid.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Patent and Patent Concentration</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has filed multiple patent applications relating to its lead product, PRP. The Company’s lead patent application has been granted and remains in force in the United States, Belgium, Czech Republic, Denmark, France, Germany, Ireland, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Liechtenstein, Turkey, United Kingdom, Australia, China, Japan, Indonesia, Israel, New Zealand, Singapore, Malaysia, South Africa, Republic of Korea, India and Brazil. In Canada and Mexico, the patent applications have been accepted as of fiscal year 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2016 and early 2017, the Company filed other patent applications. Three applications were filed under the Patent Cooperation Treaty (the “PCT”). The PCT assists applicants in seeking patent protection by filing one international patent application under the PCT, applicants can simultaneously seek protection for an invention in over 150 countries. Once filed, the application is placed under the control of the national or regional patent offices, as applicable, in what is called the national phase. One of the PCT applications filed in November 2016, entered national phase in July 2018 and another PCT application entered national phase in August 2018. A third PCT application entered the national phase in October 2018.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2020, a world-first patent was granted in Australia for the cancer treatment method patent family. Presently, there are 85 granted, allowed, or accepted patents and 5 patents filed, or under examination in key global jurisdictions relating to the use of proenzymes against solid tumors, covering the lead product candidate PRP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further patent applications are expected to be filed to capture and protect additional patentable subject matter based on the Company’s field of technology relating to pharmaceutical compositions of proenzymes for treating cancer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign Operations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2025 and 2024, the Company’s operations are based in Camberwell, Australia; however, the majority of research and development is being conducted in the European Union.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 22, 2016, the Company formed a wholly-owned subsidiary, Propanc (UK) Limited under the laws of England and Wales, for the purpose of submitting an orphan drug application with the European Medicines Agency as a small and medium-sized enterprise. As of June 30, 2025 and 2024, there has been no activity within this entity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 103900 295000 150000 127500 120000 224885 0.28 0.14 0.12 0.11 0.21 46200 160000 180000 125000 245640 98060 0.18 0.20 0.14 0.28 0.11 1 1 <p id="xdx_80B_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zQ9rdtachtw7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 - <span id="xdx_82F_zXg1yAR6znC7">DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Derivative Financial Instruments:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applies the provisions of ASC 815-40, <i>Contracts in Entity’s Own Equity</i>, under which convertible instruments and warrants, which contain terms that protect holders from declines in the stock price (reset provisions), may not be exempt from derivative accounting treatment. As a result, warrants and embedded conversion options in convertible debt are recorded as a liability and are revalued at fair value at each reporting date. If the fair value of the warrants exceeds the face value of the related debt, the excess is recorded as change in fair value in operations on the issuance date. The Company had $<span id="xdx_90A_eus-gaap--ConvertibleDebt_iI_c20250630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_z50tdYo1vWZe" title="Convertible debt">291,650</span> (9 notes) and $<span id="xdx_90D_eus-gaap--ConvertibleDebt_iI_c20240630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ConvertibleDebtMember_zpVCdSFEjPZc" title="Convertible debt">110,500</span> (3 notes) of convertible debt, which were treated as derivative instruments outstanding at June 30, 2025 and 2024, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company calculates the estimated fair values of the liabilities for derivative instruments using the Binomial Trees Method. The closing price of the Company’s common stock at June 30, 2025 was $<span id="xdx_909_eus-gaap--SharePrice_iI_c20250630_zDrfgc9vhrU4" title="Share price">4.15</span> per share. The volatility, expected remaining term, and risk-free interest rates used to estimate the fair value of derivative liabilities at June 30, 2025 and 2024 are indicated in the table that follows. The expected term is equal to the remaining term of the warrants or convertible instruments and the risk-free rate is based upon rates for treasury securities with the same term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Convertible Debt</b></span></p> <p id="xdx_89B_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zwieEA5hyYbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zw8SMHnG3MJ3" style="display: none">SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial Valuations<br/> (on new derivative<br/> instruments entered</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>into during the year ended June 30, 2025)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial Valuations<br/> (on new derivative<br/> instruments entered</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>into during the year ended June 30, 2024)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MinimumMember_z13QbxkPYQgb" title="Debt instrument, measurement input, percentages">344</span>-<span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MaximumMember_zySl38o5WKEk" title="Debt instrument, measurement input, percentages">414</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MinimumMember_zWUSn9ERGe63" title="Debt instrument, measurement input, percentages">323.40</span> – <span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MaximumMember_zncOuMpWb7bb" title="Debt instrument, measurement input, percentages">333.45</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected remaining term</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--DebtInstrumentTerm_dtY_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MinimumMember_zVngM8RDbL78" title="Debt instrument, measurement input, term">0.66</span>-<span id="xdx_900_eus-gaap--DebtInstrumentTerm_dtY_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MaximumMember_zDhypq0Xckz1" title="Debt instrument, measurement input, term">1.00</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--DebtInstrumentTerm_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember_z2LOgLcwxlu8" title="Debt instrument, measurement input, term">0.50</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MinimumMember_zvAVIcx1ZAk6" title="Debt instrument, measurement input, percentages">4.21</span>-<span id="xdx_900_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MaximumMember_zexafgEVrU93" title="Debt instrument, measurement input, percentages">4.29</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MinimumMember_z8IDMsdM0U84" title="Debt instrument, measurement input, percentages">5.42</span> - <span id="xdx_907_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MaximumMember_zAIV83YCrgv6" title="Debt instrument, measurement input, percentages">5.55</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">None</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Volatility</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zvk2FdvJicZk" title="Debt instrument, measurement input, percentages">413.55</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zJ0pvbJpq3dg" title="Debt instrument, measurement input, percentages">323.40</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected remaining term</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DebtInstrumentTerm_dtY_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zKzbN3lkcdi7" title="Debt instrument, measurement input, term">0.01</span> - <span id="xdx_905_eus-gaap--DebtInstrumentTerm_dtY_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zaazXXYgaxOe" title="Debt instrument, measurement input, term">0.95</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--DebtInstrumentTerm_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zCGTLPLsazWb" title="Debt instrument, measurement input, term">0.01</span> - <span id="xdx_90C_eus-gaap--DebtInstrumentTerm_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zIYMEqRfZqH9" title="Debt instrument, measurement input, term">0.28</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zXFhxUABo1Vl" title="Debt instrument, measurement input, percentages">4.21</span> – <span id="xdx_906_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_z3gM3VdSToWj" title="Debt instrument, measurement input, percentages">4.45</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zsuWu6EZVgn" title="Debt instrument, measurement input, percentages">5.45</span> - <span id="xdx_905_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zUFe2LMuMx2g" title="Debt instrument, measurement input, percentages">5.47</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A4_zpSXCw14Fdz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair Value Measurements:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable warrants and embedded conversion options have been recorded as determined utilizing the Binomial Trees model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zNRogZBsCopi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2025:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_zL8vhzexdLrh" style="display: none">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance at<br/> June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Markets for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identical Assets</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 1)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 2)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 3)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Embedded conversion option liabilities</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20250630_zxbKFTp9TWs8" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zx95tcRk6tg" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5193">—</span></span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zwlauHqvWB4e" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5195">—</span></span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zXieolDqR426" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--DerivativeLiabilities_iI_c20250630_zNWawC5Sv72l" style="border-bottom: Black 1pt solid; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--DerivativeLiabilities_iI_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zcJ5dWt5lXgl" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5201">—</span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--DerivativeLiabilities_iI_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zbzr5FU6osW4" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5203">—</span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iI_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zngCINdgdiNc" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance at<br/> June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Markets for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identical Assets</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 1)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 2)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 3)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Embedded conversion option liabilities</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20240630_zlzLDWrAMxKj" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">133,886</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfxYOthP0Go5" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5209">—</span></span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8r9nEHPm2R7" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5211">—</span></span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8BMgvU3Ztj4" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">133,886</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DerivativeLiabilities_iI_c20240630_zYx2R1supiQb" style="border-bottom: Black 1pt solid; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">133,886</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--DerivativeLiabilities_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ze2sfOc1RZ67" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5217">—</span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--DerivativeLiabilities_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zuDrO0JexKpj" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5219">—</span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--DerivativeLiabilities_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zIAyhcZNAx66" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif">133,886</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AF_zjmnnRSxuuc5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zOOqGDKwzxdk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a roll forward for the years ended June 30, 2025 and 2024 of the fair value liability of price adjustable derivative instruments:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zswWJNVvCks8" style="display: none">SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Fair Value of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liability for</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Derivative</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Instruments</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance at June 30, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--DerivativeLiabilities_iS_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zQ1AsYxftZ31" style="width: 16%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">423,209</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Initial fair value of embedded conversion option derivative liability recorded as debt discount</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--EmbeddedDerivativeGainOnEmbeddedDerivative_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zOa6lyuqiM8h" style="text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as debt discount"><span style="font-family: Times New Roman, Times, Serif">150,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Initial fair value of embedded conversion option derivative liability recorded as derivative expense</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--EmbeddedDerivativeLossOnEmbeddedDerivative_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zFOWpW12JHyd" style="text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as derivative expense"><span style="font-family: Times New Roman, Times, Serif">141,012</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on debt extinguishment</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zF5rbYddT8xc" style="text-align: right" title="Gain on debt extinguishment"><span style="font-family: Times New Roman, Times, Serif">(263,798</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value included in statements of operations</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zjsAhucVkCMg" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value included in statements of operations"><span style="font-family: Times New Roman, Times, Serif">(316,537</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance at June 30, 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iS_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zu2NhWrLgKh1" style="text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">133,886</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Initial fair value of embedded conversion option derivative liability recorded as debt discount</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--EmbeddedDerivativeGainOnEmbeddedDerivative_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zE22L6ni9Zr8" style="text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as debt discount"><span style="font-family: Times New Roman, Times, Serif">222,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Initial fair value of embedded conversion option derivative liability recorded as derivative expense</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--EmbeddedDerivativeLossOnEmbeddedDerivative_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zBlctOMQ3Jjh" style="text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as derivative expense"><span style="font-family: Times New Roman, Times, Serif">333,596</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on debt extinguishment</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zMUNICaEdws" style="text-align: right" title="Gain on debt extinguishment"><span style="font-family: Times New Roman, Times, Serif">(73,640</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value included in statements of operations</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zFCTaFrudW9a" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value included in statements of operations"><span style="font-family: Times New Roman, Times, Serif">(212,450</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance at June 30, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iE_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zjKkGGhROYwf" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A4_zPKiRjbkgWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 291650 110500 4.15 <p id="xdx_89B_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zwieEA5hyYbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zw8SMHnG3MJ3" style="display: none">SCHEDULE OF FAIR VALUE MEASUREMENTS, RECURRING AND NONRECURRING, VALUATION TECHNIQUES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial Valuations<br/> (on new derivative<br/> instruments entered</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>into during the year ended June 30, 2025)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial Valuations<br/> (on new derivative<br/> instruments entered</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>into during the year ended June 30, 2024)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MinimumMember_z13QbxkPYQgb" title="Debt instrument, measurement input, percentages">344</span>-<span id="xdx_902_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MaximumMember_zySl38o5WKEk" title="Debt instrument, measurement input, percentages">414</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MinimumMember_zWUSn9ERGe63" title="Debt instrument, measurement input, percentages">323.40</span> – <span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MaximumMember_zncOuMpWb7bb" title="Debt instrument, measurement input, percentages">333.45</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected remaining term</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--DebtInstrumentTerm_dtY_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MinimumMember_zVngM8RDbL78" title="Debt instrument, measurement input, term">0.66</span>-<span id="xdx_900_eus-gaap--DebtInstrumentTerm_dtY_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MaximumMember_zDhypq0Xckz1" title="Debt instrument, measurement input, term">1.00</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--DebtInstrumentTerm_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember_z2LOgLcwxlu8" title="Debt instrument, measurement input, term">0.50</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MinimumMember_zvAVIcx1ZAk6" title="Debt instrument, measurement input, percentages">4.21</span>-<span id="xdx_900_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MaximumMember_zexafgEVrU93" title="Debt instrument, measurement input, percentages">4.29</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MinimumMember_z8IDMsdM0U84" title="Debt instrument, measurement input, percentages">5.42</span> - <span id="xdx_907_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NewDerivativeInstrumentsMember__srt--RangeAxis__srt--MaximumMember_zAIV83YCrgv6" title="Debt instrument, measurement input, percentages">5.55</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">None</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Volatility</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zvk2FdvJicZk" title="Debt instrument, measurement input, percentages">413.55</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zJ0pvbJpq3dg" title="Debt instrument, measurement input, percentages">323.40</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected remaining term</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DebtInstrumentTerm_dtY_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zKzbN3lkcdi7" title="Debt instrument, measurement input, term">0.01</span> - <span id="xdx_905_eus-gaap--DebtInstrumentTerm_dtY_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zaazXXYgaxOe" title="Debt instrument, measurement input, term">0.95</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--DebtInstrumentTerm_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zCGTLPLsazWb" title="Debt instrument, measurement input, term">0.01</span> - <span id="xdx_90C_eus-gaap--DebtInstrumentTerm_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zIYMEqRfZqH9" title="Debt instrument, measurement input, term">0.28</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zXFhxUABo1Vl" title="Debt instrument, measurement input, percentages">4.21</span> – <span id="xdx_906_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_z3gM3VdSToWj" title="Debt instrument, measurement input, percentages">4.45</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MinimumMember_zsuWu6EZVgn" title="Debt instrument, measurement input, percentages">5.45</span> - <span id="xdx_905_eus-gaap--DebtInstrumentMeasurementInput_iI_pid_uPure_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember__srt--RangeAxis__srt--MaximumMember_zUFe2LMuMx2g" title="Debt instrument, measurement input, percentages">5.47</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 344 414 323.40 333.45 P0Y7M28D P1Y P0Y6M 4.21 4.29 5.42 5.55 413.55 323.40 P0Y3D P0Y11M12D P0Y3D P0Y3M10D 4.21 4.45 5.45 5.47 <p id="xdx_895_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zNRogZBsCopi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2025:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_zL8vhzexdLrh" style="display: none">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance at<br/> June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Markets for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identical Assets</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 1)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 2)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 3)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Embedded conversion option liabilities</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20250630_zxbKFTp9TWs8" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zx95tcRk6tg" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5193">—</span></span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zwlauHqvWB4e" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5195">—</span></span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zXieolDqR426" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--DerivativeLiabilities_iI_c20250630_zNWawC5Sv72l" style="border-bottom: Black 1pt solid; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--DerivativeLiabilities_iI_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zcJ5dWt5lXgl" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5201">—</span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--DerivativeLiabilities_iI_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zbzr5FU6osW4" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5203">—</span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iI_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zngCINdgdiNc" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance at<br/> June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prices</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Markets for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identical Assets</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Observable Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable Inputs</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 1)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 2)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Level 3)</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Embedded conversion option liabilities</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20240630_zlzLDWrAMxKj" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">133,886</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfxYOthP0Go5" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5209">—</span></span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8r9nEHPm2R7" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5211">—</span></span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8BMgvU3Ztj4" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">133,886</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DerivativeLiabilities_iI_c20240630_zYx2R1supiQb" style="border-bottom: Black 1pt solid; text-align: right" title="Embedded conversion option liabilities"><span style="font-family: Times New Roman, Times, Serif">133,886</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--DerivativeLiabilities_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ze2sfOc1RZ67" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5217">—</span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--DerivativeLiabilities_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zuDrO0JexKpj" title="Embedded conversion option liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5219">—</span></span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--DerivativeLiabilities_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zIAyhcZNAx66" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif">133,886</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 403892 403892 403892 403892 133886 133886 133886 133886 <p id="xdx_89C_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zOOqGDKwzxdk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a roll forward for the years ended June 30, 2025 and 2024 of the fair value liability of price adjustable derivative instruments:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zswWJNVvCks8" style="display: none">SCHEDULE OF DERIVATIVE LIABILITIES AT FAIR VALUE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Fair Value of</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liability for</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Derivative</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Instruments</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance at June 30, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--DerivativeLiabilities_iS_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zQ1AsYxftZ31" style="width: 16%; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">423,209</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Initial fair value of embedded conversion option derivative liability recorded as debt discount</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--EmbeddedDerivativeGainOnEmbeddedDerivative_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zOa6lyuqiM8h" style="text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as debt discount"><span style="font-family: Times New Roman, Times, Serif">150,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Initial fair value of embedded conversion option derivative liability recorded as derivative expense</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--EmbeddedDerivativeLossOnEmbeddedDerivative_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zFOWpW12JHyd" style="text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as derivative expense"><span style="font-family: Times New Roman, Times, Serif">141,012</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on debt extinguishment</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zF5rbYddT8xc" style="text-align: right" title="Gain on debt extinguishment"><span style="font-family: Times New Roman, Times, Serif">(263,798</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value included in statements of operations</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zjsAhucVkCMg" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value included in statements of operations"><span style="font-family: Times New Roman, Times, Serif">(316,537</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Balance at June 30, 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iS_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zu2NhWrLgKh1" style="text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif">133,886</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Initial fair value of embedded conversion option derivative liability recorded as debt discount</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--EmbeddedDerivativeGainOnEmbeddedDerivative_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zE22L6ni9Zr8" style="text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as debt discount"><span style="font-family: Times New Roman, Times, Serif">222,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Initial fair value of embedded conversion option derivative liability recorded as derivative expense</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--EmbeddedDerivativeLossOnEmbeddedDerivative_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zBlctOMQ3Jjh" style="text-align: right" title="Initial fair value of embedded conversion option derivative liability recorded as derivative expense"><span style="font-family: Times New Roman, Times, Serif">333,596</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on debt extinguishment</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zMUNICaEdws" style="text-align: right" title="Gain on debt extinguishment"><span style="font-family: Times New Roman, Times, Serif">(73,640</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value included in statements of operations</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zFCTaFrudW9a" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value included in statements of operations"><span style="font-family: Times New Roman, Times, Serif">(212,450</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance at June 30, 2025</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iE_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember_zjKkGGhROYwf" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif">403,892</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 423209 150000 141012 -263798 316537 133886 222500 333596 -73640 212450 403892 <p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zI7jSd9ynjXf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 – <span id="xdx_825_zs015RHlkMKg">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Issuance of promissory note</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 18, 2025, the Company entered into a promissory note agreement with an investor, pursuant to which the investor agreed to purchase a promissory note from the Company in the aggregate principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20250718__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zgnPXteK6yVl" title="Debt instrument face amount">82,500</span>, for a purchase price of $<span id="xdx_90A_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20250718__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zjWNRavyXFia" title="Purchase amount">75,000</span>. Such note is a non-convertible note. The Company intends to use the net proceeds therefrom for general working capital purposes. The maturity date of the note is <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20250718__20250718__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z7CO8e4hiAS9" title="Debt instrument maturity date">September 15, 2025</span> and bears interest at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20250718__20250718__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zv6fJALG7YK6" title="Debt instrument loan bears interest rate">10</span>% per annum and default interest rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20250718__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z30G2uwM19mi" title="Debt instrument loan default interest rate">18</span>% per annum. <span id="xdx_906_eus-gaap--DebtInstrumentPaymentTerms_c20250718__20250718__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zcY2REmcLho5" title="Debt instrument repayment term">Repayment of the note may occur as follows: (a) if the Company repays this note on or before August 18, 2025, then Company shall pay investor in cash the sum of one hundred percent (100%) of the sum of the outstanding principal amount of the note (the “Principal Amount”) at such time, all accrued interest unpaid at such time, and any other payment due; and (b) if the Company repays the note after August 18, 2025 and on or before September 18, 2025, then Company shall pay investor in cash the sum of one hundred twenty percent (120%) of the sum of the outstanding Principal Amount at such time, all accrued interest unpaid at such time, and any other payment due (the “Maximum Repayment Amount”) or (b) at such time as the Company and the investor may agree to effect repayment. The Company fully repaid this note in August 2025.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Issuance of convertible note</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">1800 Diagonal Lending</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 22, 2025 Securities Purchase Agreement</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 22, 2025, the Company entered into and closed a securities purchase agreement 1800 Diagonal (the “Investor”), pursuant to which the Investor agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20250722__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zJJeW1vdgRKk" title="Debt instrument face amount">112,350</span>, for a purchase price of $<span id="xdx_90F_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20250722__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zOzycGNWScI5" title="Purchase amount">107,000</span>. The Company intends to use the net proceeds therefrom for general working capital purposes. The maturity date of the note is <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20250722__20250722__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_ztNakXUJ0Awj" title="Debt instrument maturity date">April 30, 2026</span>, and bears interest at a rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250722__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zJO6PSZvWRei" title="Debt instrument interest rate percentage">10</span>% per annum. Such principal and the interest thereon are convertible into shares of the Company’s common stock at the option of 1800 Diagonal any time after 180 days from the date of issuance. This note contains debt issue costs of $<span id="xdx_90C_eus-gaap--DeferredFinanceCostsNet_iI_c20250722__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zLUm31CrJqJ8" title="Debt issuance costs">7,000</span>. The conversion price for this note is equal to <span id="xdx_906_ecustom--DebtInstrumentDebtConversionRate_pid_dp_uPure_c20250722__20250722__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_zDx7tvBOJhnj" title="Debt instrument conversion rate">75</span>% (<span id="xdx_909_ecustom--DebtInstrumentDiscountRate_pid_dp_uPure_c20250722__20250722__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--ThousandEightHundredDiagonalLendingLLCMember_z7YOByKTrgIi" title="Debt instrument discount rate">25</span>% discount) of the market price which means the average of the lowest ten trading prices of the common stock for the ten trading days immediately prior to the delivery of a notice of conversion. The Company fully repaid this note in August 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Loans Payable – Related Party</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between July 3, 2025 and August 14, 2025, an institutional investor affiliated with one of our directors, Josef Zelinger, loaned the Company an aggregate of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20250703__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zuUKP6YDo3Jf" title="Debt instrument face amount"><span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_uAUD_c20250814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zDNf0HAe9x38" title="Debt instrument face amount">110,000</span></span> AUD ($<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20250703__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zR0yhBcRFQWg" title="Debt instrument face amount"><span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20250814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zGoVv3s3qIui" title="Debt instrument face amount">71,450</span></span> USD). These loans bore no interest and were payable on demand. The Company fully repaid these loans on August 19, 2025.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Underwriting Agreement and the Closing of Offering</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 14, 2025, the Company entered into an underwriting agreement with D. Boral Capital, LLC, as representative of the underwriters in connection with a public offering of the Company’s common stock. The Underwriting Agreement provides for the offer and sale of <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250814__20250814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--DBoralCapitalLLCMember_ztbdFG8Lb0Q" title="Number of shares issued">1,000,000</span> shares of common stock at a price to the public of $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_c20250814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--DBoralCapitalLLCMember_z1oxEvnlv86j" title="Number of shares issued, price per share">4.00</span> per share (the “Offering”). In connection therewith, the Company agreed to issue to the Representative, warrants to purchase <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250814__20250814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--DBoralCapitalLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuLK6cw6dPD7" title="Number of shares issued">30,000</span> of shares of common stock at a price equal $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20250814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--DBoralCapitalLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z8iYzJ3R9Rui" title="Number of shares issued, price per share">4.00</span> per share (the “Representative’s Warrants”). The Representative’s Warrants are exercisable at any time and from time to time, in whole or in part, from <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20250814__20250814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--DBoralCapitalLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z2yZCHDD8yA9" title="Warrants exercisable date">February 15, 2026</span> through <span id="xdx_902_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20250814__20250814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--DBoralCapitalLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zUHwL1qQgxqd" title="Warrants exercisable date">August 15, 2030</span> and contains cashless exercise provision. The Company also granted the Underwriters an overallotment option for a period of 45 days to purchase up to an additional <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250814__20250814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__dei--LegalEntityAxis__custom--DBoralCapitalLLCMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zwTOqMO0vIre" title="Number of shares issued">150,000</span> shares of common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 18, 2025, the Offering was completed. At the closing, the Company (i) sold <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250818__20250818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zCO50aIrhLvj" title="Number of shares issued">1,000,000</span> shares of Common Stock for total gross proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20250818__20250818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zFNfsF9jE3ha" title="Gross proceeds from issuance of common stock">4,000,000</span>, and (ii) issued the Representative’s Warrants. After deducting the underwriting commissions and Offering expenses, the Company received net proceeds of $<span id="xdx_90F_ecustom--NetProceedsFromIssuanceOfCommonStock_c20250818__20250818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zmR5dTZpFhI2" title="Net proceeds from issuance of common stock">3,340,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Shares issued for conversion of convertible debt</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From August 2025 through September 2025, the Company issued an aggregate of <span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250801__20250930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zFnj8iwEvb82">194,966</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock at an average contractual conversion price of $<span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_znyoL1RSMOn3" title="Conversion price, per share">1.75</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as a result of the conversion of principal of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20250930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z2V7q8BgKrEg" title="Principal amount">257,857</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, default penalty of $<span id="xdx_909_ecustom--PenaltyAmount_c20250801__20250930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zj2cqdpUzIgh" title="Principal amount">41,563</span>, accrued interest $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zhRbMoa8uZTc">36,430</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and conversion fees of $<span id="xdx_90E_eus-gaap--DebtInstrumentFeeAmount_iI_c20250930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zyzh3dH6v4Rj">4,906</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">underlying certain outstanding convertible notes converted during such period (see Note 6). The Company reclassified $<span id="xdx_90E_ecustom--ReclassifiedFromPremiumLiabilitiesToAdditionalPaidInCapital_c20250801__20250930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z8l453rEvhpl">114,400</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in put premiums to additional paid in capital following these conversions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>PROPANC BIOPHARMA, INC. AND SUBSIDIARY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>June 30, 2025 and 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Repayment of Debts</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On August 19, 2025, the Company fully repaid the total principal of promissory notes issued from August 2023 to June 2025 amounting $<span id="xdx_905_eus-gaap--DebtInstrumentRepaidPrincipal_c20250819__20250819__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWwJyfdXgILb" title="Debt instrument repaid principal amount">352,405</span> including total accrued interest and default penalty of $<span id="xdx_90F_eus-gaap--DebtDefaultLongtermDebtAmount_iI_c20250819__us-gaap--ShortTermDebtTypeAxis__us-gaap--LoansPayableMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z537ztkzCu5b" title="Debt default long term debt amount">34,320</span> (see Note 6).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between July 2025 and August 2025, the Company fully repaid certain promissory notes issued from <span id="xdx_903_ecustom--DebtInstrumentIssuanceDateDescription_c20250701__20250731__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zO4idPJVtTz9" title="Debt instrument, issuance date description"><span id="xdx_90B_ecustom--DebtInstrumentIssuanceDateDescription_c20250801__20250831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zFabbG5K8tt4" title="Debt instrument, issuance date description">January 2025 to June 2025</span></span> with aggregate principal amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentRepaidPrincipal_c20250701__20250731__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zOYEYRQFrEK5" title="Repayment of principal amount"><span id="xdx_905_eus-gaap--DebtInstrumentRepaidPrincipal_c20250701__20250731__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zS0MvGu3F8Xa" title="Repayment of principal amount">212,060</span></span>, and accrued interest of $<span id="xdx_904_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250731__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zrlrOV7BGjf" title="Accrued interest"><span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zEmOP0NqeFS8" title="Accrued interest">31,809</span></span> (see Note 6).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between August 12, 2025 and August 15, 2025, the Company made the three installment payments under a certain promissory note issued in <span id="xdx_909_ecustom--DebtInstrumentIssuanceDateDescription_c20250812__20250815__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zpmuZ3jk6kZ8" title="Debt instrument, issuance date description">December 2024</span> for a total payment of $<span id="xdx_90A_eus-gaap--DebtInstrumentRepaidPrincipal_c20250812__20250815__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesOneMember_zKcOPHfi4cZ5" title="Repayment of principal amount">21,218 </span>(see Note 6).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 21, 2025, the Company fully repaid certain loans payable to a related party with loan dates from <span id="xdx_90C_ecustom--DebtInstrumentIssuanceDateDescription_c20250821__20250821__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zPbHL4IHn6Qd" title="Debt instrument, issuance date description">December 2024 to August 2025</span> with aggregate principal amount of $<span id="xdx_90D_eus-gaap--RepaymentsOfLongTermDebt_uAUD_c20250821__20250821__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zG5vHXaWiX8l" title="Repayments of loan">225,188</span> AUD ($<span id="xdx_908_eus-gaap--RepaymentsOfLongTermDebt_c20250821__20250821__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zt2jVFktI3J6" title="Repayments of loan">144,618</span> USD), and accrued interest of $<span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_uAUD_c20250821__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zlaikYhDoCf2" title="Accrued interest">6,205</span> AUD ($<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250821__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zrL7fqGoEic7" title="Accrued interest">3,985</span> USD) (see Note 5).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Consulting Agreement</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 15, 2025, the Company and a consultant agreed to enter into a three-month consulting agreement to provide digital marketing related services for a monthly fee of $<span id="xdx_900_ecustom--MonthlyFeeForServices_c20250812__20250815__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zc5bnuQ5dPG5">100,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and a one-time payment of $<span id="xdx_90C_eus-gaap--PaymentsForFees_c20250812__20250815__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zgaON2zUvpDd">300,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon signing this agreement. On August 30, 2025, the Company amended this agreement whereby the Company agreed to provide additional compensation by issuing <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250831__20250831__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdJ77A6ZOJRe">500,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock every three months. The first issuance of shares shall occur on September 1, 2025 and subsequent issuances shall occur on the first day of every three-month period thereafter. Except for the changes made in the amendment, all other terms and provisions of the original agreement shall remain unchanged and in full force and effect.</span></p> 82500 75000 2025-09-15 0.10 0.18 Repayment of the note may occur as follows: (a) if the Company repays this note on or before August 18, 2025, then Company shall pay investor in cash the sum of one hundred percent (100%) of the sum of the outstanding principal amount of the note (the “Principal Amount”) at such time, all accrued interest unpaid at such time, and any other payment due; and (b) if the Company repays the note after August 18, 2025 and on or before September 18, 2025, then Company shall pay investor in cash the sum of one hundred twenty percent (120%) of the sum of the outstanding Principal Amount at such time, all accrued interest unpaid at such time, and any other payment due (the “Maximum Repayment Amount”) or (b) at such time as the Company and the investor may agree to effect repayment. The Company fully repaid this note in August 2025. 112350 107000 2026-04-30 0.10 7000 0.75 0.25 110000 110000 71450 71450 1000000 4.00 30000 4.00 2026-02-15 2030-08-15 150000 1000000 4000000 3340000 194966 1.75 257857 41563 36430 4906 114400 352405 34320 January 2025 to June 2025 January 2025 to June 2025 212060 212060 31809 31809 December 2024 21218 December 2024 to August 2025 225188 144618 6205 3985 100000 300000 500000 Only convertible ratably upon exercise of Series B Warrants Only convertible ratably upon exercise of Series B Warrants On March 3, 2025, the Company cancelled all the existing warrants (0.0002 Series A warrants, 0.0003 Series B warrants, and 0.0008 Series C warrants) held by an investor pursuant to a Warrant Exchange Agreement (see above).